Benefit and risk assessment of iodization of household salt and salt used in bread and bakery products. Scientific opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food and Environment by Henjum, Sigrun et al.
VKM Report 2020: 05 
Benefit and risk assessment of 
iodization of household salt and salt 
used in bread and bakery products 
Scientific opinion of the Panel on Nutrition, Dietetic Products, Novel Food and 
Allergy of the Norwegian Scientific Committee for Food and Environment
2 
Report from the Norwegian Scientific Committee for Food and Environment (VKM) 2020:05 
Benefit and risk assessment of iodization of household salt and salt used in bread and bakery 
products 
Scientific opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the 




Norwegian Scientific Committee for Food and Environment (VKM) 
Po 4404 Nydalen 
N – 0403 Oslo 
Norway 
Phone: +47 21 62 28 00 
Email: vkm@vkm.no 
vkm.no 
Cover photo: Collage by Tanya Kristiansen, photos from Colourbox.com and 
Mostphotos.com.  
Suggested citation: VKM, Sigrun Henjum, Anne Lise Brantsæter, Kristin Holvik, Inger Therese 
L. Lillegaard, Bente Mangschou, Christine Louise Parr, Jostein Starrfelt, Tonje H. Stea, Lene 
Frost Andersen, Lisbeth Dahl, Knut Tomas Dalen, Martinus Løvik, Stine Marie Ulven, Tor A. 
Strand (2020). Benefit and risk assessment of iodization of household salt and salt used in 
bread and bakery products. Scientific opinion of the Panel on Nutrition, Dietetic Products, 
Novel Food and Allergy of the Norwegian Scientific Committee for Food and Environment. 
VKM report 2020:05, ISBN: 978-82-978-82-8259-343-4, ISSN: 2535-4019. Norwegian 




Benefit and risk assessment of iodization in household salt and 
salt used in bread and bakery products  
Preparation of the opinion 
The Norwegian Scientific Committee for Food and Environment (Vitenskapskomiteen for mat 
og miljø, VKM) appointed a project group to answer the request from the Norwegian Food 
Safety Authority. The project group consisted of nine persons, including a project leader 
from the VKM secretariat. Two external referees commented on and reviewed the opinion. 
The VKM Panel on Nutrition, Dietetic Products, Novel Food and Allergy have discussed draft 
reports and evaluated and approved the final opinion drafted by the project group.  
Authors of the opinion 
Members of the project group that contributed to the drafting of the opinion (in alphabetical 
order after chair of the project group): 
Sigrun Henjum – Chair of the project group and member of the Panel on Nutrition, Dietetic 
Products, Novel Food and Allergy in VKM. Affiliation: 1) VKM; 2) OsloMet–Oslo Metropolitan 
University, Faculty of Health Sciences, Department of Nursing and Health Promotion. 
Anne Lise Brantsæter – Member of the project group and member of the Panel on 
Contaminants in VKM. Affiliation: 1) VKM; 2) Norwegian Institute of Public Health, 
Department of Environmental Health, Oslo. 
Kristin Holvik – Member of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy 
in VKM. Affiliation: 1) VKM; 2) Norwegian Institute of Public Health, Department of Chronic 
Diseases and Ageing, Oslo. 
Inger Therese L. Lillegaard – VKM secretariat. Affiliation: VKM.  
Bente Mangschou – VKM secretariat, leader of the project. Affiliation: VKM. 
Christine Louise Parr – Member of the project group and member of the Panel on Nutrition, 
Dietetic Products, Novel Food and Allergy in VKM. Affiliation: 1) VKM; 2) Norwegian Institute 
of Public Health, Department of Chronic Diseases and Ageing, Oslo. 
Jostein Starrfelt – VKM secretariat. Affiliation: VKM. 
Tonje H. Stea – Member of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy 
in VKM. Affiliation: 1) VKM; 2) University of Agder, Department of Health and Nursing 
Science. 
Tor A. Strand – Member of the project group and Chair of the Panel on Nutrition, Dietetic 




Health, University of Bergen and Innlandet Hospital Trust, Department of Research, 
Lillehammer. 
Members of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy that 
contributed to the assessment and approval of the opinion. In addition to Sigrun Henjum, 
Kristin Holvik, Christine Louise Parr, Tonje H. Stea and Tor A. Strand, these were (in 
alphabetical order): 
Lene Frost Andersen – Vice chair of the Panel on Nutrition, Dietetic Products, Novel Food and 
Allergy in VKM. Affiliation: 1) VKM; 2) University of Oslo, Department of Nutrition, Institute 
of Basic Medical sciences. 
Lisbeth Dahl – Member Panel on Nutrition, Dietetic Products, Novel Food and Allergy in VKM. 
Affiliation: 1) VKM; 2) Institute of Marine Research (IMR), Bergen. 
Knut Tomas Dalen – Member of the Panel on Nutrition, Dietetic Products, Novel Food and 
Allergy in VKM. Affiliation: 1) VKM; 2) University of Oslo, Department of Nutrition, Institute 
of Basic Medical sciences. 
Martinus Løvik – Member of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy 
in VKM. Affiliation: 1) VKM; 2) Norwegian University of Science and Technology (NTNU), 
Department of Clinical and Molecular Medicine, Trondheim 
Stine Marie Ulven – Member of the Panel on Nutrition, Dietetic Products, Novel Food and 
Allergy in VKM. Affiliation: 1) VKM; 2) University of Oslo, Department of Nutrition, Institute 
of Basic Medical sciences. 
Acknowledgment  
VKM would like to thank  
- Margaretha Haugen, former Chair of the Panel on Nutrition, Dietetic Products, Novel Food 
and Allergy in VKM for screening and reading of full text articles from the first literature 
search and contribution to text in chapter 6. 
- Daniel Flø, VKM secretariat, for the Monte Carlo Risk Assessment and contribution to text in 
Appendix IV.  
- Ingrid Kvestad, NORCE Norwegian Research Centre AS, for reviewing and commenting on 
text on neurodevelopmental outcomes in chapter 3 and 5, and especially the systematic 
literature review of iodine and neurodevelopment in sections 5.4.1 and 5.5. 
Tim Korevaar for, Erasmus University Medical Center, for valuable inputs in the discussion of 
mild to moderate iodine deficiency, thyroid function and clinical relevance. 
Monica Hauger Carlsen, University of Oslo, for giving VKM access to use unpublished data on 
iodine content in mineral water and coffee. 
VKM acknowledge the referees Inger Aakre (Norwegian Institute of Marine Research), Jan 




Public Health) and Maria Andersson (Kinderspital Zurich, Eleonorenstiftung) for valuable 
reviewing and commenting on the manuscript.  
Competence of VKM experts 
Persons working for VKM, either as appointed members of the Committee or as external 
experts, do this by virtue of their scientific expertise, not as representatives for their 
employers or third party interests. The Civil Services Act instructions on legal competence 




Table of Contents 
Summary .............................................................................................................. 12 
Sammendrag på norsk ......................................................................................... 16 
Abbreviations and definitions ............................................................................... 20 
EFSA - Dietary Reference Values (DRVs) (EFSA, 2010c) .......................................... 22 
IOM - Dietary Reference Intakes (DRIs) (IOM, 2000) .............................................. 23 
NNR -Recommended Intake (NNR Project Group, 2012) .......................................... 24 
World Health Organization (WHO, 2007) ................................................................ 24 
Background as provided by the Norwegian Food Safety Authority ...................... 25 
Terms of reference as provided by the Norwegian Food Safety Authority ........... 27 
Assessment .......................................................................................................... 29 
1 Introduction ................................................................................................. 29 
1.1 Global recommendation for salt iodization .............................................................. 30 
 Current salt iodization in Norway ................................................................ 31 
1.2 Methodology for this benefit and risk assessment ................................................... 31 
2 Iodine physiology and metabolism .............................................................. 33 
2.1 Chemistry ............................................................................................................ 33 
2.2 Absorption, distribution, metabolism and excretion ................................................. 33 
2.3 Biomarkers of iodine status and thyroid function ..................................................... 34 
Urinary iodine concentration (UIC) ........................................................................ 35 
Thyroid stimulating hormone (TSH), triiodothyronine (T3) and thyroxine (T4) ........... 36 
Thyroglobulin (Tg) ............................................................................................... 37 
Thyroid volume (Tvol) .......................................................................................... 38 
3 Health consequences of iodine deficiency or excessive iodine ..................... 39 
3.1 Health consequences of iodine deficiency ............................................................... 40 
 Reduced thyroid function and goiter ........................................................... 40 
 Neurodevelopmental outcomes ................................................................... 41 
 Other health consequences of severe iodine deficiency ................................. 42 
3.2 Health consequences of excessive iodine ............................................................... 42 
3.3 Thyroid cancer ..................................................................................................... 44 
3.4 Vulnerable groups for iodine deficiency and excessive iodine ................................... 45 
3.5 Summary of health consequences of iodine deficiency and excessive iodine .............. 45 
4 Dietary reference values for iodine .............................................................. 47 




 Institute of Medicine, USA (2001) ............................................................... 47 
 WHO (2005 and 2007) ............................................................................... 48 
 Nordic and Norwegian Nutrition recommendations (2012) ............................ 49 
 Dietary Reference Values from EFSA (2014) ................................................ 50 
 Overview of dietary reference values from previous reports .......................... 51 
4.2 Tolerable upper intake levels (UL) for iodine .......................................................... 52 
 Institute of Medicine, US (2001) ................................................................. 52 
 Scientific Committee on Food, EU (2002) ..................................................... 52 
 Expert Group on Vitamins and Minerals, Great Britain (2003) ........................ 53 
 Nordic Nutrition Recommendations (2012) .................................................. 54 
 Overview ULs from previous reports............................................................ 54 
4.3 Summary of dietary reference values and discussion of use of reference values for 
comparison ......................................................................................................... 54 
5 Systematic literature review and grading of evidence on the health effects of 
mild to moderate iodine deficiency .............................................................. 57 
5.1 Systematic literature review concerning adverse health effects of mild to moderate 
iodine deficiency .................................................................................................. 57 
5.2 Methodological considerations of the included publications ...................................... 59 
 Sample size and study design ..................................................................... 59 
 Measures of iodine status and exposure ...................................................... 60 
5.3 Grading the evidence - guidelines .......................................................................... 61 
5.4 Studies concerning mild to moderate iodine deficiency ............................................ 64 
 Neurodevelopment .................................................................................... 64 
5.4.1.1 Iodine status before conception and during pregnancy and 
neurodevelopmental outcomes .............................................................................. 65 
5.4.1.2 Grading of neurodevelopment – prenatal exposure .................................... 76 
5.4.1.3 Iodine status in schoolchildren and neurodevelopmental outcomes ............. 78 
5.4.1.4 Grading of neurodevelopment – schoolchildren ......................................... 79 
 Thyroid function ........................................................................................ 80 
5.4.2.1 Iodine status in non-pregnant adults and thyroid function .......................... 81 
5.4.2.2 Grading of thyroid function – non pregnant adults ..................................... 82 
5.4.2.3 Iodine status in pregnant women and thyroid function............................... 83 
5.4.2.4 Grading of thyroid function – pregnant women ......................................... 84 
5.4.2.5 Iodine status in schoolchildren and thyroid function ................................... 84 
5.4.2.6 Grading of thyroid function – schoolchildren ............................................. 90 
 Fertility and birth outcomes ........................................................................ 90 




5.5 Evidence table and grading of health effects related to mild to moderate iodine 
deficiency ............................................................................................................ 94 
6 Best available evidence on the upper level (UL) of iodine intake ................. 99 
6.1 Literature search concerning the upper level (UL) of iodine intake ............................ 99 
6.2 Included studies concerning the upper level (UL) of iodine intake .......................... 100 
 Study of upper level (UL) of iodine intake in adults ..................................... 100 
 Studies of relevance to the upper level (UL) of iodine intake in children and 
adolescents ....................................................................................................... 102 
6.2.2.1 Results based on changes in thyroid volume and risk of goiter ................. 103 
6.2.2.2 Results based on thyroid function .......................................................... 104 
 Discussion and summary of studies on excessive iodine intake and upper level
 105 
7 Exposure assessment ................................................................................. 107 
7.1 Food composition data ....................................................................................... 107 
7.2 Food consumption data ...................................................................................... 108 
 Consumption of total salt and household salt ............................................. 110 
 Consumption of bread ............................................................................. 112 
7.2.2.1 Salt content in bread ............................................................................ 113 
 Consumption of food supplements with iodine ........................................... 113 
7.3 Iodine exposure estimates .................................................................................. 114 
 Exposures in adults, 13-, 9- and 4-year-olds .............................................. 117 
7.3.1.1 Model-based iodine exposure estimates .................................................. 117 
 Exposures in 1- and 2- year-olds .............................................................. 119 
 Groups at risk of too low or high intakes ................................................... 121 
 Plant-based alternatives to cow’s milk ....................................................... 122 
7.4 Scenarios with different iodization levels .............................................................. 122 
 Effect of potential salt reduction on the scenario estimates for iodine .......... 142 
7.5 Discussion and summary of exposure/intake ........................................................ 142 
8 Benefit and risk assessment....................................................................... 146 
8.1 Benefit and risk assessment - guidelines .............................................................. 146 
8.2 Benefit and risk characterisation .......................................................................... 146 
 Groups at risk of low and high iodine intakes ............................................. 147 
8.2.1.1 Groups at risk of low intakes – current level and scenarios ....................... 147 
8.2.1.2 Groups at risk of high intakes – current level and scenarios ...................... 149 
 Risk characterisation ................................................................................ 151 




8.2.2.2 Risks related to high iodine intakes ........................................................ 153 
 Benefit characterisation ........................................................................... 154 
8.3 Summary of benefit and risk assessment ............................................................. 155 
9 Uncertainties .............................................................................................. 157 
9.2 Uncertainties related to iodine exposure .............................................................. 159 
 Uncertainties related to the modelling method (Mixed Models approach) ...... 162 
10 Answers to the terms of reference and concluding remark........................ 163 
10.1 Current iodine intake .......................................................................................... 163 
Current intakes in adults, 13-, 9- and 4-year-olds, the general population ............... 164 
Current intakes in 1- and 2-year-olds, the general population ................................ 164 
Current intakes in groups at risk of low and high intakes ....................................... 165 
10.2 The scenarios - the iodine intake if household salt and industrial salt used in bread 
were to be iodized ............................................................................................. 165 
The scenarios –adults, 13-, 9- and 4-year-olds, the general population ................... 166 
The scenarios – 2-year-olds, the general population ............................................. 166 
The scenarios – other specified risk groups of low and high iodine intakes. ............. 167 
Plant-based alternatives to cow’s milk .................................................................. 168 
Effect of potential salt reduction on the scenario estimates for iodine ..................... 168 
10.3 Health effects related to the various iodization levels ............................................ 168 
10.4 Concluding remarks ........................................................................................... 170 
11 Data gaps ................................................................................................... 172 
References ......................................................................................................... 175 
Appendix I - Literature searches ........................................................................ 188 
a) Search strategy for health outcomes mild and moderate iodine deficiency .............. 188 
Publication selection and data extraction ...................................................................... 196 
Publication selection and data extraction for articles relevant for iodine deficiency ... 196 
Publication selection and data extraction for articles relevant for iodine excess ........ 198 
Appendix II – List of papers categorised as A, B or C ......................................... 200 
a) List of papers categorised as A or B ..................................................................... 200 
Appendix III – Summary Tables for papers categorised as A or B ..................... 212 
Summary Tables 1-36 ................................................................................................. 212 
ST1 Summary table iodine .................................................................................. 212 
ST1 Dietary information* .................................................................................... 214 
ST2 Summary table iodine .................................................................................. 215 
ST2 Dietary information* .................................................................................... 216 




ST3 Dietary information* .................................................................................... 219 
ST4 Summary table iodine .................................................................................. 221 
ST4 Dietary information ...................................................................................... 223 
ST5 Summary table iodine .................................................................................. 224 
ST6 Summary table iodine .................................................................................. 226 
ST7 Summary table iodine .................................................................................. 228 
ST8 Summary table iodine .................................................................................. 229 
ST9 Summary table iodine .................................................................................. 230 
ST10 Summary table iodine ................................................................................ 231 
ST11 Summary table iodine ................................................................................ 232 
ST12 Summary table iodine ................................................................................ 233 
ST13 Summary table iodine ................................................................................ 235 
ST14 Summary table iodine ................................................................................ 237 
ST15 Summary table iodine ................................................................................ 239 
ST16 Summary table iodine ................................................................................ 241 
ST17 Summary table iodine ................................................................................ 243 
ST18 Summary table iodine ................................................................................ 245 
ST19 Summary table iodine ................................................................................ 247 
ST20 Summary table iodine ................................................................................ 249 
ST20 Dietary information* .................................................................................. 251 
ST21 Summary table iodine ................................................................................ 253 
ST22 Summary table iodine ................................................................................ 256 
ST23 Summary table iodine ................................................................................ 259 
ST24 Summary table iodine ................................................................................ 261 
ST25 Summary table iodine ................................................................................ 265 
ST25 Dietary information* .................................................................................. 267 
ST26 Summary table iodine ................................................................................ 268 
ST26 Dietary information* .................................................................................. 270 
ST27 Summary table iodine ................................................................................ 271 
ST28 Summary table iodine ................................................................................ 273 
ST29 Summary table iodine ................................................................................ 275 
ST30 Summary table iodine ................................................................................ 276 
ST31 Summary table iodine ................................................................................ 277 
ST32 Summary table iodine ................................................................................ 279 




ST34 Summary table iodine ................................................................................ 283 
ST35 Summary table iodine ................................................................................ 284 
ST35 Dietary information* .................................................................................. 286 
ST36 Summary table iodine ................................................................................ 288 
Appendix IV – Exposure – supplementary methodological information ............ 289 
Details about the MM-method ...................................................................................... 289 
Flexible decomposition of variance – not all subgroups vary in the same way .......... 289 
Multivariate models – bread and iodine intake are correlated ................................. 290 
Using a MM for exposures and scenarios - correcting for bias in survey respondents 290 
Household salt consumption ............................................................................... 291 
Model setup for iodine or bread/salt in bread intake .............................................. 291 
Models .............................................................................................................. 293 
Data ................................................................................................................. 293 
Software/ statistical environment ........................................................................ 293 
Model results ..................................................................................................... 293 
Model-based exposure (Monte Carlo Risk Assessment software) ..................................... 294 
Comparing the estimates from OIMs, MM and MCRA ..................................................... 295 
Comparing MM-method with MCRA...................................................................... 295 
Comparing OIMs with the model based approaches .............................................. 295 
Appendix V – Exposure - additional estimates ................................................... 298 
Exposures based on means of survey days (OIMs) ........................................................ 298 
Exposures and scenarios for food supplement users (users only) .................................... 299 
Appendix VI - Manuals for the QAT-tables for the various study designs .......... 305 
Quality assessment tool for clinical studies ................................................................... 305 
Quality assessment tool for prospective cohort studies .................................................. 307 






Request from the Norwegian Food Safety Authority 
Following a report from the National Nutrition Council calling for actions to secure adequate 
iodine intake in the population, the Norwegian Food Safety Authority requested the 
Norwegian Scientific Committee for Food and Environment (VKM) to conduct a benefit- and 
risk assessment of iodization of household salt and industrialised salt in bread. 
VKM addressed the request 
VKM appointed a project group consisting of members of the Panel on Nutrition, Dietetic 
Products, Novel Food and Allergy and Panel on Contaminants to answer the request.  
The Panel on Nutrition, Dietetic Products, Novel Food and Allergy has reviewed and revised 
drafts prepared by the project group and finally approved the benefit- and risk assessment  
This benefit and risk assessment is based on 1) established knowledge about health 
consequences from severe iodine deficiency, 2) systematic literature review of the evidence 
for health consequences of mild to moderate iodine deficiency, 3) literature review of studies 
on adverse health effects from excessive iodine intakes to re-evaluate existing tolerable 
upper intake levels (ULs), 4) evaluation of estimated iodine intake levels in different 
population groups in Norway compared to established dietary reference values, specifically 
estimated average requirement (EAR) and UL, and finally 5) an estimation of the effect of 
different scenarios of increasing iodization levels in household salt and salt in bread on iodine 
intake levels in different population groups compared to the established dietary reference 
values EAR and UL. 
For the purpose of this benefit and risk assessment of iodization in household salt and salt in 
bread, risk may be understood as risk of adverse health effects related to too high or too low 
iodine intakes. Benefit may be understood as reduction or avoidance of adverse health 
effects related to too high or too low iodine intakes. For iodine, this is a challenging 
maneuver, as the gap between too low and too high intakes is narrow. 
The project group conducted two systematic literature reviews. One was performed to 
evaluate the evidence for the impact of mild- to moderate iodine deficiency on 
neurodevelopment, thyroid function and birth outcomes, the other to evaluate the evidence 
for adverse health effects from excessive iodine intake to possibly re-evaluate the existing 
tolerable upper intake levels. 
Current evidence for adverse health effects of iodine deficiency 
Severe iodine deficiency resulting in hypothyroidism during foetal life, infancy, or early 
childhood may lead to permanent intellectual disability. Severe maternal iodine deficiency in 




abnormalities. These effects are due to low levels of thyroid hormones affecting the 
developing tissues. 
The health effects of severe iodine deficiency are well established, but for mild to moderate 
deficiency the effects are less known. After screening of more than 15 000 titles and 
abstracts and quality assessment of 131 full text scientific papers, 36 publications were 
included for the grading of evidence for consequences of mild to moderate iodine deficiency.  
We used the criteria proposed by the World Cancer Research Fund for grading of evidence. 
Based on our systematic literature review, the evidence for adverse effects from mild to 
moderate iodine deficiency and neurodevelopment was judged to meet the criteria for 
limited suggestive. Limited suggestive means that the evidence is too limited to permit a 
probable or convincing causal judgement but shows a generally consistent direction of effect. 
It was further concluded that there is limited (no conclusion) evidence to support that mild 
to moderate iodine deficiency causes thyroid dysfunction or has negative effects on birth 
outcomes. Limited (no conclusion) means that the evidence is so limited that no firm 
conclusion can be made.  
Established reference values for iodine requirement 
Several competent bodies have established dietary reference values for iodine. We have 
based this benefit and risk assessment on estimated average requirements (abbreviated EAR 
or AR) from the Nordic Nutrition Recommendations (2012) for adults, and from the Institute 
of Medicine (2001) for adolescents and children. Estimated average requirement is an iodine 
intake that is estimated to meet the requirement of half the healthy individuals in the 
population. The iodine intake is considered to be adequate if 97.5% of a population has a 
habitual intake above the estimated average requirement. 
Re-evaluation of tolerable upper intake levels 
As the evidence for health effects of excessive iodine intakes is far less comprehensive than 
for iodine deficiency, we did not aim at evaluating the literature for excess intakes with the 
same weight of evidence tools as for deficiency. We have only evaluated whether recent 
literature is in line with the existing tolerable upper intake levels or if it supports that 
tolerable upper intake levels should be changed. Generally, UL is the maximum level of total 
chronic daily intake judged to be unlikely to pose a risk of adverse health effects, and in the 
case of iodine the UL for adults is the maximum daily intake where changes in TSH are 
unlikely to occur (SCF, 2002). 
After screening more than 2500 titles and abstracts, five studies fulfilled the inclusion criteria 
and were found relevant and included for evaluation of existing ULs. The existing ULs from 
the Scientific Committee on Food from 2001 is maintained. However, according to findings in 
new studies, the lowest-observed-adverse-effect levels (LOAEL) for excessive iodine intake 
may be lower than previously assumed, and the uncertainty factor inherent in the 




LOAEL for the existing ULs in children. Changes in thyroid stimulating hormone (TSH) 
without changes in thyroid hormones (T3 or T4), that is subclinical hypothyroidism, are 
observed in one randomised controlled dose-response study and four cross-sectional studies 
in children at iodine intakes close to the ULs. Subclinical hypothyroidism is not considered to 
be harmful, but may progress into overt hypothyroidism. 
Iodine intake in Norwegian population groups and implications of salt iodization  
Iodine intakes in adults are higher in men than in women and increase with increasing age 
for both sexes. Women of childbearing age and 13-year-old girls have the lowest estimated 
iodine intakes. 26% of the women of childbearing age have intakes below the estimated 
average requirement of 100 µg/day, and 38% of the 13-year-old girls have intakes below the 
estimated average requirement of 73 µg/day. The estimated iodine intakes in the 5th 
percentile of women of childbearing age and 13-year-olds is 70 and 38 µg/day, respectively. 
All adults and 13-, 9- and 4- year-olds have individual intakes below the tolerable upper 
intake levels. 
The estimates for 2-year-olds show that 9% have intakes below the estimated average 
requirement, and 8% have intakes above the tolerable upper intake level. The estimated 
iodine intake in the 95th percentile is 215 µg/day, slightly above the tolerable upper intake 
level of 200 µg/day. The estimates for non-breastfed 1-year-olds show that 8% have intakes 
below the estimated average requirement, and 18% have intakes above the tolerable upper 
intake level. The estimated iodine intake in the 95th percentile for this group is 259 µg/day. 
We present 12 scenario tables combining three scenarios (household salt alone, salt in bread 
alone and both household salt and salt in bread) with four iodization levels (15, 20, 25 and 
50 mg iodine per kg salt). The percentages of the population groups with intakes above the 
estimated average requirement increases with increasing iodization levels, but so does the 
percentages with intakes above tolerable upper intake levels for some groups of the 
population.  
The scenarios that seem to elevate iodine intakes in women of childbearing age and 13-year-
olds up to adequate intakes, are iodization up to 15 or 20 mg iodine per kg salt, including 
iodization of salt in bread. Above these iodization levels, no increased benefit would be 
expected in women of childbearing age and 13-year-olds. For 1- and 2-year-olds all 
scenarios lead to an increase in the proportion of toddlers with estimated intakes above the 
tolerable upper intake level.  
Benefit- and risk characterisation of iodization of household salt and 
industrialised salt in bread 
Low estimated iodine intakes in adolescents (13-year-olds) and women of childbearing age 
(18-45 years) cannot be sufficiently corrected by the proposed increased iodization levels of 




VKM assumes that the women of childbearing age and 13-year-olds will benefit from 
increased iodization levels in salt and bread. This will also benefit other groups that, for 
various reasons, have few iodine-rich sources in their diet, e.g., people who do not eat lean 
fish or consume milk or other dairy products. The risk imposed on the youngest age groups 
is a higher proportion of the 1- and 2-year-olds with iodine intakes above the tolerable upper 
intake level. 
Based on the scientific evidence and the data presented in this benefit and risk assessment it 
cannot be concluded that a specific iodization level benefits all age and gender groups 
without posing increased risk of harm to others or that the benefits in one population group 
outweighs the risks in others, or that the benefits in one group outweigh the risks in others.  
It should be noted that recommendations for nutrients are set to secure adequate growth, 
development, maintenance of health, and to reduce the risk of chronic illnesses. Thus, iodine 
intakes below EAR or above UL will decrease the possibilities of achieving the beneficial 
effects of adequate intake. Current iodine intake in certain population groups is worryingly 
low, and trend studies indicate that consumption of milk and dairy products in Norway, the 
most significant iodine sources in the diet, is declining, especially among young women. 
Several studies show that especially adolescents and women of childbearing age have 
insufficient iodine intakes, which may leave some at risk of severe iodine deficiency. There 
are, however, to our knowledge, no data on the prevalence of severe iodine deficiency in 
Norway. In other words, we do not know how many, if any, there are who have clinical 
consequences of inadequate iodine intakes.  
The scenarios that seem to elevate iodine intakes in women of childbearing age and 13-year-
olds (the groups at highest risk of low intakes) to adequate levels are iodization up to 15 or 
20 mg iodine per kg salt, including iodization of salt in bread. Above these iodization levels, 
no increased benefit would be expected in women of childbearing age and 13-year-olds 
whereas several population groups will be at risk of exceeding UL, especially in 1- and 2-
year-olds. 
The WHO recommends salt as a vehicle for correcting iodine deficiency in a population, 
followed by a close monitoring of the iodization program. 
Key words: VKM, benefit- and risk assessment, Norwegian Scientific Committee for Food 





Sammendrag på norsk 
Oppdraget fra Mattilsynet 
På bakgrunn av en rapport fra Nasjonalt råd for ernæring som konkluderte med at det var 
behov for tiltak for å sikre økt jodinntak i den norske befolkningen, ba Mattilsynet 
Vitenskapskomiteen for mat og miljø (VKM) om å foreta en nytte- og risikovurdering av 
tilsetning av jod i husholdningssalt og industrisalt i brød. 
Hvordan VKM har løst oppdraget 
VKM utnevnte en prosjektgruppe bestående av medlemmer fra faggruppen for ernæring, 
dietetiske produkter, ny mat og allergi og et medlem fra faggruppen for forurensninger, 
naturlige toksiner og medisinrester for å utrede og besvare oppdraget. 
Faggruppen for ernæring, dietetiske produkter, ny mat og allergi har gjennomgått og 
revidert flere utkast utarbeidet av prosjektgruppen, og godkjent den endelige nytte- og 
risikovurderingen. 
Denne nytte- og risikovurderingen er basert på følgende elementer: 1) etablert kunnskap om 
helsemessige konsekvenser av alvorlig jodmangel, 2) en systematisk litteraturgjennomgang 
av kunnskapsgrunnlaget for helsemessige konsekvenser av mild til moderat jodmangel, 3) 
litteraturgjennomgang av studier om negative helseeffekter av høye jodinntak for eventuelt å 
revurdere eksisterende tolerable øvre inntaksnivåer (UL), 4),  vurdering av beregnede 
estimater av inntak av jod i ulike befolkningsgrupper i Norge, og  sammenlikning av disse 
estimatene opp mot såkalte referanseverdier for jod, nærmere bestemt det som på engelsk 
heter estimated average requirement (EAR), her oversatt til jodbehov og tolerable øvre 
inntaksnivåer (UL), og til slutt 5)  vurdering av beregnet jodinntak ved ulike scenarier for 
økte nivåer av tilsetning av jod til husholdningssalt og industrisalt i brød og sammenlikning 
mot de etablerte referanseverdiene for jodbehov (EAR) og tolerabelt øvre inntaksnivå (UL). 
I denne nytte- og risikovurderingen skal risiko forstås som risiko for negative helseeffekter 
relatert til for høye eller for lave inntak av jod. Nytte skal forstås som reduksjon eller fravær 
av negative helseeffekter relatert til for høye eller for lave inntak av jod. Dette er en 
utfordrende øvelse for næringsstoffet jod, fordi området mellom for lavt og for høyt 
jodinntak er smalt. 
Prosjektgruppen gjennomførte to systematiske litteraturgjennomganger: én for å vurdere 
evidensen for negative effekter av mild til moderat jodmangel på nevroutvikling, 
skjoldbruskkjertelfunksjon, fødselsutfall og fertilitet, og én for å vurdere negative 
helseeffekter av høyt inntak av jod og hvorvidt det er grunnlag for å endre eksisterende 




Kunnskapsgrunnlag for negative helseeffekter av mild til moderat jodmangel 
Alvorlig jodmangel i form av hypotyreose i fosterlivet, spedbarnsalder eller tidlig barndom, 
kan føre til permanent psykisk utviklingshemming. Alvorlig jodmangel i svangerskapet kan 
også føre til spontanaborter, for tidlig fødsel, dødfødsel og medfødte misdannelser. Alle disse 
negative helseeffektene skyldes endringer i nivå av skjoldbruskhormoner, som er svært 
viktige for vekst og utvikling. 
Etter en screening av mer enn 15 000 titler og abstrakts og kvalitetsvurdering av 131 
fulltekstartikler, ble 36 vitenskapelige artikler inkludert for evidensvurderingen av negative 
helseeffekter av mild til moderat jodmangel. 
Vi benyttet vurderingskriterier lansert av World Cancer Research Fund. Basert på vår 
systematiske litteraturgjennomgang og bruk av World Cancer Research Funds retningslinjer 
for vurdering av evidens, ble evidensen for mild til moderat jodmangel og nevroutvikling 
vurdert å oppfylle kriteriene for limited suggestive – her oversatt til begrenset antydende. 
Begrenset antydende betyr at evidensen overordnet peker i en retning, men er for svak til å 
konkludere med at det er en sannsynlig eller overbevisende årsakssammenheng. 
Det ble videre konkludert med at det er limited (no conclusion) evidens for at mild til 
moderat jodmangel forårsaker dysfunksjon i skjoldbruskkjertelen eller har negative effekter 
på fødselsutfall eller fertilitet (her oversatt til begrenset (ikke konkluderende)). Begrenset 
(ikke konkluderende) betyr at evidensen er for begrenset til det kan gis en sikker konklusjon. 
Etablerte referanseverdier for jodbehov 
Flere internasjonale organisasjoner har etablert såkalte referanseverdier for jod. Vi har 
basert denne nytte- og risikovurderingen på én type referanseverdi for jodbehov (forkortet 
EAR eller AR) fra de nordiske næringsstoffanbefalingene (2012) for voksne, og fra Institute 
of Medicine (2001) fra USA for barn og unge. Jodbehov (EAR eller AR) tilsvarer et daglig 
inntak av jod som anslås å dekke behovet hos halvparten av den friske befolkningen. 
Inntaket anses som adekvat hvis 97,5 % av befolkningen har et inntak over den fastsatte 
verdien for behov (EAR eller AR). 
Re-evaluering av eksisterende tolerable øvre inntaksnivåer 
Ettersom det er langt færre studier som har undersøkt hvordan høye inntak av jod påvirker 
helsen, var det ikke et mål å systematisk vurdere kunnskapsgrunnlaget for helseeffekter av 
høyt jodinntak etter samme metode som for mild til moderat jodmangel. Vi har kun vurdert 
om nyere litteratur støtter eksisterende tolerable øvre inntaksnivåer (UL), eller om det bør 
fastsettes nye nivåer. 
Generelt er et tolerabelt øvre inntaksnivå (UL) det maksimale nivået av totalt kronisk daglig 
inntak som anses å ikke utgjøre en risiko for negative helseeffekter. For jod, er UL for 
voksne det maksimale daglige inntaket man kan ha uten sannsynlighet for at det fører til 




Etter screening av mer enn 2500 titler og abstrakts, ble fem nye studier funnet relevante og 
inkludert for vurdering av eksisterende UL. VKM foreslår etter gjennomgangen av studiene å 
opprettholde de allerede fastsatte tolerable øvre inntaksnivåene fra Den europeiske 
vitenskapskomiteen for mat (SCF) fra 2001.  
Nyere studier tyder imidlertid på at den laveste dosen som har gitt negative helseeffekter 
ved høyt jodinntak (LOAEL) er lavere enn tidligere antatt, og den iboende 
usikkerhetsfaktoren i det tolerable øvre inntaksnivået er derfor redusert fra 3 til 1,3. Årsaken 
er at det er rapportert om endringer i skjoldbruskstimulerende hormon (TSH) uten endringer 
i skjoldbruskhormoner (T3 eller T4), altså såkalt subklinisk hypotyreose, i en randomisert 
kontrollert dose-responsstudie med voksne og i fire tverrsnittsstudier med barn ved jodinntak 
nært opptil disse tolerable øvre inntaksnivåene. Subklinisk hypotyreose anses ikke for å være 
skadelig, men kan utvikle seg til hypotyreose. 
Inntak av jod i den norske befolkningen – inkludert scenarier ved økt tilsetning 
av jod til salt og brød 
Jodinntaket hos voksne er høyere hos menn enn hos kvinner, og øker med alderen hos 
begge kjønn. Kvinner i fertil alder har det laveste estimerte jodinntaket blant voksne, og 
26 % av kvinner i fertil alder har et jodinntak som ligger under jodbehovet (EAR eller AR). 
Jodbehovet (EAR) hos voksne er 100 mikrogram per dag. Jenter i 13 års alderen har det 
laveste jodinntaket, og 38 % av disse jentene har et inntak under jodbehovet (EAR eller AR) 
som er 73 mikrogram per dag for denne aldersgruppen. Det estimerte jodinntaket i den 
femte persentilen av kvinner i fertil alder og 13-åringer, er henholdsvis 70 og 38 mikrogram 
per dag. Alle voksne og 13-, 9- og 4- åringer har et beregnet jodinntak under de tolerable 
øvre inntaksnivåene. 
Inntaksberegningene for 2 år gamle barn viser at 9 % har et jodinntak under jodbehovet 
(EAR eller AR), og 8 % har inntak over det tolerable øvre inntaksnivået. Det estimerte 
jodinntaket i 95-persentilen av 2-åringene er 215 mikrogram per dag, litt over det tolerable 
øvre inntaksnivået på 200 mikrogram per dag for denne aldersgruppen. 
Inntaksberegningene for 1-åringer som ikke ammes, viser at 8 % har et jodinntak under 
jodbehovet (EAR eller AR), og 18 % har inntak over det tolerable øvre inntaksnivået på 
200 mikrogram per dag. Det estimerte jodinntaket i 95-persentilen av 1-åringene som ikke 
ammes, er 259 mikrogram per dag. 
Vi har presentert 12 scenariotabeller; tre scenarioer (bare husholdningssalt alene, bare salt i 
brød alene, samt både husholdningssalt og salt i brød) for fire nivåer av tilsetning av jod (15, 
20, 25 og 50 mg jod per kg salt). Andelen av befolkningen med et jodinntak over behovet 
(EAR eller AR) øker med økt tilsetning av jod, men samtidig øker også andelen med et 
jodinntak over tolererbare øvre inntaksnivåer i noen grupper av befolkningen. 
Scenarioene som ser ut til å øke jodinntaket hos kvinner i fertil alder og 13-åringer opp til et 
adekvat inntak, er tilsetning av jod opp til 15 eller 20 mg jod per kg salt, inkludert tilsetning 




i fertil alder eller 13-åringer. For 1- og 2-åringer fører alle scenarioer til en økning i andelen 
småbarn med et beregnet jodinntak over det tolerable øvre inntaksnivået. 
Nytte- og risikovurdering av tilsetning av jod til husholdningssalt og 
industrialisert salt i brød 
De lave beregnede inntakene av jod hos ungdom (13-åringer) og kvinner i fertil alder (18-45 
år) kan ikke korrigeres i tilstrekkelig grad av de foreslåtte økte tilsetningene av jod til 
husholdningssalt og/eller industrisalt i brød, uten at det medfører høye jodinntak hos 1- og 
2-åringer. 
VKM antar at kvinner i fertil alder og 13-åringer vil ha nytte av økt tilsetning av jod i salt og 
brød. Dette vil også være til fordel for andre grupper som av forskjellige årsaker har få 
matvarer som utgjør de viktigste kildene til jod i kostholdet, for eksempel mennesker som 
ikke spiser mager fisk eller bruker melk eller andre meieriprodukter. Risikoen dette medfører 
for de minste barna, er en høyere andel av 1- og 2-åringene som kommer over det tolerable 
øvre inntaksnivået. Basert på vitenskapelige studier/evidens og dataene som er presentert i 
denne nytte- og risikovurderingen, kan det derfor ikke konkluderes med at et spesifikt nivå 
av tilsetning av jod til salt og brød vil representere en nytte for alle populasjonsgrupper 
(alder og kjønn) uten at det samtidig utgjør en økt risiko for negative helseeffekter hos 
andre, eller at nytten i en populasjonsgruppe oppveier risikoen i en annen.  
Det er viktig å understreke at anbefalinger for næringsstoffer er satt for å sikre tilstrekkelig 
vekst og utvikling, opprettholde god helse og redusere risikoen for kroniske sykdommer. 
Inntak av jod under EAR eller over UL reduserer mulighetene for å oppnå de gunstige 
effektene av tilstrekkelig inntak. Dagens jodinntak hos visse grupper er bekymringsfullt lavt, 
og trendstudier viser et synkende inntak av melk og meieriprodukter, de viktigste kildene til 
jod i det norske kostholdet, spesielt blant unge kvinner. 
Flere studier viser at spesielt ungdom og kvinner i fertil alder har utilstrekkelig inntak av jod, 
noe som kan medføre at en rekke individer også har økt risiko for alvorlig jodmangel. Det er 
så vidt vi vet, ingen data om forekomst av alvorlig jodmangel i Norge. Med andre ord, vi vet 
ikke hvor mange, om noen, som har kliniske konsekvenser på grunn av for lavt jodinntak. 
Scenarioene som ser ut til å øke jodinntaket til adekvat nivå hos kvinner i fertil alder og hos 
13-åringer (gruppene som har høyest risiko for lavt inntak), er tilsetning av jod opp til 15 
eller 20 mg jod per kg salt, inkludert salt i brød. Over disse nivåene forventes det ikke økt 
fordel for kvinner i fertil alder og 13-åringer, mens flere befolkningsgrupper vil ha en risiko 
for å overskride tolerabelt øvre inntaksnivå, og spesielt 1- og 2-åringer. 
WHO anbefaler salt som kilde for jodtilsetning for å korrigere jodmangel i en populasjon, 





Abbreviations and definitions 
Abbreviations 
AI – adequate intake 
AR – average requirement 
bw – body weight 
CI – confidence interval 
Cr – creatinine 
DRI – dietary reference intake 
DRV – dietary reference value 
EAR – estimated average requirement (IOM) 
EFSA – European Food Safety Authority 
EVM – Expert group on vitamins and minerals of the Food Standard Agency, UK 
FFQ – food frequency questionnaire 
fT3 – free triiodothyronine 
fT4 – free thyroxine 
ID – iodine deficiency 
IDD – iodine deficiency disorders 
IIH – iodine induced hyperthyroidism 
IQR – interquartile range 
IOM – Institute of Medicine, USA 
KBS – kostberegningssystemet (Software system used to calculate dietary intake) 
LOAEL – lowest observed adverse effect level 
MCRA – Monte Carlo risk assessment 
MoBa – the Norwegian Mother and Child Cohort 
NFSA – Norwegian Food Safety Authority [Norw.: Mattilsynet] 
NIS – Na+/I- symporter 
NNR – Nordic Nutrition Recommendations 
NOAEL – no observed adverse effect level 
OIMs – observed individual means 
PRI – population reference intakes 
RDA – recommended dietary allowances 
RI – recommended intake 
SCF – Scientific Committee for Food 
SGA – small for gestational age 
SUL – safe upper intake level 
T3 – triiodothyronine 
T4 – thyroxine 
TBG – thyroxin binding globulin 
TDI – tolerable daily intake 
Tg – thyroglobulin 




TGR – total goiter rate 
Thyroid nodules - abnormal growth of thyroid cells that forms a lump within the thyroid 
gland 
TPOAb – thyroid peroxidase antibody 
TRH – thyrotropin-releasing hormone 
TSH – thyroid stimulating hormone also known as thyrotropin 
Tvol – thyroid volume 
UF – uncertainty factor 
UIC – urinary iodine concentration 
UL – tolerable upper intake level 
VKM – Norwegian Scientific Committee for Food and Environment [Norw.: 
Vitenskapskomiteen for mat og miljø] 
Definitions 
Household salt: Salt (NaCl) for home cooking including table salt. 
“Jod-Basedow effect”/syndrome: Iodine-induced hyperthyroidism is a rare cause of 
thyrotoxicosis seen typically after the administration of exogenous iodine. It appears to result 
from loss of the normal adaptation of the thyroid to iodide excess. 
Mild iodine deficiency: In groups of children (> 6 years) and non-pregnant adults, iodine 
deficiency is characterised as mild when median urinary iodine concentration (UIC) is 50-99 
µg/L (WHO, 2007; WHO, 2013). WHO defines median UIC<150 µg/L as insufficient and has 
no definition of mild iodine deficiency.  
Moderate iodine deficiency: In groups of children (> 6 years) and non-pregnant adults, 
iodine deficiency is characterised as moderate when median UIC is 20-49 µg/L (WHO, 2007; 
WHO, 2013). In pregnant women, mild-to-moderate iodine deficiency is defined as median 
UIC in the range 50-149 µg/L (Zimmermann, 2007). 
Percentile is a statistical measure indicating the value below which a given percentage of 
the observations fall. Percentiles can be reported as PX, i.e. that P5 indicates the level of a 
measurement for which 5% of the observations fall below. P50 is the same as median.  
P5, P25, P50, P75 or P95-exposure is the calculated exposure at the 5, 25, 50, 75 or 95-
percentile. 
Severe iodine deficiency: In groups of children (> 6 years) and non-pregnant adults, 
iodine deficiency is characterised as severe when median UIC is < 20 µg/L (WHO, 2007; 
WHO, 2013). In pregnant women, severe iodine deficiency is defined as UIC <50 µg/L 
(Zimmermann, 2007).  
“Wolff-Chaikoff effect”: a description of the acute auto regulatory phenomenon, whereby 
the thyroid detects iodine excess and down-regulate the processes involved in thyroid 




EFSA - Dietary Reference Values (DRVs) (EFSA, 2010c) 
Average Requirement (AR) is the level of intake of a defined group of individuals 
estimated to meet the physiological requirement of metabolic demand, as defined by the 
specific criterion for adequacy for the nutrient, in half of the healthy individuals in a life stage 
or sex group, on the assumption that the supply of other nutrients and energy is adequate. 
If an AR cannot be determined, then an Adequate Intake is used. 
Adequate Intake (AI) is defined as the average (median) daily level of intake based on 
observed, or experimentally determined approximations or estimates of a nutrient intake, by 
a group (or groups) of apparently healthy people, and therefore assumed to be adequate. 
The practical implication of an AI is similar to that of a population reference intake, i.e. to 
describe the level of intake that is considered adequate for health reasons. The 
terminological distinction relates to the different ways in which these values are derived and 
to the resultant difference in the “firmness” of the value.  
Population Reference Intake (PRI) is derived from AR of a defined group of individuals 
in an attempt to take into account the variation of requirements between individuals.  
 
 
Figure 1 Population reference intake (PRI and average requirements (AR), if the requirement has a 
normal distribution and the inter-individual variation is known (EFSA, 2010b). 
Lower Threshold Intake (LTI) is the lowest estimate of requirement from the normal 
distribution curve, and is generally calculated on the basis of the AR minus twice its SD. This 
will meet the requirement of only 2.5% of the individuals in the population.  
Tolerable Upper Intake Level (UL) is the maximum level of total chronic daily intake of a 






Figure 2 Relationship between individual intake and risk of adverse effects due to insufficient or 
excessive intake. 
IOM - Dietary Reference Intakes (DRIs) (IOM, 2000) 
Estimated Average Requirement (EAR) is a nutrient intake value that is estimated to 
meet the requirement of half the healthy individuals in a life stage and gender group.  
Recommended Dietary Allowances (RDA) is the dietary intake level that is sufficient to 
meet the nutrient requirement of nearly all (97 to 98 percent) healthy individuals in a 
particular life stage and gender group. RDA = EAR + 2 SDEAR  or if insufficient data to 
calculate SD a factor of 1.2 is used to calculate RDA; RDA = 1.2*EAR 
Adequate Intake (AI) is the recommended intake value based on observed or 
experimentally determined approximations or estimates of nutrient intake by a group (or 
groups) of healthy people that are assumed to be adequate – used when an RDA cannot be 
determined 
Tolerable Upper Intake Level (UL) is the highest level of nutrient intake that is likely to 





Figure 3 Dietary reference intakes. 
NNR -Recommended Intake (NNR Project Group, 2012) 
Average Requirement (AR) is defined as the lowest long-term intake level of a nutrient 
that will maintain a defined level of nutritional status in an individual i.e. the level of a 
nutrient that is sufficient to cover the requirement for half of a defined group of individuals 
provided that there is a normal distribution of the requirement. 
ARNNR = EARIOM = AREFSA 
Recommended Intake (RI) is defined as the amount of a nutrient that meets the known 
requirement and maintains good nutritional status among practically all healthy individuals in 
a particular life stage or gender group. RI= AR + 2SDAR. 
RINNR = RDAIOM = PRIEFSA 
Upper Intake Level (UL) is defined as the maximum level of long-term (months or years) 
daily nutrient intake that is unlikely to pose a risk of adverse health effects in humans. 
ULNNR =ULIOM = ULEFSA 
The Lower Intake (LI) is defined as a cut-off intake value below which an intake could lead 
to clinical deficiency symptoms in most individuals. Same as LTI in EFSA’s terminology. 
World Health Organization (WHO, 2007) 





Background as provided by the 
Norwegian Food Safety Authority 
Risk of iodine deficiency in Norway 
Iodine is an essential nutrient required for the synthesis of the thyroid hormones 
triiodothyronine and thyroxine. These hormones help regulating key metabolic processes in 
every cell of the body and are particularly important for brain cell development. Both iodine 
deficiency and iodine excess increase the risk of thyroid disturbances.  
In June of 2016, the National Nutrition Council in Norway published the report “Risk of iodine 
deficiency in Norway. Identifying an immediate need for action” (Nasjonalt råd for ernæring, 
2016). The report shows insufficient iodine intake among fertile, pregnant and breastfeeding 
women. Iodine deficiency in pregnancy or during breastfeeding can impair the neurological 
development of the child. The World Health Organization (WHO) estimates that severe 
iodine deficiency is the leading cause of preventable brain damage in infants worldwide.  
The main sources of iodine in the Norwegian diet are dairy products, eggs, fish and other 
seafood. Low iodine intake among Norwegian women is primarily caused by a decrease in 
the consumption of dairy products and fish. Other risk groups that may have too low iodine 
intake are vegans, individuals who are allergic to milk and fish and some ethnic minorities. 
According to the report from the National Nutrition Council, adult men and children aged 2 
generally have adequate iodine intake. The recommended iodine intake for adults and 
children aged 10 and above is 150 μg of iodine daily.  
An excessive iodine intake is associated with disruption of thyroid gland function. It may 
cause goiter, hypo- and hyperthyroidism as well as inflammation of the thyroid gland 
(thyroiditis). For adults, including pregnant and breastfeeding women, the tolerable upper 
intake level (UL) for iodine, that is the maximum level of total chronic daily intake of a 
nutrient (from all sources) judged to be unlikely to pose a risk of adverse health effects to 
humans, is set at 600 μg per day (NNR Project Group, 2012).  
Iodized salt and other food items  
Iodized household salt is available in Norway. Iodization of salt is currently not compulsory in 
Norway and only allowed in concentrations up to 5 μg of iodine per gram of salt. Some foods 
on the Norwegian market also contain iodized salt. These are primarily imported foods such 
as bread, baked goods, soups and sauces.  
The report from the National Nutrition Council suggests various measures to increase iodine 
intake in the population, especially among women who are of childbearing age, pregnant or 
breastfeeding. The suggested measures include recalculating how much iodine should be 




compulsory use of iodized salt in parts or all of the food industry. Iodine concentrations in 
salt vary across Europe, from 5 μg/g up to 75 μg/g. For example, Sweden and Finland have 
increased iodine intake in their population by using respectively 50 and 25 μg iodine per 
gram of salt. In Denmark, the salt iodization level required by the authorities of iodine in salt 
has been 13 µg/g but was increased to 20 µg/g from 1 July 2019. The order made by the 
Danish Ministry of the Environment and Food, applies to bread and general bakery.  
The iodine compounds used for addition to foods are potassium iodide (KI), sodium iodide 
(NaI) and potassium iodate (KIO3).  
Salt intake  
The average salt intake in Norway is estimated to be about 10 grams per day for men and a 
little less for women. “The National action plan to reduce salt intake 2014-18” is based on 
the National Nutrition Council’s Strategy for reducing salt intake in the population. The 
national action plan aims at reducing salt intake in the Norwegian population by 15 percent 
in 2018 and 30 percent by 2025.  
Iodine in milk 
The report also suggests regulating iodine content in Norwegian milk. Milk contains iodine 
which is added to cow feed in order to avoid iodine deficiency in cattle. Iodine fortification in 
animal feed is intended to cover the animal’s needs rather than increasing iodine 
concentration in milk meant for human consumption. In recent years, the iodine 
concentration in milk has been stable in Norway (16 μg/100 g milk) and feed regulations 
remain difficult to alter. The possibility of reducing and/or standardising iodine concentration 
in milk was therefore not included in the terms of reference to VKM.  
New data  
The publication of the National Nutrition Council’s report has been followed by the 
announcement of new data on iodine contents in foods as well as a new dietary survey 
carried out among children and adolescents (Ungkost 3). These new data offer an 
opportunity to adjust current estimates of iodine intake in the Norwegian population. New 
data on iodine intake among Norwegian women during pregnancy and breastfeeding have 
also been published.  
In May 2018, the Norwegian Food Composition Table was published with updated iodine 





Terms of reference as provided by the 
Norwegian Food Safety Authority 
The Norwegian Food Safety Authority (NFSA) hereby requests the Norwegian Scientific 
Committee on Food and Environment (VKM) to conduct a benefit-risk assessment of 
iodization of household salt and of industrial salt used in bread. The assessment should 
include subpopulations which are at risk of overly low or high intake of iodine, including 
women of childbearing age, women who are pregnant and breastfeeding, men and children. 
Other risk groups such as vegans, individuals suffering from allergy or intolerance to fish and 
dairy products, relevant ethnic minorities and individuals consuming iodine supplements 
should also be considered. Iodization of plant-based alternatives to cow milk products should 
also be considered. Imported foods that are fortified with iodine and sold on the Norwegian 
market should also be taken into account. 
The aforementioned benefit-risk assessment should be executed in parallel with a separate 
assignment sent to VKM: establishing a new maximum limit for iodine in food supplements. 
The benefit-risk assessment should cover the following:  
1. What is the iodine intake in the general population and among identified risk groups? 
Risk groups meaning subpopulations at risk for overly low or high iodine intake.  
2. What would the iodine intake in the general population and among identified risk groups 
(see above) be if household salt and industrial salt used in bread were to be iodized and 
if plant-based milks were to be fortified with iodine levels comparable to those in cow 
milk? Table 1 shows the iodization levels in salt for which the potential effect on iodine 
intake is to be estimated. The iodine intake resulting of the various scenarios should be 
estimated both with and without the added effect of iodine fortification of plant-based 
alternatives to dairy products (milk 16 μg/100 g). The estimates should also be 
considered in the context of the Salt Strategy 2015 (governmental initiatives to reduce 
salt consumption).  
 
Table 1 Requested scenarios. 
Iodization levels 
Food items 
20 mg iodine/kg 
Household salt  
 Industrial salt used in bread 
Household salt + Industrial salt used in bread 
25 mg iodine/kg 
Household salt  
 Industrial salt used in bread 






50 mg iodine/kg 
 
Household salt  
 Industrial salt used in bread 
Household salt + Industrial salt used in bread 
 
3. What potential health effects will the various iodization levels have for the general 
population and the identified risk groups (see above)?  
NFSA requires that VKM estimates iodine intake based on data from the national dietary 
surveys among adults (Norkost 3; age 18-70 years) children and adolescents (Ungkost 3; 
ages 4-, 9- and 13-years), infants and children age 1 and 2 years (Spedkost and 
Småbarnskost), the Norwegian Mother and Child Cohort Study (MoBa) as well as other 







Iodine is an essential micronutrient required for synthesis of the thyroid hormones 
triiodothyronine (T3) and thyroxine (T4). Through these hormones, iodine has an important 
role in energy-yielding metabolism and on the expression of genes that affect many 
physiological functions, including embryogenesis and growth, and the development of 
neurological and cognitive functions (Zimmermann et al., 2008). 
Iodine deficiency has since the beginning of this century been recognised as a worldwide 
problem and is the most common preventable cause of brain damage (Hetzel, 2012). 
Although there has been remarkable progress in ameliorating iodine deficiency, it still 
remains a public health concern in many countries, including some European countries 
(Lazarus, 2014; WHO, 2007). Also, iodine deficiency in the population has re-emerged in 
some European countries previously considered iodine sufficient, including Norway. 
According to the report from the National Nutrition Council in Norway “Risk of iodine 
deficiency in Norway”, iodine intake is particularly low among women of childbearing age 
including pregnant and breastfeeding women (Nasjonalt råd for ernæring, 2016).  
A recent systematic review has confirmed that inadequate iodine intake is widespread in 
Norway among women of childbearing age, also pregnant and breastfeeding women, infants 
who are exclusively breastfed, elderly persons, vegans and Somali immigrants (Henjum et 
al., 2019). In particular, the authors of the review expressed concern regarding iodine status 
among women of childbearing age, as all included studies published after 2016 showed a 
median urinary iodine concentration (UIC) lower than the cut-off for adequate group median 
set by the WHO for this group (see Figure 1-1). 
The need for action to secure adequate iodine intake in Norway, particularly in vulnerable 
groups is emphasised in the report from the Norwegian National Nutrition Council (Nasjonalt 
råd for ernæring, 2016). Increased iodization of salt and use of iodized salt in bread and 





Figure 1-1 Median urinary iodine concentration (UIC) in Norwegian women of childbearing age. The 
dotted lines represent UIC cut-offs for insufficient iodine intake set by the WHO (median 
UIC<150 µg/L for pregnant women and median UIC<100 µg/L for non-pregnant) (WHO, 2007). The 
figure is based on eight Norwegian studies summarised by (Henjum et al., 2019).  
1.1 Global recommendation for salt iodization 
Iodization of salt (sodium chloride) has been recommended by the WHO as the preferred 
strategy for preventing iodine deficiency disorders in the global context (WHO, 2014), and is 
currently implemented in more than 120 countries worldwide. The recommendation was 
justified by a comprehensive systematic review and meta-analysis that provided a synthesis 
of available data comparing the effect of consumption of iodized salt on an array of health 
outcomes related to iodine deficiency, including goiter, cretinism, cognitive function, hypo- 
and hyperthyroidism. The authors concluded that iodized salt has a large effect on reducing 
the risk of iodine deficiency, goiter, cretinism and low cognitive function (Aburto et al., 
2014). The authors also emphasised the importance of robust monitoring of salt iodization 
programmes to ensure safe and effective levels of iodine consumption, especially as 
countries implement programmes to reduce population salt intake. 
According to the WHO, the reasons for salt being an appropriate vehicle for iodization 
include:  
“(i) it is widely consumed by virtually all population groups in all countries, with little 
seasonal variation in consumption patterns, and salt intake is proportional to energy 
intake/requirements; (ii) in many countries, salt production is limited to a few centres, 
facilitating quality control; (iii) the technology needed for salt iodization is well 
established, inexpensive and relatively easy to transfer to countries around the world; 
(iv) addition of iodate or iodide to salt does not affect the taste or smell of the salt or 
foods containing iodized salt, and therefore consumer acceptability is high; (v) iodine 




such as bouillon cubes, condiments and powder soups, and hence these products 
become sources of iodine; and (vi) iodization is inexpensive (the cost of salt iodization 
per year is estimated at US$ 0.02–0.05 per individual covered, and even less for 
established salt-iodization programmes)” (WHO, 2014). 
WHO recommends salt as a vehicle for correcting iodine deficiency in a population, and 
furthermore, WHO recommends that iodization programs should be monitored (UNICEF, 
2018; WHO, 2007). 
The WHO report outlined the suggested iodization levels to account for recommended iodine 
intake (150 µg/day), losses before consumption (30%) and bioavailability (92%) at various 
salt consumption levels. At an estimated salt consumption of 10 g/day, the average 
suggested iodization level is 20 mg iodine per kg salt, while the suggested iodine 
concentration at an estimated salt consumption of 5 g/day is 39 mg per kg salt (WHO, 
2014). 
 Current salt iodization in Norway 
In Norway, most salt is currently not fortified with iodine. One type of household salt 
containing 5 mg added iodine per kg salt is available. Iodized salt is generally not used in the 
food industry, except that a few manufacturers have added iodized salt to selected products. 
At the current assumed intake level of 10 g salt per day, it would provide a maximum of 
50 µg iodine per day if all salt was iodized at this level. Assuming a mean population salt 
intake of 5 grams per day, which is the long-term target in the governmental initiatives to 
reduce salt consumption, and that all salt used was iodized, salt would provide an average of 
25 µg iodine per day with the current iodization level.  
1.2 Methodology for this benefit and risk assessment 
The overall aim of this report is to provide a benefit and risk assessment of the health impact 
related to current iodine intakes in the Norwegian population, and the health impact of 
increased iodization levels in household salt and salt in bread.  
Established knowledge 
In the first chapters; 2, 3 and 4 we describe what may be considered general and 
established knowledge about the physiology of iodine and health consequences of both low 
and high intakes. We also describe established dietary reference values e.g. recommended 
intakes, average requirement and tolerable upper intake levels based on values from other 
competent bodies. 
Updated literature and evidence for health outcomes 
In chapters 5 and 6, to identify the best available and updated evidence on the health 
effects of mild to moderate iodine deficiency and excessive iodine intakes, we review papers 




deficiency, the literature was reviewed with a specific objective to identify all published 
scientific papers addressing how mild to moderate iodine deficiency affects health, and the 
literature was reviewed according to established methods for weight of evidence. As the 
evidence base for how excessive iodine affects health is far less comprehensive than for 
iodine deficiency, we did not aim at evaluating the literature for excess intakes with the 
same weight of evidence tools as for deficiency. We have only evaluated if new literature is 
in line with the existing tolerable upper intake levels or if new levels should be established. 
Calculated iodine intakes – including the requested scenarios 
In chapter 7 we calculate iodine intakes in the Norwegian population and compare the 
intakes to a selected set of the established dietary reference values described in chapter 4, 
and also calculate the requested scenario of increased iodization levels in household salt and 
salt in bread. 
Bringing it all together 
In the benefit and risk assessment in chapter 8, we bring together and discuss all relevant 
elements in the previous chapters and discuss and weigh the benefits from avoidance of 
iodine deficiency (or risks related to iodine deficiency), the risk related to excessive iodine 
intakes, and the impact of increased iodization levels in household salt and salt in bread. 
Uncertainty, data gaps and conclusion 
Finally, we describe the most evident uncertainties and data gaps and answere the questions 
in the terms of reference. 
Iodine from food supplements 
We have not taken into account intervention studies that have investigated effects of 
individual supplementation specifically. Furthermore, in the chapters describing and 
discussing the iodine exposure and the increased iodization scenarios, our conclusions are 
based upon calculations without iodine supplements. However, calculations for supplement 
users are presented in Appendix V. 
In a separate assignment from the Norwegian Food Safety Authority, VKM is requested to 
evaluate the consequences of establishing maximum limits for iodine at 150, 250, 450, 600 
or 1100 μg/day, as examples in food supplements, and to evaluate the total intakes of iodine 
in exposure scenarios including basic foods, iodized foods and food supplements, against 





2 Iodine physiology and metabolism 
2.1 Chemistry 
Nonradioactive iodine-127 is the most stable and common isotype of the 37 isotopes found 
in nature. Iodine belongs to the group of elements known as halogens. Due to its large 
atomic size, it is the least reactive of the halogens, but it can exist in different chemical 
states, including iodide (I-), elemental iodine (I2), iodate (IO3-) and periodate (IO4-). This 
redox sensitive chemical speciation makes the iodine cycle in the environment extremely 
complex. Approximately 70% of global iodine is present in marine systems. Iodine in the 
lithosphere and pedosphere is often limited, which causes iodine deficiency in some parts of 
world (Cox and Arai, 2014). Potassium iodide (KI) and potassium iodate (KIO3) are often 
used for iodization of refined table salt. Iodate is less soluble and more stable than iodide. 
Foods contain iodine mainly as iodide (I-), but also as iodate (IO3-), or thyroxine. 
2.2 Absorption, distribution, metabolism and excretion 
Iodine is an essential micronutrient for humans. The human body possesses a number of 
mechanisms by which it can absorb, collect, concentrate and excrete iodine in the form of its 
monovalent anion iodide. This system encompasses several organ systems and different 
physiological processes, all to ensure strict control of iodine processing and utilisation.  
Iodine in the form of inorganic iodide (I-), is rapidly and nearly completely absorbed (>90%) 
in healthy adults (Nath et al., 1992; van der Reijden et al., 2019). Other chemical states of 
iodine, such as iodate and protein-bound iodine in foods, are reduced in the gastrointestinal 
tract to iodide prior to being absorbed. The sodium/iodide symporter (NIS), a transport 
protein of the apical surfaces of enterocytes, mediates active uptake of iodine from the 
stomach and small intestine (Nicola et al., 2009). NIS is also located on the basal membrane 
in thyroid follicular cells. As the activity of NIS is three to four times greater in the thyroid 
gland than in any other tissue in the body, it allows the gland to sequester iodide from the 
blood and accumulate iodine as a precursor for synthesis of thyroid hormones (T3 and T4) 
(Carrasco, 2003; Dohan and Carrasco, 2003).  
The expression and function of NIS is under hormonal regulation by thyroid stimulating 
hormone (TSH) (Riedel et al., 2001). At low TSH levels, NIS transport activity is inhibited, 
while NIS is downregulated when the amount of iodide taken up from food increases 
(Callejas et al., 2016; Leoni et al., 2011; Nicola et al., 2012). Thus, the thyroid sequesters 
and accumulates iodide depending on iodine and thyroid hormone homeostasis (Doggui and 
El Atia, 2015; Portulano et al., 2014; Zimmermann, 2009).  
A sudden excess of circulating iodide, as a consequence of high iodine intake, rapidly 
decreases iodine transfer into the thyroid, as well as production and release of thyroid 
hormones (Laurberg et al., 2010; Wolff and Chaikoff, 1949). This thyroid block, called the 




transient and thyroid function returns to normal after a few days. In some individuals, the 
“Wolff-Chaikoff effect” does not occur and excess iodine leads to a sustained increase in 
hormone synthesis, resulting in iodine-induced hyperthyroidism, also known as the “Jod-
Basedow effect”. This effect is most frequently observed following iodine supplementation or 
fortification in areas with very low iodine intake (Delange et al., 1999).  
A healthy adult body contains 15-20 mg of iodine, 70-80% of which is stored in the thyroid 
gland (Callejas et al., 2016). In chronic iodine deficiency, the iodine content of the thyroid 
may fall below 20 µg (Zimmermann, 2009). The thyroid takes up approximately 10% of the 
iodine from the circulation in an iodine-sufficient human, whereas in states of chronic iodine 
deficiency, the thyroid can take up more than 80% of the circulating iodine (DeGroot, 1966; 
Stanbury, 1954). During lactation, the mammary glands concentrate iodine and actively 
secrete it into milk for the infant. A few other tissues take up small amounts of iodine, 
including the salivary glands, gastric mucosa, and choroid plexus (Callejas et al., 2016). 
When dietary iodine intake is abundant, absorbed iodide is distributed through the 
extracellular space with a half-life of approximately 10 h in the circulation. Approximately 
90% of ingested iodine is excreted, mainly in urine and the remainder in feces (Callejas et 
al., 2016). In states of iodine deficiency, however, the half-life varies due to a more rapid 
thyroid uptake and increased glomerular filtration rate. Thus, losses via urine are regulated 
both through circulating levels (urine content is proportional to blood concentration) and the 
efficiency of tubular reabsorption (Kohlmeier, 2015). 
2.3 Biomarkers of iodine status and thyroid function 
Several different indicators are used to assess the iodine status and thyroid function in a 
population: urinary iodine concentration (UIC), serum thyroid stimulating hormone (TSH) or 
thyroid hormones (T3 and T4) concentrations, serum thyroglobulin (Tg), and thyroid volume 
(Tvol) by palpation and/or by ultrasonography. These indicators are complementary, in that 
UIC is a sensitive indicator of recent iodine intake (days), Tg is an indicator of intermediate 
response (weeks to months), whereas changes in Tvol and goiter rate reflect long-term 
iodine nutrition (months to years) (Zimmermann, 2008).  
Figure 2.3-1 below illustrates a simplified model of human iodine and thyroid status at 
different stages (left to right) of decreasing iodine intake, published by (Zimmermann and 
Andersson, 2012). The three stages iodine sufficiency, iodine deficiency with increased 
thyroidal iodine clearance, and iodine deficiency leading to thyroid dysfunction, are 





Figure 2.3-1 The physiological stages of iodine status (Source: Figure 5 (Zimmermann and 
Andersson, 2012). 
 
According to Zimmermann, the scientific evidence is limited with regard to the absolute 
levels of habitual daily iodine intake at which thyroid stores decrease and thyroid dysfunction 
occurs. In addition, thyroid function is inhibited when iodine intake becomes too high (Laurberg et 
al., 2010). The biomarkers of iodine status are described in more details below. 
Urinary iodine concentration (UIC) 
Urinary iodine concentration (UIC) provides direct information about iodine intakes as ≥92% 
of dietary iodine is absorbed and, in healthy, iodine-replete adults >90% is excreted in the 
urine within 24-48 h (Callejas et al., 2016). Therefore, UIC is regarded as a reliable 
biomarker and the most commonly used indicator for assessing recent iodine intake at group 
level and to classify populations worldwide as iodine deficient, iodine sufficient or with 
excessive iodine intake (WHO, 2007; Zimmermann et al., 2008). Random spot urine samples 
are the most widely used specimen for biochemical measurement of UIC (Soldin, 2002) and 
has been recommended as an acceptable biomarker of short-term iodine intake at a 
population level (Rohner et al., 2014; WHO, 2014). The high day-to-day variability in the 
dietary iodine intake of individuals results in high day-to-day variation in UIC which limits the 
usefulness of this measure for assessing iodine status at an individual level (Andersen et al., 
2008). It is therefore not correct to assume that all individuals with UIC<100 µg/L are iodine 
deficient, unless the UIC is based on several repeated measurements. According to one 
study, at least ten spot urine samples or 24-hour urine collections are needed to assess 
individual iodine status with 20% precision (Konig et al., 2011). Because the 24-h excretion 




for urine volume has also been used for estimation of 24-h iodine excretion from spot urine 
samples (Pearce and Caldwell, 2016).  
WHO has established criteria for assessing iodine status based on UIC. These criteria are 
presented in Table 2.3-1. A median urinary iodine concentration of 100 μg/L corresponds 
roughly to an average daily iodine intake of 150 μg (IOM, 2001). 
Table 2.3-1 Epidemiological criteria for assessing iodine status in a population, based on median or 
range of urinary iodine concentrations, modified from (WHO, 2007). 
MEDIAN UIC IODINE INTAKE IODINE STATUS 
School-aged children (≥6 years) and non-pregnant adults 
<20 μg/L Insufficient Severe iodine deficiency 
20–49 μg/L Insufficient Moderate iodine deficiency 
50–99 μg/L Insufficient Mild iodine deficiency 
100–199 μg/L Adequate Adequate iodine nutrition 
200–299 μg/L Above requirements Likely to provide adequate intake for 
pregnant/lactating women, but may pose a slight risk 
of more than adequate intake in the overall 
population 
≥300 μg/L Excessive Risk of adverse health consequences (iodine-induced 
hyperthyroidism and autoimmune thyroid disease) 
Pregnant women   
<150 μg/L Insufficient  
150–249 μg/L Adequate  
250–499 μg/L Above requirements  
≥500 μg/L Excessive  
Lactating women   
<100 μg/L Insufficient  
≥100 μg/L Adequate  
Children < 2 years of age   
<100 μg/L Insufficient  
≥100 μg/L Adequate  
Urinary iodine concentration (UIC) does not provide direct information on the effect of iodine 
intakes on thyroid function, but low UIC values reflect low iodine intakes and thereby 
suggest that populations have increased risk of developing thyroid disorders (Zimmermann, 
2009). 
Thyroid stimulating hormone (TSH), triiodothyronine (T3) and thyroxine (T4) 
Regardless of cause, serum thyroid stimulating hormone (TSH) is a sensitive early indicator 
of thyroid dysfunction (Spencer et al., 1990), and the thyroid gland secretes the thyroid 
hormones T3 and T4 in response to TSH, which is produced in the pituitary gland (Pearce 




The thyroid gland may adapt to iodine deficiency in several ways (Dayan and Panicker, 
2009). Iodine deficiency will cause an increased avidity of the thyroid gland for available 
iodine, an increase in the ratio of T3 to T4 production (Stevenson et al., 1974), increased T4 
to T3 conversion in peripheral tissues, and thyroid gland enlargement (Patel et al., 1973). In 
most populations with mild to moderate iodine deficiency, serum TSH, T3 and T4 are still in 
the normal range. An exception is shown in some areas of mild to moderate iodine 
deficiency, especially among elderly, in whom serum TSH values may be decreased due to 
the increased prevalence of hyperthyroidism from autonomously functioning nodular goiter 
(Knudsen et al., 2000). 
In populations living in moderate to severe iodine-deficient areas, serum TSH levels may be 
elevated whereas T4 levels may be slightly low and T3 levels may be slightly high compared 
to those living in iodine-sufficient areas (Chopra et al., 1975). Changes in T3 and T4 
concentration due to decreased iodine intakes can be explained by a preferential secretion of 
T3 by the thyroid which occurs because the activity of T3 is roughly four times that of T4, 
and T3 only needs 85% as much iodine for its synthesis (Callejas et al., 2016). 
Likewise, studies show that excessively high iodine intakes can lead to thyroid dysfunction, 
which may result in slightly elevated serum TSH values (Laurberg et al., 2010; Meng et al., 
2013). Although TSH may be slightly increased by mild to moderate iodine deficiency and 
excessive iodine exposure, values often remain within the reference range and TSH is an 
insensitive marker of iodine status and therefore a poor indicator of iodine status in older 
children and adults (Zimmermann, 2009; Zimmermann et al., 2008). However, a systematic 
review by (Zimmermann, 2008) concluded that in iodine deficient populations, TSH is a 
sensitive indicator of iodine status in newborns. 
Thyroglobulin (Tg) 
Thyroglobulin (Tg) is a protein synthesised and secreted by the thyroid gland. Serum Tg is 
widely used as a marker for monitoring thyroid cancer and also in the diagnosis of certain 
other thyroid diseases (Knudsen et al., 2001). Increased plasma Tg is seen both during 
iodine deficiency and iodine excess and is considered a sensitive marker for iodine status (Ma 
and Skeaff, 2014). For example, when iodine intakes decrease, an increase in Tg and thyroid 
volume will follow. Increased Tg or thyroid volume (Tvol) is as an early sign of increased 
thyroid activity and is not regarded as a clinically relevant endpoint for thyroid dysfunction if 
thyroid hormone production is still within the normal range. 
In iodine sufficiency, small amounts of Tg are secreted from the thyroid into the circulation 
(Spencer and Wang, 1995). In iodine deficiency, serum Tg increases due to greater thyroid 
cell mass and TSH stimulation (Zimmermann, 2008). Studies have reported that serum Tg 
appears to be well correlated with the severity of iodine deficiency as measured by UIC and 
that Tg is a more sensitive indicator of iodine status than TSH or T4 (Bath et al., 2017; 




It is important to notice, however, that the validity of Tg as a measure of iodine deficiency is 
limited in people with detectable anti-thyroglobulin antibodies (TgAb), who comprise ~10% 
of the adult population (Hollowell et al., 2002; Spencer and Wang, 1995).  
Furthermore, serum Tg levels are affected by the highly increased levels of human chorionic 
gonadotropin (hCG) during the first trimester of pregnancy, which stimulate thyroid function 
(Fantz et al., 1999). Some studies have therefore questioned whether Tg is a valid marker of 
iodine deficiency in pregnancy, at least in mildly iodine-deficient environments (Koukkou et 
al., 2016; Laurberg et al., 2007), whereas another study concluded that Tg shows promise 
as a long-term marker of iodine status in pregnant women (Bath et al., 2017).  
Thus, researchers have suggested that future studies among pregnant women should 
consider measurement of Tg concentration concurrently with TgAb, in addition to urinary 
iodine-to-creatinine ratio and that validated assays with trimester-specific reference ranges 
may be needed when assessing the iodine status of pregnant women (Bath et al., 2017; 
Pearce and Caldwell, 2016). 
Thyroid volume (Tvol) 
Goiter, an enlarged thyroid gland, is the most visible effect of iodine deficiency. 
Correspondingly, large excesses of iodine inhibit thyroid hormone production, and may lead 
to increased TSH stimulation, thyroid growth and goiter (Farebrother et al., 2019a). 
Enlargement of the thyroid gland and prevalence of goiter is commonly measured by two 
different methods: neck inspection and palpation, and thyroid ultrasonography. In areas of 
mild to moderate iodine deficiency, the sensitivity and specificity of palpation are poor and 





3 Health consequences of iodine 
deficiency or excessive iodine 
Both severe iodine deficiency and excessive iodine intake can result in thyroid dysfunction. 
Iodine is essential for the synthesis of the thyroid hormones that are required for healthy 
development, growth, and metabolism (Zimmermann, 2011). Thyroid hormones are critically 
important for the foetus and young infant by affecting the development and maturation of 
the nervous system, skeletal muscles, and lungs. The health consequences of both deficiency 
and excess are accordingly mediated through altered thyroid function. This chapter describes 
the consequences of severe iodine deficiency and excess. 
As discussed in chapter 2, there are substantial limitations in the iodine biomarkers. UIC is 
suitable to describe the status in populations but not in individuals. Severe iodine deficiency 
causes hypothyroidism. It is also prudent to assume that mild to moderate deficiency can 
have similar, but milder consequences. The limitations in defining iodine status in individuals, 
however, challenges the identification of a level at which adverse effects occur.  
When the population median UIC is low, a higher proportion is likely to have severe 
deficiency compared to when the UIC is higher. Associations between UIC or iodine intake 
and thyroid-related health outcomes have been observed in populations with mild to 
moderate deficiency, however, whether these associations are due to consequences of mild 
to moderate or severe deficiency is not known. 
The association between iodine intake and the occurrence of thyroid disorders in a 
population is U-shaped (Laurberg and Nohr, 2002) as illustrated in Figure 3-1. 
 




3.1 Health consequences of iodine deficiency 
The thyroid is estimated to use 60-80 µg of iodide daily to produce its customary output of 
thyroid hormones (Zimmermann, 2012). About a quarter of this is acquired from recycling 
endogenous iodide and the rest is acquired from the diet (Zimmermann et al., 2008). 
 Reduced thyroid function and goiter 
When the availability of iodine decreases, various auto regulatory mechanisms are triggered 
to maintain normal thyroid function (euthyroidism). These include increased thyroid activity 
to maximise iodine uptake and preferential production of T3 to T4 to save one iodine atom 
per hormone molecule and secure availability of T3, the directly active form of thyroid 
hormone (Obregon et al., 2005). Therefore, many individuals in iodine deficient areas are 
clinically euthyroid and their TSH levels are not elevated because the level of circulating T3 is 
normal. Increased TSH production stimulates excessive growth of the thyroid gland, i.e. 
goiter, and occurs when thyroidal mechanisms are no longer sufficient to maintain normal T3 
levels. Goiter may in the most severe form lead to mechanical difficulties such as difficulty in 
swallowing and breathing and may evolve into a life-threatening condition. 
Hypothyroidism may also be caused by several other conditions than iodine deficiency. 
Common causes are autoimmune disease, such as Hashimoto’s thyroiditis, surgical removal 
of the thyroid, and radiation treatment. 
It has been reported that endemic goiter appears in populations where daily iodine intake is 
less than 50 µg/day (Hetzel, 1988; Stanbury and Hetzel, 1980), leading to a reduction in the 
iodine content of the thyroid gland. The most important functions of the thyroid hormones 
are regulation of metabolism, heart rate and organ development. Iodine deficiency may lead 
to several severe complications mediated through poor thyroid function, collectively termed 
iodine deficiency disorders (IDD). Iodine deficiency affects all populations at all stages of life, 
from the intrauterine stage to old age as shown in Table 3.1-1. 
 
Table 3.1-1 Effects of severe iodine deficiency, by life stage (Source: Adapted from WHO, 2005). 
Life stage Effects 
Foetus Abortions 
 Stillbirths 
 Congenital anomalies 
 Increased perinatal mortality 
 Increased infant mortality 
 Neurological cretinism: mental deficiency, deaf mutism, spastic 
diplegia and squint 
  
Neonate Neonatal goiter 
 Neonatal hypothyroidism 
  
Child and adolescent Goiter 




Life stage Effects 
 Impaired mental function 
 Retarded physical development 
  
Adult Goiter with its complications 
 Hypothyroidism 
 Impaired mental function 
 Iodine-induced hyperthyroidism 
 
 
 Neurodevelopmental outcomes 
As thyroid hormones stimulate the metabolism in most body tissues, and are essential for 
brain development (Delange, 2001), poor iodine status may lead to poor development of 
foetuses, infants, and children.  
The central nervous system grows rapidly during foetal life and into early childhood. The first 
1000 days of life, counting from conception, are regarded as the most critical period for 
negative influences that may affect neurological development. The growth of the central 
nervous system is sequential, where the various steps may depend on each other, and each 
step may be particularly crucial for a distinct function. The severity and specific outcomes 
affected by negative influences are accordingly related to both the timing and magnitude of 
the exposure (Zoeller and Rovet, 2004). The different phases of brain development are 
depicted in Figure 3.1.2-1 below. 
Thyroid hormone receptors are present in the foetal brain from around nine weeks after 
conception, and the foetal hormone production commences around week 14. However, little 
hormone synthesis occurs until the 18th to 20th week (Bernal, 2007). During this period, the 
foetus depends on maternal thyroid hormones, particularly T4, since T3 found in the foetal 
brain is predominantly derived locally from T4 (Obregon et al., 2005).  
The thyroid hormones are required for neurogenesis, axon and dendrite growth, neuronal 
migration and differentiation of neural cells, for generating synapses, and for myelination of 





Figure 3.1.2-1 Human brain development (Source: adapted from (Thompson and Nelson, 2001). 
The x-axis is time from birth (conception = -9 months), y-axis is a relative scale indicating the 
magnitude of development of a particular neurodevelopmental function. 
As illustrated in Figure 3.1.2-1, hypothyroidism due to iodine deficiency, occurring during 
certain sensitive periods of foetal life, infancy, or early childhood have the potential to 
hamper neurodevelopment and result in lasting suboptimal cognitive function. The impact 
and which functions that are affected, however, will depend on the timing and severity of 
deficiency. Severe iodine deficiency during these critical phases can lead to permanent 
intellectual disability, which in its most severe form is known as cretinism. This syndrome is 
characterised by permanent brain damage, mental retardation, deaf mutism, spasticity and 
stunting. Cretinism is currently hardly ever seen in Norway and most other affluent 
countries. While it is well documented that severe iodine deficiency during foetal life may 
cause impaired neurodevelopment in children, the potential adverse effects of mild to 
moderate deficiency are unclear (Zimmermann et al., 2008).  
It should be noted that hypothyroidism is also a significant cause of infertility so that women 
with severe deficiency often fail to reproduce. Iodine deficiency is also a risk factor for 
thyroid cancer, particularly the more severe cancer forms (Zimmermann and Galetti, 2015). 
 Other health consequences of severe iodine deficiency 
Severe maternal iodine deficiency in pregnancy may also result in miscarriages, preterm 
delivery, stillbirth, and congenital abnormalities. These effects are mediated through the 
action of thyroid hormones on the developing tissues as well as an indirect effect of 
decreased metabolism following reduced thyroid function (Zimmermann and Boelaert, 2015). 
Severe iodine deficiency in infancy increases neonatal and infant mortality (DeLong et al., 
1997). 
3.2 Health consequences of excessive iodine 
In general, there have been more studies and reports of adverse health consequences of 
iodine deficiency than of iodine excess. However, it has been established that excessive 




decreased (hypothyroidism) thyroid hormone production (Burgi, 2010; Farebrother et al., 
2019a; Katagiri et al., 2017; Laurberg et al., 2010).  
Iodine-induced hyperthyroidism (IIH) may occur in individuals with thyroid nodular changes, 
as a side effect of iodine supplementation or in populations with increased iodine intake 
following recent iodine fortification (Delange et al., 1999; Stanbury et al., 1998). In this 
condition, excess iodine leads to a sustained increase in hormone synthesis (“Jod-Basedow 
effect)”. IIH might be transient or permanent, and risk factors include thyroid diseases and 
chronic iodine deficiency (Laurberg et al., 2010; Pramyothin et al., 2011). 
The other harmful consequence of iodine excess is hypothyroidism. In order to protect 
against hyperthyroidism due to excess iodine, the normal physiological response is to block 
iodine transport into the thyroid, thereby inhibiting the production and release of thyroid 
hormones. This is called the “Wolff-Chaikoff effect” (Wolff and Chaikoff, 1949). Typically, 
thyroid hormone levels return to normal after a few days of this effect, termed the “escape” 
or “adaption” from the “Wolff-Chaikoff effect” (Eng et al., 1999). Failure to adapt and return 
to normal thyroid hormone production is considered to play a role in the development of 
clinical or subclinical hypothyroidism (Katagiri et al., 2017). Risk factors for iodine-induced 
hypothyroidism include previous iodine deficiency, underlying thyroid autoimmunity for which 
Caucasian populations may have a genetic predisposition (Laurberg et al., 2010), or a history 
of partial thyroidectomy.  
Reviews of the epidemiological evidence on excess iodine in relation to thyroid function 
suggest that high iodine intake is associated with subclinical hypothyroidism more often than 
hyperthyroidism. The evidence is more limited in children than in adults. 
The clinical consequence of excessive intakes in young children is uncertain, and the studies 
found adequate for comparison with the existing UL (chapter 6.2.2) only include children at 
or above the age of 6 years. However, a recent non-systematic review study of iodine excess 
and thyroid function highlights three publications that include children aged 6-24 months 
from areas of Africa, Asia, or Europe (Croatia only). The overall conclusion was that “…long 
term effects of chronic excessive iodine on thyroid function and somatic growth and 
development in infants and young children remain uncertain” (Farebrother et al., 2019a). 
One of the studies included in this review assessed thyroid function and Tg concentrations in 
6-24 month-old infants from several countries and observed an increase in Tg in infants with 
estimated habitual iodine intakes >230 µg/day. The authors concluded that “The association 
between UIC and Tg concentration follows the same U-shaped association in 6-24 months 
weaning infants as in other population groups. However, our data suggest the optimal intake 
range is narrower than in older children or adults» (Farebrother et al., 2019b). The two other 
studies were carried out in groups with more extreme iodine intakes (median UIC > 
400 µg/L) and reported an increased prevalence of subclinical hypothyroidism (Aakre et al., 
2016; Nepal et al., 2015). Whether these findings have clinical or developmental 
consequences is uncertain, but subclinical hypothyroidism may in some cases progress to 




Iodine excess may be particularly harmful in certain life-stages and population groups, 
notably pregnant women, infants, and toddlers (Leung and Braverman, 2014). For this 
reason, high doses of iodine are contraindicated during pregnancy (Carswell et al., 1970; 
Frey, 1971). It has been pointed out that infants and children have a higher turnover of 
thyroid hormones than adults and that changes in thyroid physiology during infancy could 
increase the vulnerability of infants to extremes of iodine intake (Farebrother et al., 2019a). 
Whether excessive iodine exposure, acute or chronic, is a significant cause of poor 
neurodevelopment or other adverse health outcomes is still a matter of debate. 
Developmental brain damage due to excess iodine has only been demonstrated in animal 
models for extremely high doses. 
3.3 Thyroid cancer 
Both low and high iodine intakes may contribute to the development of thyroid cancer 
(Zimmermann and Galetti, 2015). The cited reviews are all found in the literature search, 
even though thyroid cancer was not included in the search terms, and the summary in this 
chapter is not systematic.  
A comprehensive review including both animal and human studies, assessed the relationship 
between iodine intake and risk of thyroid cancer (Zimmermann and Galetti, 2015). Animal 
studies indicate that iodine deficiency is a strong promoter of thyroid cancer, mainly of the 
follicular, more malignant type. The proposed mechanism for the effects of iodine deficiency 
is chronic elevation of TSH that stimulates thyrocyte proliferation and increases the likelihood 
of mutagenesis. However, the relevance of these findings from animal studies to humans are 
uncertain (Zimmermann and Galetti, 2015). 
Over the past two to three decades, there has been a clear temporal relationship in many 
countries between introduction of iodized salt and an increase in incidence of papillary 
thyroid cancer which is a mild form of thyroid cancer. However, at the same time, several 
countries that have stable or decreasing iodine intakes, including Australia, the U.S. and 
Switzerland have also experienced an increase in this cancer type. Although a causal role of 
iodine intake in the etiology of papillary thyroid cancer cannot be ruled out, a more likely 
explanation for the increasing incidence of papillary thyroid cancer worldwide is the 
introduction and wider use of improved thyroid diagnostics (Zimmermann and Galetti, 2015). 
The overall incidence of thyroid cancer in populations does not appear to be influenced by 
the usual range of iodine intakes from dietary sources. Data from countries before and after 
iodine prophylaxis have demonstrated a change in the distribution to less malignant 
subtypes, which is in line with the findings from animal studies. Thus, evidence from animal 
and ecological studies indicate that iodized salt programs might be contributing to the 




3.4 Vulnerable groups for iodine deficiency and excessive iodine 
In the following, vulnerable groups refer to populations that for biological reasons are 
especially vulnerable to low or high iodine intakes. Populations at particular risk of low or 
high iodine intakes are described in chapter 7.3.3. 
Due to the massive and stepwise growth of the central nervous system in early life, foetuses, 
infants and toddlers face the most severe consequences of iodine deficiency and inadequate 
thyroid hormone production (Zoeller and Rovet, 2004). Even small impairments during this 
period may have severe and irreversible consequences for later life particularly for delicate 
systems such as the brain. Therefore, an adequate iodine intake is especially important in 
women of childbearing age and children.  
Both inadequate and excess iodine intake lead to insufficient production of thyroid hormones 
and subsequent health consequences. Pregnant women, their foetuses, and young children 
are therefore also vulnerable to excessive iodine intakes. Some observational studies indicate 
that even a small abrupt increase in iodine intake in pregnant women with previous low 
iodine intake, e.g. from initiation of iodine supplement use, may result in “thyroid stunning”, 
similar to the “Wolff-Chaikoff effect” (Moleti et al., 2011). This effect supports the 
importance of adequate iodine intake and maximised thyroidal iodine stores prior to 
conception (Bath, 2019).  
Individuals with previous or ongoing thyroid dysfunction or those who have suffered from 
iodine deficiency for a long time are also at risk of disturbances in thyroid hormone status 
resulting from sudden increase or excess iodine intake.  
Elderly women are susceptible to nodular goiter. An increased incidence of nodular goiter 
has been described in some populations after introduction of salt fortification, mainly seen in 
older women (Krejbjerg et al., 2014). However, this effect usually disappears when the 
overall iodine status in the population improves. Furthermore, the observed increased 
incidence of noduli is not associated with other clinical consequences, or increased use of 
thyroxine (T4) medication.  
Dermatitis herpetiformis is an autoimmune blistering skin disease associated with gluten 
intolerance and celiac illness. Individuals with dermatitis herpetiformis may experience flare-
ups when exposed to iodine in food or directly on the skin. Small amounts of iodine around 
the recommended daily requirements are not of concern (Nicolas et al., 2003). 
3.5 Summary of health consequences of iodine deficiency and 
excessive iodine 
Iodine deficiency and iodine excess both impair the production of thyroid hormones. Severe 
iodine deficiency will impair growth and neurodevelopment through lower production of 
thyroid hormones. The most severe effect is damage to the foetus resulting in irreversible 




women of childbearing age. It is, however, less clear to which degree mild to moderate 
iodine deficiency may affect growth and development in infancy and childhood. The extent 
to which there is a dose-response relationship between iodine status and health outcomes in 
the mild to moderate deficiency range has not been well described.  
Excessive iodine may lead to both increased (hyperthyroidism) and decreased 
(hypothyroidism) thyroid hormone production. Iodine-induced hyperthyroidism after 
excessive iodine intakes may be transient or permanent, and the risk is increased in persons 
with thyroid disease or chronic iodine deficiency. The observed health consequences of 




4 Dietary reference values for iodine 
Dietary reference values (DRVs) is an umbrella term for a set of nutrient reference values 
that includes the average requirement (AR), the population reference intake (PRI), the 
adequate intake (AI) and the reference intake range for macronutrients (RI). These values 
guide professionals on the amount of a nutrient needed to maintain health in an otherwise 
healthy individual or group of people. DRVs also include the tolerable upper intake level (UL), 
which is the maximum amount of a nutrient that can be consumed safely over a long period 
of time. These terms are described in detail in the chapter listing Abbreviations and 
definitions. 
4.1 Iodine requirement and recommended intakes 
 Institute of Medicine, USA (2001)  
In 2001, the US Institute of Medicine established a recommended dietary allowance (RDA) 
for iodine at 150 µg/day for adults. Thyroid iodine accumulation and turnover were used to 
set the estimated average requirement (EAR). The US Institute of Medicine (IOM) has 
recently been renamed and incorporated into the National Academies of Science, 
Engineering and Medicine (NASEM). Thus, all DRI reports through 2011 were published by 
IOM, while all subsequent reports are published by NASEM.  
IOM (2001) proposed the following equation to calculate daily iodine intake from UIC:  
Daily iodine intake = UIC (μg/L) × 0.0235 × bodyweight (kg) 
The equation assumes that 92% of dietary iodine is absorbed. Although body weight is 
poorly correlated with urine volume in adults, the equation is a good approximation 
considering an average 24-h urine volume of 1.5 L/day in adults. Alternatively, daily iodine 
intake can be estimated from UICs by estimating the daily urinary iodine excretion by means 
of the urinary creatinine concentration. 
The EAR for adolescents ≥14 years and adults was set to be 95 µg/day, assuming a 
coefficient of variation of 40%. The EAR for pregnant and lactating women was set to be 
160 and 209 µg/day, respectively, with a coefficient of variation of 20%. The EARs for 
children 1-8 years an 9-13 years were set to 65 and 73 µg/day, respectively. For children 1-8 
years, the EAR is based on iodine balance studies in children (Malvaux, 1969; Ingenbleek 
and Malvaux, 1974 both cited in IOM, 2001). For adolescents aged 9-13 years, the EAR was 
extrapolated from adult EARs on a metabolic body weight basis allowing for growth needs 
(kg 0.75). 
The RDA was defined as equal to the EAR plus twice the coefficient of variation to cover the 
needs of 97 to 98 percent of the individuals in the group. The calculated values for RDA 
were rounded up to the nearest 50 µg. The suggested RDA values for various age groups 




In collaboration with WHO and FAO, NASEM has proposed harmonised nutrient reference 
values for populations. Instead of the term EAR, AR should be used, and for iodine the 
harmonised AR (h-AR) is the previous EAR for all age groups (Allen et al., 2019). 
Table 4.1.1-1 Suggested recommended dietary allowances (RDAs) for iodine from IOM, µg/day 
(2001). 
 
Adults Pregnant Lactating Children and adolescents 





150 220 290 90 120 130 
EAR* 95 160 209 65 73 95 
*The definition of EAR by IOM corresponds to the term AR used by NNR and the updated proposed harmonised 
nutrient reference values from NASEM (previously IOM). 
 WHO (2005 and 2007) 
Based on recommendations from the Food and Nutrition Board of the United States National 
Academy of Sciences from 1989 and previous WHO-reports, WHO (2005) recommended a 
daily iodine intake of 40 µg/day for young infants (0–6 months), 50 µg/day for older infants 
(7–12 months), 60–100 µg/day for children (1–10 years), and 150 µg/day for adolescents 
and adults (WHO, 2005). According to WHO, these recommended values will ensure normal 
T4 production without stressing the thyroid iodide trapping mechanism or raising TSH levels. 
The recommended nutrient intake (RNI) at 150 µg iodine/day for adolescents and adults is 
justified by the fact that it corresponds to the daily urinary excretion of iodine and to the 
iodine content of food in non-endemic areas (i.e. in areas where iodine intake is adequate). 
Furthermore, it represents the intake of iodine necessary to maintain the plasma iodide 
concentration above the critical limit of 0.10 µg/dL, which is the average level likely to be 
associated with the onset of goiter. Moreover, 150 µg iodine/day is required to maintain 
iodine stores in the thyroid above the critical threshold of 10 µg, to avoid disorders in the 
production of thyroid hormones (WHO, 2005).  
In 2007, WHO/UNICEF/ICCIDD increased the recommended nutrient intake (RNI) for iodine 
during pregnancy and lactation from 200 to 250 µg/day (WHO, 2007). During lactation, 
thyroid hormone production and UIC return to normal, but iodine is concentrated in the 
mammary gland for excretion into breast milk. Thus, using the UIC to estimate intake may 
lead to an underestimate of requirements. To ensure sufficient iodine from breast milk to 
build reserves in the thyroid gland in the infant, WHO increased the RNI for iodine for 
lactating women to 250 µg/day. On the other hand, the rationale for increasing the RNI for 
pregnant women was not well described. The consensus reached by the 
WHO/UNICEF/ICCIDD in 2007 emphasised that in countries without universal salt iodization, 
women of childbearing age should be given oral iodine supplementation to ensure that the 
total iodine intake meets the recommendation of 150 µg iodine per day. However, pregnant 
women should not be recommended to take iodine-containing supplements if the population 




Table 4.1.2-1 Recommended nutrient intakes (RNIs) of iodine from FAO/WHO (20051and 20072), 
µg/day.  




150 250 250 90-120 
 Nordic and Norwegian Nutrition recommendations (2012) 
Prior to the 5th revision of the Nordic Nutrition recommendations (2012), an expert group 
conducted a systematic literature review aiming to summarise the scientific basis for the 
previous iodine recommendation in the Nordic countries (Gunnarsdottir and Dahl, 2012). The 
recommended intake of iodine from 2004 remained unchanged for adults and children 
because no new data supported any changes in the 2012 revision. The iodine requirement to 
prevent goiter was estimated to be 50-75 µg/day for adult women and men, and the AR was 
estimated to be 100 µg/day, an intake level at which the iodine concentration in the thyroid 
gland reaches a plateau. The recommended intake (RI) for adults and adolescents therefore 
remained 150 µg/day and this amount includes a safety margin for goitrogenic substances 
(foods containing substances interfering with uptake of iodine in the thyroid gland, e.g. soy 
and cabbage).  
The NNR expert group also evaluated the scientific rationale for the recommended increased 
iodine intake during pregnancy and lactation from WHO (Gunnarsdottir and Dahl, 2012). In 
pregnancy, a higher iodine intake is recommended to cover for the higher thyroid hormone 
production and simultaneously increased excretion in the urine (Andersen and Laurberg, 
2016). A higher iodine intake is also recommended during lactation to ensure sufficient 
iodine in the breast milk. Although WHO decided to increase the recommended intake of 
iodine for pregnant and lactating women from 200 to 250 µg/day in 2007, these changes 
were not adopted in NNR (2012). The experts responsible for NNR (2012) based this 
decision on lack of new data to support changes in recommended iodine intake for this 
particular group, and that women in the Nordic countries were considered iodine replete 
before pregnancy and having easy access to iodine rich food, such as milk, seafood, and 
dietary supplements. The Norwegian recommendations were based on the Nordic 
recommendations, and the Nordic and Norwegian recommendations for intake of iodine in 
various age groups and pregnant and lactating women are shown in Table 4.1.3-1. 
Table 4.1.3-1 Nordic and Norwegian dietary reference values for iodine, µg/day (NNR Project Group, 
2012). 
 







12-23 mo 2-5 y 6-9 y 
Recommended 
intake (RI) 
















12-23 mo 2-5 y 6-9 y 
Lower intake 
level (LI) 
70      
*the definition of AR corresponds to the term EAR used by IOM (USA). 
 Dietary Reference Values from EFSA (2014) 
The most recent dietary reference values (DRVs) for iodine were set by EFSA in 2014. The 
EFSA Panel concluded that there was insufficient evidence to derive an average requirement 
(AR) or a population reference intake (PRI) for iodine and decided to set an adequate intake 
(AI). The AIs from EFSA were based on studies exploring the relationship between iodine 
intake/status and thyroid gland volumes/prevalence of goiter as markers of mid to long-term 
iodine intakes (EFSA, 2014).  
For adults and children, the AI was based on iodine intakes ensuring a UIC which had been 
associated with the lowest prevalence of goiter in school-aged children (≥100 μg/L). An UIC 
of 100 µg/L corresponds to an approximate daily intake of 150 µg iodine in older adolescents 
and adults. An average urinary volume of 1.5 L/day in adults derived from the water intake 
recommendations, was used to estimate the intake based on UIC at 100 µg/day. 
For infants and young children the proposed AI was also based on the UIC, which had been 
associated with the lowest prevalence of goiter in school-aged children. For children, age-
specific urinary volumes and absorption efficiency of dietary iodine were taken into account 
to calculate the AI. 
For pregnant women, iodine intake was assumed to be adequate before conception. The AI 
for pregnant women at 200 µg/day takes into account the additional needs because of 
increased thyroid hormone production, and iodine uptake by the foetus, placenta and 
amniotic fluid accounting for an additional iodine requirement of 50 µg/day.  
The proposed AI for lactating women of 200 µg/day takes into account the existence of large 
iodine stores in conditions of adequate iodine status before pregnancy and considers that a 
full compensation of the transitory loss of iodine secreted in breast milk is not justified for 
the derivation of an increased AI for iodine for lactating women. Thus, the same AI was set 
for pregnant and lactating women. 
Table 4.1.4-1 Adequate intakes (AIs) for iodine from EFSA (2014), µg/day. 
 
Adults Pregnant Lactating Children and adolescents 
≥18 y   1-10 y 11-14 y 15-17 y 
Adequate 
Intakes (AI) 





 Overview of dietary reference values from previous reports 
Table 4.1.5-1 gives an overview of the recommended dietary iodine intake in adults, whereas 
Table 4.1.5-2 gives reference values for recommended iodine intake in pregnant and 
lactating women. 
Table 4.1.5-1 Overview of dietary reference values for iodine in adults. 
Authority µg/day Critical endpoint 
EFSA, 2014 AI1=150 Thyroid volume enlargement 
NNR, 2012 RI2=150 Thyroid volume enlargement 
WHO, 2005 RNI3=150 Maintain normal T4 production and 
prevention of goiter 
IOM, 2001/ NASEM 
(Allen et al., 2019) 
RDA4=150 Thyroid iodine accumulation and turnover 
1AI=Adequate Intake, 2RI=Recommended intake, 3RNI=Recommended nutrient intake, 4RDA=Recommended 
Dietary Allowances. 
 
Table 4.1.5-2 Overview of DRVs for iodine in pregnant and lactating women and the rationale for 





Rationale for higher intakes than adults 
EFSA, 2014 AI1=200 AI=200 Pregnancy: Increased thyroid hormone production, iodine uptake 
by foetus, placenta and amniotic fluid. Additional need approx. 50 
µg/day, assuming adequate intakes before pregnancy. 
Lactation: Daily iodine losses in breast milk= 60-90 µg. However, 
to further increase iodine intake to cover full compensation for 
iodine losses in breast milk were not considered justified. 
NNR, 2012 RI2=175 RI=200 Pregnancy: To cover the needs of the foetus and to maintain 
maternal thyroid gland function. Assuming adequate intakes 
before pregnancy. 
Lactation: To provide sufficient iodine in the breast milk.  
WHO, 2007 RNI3=250 RNI=250 Pregnancy: Increased glomerular filtration in pregnant women. 
Lactation: To ensure sufficient iodine from breast milk to build 
reserves in the thyroid gland in the infant.  
IOM, 2001 RDA4=220 RDA=290 Pregnancy: Thyroid iodine uptake by the foetus approx 75 μg/day 
Lactation: Average daily loss of iodine in breast milk approx 
114 μg. 
1AI=Adequate Intake, 2RI=Recommended intake, 3RNI=Recommended nutrient intake, 4RDA=Recommended 




4.2 Tolerable upper intake levels (UL) for iodine 
Institute of Medicine (IOM) in US established ULs for iodine in 2001, and Scientific 
Committee on Food (SCF) in EU established ULs for iodine in 2002. The Expert Group on 
Vitamins and Minerals (EVM) in Great Britain suggested safe upper level (SUL) for iodine in 
2003, as did Nordic Nutrition Recommendations in 2012. 
 Institute of Medicine, US (2001) 
The IOM stated that there is little uncertainty regarding the range of iodine intakes that are 
likely to induce elevated TSH concentrations. A lowest observed adverse effect level (LOAEL) 
of 1700 μg iodine per day and a no observed adverse effect level (NOAEL) of 1000 to 
1200 μg iodine per day were estimated for adults (based on Gardener et al. (1988) and Paul 
et al. (1988) cited in IOM, 2001) (IOM, 2001). The IOM chose an uncertainty factor (UF) of 
1.5 to derive a NOAEL from a LOAEL. A higher uncertainty factor was not considered 
necessary because of the mild, reversible nature of elevated TSH over baseline. 
The LOAEL of 1700 μg/day was divided by a UF of 1.5 to obtain a UL of 1133 μg/day of 
iodine, which was rounded down to 1100 μg/day. 
Table 4.2.1-1 Tolerable upper intake levels for iodine in different age groups adjusted by body 
weight suggested by the Institute of Medicine (2001).  






19 and older 1100* 
*Including during pregnancy and lactation. 
In a proposed update from National Academies of Science, Engineering and Medicine 
(NASEM), the harmonised UL (h-UL) is reduced to 200-500 µg/day for children and 
600 µg/day for adults (Allen et al., 2019).  
 Scientific Committee on Food, EU (2002) 
The Scientific Committee on Food (SCF) also established an UL based on changes in TSH 
levels and the TSH response to thyrotropin-releasing hormone (TRH) administration (SCF, 
2002). The changes were all considered to be of a biochemical nature and not associated 
with any clinical adverse effects. The elevated serum levels of TSH were regarded as 
indicators of an existing risk of induced hypothyroidism. Even though it was recognised that 
the changes were not associated with any clinical adverse effects at estimated intakes of 
1700 and 1800 µg/day, the SCF used 1800 µg/day as a LOAEL. Most of the studies (also 
including Gardener (1988) and Paul (1988)) were characterised by short duration, few 
participants and low precision of the actual total dietary intakes. The results were, however, 




μg/kg bw per day (equivalent to approximately 1800 μg iodide/day) in which no clinical 
thyroid pathology occurred. An UF of 3 was considered adequate and provided an UL for 
adults of 600 µg/day. An UL of 600 µg/day was also considered acceptable for pregnant and 
lactating women based on evidence of lack of adverse effects at exposures significantly in 
excess of this level. Since there is no evidence of increased susceptibility to excess iodine 
intake in children, the ULs for children were derived by adjustment of the adult UL based on 
body surface area (body weight 0.75). 
Table 4.2-2 Tolerable upper intake levels for iodine for different age groups adjusted for body 
surface area (body weight0.75) suggested by the Scientific Committee for Food (2002). 








*Acceptable also for pregnant and lactating women. 
 Expert Group on Vitamins and Minerals, Great Britain (2003) 
The Expert Group on Vitamins and Minerals (EVM) in UK concluded that there were 
insufficient data from human or animal studies to establish a Safe Upper Level for iodine. 
They cited some of the same studies as IOM, but interpreted the increase in TSH differently 
(EVM, 2003):  
“A few studies (Paul et al., 1988; Chow et al., 1991; Gardner et al., 1988) have reported that 
supplemental doses of 0.5 to 1.5 mg iodine/day produced small changes in the levels of 
thyroid hormones. Other studies (Saxena et al., 1962; Freund et al., 1966) indicate that 
supplemental doses of 2 mg/day, in addition to the iodine present in the diet, result in the 
blockage of further iodine uptake. Although 0.5 mg supplemental iodine/day has been 
reported to alter thyroid parameters in some studies, the changes are likely to represent 
normal feedback processes rather than adverse effects.” 
For guidance purposes only, EVM suggested that a supplemental intake of 0.5 mg/day 
(equivalent to 0.003 mg/kg bw in a 60 kg adult), in addition to dietary iodine would not give 
significant adverse effects in adults. No uncertainty factors were applied as the data were 
considered to be derived from a number of well-designed, controlled human studies.  
Assuming an intake of iodine from the diet of 0.43 mg/day, this equated to a total intake of 
0.94 mg/day (equivalent to 0.015 mg/kg bw/day in a 60 kg adult), which was expected to be 
without adverse effects. The EVM commented that some consumers might have higher 




 Nordic Nutrition Recommendations (2012) 
NNR Project Group (2012) refers to tolerable upper intake levels for iodine established by 
SCF (2002) (described above) and mentions one additional study among children. This 
additional study is also included our own literature search described in chapter 5. Therefore, 
results from this particular study will not be further elaborated in this section.  
 Overview ULs from previous reports 
Table 4.2.5-1 gives an overview of the conclusions for ULs/GL for iodine in adults in previous 
reports. 
Table 4.2.5-1 Overview of the conclusions for ULs/GL for iodine in adults in previous reports. 
 
4.3 Summary of dietary reference values and discussion of use 
of reference values for comparison 
IOM/NASEM, WHO, NNR and EFSA have all established dietary reference values for iodine, 
and they have all agreed upon a recommended daily iodine intake of 150 µg/day for adults. 
However, based on various arguments, the recommendations for pregnant women vary 
between 175 (NNR Project Group, 2012) and 250 (WHO, 2007) µg/day and for lactating 
women between 200 (EFSA, 2014; NNR Project Group, 2012) and 290 (IOM, 2001) µg/day. 
The recommendations for children and adolescents are in the range between 90 and 
120 µg/day depending on age. In addition to recommended intakes, average requirements 
(AR or EAR), intake values that are estimated to meet the requirement of half the healthy 
individuals in a population, are established. In (NNR Project Group, 2012) the AR for adults 
was set to 100 µg iodine per day, but no values were set for children or adolescents. The 
IOM (2001) set the estimated average requirement for children and adolescents between 65 
to 95 µg/day for children aged 1 to 18 years. The EFSA Panel (2014) concluded that there 
was insufficient evidence to derive an average requirement (AR). 
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The VKM project group responsible for the present report discussed which of the dietary 
reference values that is most appropriate for the purpose of comparison with the levels of 
iodine exposure described in chapter 6, including which of the datasets for intakes in the low 
range that holds a similar likelihood of inadequacy (and risks related to inadequacy) as does 
the UL and a likelihood of excessive intakes (and risks related to excess). The project group 
decided to use EAR and UL as comparison values, and this is in line with the recent proposal 
for harmonised dietary reference values from WHO, FAO, NASEM where AR and UL are 
considered the core values for evaluating population intakes (Allen et al., 2019). 
The AR/EAR is the primary reference value for evaluation of nutrient intakes, and the RI, LI 
and UL can be used as complementary values (NNR Project Group, 2012). Comparison of 
population intakes with RI would give an overestimate of inadequacy as the RI is set to 
cover almost all individuals. 
EAR is defined as an intake that is estimated to meet the requirement of approximately half 
of the healthy individuals in a life stage and gender group (i.e., median requirement). RI is 
derived by adding two standard deviations to EAR and is defined as the average long-term 
intake level of a nutrient that is estimated to meet the requirement of and maintain good 
nutritional status in almost all healthy individuals in a group. The range of optimal iodine 
intake is small. Using EAR rather than RI as the lower cut-off for acceptable iodine intake in 
the iodization scenarios will accommodate a higher flexibility, achieving a distribution of 
iodine intake levels that prevent deficiency without pushing the intake distribution to the 
higher end and thus increasing the probability of exceeding UL. 
A simplified approach referred to as the EAR cut-point method can under certain 
assumptions, be used to estimate the prevalence of inadequate intake directly as the 
proportion with intake below the EAR (IOM, 2001). This method does not rely on a known 
requirement distribution, but the distribution should be symmetrical around the EAR, the 
variance of intake should be greater than the variance in requirements, and the intake and 
requirement should be independent (i.e. have a low correlation) implying that individuals 
with high requirements do not tend to have higher intakes. Assumptions related to 
requirements are in practice difficult to verify, but we have not come across literature or data 
to indicate that these assumptions do not hold for iodine. 
In the iodization scenarios, the prevalence of inadequate iodine intake considered acceptable 
is ultimately a matter of judgment, but 2 to 3 percent has been used when planning diets for 
groups. According to the EAR cut-point method, 2.5% of the population will then have 
intakes below the EAR, and intake will be adequate for >97.5% of the population with 
intakes >EAR (IOM, 2003). While we present percentages > EAR in text and tables in this 
benefit and risk assessment, it should be kept in mind that the uncertainty in the estimated 





Generally, UL is the maximum level of total chronic daily intake judged to be unlikely to pose 
a risk of adverse health effects, and in the case of iodine the UL for adults is the maximum 
daily intake where changes in TSH are unlikely to occur (SCF, 2002). 
Derived from the arguments above, the project group decided to compare the exposures in 
chapter 6 with the AR/EAR for adults from NNR (2012) and EAR for children and adolescents 
from IOM (2001) and the ULs established by the SCF (2002) as the cut-off for acceptable 
intake in the lower end and UL as the cut-off in the upper end of iodine intakes. Even though 
these cut-offs are not fully comparable, they were considered to be the most appropriate 
dietary reference values for comparison with the exposures for iodine. The health 
consequences from having intakes below EAR or above UL is elaborated on in the following 
chapters (5, 6, 8 and 10). 
Table 4.3-1 Overview of values for comparison used to evaluate the iodine intake estimates in 
chapter 7. 
EAR/AR Adults (18-70 
years) 
13-year-olds 9-year-olds 4-year-olds 2-year-olds 1-year-olds 
EAR/AR 100 73 73 65 65 65 
UL 600 450 300 250 200 200 
A review of new literature after year 2002 to re-evaluate the existing ULs is given in chapter 





5 Systematic literature review and 
grading of evidence on the health 
effects of mild to moderate iodine 
deficiency  
Systematic literature searches were conducted to retrieve the best available evidence on 
health effects of mild to moderate iodine deficiency to respond to the question concerning 
potential health effects of the various iodization levels suggested in the terms of reference 
for the general population and relevant risk groups. It is well recognised that severe iodine 
deficiency has severe health implications, but knowledge about possible adverse health 
effects of mild or moderate iodine deficiency is less established. The objective of the 
systematic literature search was therefore to identify all published scientific papers 
addressing how mild to moderate iodine deficiency might affect health. Based on knowledge 
about health outcomes related to severe iodine deficiency, expert judgement and test 
searches, we included search terms for neurodevelopment, thyroid function and birth 
outcomes and fertility. 
Chapter 5 is divided into the following sections; a presentation of the literature search (5.1) 
(the search terms, databases and inclusion/exclusion criteria, publication selection and data 
extraction of all the included studies are described in detail in Appendix I, and therefore only 
briefly described here), methodological consideration of the included publications (5.2), a 
presentation of the guidelines for grading evidence (5.3) and results from the literature 
search (5.4) on neurodevelopment (5.4.1), thyroid function (5.4.2) and fertility and birth 
outcomes (5.4.3) and an evidence table with the grading of health effects related to mild to 
moderate iodine deficiency (5.5).  
5.1 Systematic literature review concerning adverse health 
effects of mild to moderate iodine deficiency 
Literature searches for studies investigating health outcomes related to mild to moderate 
iodine deficiency were performed in MEDLINE, EMBASE, Web of Science and PsycINFO, with 
no lower limit for publication year. The first literature search, performed in July 2018, 
resulted in 13 399 records after automatic and manual duplicate removal. It should, 
however, be noted that due to the vast number of articles, a large number of duplicates 
remained. The number of unique original records in this search is, therefore, lower than 13 
399. The updated literature search, performed 14th May 2019, resulted in 899 records, and 
the latest update 18 November 2019 resulted in 622 records. Both the updated searches 




articles could not be summarised. Details about the search strategy and publication selection 
are given in Appendix I. 
To assess the evidence for a causal relationship between mild to moderate iodine deficiency 
and the health outcomes covered by the systematic literature review, we have used the 
guide for conducting systematic literature reviews updated version for the 5th edition of the 
Nordic Nutrition Recommendations (NNR5 working group, 2011; Shea et al., 2007), slightly 
modified for our purpose. Each individual study is rated with an A, B or C-category. The 
rating criteria are given in Appendix VI. Only studies categorised as A or B are included in 
the results. Studies categorised as A or B are listed in Appendix IIa. Each study with an A or 
B rating has been summarised in Summary Tables (Appendix III) and are described in 
chapter 5.4. Studies categorised as C are listed in Appendix IIb where also the most 
common reasons for grading/rating as category C are mentioned.  
 
Figure 5.1-1 Flow chart for publication selection for literature concerning adverse health effects of 




The systematic literature searches on mild to moderate iodine deficiency resulted in 131 
studies, which were rated for quality (A-B-C). Of these, 1 study was categorised as A, while 
35 studies qualified for category B, and 95 category C. The category C-studies were not 
considered further. Figure 5.1-1 shows a flow chart for the literature search and selection 
process for health outcomes related to mild to moderate iodine deficiency. 
5.2 Methodological considerations of the included publications 
 Sample size and study design  
The sample size varied substantially across the 36 publications included in the systematic 
literature review on health consequences of mild to moderate iodine deficiency, from large 
cohort studies with up to 39 471 participants to small studies with as few as 54 participants.  
The included studies used different study designs, including RCTs, prospective cohort studies 
and cross-sectional studies. RCTs, if adequately designed and conducted, provide the best 
evidence for a causal relationship between an exposure and an outcome. Well-designed 
RCTs investigating health effects of iodine supplementation in populations with mild to 
moderate iodine deficiency, can provide evidence about the relationship between mild to 
moderate iodine deficiency and health outcomes. However, it is important that iodine status 
and intake at baseline is appropriately quantified and that the intervention is well-defined, 
such as a fixed daily dose of iodine as monotherapy, and a comparison group receiving 
placebo. In our literature search, five RCTs were identified that met these inclusion criteria 
investigating neurodevelopment in relation to thyroid function in various population groups.  
Among the observational studies, the prospective cohort is generally regarded superior to 
case-control and cross-sectional studies. The majority of studies on mild to moderate iodine 
deficiency in the systematic literature review were prospective cohort studies. In a cohort 
design, a population is followed over time and disease and health outcomes that occur are 
registered prospectively. Concerning the influence of iodine status in pregnancy, several 
large-scale mother-and-child cohorts have been established that provide data about the 
associations between iodine intake/status prior to or during pregnancy and birth outcomes 
and developmental outcomes in the offspring. These include the Australian Gestational 
Iodine Cohort; the Norwegian Mother; Father and Child Cohort Study (MoBa); the Little in 
Norway (LiN) study; the Dutch Generation R study; the Southampton Women’s Survey; the 
Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC); the European Longitudinal 
Study of Pregnancy and Childhood (ELSPAC); and the Infancia y Medio Ambiente; 
Environment and Childhood (INMA) cohort in Spain. In these cohorts, data have been 
collected on maternal diet through FFQs, and/or stored biological samples that have been 
used to assess iodine status and/or markers of thyroid function in pregnancy.  
While cross-sectional studies are pertinent for describing the prevalence of iodine deficiency, 
they are less suitable to investigate causal associations between iodine intakes or iodine 
status and health outcomes, since the exposure and the outcome are measured at the same 




since they are feasible and require a relatively shorter time commitment and fewer resources 
to conduct. Evidence from studies with cross-sectional design alone is not sufficient to infer 
evidence for a causal effect between an exposure and an outcome, not even “limited – 
suggestive”, but they add to the information from studies with RCT and cohort designs. For 
the current purpose, cross-sectional studies were considered if they addressed an association 
with a health outcome that could reasonably represent a potential causal relationship. Cross-
sectional studies assessing the association between iodine status and parameters of thyroid 
function, were included if they had sufficient quality. Cross-sectional studies constituted the 
majority of the publications forming the basis for the conclusions concerning thyroid 
function. Cross-sectional studies aiming to assess cognitive development could not be 
considered to be reliable due to the limitations of the design. 
 Measures of iodine status and exposure  
The methods used for examining iodine exposure in the reviewed literature included both 
measures of UIC and calculated iodine intake based on dietary data, mainly FFQ.  
As described in section 2.3, WHO recommends UIC as a suitable indicator of iodine status at 
the group level. However, UIC should not be used for the purposes of individual diagnosis 
and treatment as it only reflects the short term iodine intake. Although UIC is not a good 
measure of iodine status at the individual level, lack of other easily available measures of 
individual iodine staus has resulted in widespread use of UIC in observational studies 
examining associations between iodine status and health outcomes. 
Creatinine adjustment is often applied to remove variation in UIC due to hydration status. 
There is inter-individual variation in creatinine excretion, and including creatinine in the 
exposure variable provides an exposure measurement which is specific for the studied 
population as it is typically associated with participant characteristics such as age, gender, 
body mass index, life stage, and muscle mass. These are potential predictors of the outcome 
and it has therefore been advised against standardising for creatinine (Zimmermann and 
Andersson, 2012). 
Even though dietary data are prone to measurement errors, calculating iodine intake using 
validated dietary assessment methods may provide a better and more reliable measure of 
habitual intake than UIC (Rohner et al., 2014). FFQs assess habitual consumption frequency 
and portion size over a predefined period. The applicability of dietary assessment of habitual 
iodine intake is generally considered to be high in populations where the iodine 
concentration in drinking water is low and the use of iodized salt is negligible, such as in 
Norway. Studies in Norway have shown moderate to high correlations (range 0.3-0.8) 
between calculated iodine intake and 24-hour urine collections or UIC, respectively 
(Brantsaeter et al., 2008; Brantsaeter et al., 2018; Henjum et al., 2018a).  
In the reviewed cohort studies concerning the association of mild to moderate iodine 
deficiency and neurodevelopmental outcomes in children, the timing of iodine status 
assessment varied from before pregnancy, during pregnancy, and up to school age. It is 




when interpreting the results of the observational studies. In a population defined as being 
mildly to moderately iodine deficient, a proportion might have severe deficiency. For 
example, in populations with lower median UIC, a higher proportion of the population is 
expected to have iodine status in the moderate to severe deficiency range, and less likely to 
have sufficient thyroidal stores to maintain thyroid hormone production and ensure a 
sufficient supply to the foetus. On the other hand, in populations where median UIC is in the 
mild deficiency range, but close to the cut-off for adequate iodine intake (150 µg/L in 
pregnant women), it is likely that most participants have sufficient thyroidal stores to 
maintain sufficient thyroid hormone production. 
5.3 Grading the evidence - guidelines  
For appraising the evidence for a causal relationship between mild to moderate iodine 
deficiency and the health outcomes covered by the systematic literature review, we have 
used the guide for conducting systematic literature reviews updated version for the 5th 
edition of the Nordic Nutrition Recommendations (NNR). The NNR guide is based on other 
handbooks and guides, and has adopted a three-category quality grading system (AMSTAR) 
from Agency for Healthcare Research and Quality of each individual study that fulfills the 
literature inclusion criteria (NNR5 working group, 2011) and a grading system developed by 
the World Cancer Research Fund; WCRF (WCRF, 2018). This grading system is especially 
developed for a situation where observational studies form the bulk of the evidence.  
In order to assess the quality of the included studies, Quality Assessment Tool tables (QATs) 
are available for different study designs, and for this benefit and risk assessment we have 
used the QATs for RCTs, prospective cohorts and cross-sectional studies (the forms are 
shown in Appendix VI). Each individual study is rated with an A, B or C-category by two 
independent reviewers. The criteria for each category are listed in Box 1 (from (NNR5 
working group, 2011)). The grading criteria from WCRF are listed in Box 2 (WCRF, 2018).  
In this benefit and risk assessment 131 papers investigating mild or moderate iodine 
deficiency were quality assessed. To save time, the reviewers did not fill out all the questions 
in the QATs if it was evident that a paper was categorised as C. All references for A, B or C 
studies are listed in Appendix II. For all the studies categorised as A or B, data was extracted 
in Summary Tables (listed in Appendix III). Category C-studies were not considered to have 
sufficiently good quality and were therefore excluded from further evaluation and not 




Box 1 Criteria for assessing the methodological quality of the studies: The three category quality grading 
system. The studies should be evaluated and graded within their own design strata. 
A The results from studies that have an acceptably low level of bias are considered valid. These studies 
adhere mostly to the commonly held concepts of high quality including the following: a comprehensive 
study design; clear description of the participants, setting, interventions, and control group(s); appropriate 
measurement of outcomes; appropriate statistical and analytical methods and reporting; less than 30% 
percent dropout (depending on the length of the study see the QAT for clinical studies) or over 50% 
participation rate for prospective cohort studies; clear reporting of dropouts; and no obvious bias. Where 
appropriate, studies must provide a valid estimation of nutrient exposure, from dietary assessments and/or 
biomarkers with a reasonable range of measurement error, and justification for approaches to control for 
confounding in the design and analyses.  
B Studies may have some bias, but not sufficient to invalidate the results. They do not meet all the criteria in 
category “A”, they have some deficiencies but none likely to cause major bias. The study may be missing 
information, making it difficult to assess limitations and potential problems.  
C Studies have significant bias that may invalidate the results. These studies have serious errors in design, 
analysis, or reporting; there are large amounts of missing information, or discrepancies in reporting. 
The next step after quality assessment and data extraction of each study, is a judgment of 
the total evidence base for each health outcome. Evidence is classified as convincing (strong 
evidence), probable (strong evidence), limited – suggestive and limited – no conclusion 
depending on the number and quality of supporting, non-supporting and contradicting 
studies. In addition, the WCRF lists special upgrading factors that may upgrade the reached 
judgement of the evidence. The evidence should be robust enough to be unlikely to be 
modified in the near future as new evidence accumulates. Box 2 lists the criteria from the 
WCRF cancer report (WCRF, 2018). The grading of each health outcome for mild to 




Box 2 lists the criteria used in the WCRF cancer report (2018). The grades shown here are ‘convincing’, 
‘probable’, ‘limited — suggestive’, ‘limited — no conclusion’. 
Convincing (strong evidence) 
Evidence strong enough to support a judgement of a convincing causal (or protective) relationship, which 
justifies making recommendations designed to reduce risk of cancer. The evidence is robust enough to be 
unlikely to be modified in the forseeable future as new evidence accumulates. All of the following are 
generally required: 
 Evidence from more than one study type. 
 Evidence from at least two independent cohort studies. 
 No substantial unexplained heterogeneity within or between study types or in different populations 
relating to the presence or absence of an association, or direction of effect. 
 Good quality studies to exclude with confidence the possibility that the observed association results 
from random or systematic error, including confounding, measurement error, and selection bias.  
 Presence of a plausible biological gradient (‘dose response’) in the association. Such a gradient need 
not be linear or even in the same direction across the different levels of exposure, so long as this 
can be explained plausibly. 
 Strong and plausible experimental evidence, either from human studies or relevant animal models, 
that typical human exposures can lead to relevant cancer outcomes. 
Probable (strong evidence) 
Evidence strong enough to support a judgement of a probable causal (or protective) relationship, which 
generally justifies recommendations designed to reduce the risk of cancer. All the following criteria are 
generally required: 
 Evidence from at least two independent cohort studies, or at least five case-control studies.  
 No substantial unexplained heterogeneity between or within study types in the presence or 
absence of an association, or direction of effect. 
 Good quality studies to exclude with confidence the possibility that the observed association results 
from random or systematic error, including confounding, measurement error and selection bias.  
 Evidence for biological plausibility. 
Limited — suggestive 
Evidence that is too limited to permit a probable or convincing causal judgement but is suggestive of a 
direction of effect. The evidence may be limited in amount or by methodological flaws but shows a generally 
consistent direction of effect. This judgement is broad, and includes associations where the evidence falls 
only slightly below that required to infer a probably causal association through those where the evidence is 
only marginally strong enough to identify a direction of effect. This judgement is very rarely sufficient to 
justify recommendations designed to reduce the risk of cancer; any exceptions to this require special, 
explicit justification. All the following criteria are generally required: 
 Evidence from at least two independent cohort studies or at least five case-control studies. 
 The direction of effect is generally consistent though some unexplained heterogeneity may be 
present. 
 Evidence for biological plausibility. 
Limited — no conclusion  
Evidence is so limited that no firm conclusion can be made. This judgement represents an entry level and is 




where insufficient evidence exists to permit a more definitive grading. This does not necessarily mean a 
limited quantity of evidence. A body of evidence for a particular exposure might be graded ‘limited — no 
conclusion’ for a number of reasons. The evidence may be limited by the amount of evidence in terms of the 
number of studies available, by inconsistency of direction of effect, by methodological flaws (for example, 
lack of adjustment for known confounders), or by any combination of these factors.  
When an exposure is graded ‘limited — no conclusion’, this does not necessarily indicate that the Panel has 
judged that there is evidence of no relationship. With further good-quality research, any exposure graded in 
this way might in the future be shown to increase or decrease the risk of cancer. Where there is sufficient 
evidence to give confidence that an exposure is unlikely to have an effect on cancer risk, this exposure will 
be judged ‘substantial effect of risk unlikely’ 
Special upgrading factors 
These are factors that form part of the assessment of the evidence that, when present, can upgrade the 
judgement reached. An exposure that might be deemed a ‘limited – suggestive’ causal factor in the absence, 
for example, of a biological gradient, might be upgraded to ‘probable’ if one were present. The application 
of these factors (listed below) requires judgement, and the way in which these judgements affect the final 
conclusion in the matrix are stated. Factors may include the following: 
 Presence of a plausible biological gradient (‘dose response’) in the association. Such a gradient need 
not be linear or even in the same direction across the different levels of exposure, so long as this 
can be explained plausibly. 
 A particularly large summary effect size (an odds ratio or relative risk of 2.0 or more, depending on 
the unit of exposure) after appropriate control for confounders. 
 Evidence from randomized trials in humans. 
 Evidence from appropriately controlled experiments demonstrating one or more plausible and 
specific mechanism actually operating in humans. 
 Robust and reproducible evidence from experimental studies in appropriate animal models 
showing that typical human exposures can lead to relevant cancer outcomes. 
 
5.4 Studies concerning mild to moderate iodine deficiency 
 Neurodevelopment 
Sixteen studies of different study design (three RCTs and 13 prospective cohort studies) on 
different population groups (women prior to conception, pregnant women and 
schoolchildren) are included in this benefit- and risk assessment, all categorised as B.  
In regard to neurodevelopment, during the first years of life, rapid and dynamic changes in 
brain development happens and neurodevelopmental tests are therefore less reliable in early 
age than at later ages and hence have poorer predictive value for future cognitive 
performance (Mansson et al., 2019). In appraising the evidence, one could argue that more 
weight should be given to studies that assessed neurodevelopmental outcomes in children at 





An overview of available neurodevelopment instruments highlight that different tests are 
needed for the assessment of different age groups and cognitive domains (Isaacs and Oates, 
2008). There is limited guidance in the literature on which cognitive domains to assess in 
nutrition studies, and a common approach is to include a battery of tests that covers a 
variety of these. The Bayley Scales of Infant and Toddler Development is one of the most 
widely used test in infants and toddlers. The latest version of the Bayley (Bayley-III) covers 
three major areas of development assessed through direct administration with the child: 
cognitive, language (receptive and expressive) and motor (fine and gross) (Weiss et al., 
2010). Thorough training and standardisation procedures with the study staff in the 
administration of the test are prerequisites (Isaacs and Oates, 2008). In older children, the 
variety of available neurodevelopment tests is larger. Although effects will be more 
pronounced in children with severe neurological disorders than in the general population, 
several validated tests are suitable to assess more subtle changes in performance (Isaacs 
and Oates, 2008).  
The included studies had outcomes that reflected various aspects of neurodevelopment; 
such as early child development (cognitive, language and gross/fine motor skills and motor 
milestones), general ability scores (i.e. total IQ, verbal IQ and performance IQ), executive 
functioning, school performance (language, reading and writing skills, mathematics, special 
education), behaviour problems, ADHD diagnosis/ADHD symptom scores and auditory and 
short term visual memory outcomes. In some of the studies, neurodevelopmental outcomes 
were assessed using parental questionnaires that included questions from validated 
instruments or questions about teacher reports (e.g. MoBa), while in other studies trained 
study staff performed the outcome measurements directly with the study children (e.g. 
ALSPAC, INMA and the “Little in Norway” study). Moreover, the age at assessment vary from 
6 months up to 15 years. The included studies on neurodevelopmental outcomes also 
differed in terms of population, sample size, iodine status, measurement of iodine exposure 
(UIC, creatinine-corrected UIC, or dietary intake), modelling of the iodine exposure 
(continuous or categorical) and how iodine from dietary supplements was treated in the 
statistical analysis. Consequently, there was heterogeneity in the type of effect estimates 
reported and their magnitude. However, the magnitude of the associations and their 
potential public health relevance were considered for all included studies. 
5.4.1.1 Iodine status before conception and during pregnancy and 
neurodevelopmental outcomes 
We identified a total of 14 studies, one RCT and thirteen prospective studies that examined 
the association between mild or moderate iodine deficiency before conception or during 
pregnancy, and neurodevelopmental outcomes in the offspring. 
In a RCT of 832 pregnant women (median UIC at baseline 136 µg/L) in India (median UIC 
188 µg/L) and Thailand (median UIC 112 µg/L) (Gowachirapant et al., 2017) 200 µg iodine 
or placebo were given daily throughout pregnancy. The primary endpoint was child 
neurodevelopment at 5-6 years assessed by three outcomes; verbal IQ and performance IQ 




executive composite score by the Behavior Rating Inventory of Executive Function-Preschool 
Version (BRIEF-P). Secondary outcomes assessed at 5-6 years were externalising and 
internalising behaviour problems assessed by the Strengths and Difficulties Questionnaire 
(SDQ), auditory tests, anthropometrics (weight and length), and thyroid function parameters 
(TSH and T4). Moreover, several outcomes were assessed before the children were 24 
months (Neonatal Behavioral Assessment Scales (NBAS) at age 6 weeks, the Bayley Scales 
of Infant Development 3rd edition (Bayley-III) at 1 and 2 years, pregnancy outcomes and 
maternal and infant thyroid volume and thyroid function parameters). There were no 
differences between the groups receiving supplement and placebo for the primary outcomes 
at age 5-6 years. Moreover, except for a higher score on expressive language in favour of 
placebo at 1 year, there were no differences in any of the secondary outcomes at age 5-6 
years or at earlier ages.  
The Norwegian Mother, Father and Child Cohort Study (MoBa) (Abel et al., 2019), measured 
UIC (n=2001) and iodine intake in pregnancy and neurodevelopment through maternal 
report in children at age 8 (n=39 471). The neurodevelopmental outcomes were maternal 
reported child language skills (The Children’s communication checklist-Short (CCC-S)), 
reading skills (3 items selected from a sub-scale of Vineland Adaptive Behaviour Scale-II), 
writing skills (2 items selected from a sub-scale of Vineland Adaptive Behaviour Scale-II), 
school performance on reading and mathematics (mandatory mapping tests, teacher 
reports), and whether or not the child was granted special education in school due to 
disabilities or learning difficulties (extra educational services). The median UIC in gestational 
week 18 was 67 µg/L and the median iodine intake was 122 µg iodine per day. Habitual 
iodine intake was assessed by a food frequency questionnaire (FFQ) that covered food intake 
during the first half of pregnancy. The associations between iodine intake and the outcomes 
were modelled using iodine intake as a continuous variable. The curve-shaped associations 
indicated that habitual iodine intake from food lower than approximately 150 µg/day was 
associated with poorer skills in language, reading and writing, and increased likelihood low 
scores on school receiving special education, and lower score on school mapping test in 
reading, but not mathematics. Point estimates using the EAR of 160 µg/day as reference 
showed that intakes at or below 100 µg/day were associated with the child having 0.05-0.10 
SD (standardised z-score) poorer skills in language, reading, and writing, 9-43% increased 
likelihood of scoring low on mapping test in reading, 6-13% increased risk of scoring low on 
mapping test in mathematics (non-significant), and a 10-29% increased likelihood of the 
child receiving special education services. Maternal UIC in mid pregnancy (n=2001) was not 
associated with any of the neurodevelopmental outcomes. There were no associations 
between maternal use of iodine-containing supplements and the child outcomes, 
irrespectible of when in pregnancy the iodine supplement use was initiated.  
In the Little in Norway Cohort Study (Markhus et al., 2018) the median UIC in pregnancy 
was 78 µg/L (n=851). Five developmental outcomes (Bayley-III cognitive, receptive 
language, expressive language, and fine- and gross motor skills) were measured by trained 
research assistants at age 6 and 12 months by a shorter screening version, and at 18 
months by the full version. The associations between iodine intake and the outcomes were 




measures to take into account change over time. These associations showed a curvilinear 
pattern, which indicates that the negative associations of UIC with receptive and expressive 
language scores starts from an UIC of 100 µg/L or lower. A lower UIC was associated with 
lower standardised receptive language scores (difference between values above 100 µg/L 
and lowest values: -0.2 SD) and a lower expressive language score (difference between 
values above 100 µg/L and lowest values: -0.3 SD), but there was no association with 
cognitive score, fine motor skills, or gross motor skills. Maternal use of iodine-containing 
supplements was associated with lower gross motor skills (-0.18 SD), but not with other 
outcome measures. 
In a cohort from Spain (Murcia et al., 2018), the median UIC in pregnant women was 
123 µg/L (n=1803). Maternal iodine intake including the consumption of iodised salt (yes/no) 
was measured at 10-13 weeks and 28-32 weeks pregnancy by FFQ. Cognitive and motor 
development in children 4-5 years were measured by the McCarthy Scales of Children’s 
Abilities (MSCA) (both the general cognitive scale and the motor scale) adapted to the 
Spanish population. Maternal iodine intake from food during pregnancy was not associated 
with scores on the general cognitive scale but was unexpectedly inversely associated with 
scores on the motor scale, a 100 μg/day increase was associated with a 2.4 point decrease 
(95% CI −3.98 to –0.85). UIC was associated with general cognitive, but not with motor 
development. After adjusting for creatinine (Cr) by the residual method, children of women 
with UIC~ Cr <100 μg/L had ~4 points lower general cognitive scores (beta: -3.93, 95% CI: 
-6.18, -1.69) than children in the reference group (150–249 μg/L), the corresponding 
decrease when adjusting for creatinine by the ratio method was beta -4.26 (95%CI: -6.57, -
1.96) points. The coefficients were strongly attenuated by multiple imputation of missing 
creatinine values in sensitivity analyses. There were no associations with the motor scores. 
Neither use of iodine-containing supplements nor iodized salt during pregnancy appeared to 
improve children’s neurodevelopment at 4–5 years.  
In a cohort from the UK (n=654) (Robinson et al., 2018), maternal UIC (median 108 µg/L) 
and iodine intake were measured before conception and in early and late pregnancy. 
Offspring cognitive ability was measured by four outcomes at age 6-7 years. Full-scale IQ 
was assessed by two subtests of the Wechsler Abbreviated Scale of Intelligence (WASI). 
Executive functioning was measured by three subtests from the Cambridge 
Neuropsychological Test Automated Battery (CANTAB); two memory tests – the Delayed 
Matching to Subject (DMS) and the Spatial Span (SSP), and the Intra-Extra Dimensional Set 
Shift (IED) test assessing the ability of goal-directed action. Maternal IQ was also assessed 
using WASI. Data was analysed with linear regression using z-scores of the respective 
outcome measures as dependent variables and maternal preconception iodine status 
(iodine:creatinine ratio) as independent variable. There was a statistically significant positive 
linear association between preconception UIC (I/Cr ratio) and offspring full-scale IQ in 
adjusted models. In comparison with children of women with an I/Cr ≥150 μg/g, children of 
women with preconception urinary I/Cr <50 μg/g (moderate iodine pre-pregnant iodine 
deficiency) had 0.49 (95% CI: 0.79, 0.18) SD lower IQ, which is equivalent to a difference of 
7.5 IQ points. The maternal I/Cr ratio was not associated with any of the three executive 




In a prospective mother-child cohort from Australia (n=699) (Zhou et al., 2019), maternal 
UIC (median 186 µg/L) and iodine intake from food and supplements (mean 309 µg/day) 
was assessed at <20 weeks` gestation and at 28 weeks’ gestation. The Bayley Scale of 
Infant Development 3. ed (Bayley-III) cognitive, language and motor composites were 
measured in the offspring at age 18 months. In this study, iodine intake included intakes 
from both food and supplements (initiated in pregnancy), and intake data from study entry 
(<20 weeks) and 28 weeks were averaged and used as primary exposure ranked into 
quartiles. Children of mothers with iodine intakes in the lowest quartile <220 μg/day (and 
those of mothers in the highest quartile (391 μg/day) in pregnancy had lower cognitive, 
language and motor scores. In comparison to children born to mothers in the second quartile 
(reference group, intakes 220-316 µg/day) those in the lowest quartile had 4.3 points lower 
scores on cognitive and 6.3 points lower scores on language. The corresponding odds of low 
scores (Bayley III-scores<85) was 2.8 (95%CI 1.3, 5-7) for cognitive, 2.4 (95%CI 0.9, 5.8) 
for language and 2.2 (95%CI: 0.9, 5.2) for motor in this iodine-sufficient population. There 
were no associations between UIC in pregnancy and the Bayley-III outcomes.  
In a second publication from the MoBa cohort study (n=27 945) (Abel et al., 2017a), 
maternal iodine intake from food during pregnancy (median 122 µg iodine/day) and iodine 
supplement use were assessed in children at 3 years of age. Outcomes measured were 
language delay (classified according to 6 different categories from severe language delay to 
normal language development assessed by the Dale & Bishop language scale), 
communication skills (six items from the Ages and Stages Questionnaire, 2nd ed (ASQ-2)), 
motor milestones (the age at start walking), motor skills (4 items from the ASQ-2) and 
externalising and internalising behaviour at 3 years of age (Child Behaviour Check List). 
Iodine intake was modelled as a continuous exposure and the EAR value of 160 µg/day was 
set as the reference value. The results demonstrated a non-linear dose-response between 
habitual iodine intake from food during pregnancy and neurodevelopmental outcomes at 
intakes lower than approximately 150 µg/day. Iodine intakes lower than 100 µg/day were 
estimated to account for;12% (95% CI:22%, 23%) of cases of language delay; 31% (95% 
CI: 5%, 50%) of cases of severe language delay; 24% (95% CI: 17%, 31%) of cases of 
externalising behaviour problems >1.5 SD; and 24% (95% CI: 17%, 31%) of cases of 
internalising behaviour problems >1.5 SD in children at age 3 years, but not with of gross 
motor development or age at first steps unaided. There was no indication of any benefit of 
iodine supplement use during pregnancy, and some indication of an adverse association 
between uses of iodine supplements in mothers with low iodine intake from food and the 
behavioural outcomes.  
The third publication from the MoBa cohort study (Abel et al., 2017b) examined associations 
between maternal iodine intake (median 121 µg/day) and the ADHD-diagnosis and maternal 
reported ADHD symptoms in children at 8 years of age. For the child ADHD-diagnosis 
outcome, the study population included 77 364 mother-child pairs, and for maternally 
reported ADHD symptoms at child age 8 years, the study population included 27 945 
mother-child pairs. UIC was measured in a subsample (n=2938), the median was 68 µg/L in 
all, 61 µg/L in non-supplements users and 86 µg/L in iodine-supplement users. Child ADHD 




symptoms were assessed in the eight-year-old questionnaire from MoBa on a four-point 
Likert scale (never/rarely, sometimes, often, or very often) covering inattention problems 
(nine items) and hyperactivity/impulsivity (nine items) from the ADHD Rating Scale. Among 
the non-supplement users, maternal iodine intake of less than 200 µg/day was associated 
with higher maternally reported child ADHD symptom scores at eight years of age (adjusted 
difference in score up to 0.08 SD). There were no association between maternal iodine 
intake and the risk of having received an ADHD diagnosis. There was no indication of a 
benefit of maternal iodine-containing supplement use on child ADHD diagnosis or symptom 
score, but an increased risk for both outcomes when iodine supplement use was initiated in 
gestational weeks 0-12. In participants with low iodine intakes from food, iodine supplement 
use initiated in gestational week 0-12 was associated with a ~29% increased risk of ADHD 
diagnosis (95%CI: 0%, 67%) and a 0.06 SD higher average score on ADHD symptoms at 
eight years of age (95% CI: 0.01, 0.11). 
In a prospective study in 228 Australian pregnant women (Hynes et al., 2013), maternal UIC 
(median 81 µg/L) and its associations with standardised school tests (spelling, grammar, 
reading, writing and numeracy scores on the National Assessment Program – Literacy and 
Numeracy (NAPLAN) and English-literacy and mathematics-numeracy score on the Student 
Assessment and reporting information system (SARIS)) in 9 year old children were 
examined. There was a significant association between UIC (categorised at 150 µg/L) and 
spelling (NAPLAN) and borderline associations with grammar (NAPLAN) and English-literacy 
scores (SARIS), but not with reading, writing or numeracy scores. In comparison with 
children whose mothers had UIC≥150 µg/L, children whose mothers had UIC<150 µg/L had 
10% reduction in spelling (-38; 95%CI: -65.5, -11.5, p=0.005), 7% reduction in grammar (-
29.1; 95%CI; -59.9, -1.8, p=0.065), and 5% reduction in English grammar (-0.30; 95%CI: -
0.62, 0.01, p=0.059). 
A follow-up study was conducted when the children were 14-15 years old to examine 
whether the effects seen at age 9 continued into adolescence (Hynes et al., 2017). The main 
outcomes were longitudinal follow up of the standardized school tests in spelling, grammar, 
reading, writing and numeracy (NAPLAN) available for n=266 mother-offspring pairs with 
outcomes assessed at 4 time points (grade 3: age 8-9 years, grade 5: age 10-11 years, 
grade 7: age 12-13 years, and grade 9: age 14-15 years). The NAPLAN results at 8-9 years 
are the same as in (Hynes et al., 2013), but in the 2017 study these results are included in a 
mixed model with NAPLAN results at three subsequent ages. Two additional outcomes were 
obtained in a small subsample (n=45) adolescents at age 14-15 years by instruments to 
assess specific delays in language development (Comprehensive Evaluation of Language 
Fundamentals» (CELF-4)) and deficits in hearing and/or central auditory processing disorder 
(Central Auditory Processing Disorder (CAPD)). The NAPLAN results (repeated measures) 
showed that the difference in spelling scores between the <150 and ≥150 μg/L group in 
year 3, age 8-9 years (10%, -41.4 points, 95% CI -65.1, -17.6) persisted up to year 9, age 
14-15 years (5.6%, -31.6 points 95% CI; -57.0, -6.2), even after full adjustment for 
confounders (including UIC in the child at the age of the test). For grammar and reading, 
differences at year 3 continued into year 5 but not until year 9 (an initial 6.5% difference in 




year 7). At age 14-15 years, there were no significant differences in CELF-4 (language 
development) or CAPD (hearing/auditory processing) scores although all CELF-4 measures 
were lower for offspring of mothers with UIC<150 µg/L than for those of mothers with 
UIC≥150 µg/L. The statistical power was extremely low as the groups included only 15 and 
30 participants respectively. 
In a Dutch multiethnic birth cohort (Ghassabian et al., 2014), maternal UIC (median UIC 
230 µg/L) and its association with children’s cognition was examined in 1525 mother–child 
pairs. Non-verbal IQ and language comprehension were assessed when the children were 6 
years using validated Dutch test batteries (two subtests of the snijders-Oomen Niet-verbale 
intelligentie Test-Revisie and the receptive subtest of the Taaltest voor Kinderen). In total, 
188 (12%) pregnant women had UIC<150 μg/g creatinine, with a median UIC equal to 
119 μg/g creatinine. Non-verbal IQ and language comprehension scores were compared 
between children of mothers with UIC<15 µg/g and those of mothers with UIC≥150 µg/g as 
continuous scores and as the likelihood of having suboptimal scores (lowest quartile, i.e. 
scores <93 for non-verbal IQ and <0.77 for language comprehension). After adjustment for 
confounders, maternal low UIC was not associated with children’s non-verbal IQ or language 
comprehension at 6 years. For non-verbal IQ, the likelihood (OR) of having suboptimal 
scores in the low maternal iodine group was 1.33 (95%CI: 0.92, 1.92) and for language 
comprehension the likelihood of suboptimal scores in the low maternal iodine group was 
0.82 (95% CI: 0.56, 1.19).  
In a prospective cohort study from UK in pregnant women that included 958 mother-child 
pairs (Bath et al., 2013), maternal UIC (median 91 µg/L) was measured at median 10 weeks 
pregnancy and neurodevelopment in the offspring at 8 years (IQ through an abbreviated 
form of the Weschler Intelligence Scale for Children IIIuk) and 9 years (reading speed, 
accuracy and comprehension through the Neale Analyses of Reading Ability). Low maternal 
iodine status (iodine:creatinine ratio <150 µg/g) was associated with an increased risk of 
suboptimum scores on verbal IQ at age 8 years (OR: 1.58; 95%CI: 1.09, 2.30) but not 
performance IQ, and with reading accuracy at age 9 years (OR:1.69; 95%CI: 1.15, 2.49) 
and reading comprehension at age 9 years (OR: 1.54; 95% CI: 1.06, 2.23), but not with 
words read per minute or reading score. The results were adjusted for a number of potential 
confounders. Furthermore, stratification of the low-iodine mothers showed that children in 
the group with urinary iodine (<50 µg/g) had lower scores than those from the group with 
iodine 50–150 µg/g, suggestion a worsening trend (dose-response) in cognitive outcomes 
with decreasing maternal iodine status (Bath et al., 2013).   
In a prospective mother-child multi-centre cohort from Spain (INMA) (Murcia et al., 2011), 
the effect of iodine supplementation during pregnancy on infant neurodevelopment at 1 year 
(range of 11-16 months) of age was measured in one of four sub-cohorts using the Bayley 
Scales of Infant Development 2nd ed, Mental Development Index (MDI) and Psychomotor 
Development Index (PDI). The study population included 691 mother-child pairs. Maternal 
UIC, maternal iodized salt consumption or dietary intake of iodine rich foods, were  not 
associated with infant neurodevelopment. However, maternal intake of 150 μg/day or more 




PDI scores and a 1.8 fold increased risk of having PDI scores <85 (-1 SD from mean). This 
association differed by sex, the OR of having PDI <85 was 4.0 (95%CI: 1.4, 11.4) in girls 
and 1.1 (95% CI: 0.5, 2.2) in boys (Murcia et al., 2011).  
In 2013, the same study was performed in the other three sub-cohorts in other regions of 
Spain (Rebagliato et al., 2013). Maternal UIC (median 125 µg/L) and iodine intake from diet 
(median 162 µg/day) and iodine supplement use were assessed in 1519 pregnant women. 
Child development was measured using the Bayley Scales of Infant Development, 2nd ed, 
when the children were 16 months and mental development and psychomotor development 
scores were standardised and harmonised to a mean of 100 and a SD of 15. Maternal UIC, 
iodized salt consumption, and dietary iodine intake during pregnancy were not associated 
with neuropsychological development. Maternal consumption of 150 µg/day or more of 
iodine from supplements was associated with a non-significant decrease of 1.8 (95% CI: 
−5.6, 2.0) in mental scores and of 0.9 points (95% CI: −6.9, 5.0) in psychomotor scores. 
The corresponding risks of low mental and psychomotor scores (<85) when compared with 
supplemental iodine <100 μg/day were 1.7 (95% CI: 0.9, 3.0) for mental scores and 1.5 
(95% CI: 0.8, 2.9) for psychomotor scores.  
All the included papers for prenatal iodine status or iodine intakes and neurodevelopmental 
outcomes are summarised in Tables 5.4.1.1-1 (RCT) and 5.4.1.1-2 (cohorts). 
Table 5.4.1.1-1 Overview of one randomised double-blind placebo-controlled trial (RCT) for 
assessment of iodine supplementation in pregnancy in a population of mildly to moderately iodine 

























200 µg iodine or 
placebo daily from 
first trimester (mean 
10.7 gw) throughout 
pregnancy. 
Baseline median 
UIC: 131 µg/L in all 
(188 µg/L in India 











age 5-6y.   
3 primary outcomes at age 5-6 y: 
verbal IQ and performance IQ by  the 
Wechsler Preschool and Primary Scale 
of Intelligence (WPSSI-III), and global 
executive composite score by the 
Behavior Rating Inventory of Executive 
Function-Preschool Version (BRIEF-P).  
 
Secondary outcomes at age 5-6 y: 
externalising and internalising 
behaviour problems by the Strengths 
and Difficulties Questionnaire (SDQ) 
and auditory tests. Secondary 
outcomes at earlier ages: child 
neurodevelopment at 6 weeks by the 
Neonatal Behavioral Assessment 
Scales (NBAS) and at 1 and 2y using 
the Bayley Scales of Infant 
Development (BSID)-III. 
There were no 
differences between the 
groups receiving 
supplement and placebo 
for the primary 
outcomes at age 5-6y. 
Moreover, except for a 
higher score on 
expressive language in 
favour of placebo at 1y, 
there were no 
differences in any of the 
secondary outcomes at 






Table 5.4.1.1-2 Overview of prospective cohort studies included for assessment of mild to moderate 
iodine deficiency and a range of neurodevelopmental outcomes in infancy and childhood (sorted by 

















in child, age at time 
of measurement 
Main findings 






assessed by FFQ in 
pregnancy. 
Calculated median 
iodine intake from 
food was 122 µg/d. 
The median UIC 










6 outcomes at 8y: 
Language, reading and 
writing skills from 








tests, teacher reports), 
and whether the child 
received special 
educational services (all 
outcomes are 
maternally reported). 
Maternal habitual iodine intake from 
food < ~ 150 µg/d from food was 
associated with poorer skills in 
language, reading and writing, and also 
increased likelihood of the child 
receiving special educational services at 
age 8 y. Poorer outcome was found for 
all outcomes except mapping tests for 
mathematics. In the subsample with 
maternal UIC there were no 
associations with the outcomes. In the 
whole study population, there were no 
associations between the use of iodine-
containing supplements and the 
outcomes and no indication of adverse 
effects of iodine-containing supplement 
use. 




The median UIC in 
pregnancy (mean 
gestational week 
23.7) was 78 µg/L. 
Questions on 
supplement use 






5 outcomes: Bayley–III 
screening at 6 and 12 
mo and Bayley-III full 
at 18mo. Three 
subscales: cognitive, 
language (receptive 
and expressive), and 
motor (gross and fine 
motor) skills. Each 
outcome was modelled 
as repeated measures 
to take into account 
change over time. 
Children born to mothers with UIC 
below ~100 µg/L had reduced 
receptive and expressive language 
scores. For receptive and expressive 
language skills, the results showed a 
curvilinear dose-response association 
with UIC. There was no association 
with cognitive or motor skills. Maternal 
use of iodine-containing supplements 
was associated with lower gross motor 
skills, but not with other outcome 
measures. 




Median UIC in 
pregnant women 
(mean gestational 
week 13.5) was 123 
µg/L. Median UIC 
adjusted for 
creatinine (by the 
residual method; 
UIC~Cr) was 





2 outcomes at 4-5y: 
McCarthy Scales of 
Children’s Abilities; 
general cognitive and 
motor scale. 
No associations between use of iodized 
salt or the use of iodine containing 
supplements and the outcomes.  
For UIC, there were no associations 
without adjusting for creatinine. 
Children of mothers with UIC~Cr <100 
µg/L had poorer cognitive, but not fine 
motor scores at age 4-5y. Dietary 
iodine intake was inversely associated 
with motor development, but not with 
the other neurodevelopmental 
outcomes. No indication of benefit or of 
maternal use of iodine containing 































(median 3.3y prior 
to conception) UIC 
was 108 μg/L and 
median I/Cr was 
114 μg/g. 
FFQ before 
conception and in 
early and late 
pregnancy, included 
information on 




4 outcomes at 6-7y: 
WASI full scale IQ, 3 
CANTAB executive 
functioning tests 
(Delayed Matching to 
Subject, Spatial Span 
and Intra-Extra 
Dimensional Set Shift).  
Preconception I/Cr ratio was positively 
associated with child IQ. Standardised 
beta-coefficient was 0.13 (95% CI 
0.04, 0.21) SD higher IQ z-score per z-
score higher I/Cr. Compared women 
with an I/Cr ≥150 μg/g, children of 
women with preconception urinary I/Cr 
<50 μg/g (moderate iodine pre-
pregnant iodine deficiency) had 0.49 
(95% CI: 0.79, 0.18) SD lower IQ, 
which is equivalent to a difference of 
7.5 IQ points. Preconception I/Cr was 
not associated with any of the 
executive function outcomes. 




Median UIC was 
186 µg/L at study 
entry (<20 
gestational weeks). 
Total mean (SD) 
iodine intake was 
309 (127) µg/d at 
study entry. FFQ 





3 outcomes at 18mo: 
Cognitive, language 
and motor skills by 
Bayley-III.  
Both low and high iodine intakes in 
pregnancy (food and supplements 
combined) were associated with poorer 
childhood neurodevelopment in this 
iodine-sufficient population. 
There were no association between UIC 
and the cognitive outcomes. 





calculated by a 
validated FFQ: The 
calculated median 
iodine intake from 
food during 
















users only.  
5 outcomes at child age 
3 years: Language 
delay (a six-point 
ordinal language 
grammar rating scale 
developed by Dale & 
Bishop), communication 
skills (Ages and Stages 
Questionnaire, ASQ), 
motor milestone (ASQ), 
motor skills (AAQ) and 
behaviour problems 
(Child Behaviour Check 
List/ 11/2-5/LDS). All 
outcomes were 
maternally reported. 
Maternal iodine intake <160 µg/d was 
associated with child language delay, 
more externalising and internalising 
behaviour problems, and lower fine 
motor skills in children at age 3 years. 
No associations with gross motor skills 
or the likelihood of not walking unaided 




















in child, age at time 
of measurement 
Main findings 





calculated by a 
validated FFQ. 
Median iodine 
intake from food 
was 121 (IQR: 89-
162) µg/d. 
Median UIC (mean 
18.5 gw) was 61 
(IQR: 32-104) µg/L 
in non-users of 
iodine supplements 
and 86 (IQR: 43-
140) µg/L in iodine 
supplement users. 
A total of 
n=77 164 
mother-child 














2 outcomes at 8y: 
ADHD diagnosis at any 




ADHD symptom scores 
(a four-point Likert 
scale (never/rarely, 
sometimes, often, or 
very often) covering 
inattention problems 
(nine items) and 
hyperactivity/impulsivity 
(nine items) from the 
ADHD Rating Scale.).  
No association between maternal iodine 
intake from food and risk of child ADHD 
diagnosis. Maternal iodine intake from 
food lower than ~200 µg/d) was 
associated with higher standardized 
child ADHD symptom scores (adjusted 
difference in score up to 0.08 SD. In 
participants with low iodine intakes 
from food, iodine supplement use 
initiated in GW 0-12 was associated 
with a ~29% increased risk of ADHD 
diagnosis (95%CI: 0%, 67%) and a 
0.06 SD higher average score on ADHD 
symptoms at eight years of age (95% 
CI: 0.01, 0.11). 





Median UIC (mean 
of repeated UICs) 
was 83.2 µg/L in 




pairs for the 
longitudinal 
analysis, of 












5 outcomes (spelling, 
grammar, reading, 
writing and numeracy) 
from the standardized 
school test in literacy 
and numeracy (NAPLAN 
in grades 3 (age 8/9y), 
5 (10/11y), 7 (12/13y) 
and 9 (age 14/15y).   
2 outcomes (incl. 
subscales) at 14/1y: 
language delay (CELF-4 
test) and hearing 
deficits and/or a central 
auditory processing 
disorder (CAPD)  
The longitudinal follow up study 
showed reductions in spelling in 
mothers with UIC < 150 µg/L, but not 
in the other outcomes. For grammar 
and reading, differences at year 3 






Maternal UIC (mean 
13.3 gestational 
weeks) was 230 
µg/L (corresponding 




2 outcomes at 6y: Non-
verbal IQ and language 
comprehension by 
Validated Dutch test 
batteries: two subtests 
of the Snijders-Oomen 
Niet-verbale 
intelligentie Test-
Revisie (SON-R 21⁄2–7) 
(Spatial visualization 
abilities and abstract 
reasoning abilities) 
converted to a non-
verbal IQscore and the 
receptive subtest of the 
Taaltest voor Kinderen 
(TvK). 
Children of mothers with UIC<150 µg/g 
Cr had lower non-verbal IQ in crude 
analysis, but no associations were seen 
for either non-verbal IQ or language 




















in child, age at time 
of measurement 
Main findings 





Median UIC  was 
91.1 µg/L, 
equivalent to 110 
µg I/g Cr. 
Total n=958 7 outcomes at 8y or 9y: 
Abbreviated form of the 
Wechsler Intelligence 
Scale for Children 
(verbal, performance 
and total IQ) at 8 
years. The Neale 
Analysis of Reading 
Ability (reading speed, 
accuracy, and 
comprehension) and 
words read per minute 
at age 9. 
Children of mothers with inadequate 
iodine status (UIC<150 µg/g Cr) had 
lower verbal IQ, reading accuracy, and 
reading comprehension than children of 
mothers with UIC≥150 µg/g Cr in the 
fully adjusted models. Further 
stratification indicated a dose-response. 





Median UIC (mean 
of repeated UICs) 
was 81 µg/L in the 
2013 study sample. 
N=228 
mother child 
pairs in the 
2013 study 
sample. 
7 outcomes at 9y: 
Australian National 
Assessment Program—
Literacy and Numeracy 




numeracy in Australian 
children and Student 
Assessment and 
Reporting Information 
System (SARIS) scores 
of English-literacy and 
mathematics-numeracy 
in Tasmanian children).  
This study showed reduced spelling, 
grammar and general English-literacy 
performance at age 9y in children of 
mothers with UIC<150 µg/L. No 






Median UIC was 
125 µg/L. 
Median iodine 
intake from diet was 
162 µg/d.  
Mean 
supplementary 
iodine intake was 
classified as a mean 
dose <100 µg/d, 
100-149 µg/d, or 
≥150 µg/d (range, 




2 outcomes by Bayley 




Maternal UIC, iodized salt consumption, 
and dietary iodine intake during 
pregnancy were not associated with 
neuropsychological development. 





status (median UIC 
for group) not 
reported, but 55% 
of the women had 




2 outcomes by Bayley 
at 12mo (range 11-
16mo): Mental and 
psychomotor scores. 
No association between UIC and infant 
neurodevelopment. However, maternal 
intake of 150 µg/d iodine supplement 
was associated decreased psychomotor 





5.4.1.2 Grading of neurodevelopment – prenatal exposure  
Our literature review included 14 studies that investigated associations between mild to 
moderate iodine deficiency (measured by UIC, iodine intake and/or iodine supplements) 
assessed prior to or during pregnancy and neurodevelopmental outcomes in children; one 
RCT and 13 prospective cohort studies (see Tables 5.4.1.1-1 and 5.4.1.1-2). Six of the 14 
studies found an association between mild to moderate iodine deficiency (measured by UIC) 
and poorer neurodevelopmental outcomes, i.e. that children of mothers with UIC in the mild 
to moderate range had poorer neurodevelopmental outcomes. Four of the studies found an 
association between mild to moderate iodine deficiency (measured by iodine intake) and 
poorer neurodevelopmental outcomes, i.e. that children of mothers with iodine intakes in the 
lower range (<100-150 µg/day) had poorer neurodevelopmental outcomes. One study 
(Murcia et al., 2018) found an inverse association with mild to moderate iodine deficiency 
(measured by iodine intake), i.e. poorer neurodevelopmental outcomes with higher iodine 
intakes. Concerning iodine supplements, five of the 14 studies found that use of iodine-
containing supplements in mild to moderate iodine deficient women was associated with 
poorer neurodevelopmental outcomes in the children.  
The studies on iodine supplementation in pregnancy on neurodevelopment (Murcia et al., 
2011; Rebagliato et al., 2013) showed that iodine supplementation did not improve infant 
neuropsychological development at 1 year of age but was inversely associated with Bayley II 
psychomotor scores. A sudden increase in iodine intake, although modest and within the 
recommendations, might also lead to a ‘‘stunning effect,’’ with transient inhibition of 
maternal or fetal thyroid hormone production. In addition, the MoBa Study showed no 
protective effects of iodine supplementation during pregnancy on offspring 
neurodevelopment; there was also some suggestion of harmful effects of supplementation 
among women who had low dietary iodine intakes.  
Fourteen studies investigated neurodevelopmental outcomes in children born to mothers 
with mild to moderate iodine deficiency prior to or during pregnancy, and 10 of these 
reported findings indicating an association between mild or moderate iodine status and 
various neurodevelopmental outcomes. However, the ten studies varied in study design, 
sample size, in neurodevelopmental domains, neurodevelopmental assessment tools, iodine 
status in the studied population and age of children at the time of outcome assessment 
(from 6 months to 15 years). Neurodevelopmental tests are less reliable in early age (<3 
years) than at later ages and hence have poorer predictive value for future cognitive 
performance. Three of the 14 studies were performed in children less than 3 years old and 
more weight have been given to studies that assessed neurodevelopmental outcomes in 
children older than 3 years. However, the variation in neurodevelopmental domains and 
outcomes made it difficult to draw a clear conclusion. 
The results from the included cohort studies on neurodevelopmental outcomes also differed 
in measurement of iodine exposure (UIC, creatinine-corrected UIC, dietary intake and 
supplements). Consequently, there was heterogeneity in the type of effect estimates 




Concerning iodine status, the studies which did not find associations between low UIC (or 
low iodine intake) and poorer neurodevelopmental outcomes generally included study 
populations having median UIC only slightly below WHO cut-off of 150 µg/L defining 
adequate iodine intake in pregnant women, i.e. in the upper end of the mild to moderate 
iodine deficiency range (50-149 µg/L). When a median UIC is above 100 µg/L, which is the 
cut-off for non-pregnant women, few women are truly iodine deficient. In the RCT 
(Gowachirapant et al., 2017), after the intervention, there was no difference in UIC between 
the pregnant women in the iodine supplementation group (intervention) and the placebo 
group. Median UIC at baseline (131 µg/L) (Gowachirapant et al., 2017), indicating mild 
iodine deficiency was considerable higher than median UIC in the observational studies from 
UK (mean 91 µg/L) (Bath et al., 2013) and from Australia (mean 82 µg/L) (Hynes et al., 
2017; Hynes et al., 2013, where an association between UIC (or low iodine intake) and 
poorer neurodevelopmental outcomes were found. Median UIC was also < 100 µg/L in four 
studies from Norway included in the literature review for neurodevelopmental outcomes. 
Three were from the large population-based MoBa study (Abel et al. 2017, 2018, 2019) and 
one from the population-based Little in Norway study (Markhus et al. 2018). These studies 
reported subtle impairments in neurocognitive outcomes, including communication, 
behaviour and school performance spanning from age 18 months to age 8 years. Median 
UIC<100 µg/L has consistently been shown also in more recent status studies (or cross-
sectional) studies in women of childbearing age as shown in Figure 1.1 (Henjum et al., 
2019).  
The quality of the included studies were evaluated, and one of the criteria for being 
categorised as a B article was that the associations had been adjusted for possible and 
relevant confounders. However, residual confounding can never be excluded in observational 
studies. Due to shortcoming of measuring individual iodine status, participants with a severe 
deficiency may have been misclassified as being mild to moderate deficient.  
The biological mechanism for severe iodine deficiency and poorer neurodevelopmental 
outcomes is well known and presented in in chapter 3. The current understanding suggests 
that the effect of low iodine intake on child brain development is mediated by a combined 
impairment of maternal and fetal thyroid function, caused by inadequate levels of substrates 
for thyroid hormone synthesis. There is no clear distinction between moderate and severe 
iodine deficiency in pregnancy, and therefore, reason to assume that the adverse effect may 
appear along a continuum of decreasing long-term iodine intake and that the evidence for 
biological plausibility is strong.  
The WCRF grading system includes factors (Box 2) that form part of the assessment of the 
evidence that, when present, can upgrade or strengthen the judgement reached. An 
exposure that might be judged as ‘limited – suggestive’ in the absence, for example, of a 
biological gradient, might be upgraded to ‘probable’ if one is present. Four of the included 
studies in the literature review on neurodevelopment showed a dose response in the 




Our literature review included 14 studies of which ten found poorer neurodevelopmental 
outcomes in children born to mothers with seemingly mild to moderate iodine deficiency. 
However, based on our systematic literature review and use of WCRF guidelines for grading 
of evidence, the evidence was not judged strong enough to meet the criteria for probable 
evidence. The three criteria for limited suggestive were met: 1) Evidence from at least two 
independent cohort studies or at least five case-control studies. 2) The direction of effect is 
generally consistent though some unexplained heterogeneity may be present. 3) Evidence 
for biological plausibility. It was therefore concluded that there is limited suggestive evidence 
for a causal relationship between mild to moderate iodine deficiency and poorer 
neurodevelopmental outcomes in children. Limited suggestive means that the evidence is too 
limited to permit a probable or convincing causal judgement but is suggestive of a direction 
of effect. The evidence may be limited in amount or by methodological flaws but shows a 
generally consistent direction of effect. 
5.4.1.3 Iodine status in schoolchildren and neurodevelopmental outcomes 
For schoolchildren, two RCTs were identified on mild or moderate iodine deficiency and 
neurodevelopmental outcomes. 
In a double-blind RCT from New Zealand (Gordon et al., 2009), 166 mildly iodine deficient 
(median UIC 63 µg/L) children aged 10-13 years were randomised into 2 groups; the 
intervention group receiving 150 µg supplemental iodine daily and a placebo group (duration 
28 weeks). Cognitive performance was assessed by four tests from the Wechsler Intelligence 
Scale for Children, fourth edition (WISC-IV): Picture concepts and Matrix reasoning (both 
assessing perceptual reasoning), Letter-number sequencing (working memory), and Symbol 
search (processing speed). Supplementation with 150 µg iodine per day corrected iodine 
deficiency by increasing median UIC from 66 to 145 µg/L and decreasing thyroglobulin from 
16.5 to 8.5 µg/L. Iodine supplementation improved performance on the two tests of 
perceptual reasoning (picture concepts and matrix reasoning) compared to the placebo 
group. The overall cognitive score in the iodine supplementation group was 0.19 SDs higher 
than in the placebo group.  
In a double-blind RCT from Albania (n=310) (Zimmermann et al., 2006) on schoolchildren 
10-12 year old (median UIC 43 µg/L), the intervention group were provided with 400 µg 
iodine as iodized poppy seed oil capsule and the placebo group with sunflower-oil. Seven 
tests of cognitive and motor performance were performed by the children at baseline and 
after 24 weeks. These tests included; the Raven’s Coloured Progressive Matrices (test of 
intelligence), Bead threading (fine motor), Rapid target marking, Digit span (short-term 
memory), Symbol search (visual perception and processing speed), Coding (short-term visual 
memory and processing speed), and Rapid object naming). The iodine intervention group 
significantly improved performance (adjusted treatment effect (95% CI)) on four of the 
seven tests; Raven’s Coloured Progressive Matrices (4.7 (3.8, 5.8) points), Rapid target 
marking (2.8 (1.4, 4.0) points), Symbol search (2.8 (1.9, 3.6) points), and Rapid object 




improved information processing rates and the ability to reason and solve problems in these 
10-12 year old schoolchildren. 
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82 in the 
placebo 
group. 
4 outcomes at 10-13y 
from the Wechsler 
Intelligence Scale for 





sequencing and overall 
cognitive scores. 
Supplementation with 150 µg 
I/day corrected iodine 
deficiency by increasing median 
UIC from 66 to 145 µg/L. 
Iodine supplementation 
improved performance on 2 of 
the 4 cognitive tests (picture 
concepts and matrix reasoning 
scores)  relative to the placebo.  
Zimmermann 
































7 outcomes at 10-12y. 
Cognitive and motor 
performance tests at 
baseline and after 24 
weeks: rapid target 
marking, symbol search 
(from WISC), rapid 
object naming, Raven’s 
Coloured Progressive 
Matrices, Bead 
threading, Digit span 
(from WISC), and 
Coding (from WISC). 
The intervention group 
significantly improved 
performance on 4 of the 7 
tests; Raven’s Coloured 
Progressive Matrices, Rapid 
target marking, Symbol search, 
and Rapid object naming. 
 
5.4.1.4 Grading of neurodevelopment – schoolchildren 
Our literature review included two RCTs on iodine supplementation in schoolchildren and 
neurodevelopment. Iodine supplementation in schoolchildren improved perceptual reasoning 
in mildly iodine-deficient children and improved information processing, fine motor skills, and 
visual problem solving in moderate iodine deficient children. However, both RCTs were 
conducted in areas with longstanding iodine deficiency and high goiter rates. The first 
criteria (evidence from at least two independent cohort studies), the second criteria (the 
direction of effect is generally consistent though some unexplained heterogeneity may be 
present) and the third criteria (evidence for biological plausibility) were met. The project 
group therefore concluded that the evidence is limited suggestive that mild to moderate 





 Thyroid function 
As described in chapter 3 and Figure 3-1, the association between iodine intake and thyroid 
function is U-shaped, with increased risk of altered thyroid function both at low and high 
iodine intakes (Laurberg and Nohr, 2002; Taylor et al., 2018). As an indicator of iodine 
intake, median UIC does not provide direct information about thyroid function. However, a 
low median UIC indicates that a population is at risk of developing thyroid disorders (WHO, 
2007). 
Fourteen studies of different study design (two RCTs, two prospective cohort studies and ten 
cross-sectional studies) in different population groups (non-pregnant adults, pregnant 
women and schoolchildren) were included. One RCT is categorised as A, and the other 
studies as category B.  
Potential effects of mild to moderate iodine deficiency on thyroid hormones and thyroid 
function parameters are difficult to assess and are expected to differ across age and life 
stages. In populations with mild-to-moderate iodine deficiency, overall serum Tg 
concentrations are typically elevated and thyroid size is often increased, while TSH, T3, and 
T4 remain within the normal range (Zimmermann and Boelaert, 2015). Normal physiological 
changes in pregnancy (e.g. plasma volume expansion and increased thyroid hormone 
turnover) affect the concentrations of thyroid hormones and TSH. Consequently, it is difficult 
to distinguish between normal changes and changes that may result from mild or moderate 
iodine deficiency. Observational studies and experimental animal studies have shown that 
not only maternal hypothyroidism, but also that isolated hypothyroxinemia (low T4 and 
normal TSH) can adversely affect affects foetal neurodevelopment (Velasco et al., 2018). A 
recent meta-analysis of three European birth cohorts, demonstrated that low maternal T4 in 
the first half of pregnancy was associated with lower verbal and non-verbal child IQ (Levie et 
al., 2018). The results corroborate the findings of six observational studies (Haddow et al., 
1999; Henrichs et al., 2010; Julvez et al., 2013; Korevaar et al., 2016; Pop et al., 2003; 
Roman et al., 2013) of which three were included in the meta-analysis. However, two 
randomised controlled trials of effects of levothyroxine (T4) treatment for women with 
subclinical hypothyroxinemia on child neurocognitive outcomes found no beneficial effects of 
T4 treatment initiated in mean gestational week (gw) 18 (range 8-20 gw) (Casey, 2017) or 
median gestational week 13 (range 12-20) (Lazarus et al., 2012). A possible explanation for 
the lack of treatment effect in these studies may be that treatment was initiated too late.  
Auto-regulatory processes are initiated in the thyroid gland when the availability of iodine is 
reduced, resulting in preferential secretion of T3 over T4, in order to save one iodine atom 
per hormone produced. The fetus is especially vulnerable to maternal iodine deficiency in 
early pregnancy when the foetus depend on supply of maternal T4 (Bernal, 2007; Obregon 
et al., 2005).  
Several papers included in the literature review on potential adverse effects of iodine 




sectional studies are generally not valid for causal inference, such studies were included due 
to the rapid response of the thyroid to increased iodine intakes (Zimmermann et al., 2013).  
5.4.2.1 Iodine status in non-pregnant adults and thyroid function 
For non-pregnant adults, seven studies have been identified on mild or moderate iodine 
deficiency and thyroid function; one RCT (categorised as A), two prospective studies, and 
four cross-sectional studies. 
In a double blind placebo controlled RCT with factorial design from New Zealand (Thomson 
et al., 2009) men and women aged 60-80 years with median UIC 48 µg/L at baseline 
received iodine and selenium supplements (80 µg iodine/day) for three months. Thyroid 
stimulating hormone (TSH), free triiodothyronine (T3) and free thyroxine (fT4), thyroglobulin 
(Tg) and UIC were measured. Tg concentration decreased by 24% and 13% of baseline in 
the participants receiving iodine (iodine- and selenium plus iodine groups) in comparison 
with the placebo group. UIC increased from baseline only in the iodine group. No significant 
treatment effects were found for TSH, fT3, fT4, or ratio of T3 to T4. The authors concluded 
that iodine supplementation alleviated the moderate iodine deficiency and reduced elevated 
Tg concentrations (Thomson et al., 2009). 
In a prospective cohort study from Denmark (DanThyr) (Krejbjerg et al., 2015) in women 
and men from a mild iodine deficient area (Copenhagen median UIC 61 µg/L) and a 
moderate iodine deficient area (Aalborg median UIC 45 µg/L), Tg was measured (at baseline 
in 1997-98 and at follow-up in 2008-10). After iodine fortification with 13 µg iodine/g salt in 
household salt and salt for the production of bread, there was no change in median Tg in 
adults living in Copenhagen, while Tg decreased significantly in adults living Aalborg. 
Regional differences in Tg evident before iodine fortification disappeared after iodine 
fortification. However, median Tg among non-users of iodine supplements were still higher 
than median Tg among iodine supplement users after iodine fortification. The authors raise 
the question whether the moderate level of iodine fortification of the salt was insufficient to 
secure adequate iodine intake in the entire study population (Krejbjerg et al., 2015).  
In the same prospective cohort study as presented above, with men and women from 
Denmark (Rasmussen et al., 2002) on iodine status in two different areas (mild iodine status 
(Copenhagen, median UIC 61 µg/L) and moderate iodine status (Aalborg, median UIC 
45 µg/L)), thyroid volume, thyroid enlargement, presence of thyroid nodules, serum Tg, TSH 
and thyroglobulin antibodies (TgAbs) were measured. A significant relation between iodine 
intake and thyroid volume was found. All measures of iodine intake, except iodine excretion 
measured as a urinary concentration, predicted thyroid volume (Rasmussen et al., 2002). 
The associations between iodine status and thyroid antibodies were investigated in a cross-
sectional study in 2808 adult men and women recruited in Shanghai, China, in 2016 (Wang 
et al., 2019). The median UIC was 165 µg/L. UIC was divided into four groups: 
UIC<100 µg/L (deficient), UIC 100-199.9 µg/L (adequate), UIC 200-299.9 µg/L (more than 
adequate), and UIC ≥ 300 µg/L (excess). UIC was not associated with TPOAb or TgAb 




autoimmunity (TAI). The findings showed that the U-shaped relationships between iodine 
intake and TAI risk, and that both iodine deficiency and excessive iodine status were risk 
factors of TAI among adults.  
A community-based cross-sectional study from eastern and central parts of China aimed at 
investigating the association between UIC and thyroglobulin antibodies (TgAbs) (Chen et al., 
2018b). In men and women aged 15 years and older (mean age 45 years), UIC was 
measured in spot urine samples. Blood samples were drawn for measurement of TgAbs, 
TSH, TPOAbs in serum. FT4 and fT3 were measured only for those whose TSH levels were 
outside the reference range. Median UIC was 205 µg/L. A total of 2508 participants (17.6%) 
had UIC below 100 µg/L. The prevalence of isolated TgAb positivity decreased across 
increasing UIC categories (6.14%, 5.62%, 5.34%, and 5.15%). The same trend was not 
seen for the prevalence of isolated TPOAb positivity or TSH. Thus, the results showed that 
the prevalence of TgAb positivity was higher at UIC<100 µg/L in both men and women. 
In a cross-sectional study from Tianjin, China (Fan et al., 2018), characteristics associated 
with the presence of thyroid nodules (TNs) were studied in adults. Median UIC was 134 µg/L 
and 35.6% had UIC below 100 µg/L. Prevalence of TNs was 25% when the UIC was in the 
range of 100-300 μg/L, and the prevalence of TNs was significantly decreased when the UIC 
was above 150 μg/L. A U-shaped association was observed between UIC and the prevalence 
of TN, with the highest prevalence at low (<100 µg/L) and very high UIC levels (>500 µg/L). 
The highest prevalence of TN of 30.7% was observed in the group with UIC levels 50-100 
µg/L (183 out of 596). The prevalence of TN was 27.2% in those with UIC 100-150 µg/L 
(140 out of 515), 25.9% in those with UIC 150-200 µg/L (108 out of 417), 22.3% in those 
with UIC 200-250 µg/L (61 out of 273) and 22.4% in those with UIC 250-300 µg/L (34 out of 
152 participants).  
In another cross-sectional study from New Zealand (Thomson et al., 2001), men and women 
with mean UIC 59 µg/L were divided into three groups according to 24-hour iodine excretion 
(24 h urinary iodide excretion (<60, 60 ± 90; >90 µg iodide/day). Serum total T4, TSH and 
Tg as well as thyroid volumes were measured. Elevated Tg concentrations were found 
among participants with lower iodine status (<60 µg iodide/day). No associations with 
plasma TSH or T4 were observed. There was a significant difference in thyroid volume 
between the three groups, with larger thyroid volume at lower iodine status. No differences 
were observed when subjects were categorised according to UIC in µg/L.  
5.4.2.2 Grading of thyroid function – non pregnant adults 
Seven studies on iodine status and thyroid function were identified in the literature review; 
one RCT, two cohort studies and four cross-sectional studies. The studies showed an 
increase in either Tg or Tvol, however an increase in one of these markers without an 
accompanying change in thyroid hormone levels was not regarded as sufficient to indicate 
thyroid dysfunction. It is therefore concluded that the evidence is limited (no conclusion) 
that mild to moderate iodine deficiency in non-pregnant adults is associated with thyroid 
dysfunction. Limited (no conclusive) means that the evidence is so limited that no firm 




the number of studies available, by inconsistency of direction of effect, by methodological 
flaws (lack of adjustment for known confounders). 
5.4.2.3 Iodine status in pregnant women and thyroid function  
For pregnant women, six studies have been identified on mild or moderate iodine deficiency 
and thyroid function; one RCT and five cross-sectional studies. 
In a RCT on iodine supplementation (200 µg/day) in pregnant women from Denmark  
(duration up to 34 weeks), thyroid function was measured as serum TSH, Tg, T4, T3, fT4, 
ratio T4/T3 and thyroid volume (Pedersen et al., 1993). In women with median UIC at 51 
and 55 µg/L, in control and intervention group, respectively, thyroid volume increased more 
in the control group than in the supplemented group during pregnancy. Maternal Tg values 
were significantly higher in controls at all-time points, except before initiation of iodine 
supplementation. In the control group, there was a significant increase in TSH during 
pregnancy. During the postpartum period, there was no significant difference in TSH 
between groups. No significant differences were found between the groups in the 
developments of T4, T3, ratio T4/T3 or fT4 during pregnancy or postpartum. The mild to 
moderate iodine deficient women in the control group had higher thyroid volume and Tg. 
The associations of UIC with thyroid function and autoantibodies was investigated in 2009 
pregnant women in the Swedish Environmental Longitudinal Mother and child Asthma and 
Allergy (SELMA) study (Levie et al., 2019). Data on UIC, creatinine and thyroid function 
parameters were collected at median gestation age 10 weeks (95% CI: 6-14 weeks). Median 
UIC was 90 (95%CI: 38, 439 µg/L) and when adjusted for creatinine the median was 85 
(95%CI: 36, 386) µg/g. Gestational reference ranges for thyroid function tests did not differ 
substantially by iodine status. We show that a lower UIC/creatinine was associated with 
significantly lower TSH, higher TT4, and a higher risk of TPOAb positivity. A lower 
UIC/creatinine was also associated with a higher fT4, fT3, and TT3, but these associations 
did not reach statistical significance (p < 0.10). The fT4/fT3 and TT4/TT3 ratios were stable 
across the full range of UIC/creatinine. 
A cross-sectional study in two Chinese cities examined the associations between iodine 
status and thyroid antibodies in 7073 pregnant women recruited in early pregnancy 
(gestational weeks 4-8) during 2012-2014 (Sun et al., 2019). The median UIC was 154 µg/L, 
indicating iodine sufficiency. Iodine deficiency (UIC < 100 μg/L) was associated with higher 
risks of TPOAb positivity and TgAb positivity. Women with isolated TPOAb positivity, isolated 
TgAb positivity, or both TPOAb and TgAb positivity increased risk of overt hypothyroidism, 
and increased risk of subclinical hypothyroidism. Moreover, the risks of overt and subclinical 
hypothyroidism in women with a high TPOAb were higher than in TPOAb-negative women. 
The risk of overt hypothyroidism in women with a high TgAb titer was higher than in TgAb-
negative women. 
In a cross-sectional study on mild to moderate iodine deficient pregnant women from 
Norway (Abel et al., 2018)) based on data from The Norwegian Mother and Child Cohort 




pregnancy (mean gestational week 18.5). Median iodine intake from food was 121 µg/day 
and median UIC was 59 µg/L among those who did not use supplements at the time of 
sampling and 98 µg/L in the women taking supplements, indicating mild to moderate iodine 
deficiency in both groups. Habitual iodine intake from food calculated by the FFQ was not 
significantly associated with any of the outcome measures. UIC <100 µg/L (moderate iodine 
deficiency in pregnant women), was associated with an elevated fT3, and a higher UIC was 
associated with a slightly lowered fT4 concentration. In addition, introduction of iodine 
supplementation after gestational week 12 (i.e. period covering the time of sampling) was 
significantly associated with lower T4, but not T3.  
In a cross-sectional national representative study on mild iodine deficient pregnant women 
from Belgium (Moreno-Reyes et al., 2013), the prevalence of thyroid disorders in 1st and 3rd 
trimesters based on maternal serum fT4, fT3, TSH, Tg, TPOAb, and TgAb, was measured. 
The prevalence of subclinical hypothyroidism and thyroid autoimmunity was increased 
among the pregnant women. Differences in Tg was only found between pregnant women 
with UIC/Cr=150–249 µg/g (adequate iodine status in pregnant women) and UIC/Cr ≤49 
µg/g (severe iodine deficiency in pregnant women), with a significantly lower median Tg 
concentration in the group with adequate iodine status.  
In a cross-sectional study on mildly iodine deficient pregnant women from Spain (Rebagliato 
et al., 2010), measuring TSH, fT4, urinary iodine and iodine intake, a higher TSH was found 
in women who consumed 200 µg or more of iodine supplements daily compared to those 
consuming less than 100 µg/day. The results showed no association between UIC and TSH 
levels.  
5.4.2.4 Grading of thyroid function – pregnant women 
Six studies on iodine status in pregnant women and thyroid function were identified in the 
literature review; one RCT and five cross-sectional studies. The studies showed that mild to 
moderate iodine deficiency might affect thyroid function negatively by increased Tvol and 
elevated Tg and free triiodothyronine (T3). However, elevated T3 was only found in one 
study. According to the WCRF grading system, the criteria for grading evidence as limited 
suggestive, findings from at least two independent cohort studies are required. It is 
therefore concluded that the evidence is limited (no conclusion) that mild to moderate iodine 
deficiency during pregnancy is associated with thyroid dysfunction. 
5.4.2.5 Iodine status in schoolchildren and thyroid function 
For schoolchildren, one study was identified on mild or moderate iodine deficiency and 
thyroid function. 
In a cross-sectional study of schoolchildren from New Zealand (Skeaff et al., 2012), serum 
Tg, serum TSH, plasma fT4 and fT3 were measured. Tg was lower at UIC ≥100 µg/L 
(adequate UIC in children > 6 years) and higher at UIC <50 µg/L (moderate iodine 
deficiency in children > 6 years). Compared with children who had UIC ≥50 µg/L, those with 




differ according to this cut-off. Correspondingly, compared with children who had UIC 
≥100 µg/L, those with UIC <100 µg/L had statistically significantly higher Tg and fT3, while 
TSH and fT4 did not differ between the groups.  
Overview of studies included for mild to moderate iodine deficiency and thyroid dysfunction 
in sections 5.4.2.1-5.4.2.5 are presented in Tables 5.4.2-1 to 5.4.2-3. 
Table 5.4.2-1 Overview of RCTs included for assessment of mild to moderate iodine deficiency and a 




















Median UIC at 
baseline was 48 
µg/L (IQR:31-79 
µg/L). 
A population with 
moderate iodine 
deficiency (median 
UIC 48 µg/L) 
received either 100 
µg Se (selenium 
group), 80 µg I 
(iodine group), 100 
µg Se + 80 µg I 
(selenium plus 
iodine group), or 
placebo daily for 3 
months. 
100 men and 
women aged 











TSH, fT3, T4 
and Tg. 
Tg concentration 
decreased by 24% and 
13% of baseline in the 
iodine and selenium plus 
iodine groups in 
comparison with the 




effects were found for 
TSH, fT3, fT4, or ratio of 





Median (95% CI) 
for UIC spot urine 
in pregnant women 
at initial visit was 
51 (32-58) µg/L in 
controls and 55 
(30-73) µg/L in 






from weeks 17-18 of 












28, 37; and 5 
days, 26 wks, 









T4, fT4, Tg 
and Tvol. 
Thyroid volume was 
higher in the control than 
in the intervention group.  
There were no differences 
between the groups in the 
developments of T4, T3, 
ratio T4/T3 or fT4 during 
pregnancy or postpartum.  
Maternal Tg was 
significantly higher in 
controls at all time points, 
except before initiation of 
iodine supplementation.  
In the control group, TSH 
increased during 
pregnancy (p <0.01), but 
not in the intervention 
group. During the 
postpartum period, there 
was no difference in TSH 






Table 5.4.2-2 Overview of prospective cohort studies and included for assessment of mild to 


















98) median UIC 
in Copenhagen 
was 68 µg/L in 
supplement 
users and 
61 µg/L in non-
supplement 
users. 
Median UIC in 
















iodine/g salt in 
household salt 
and salt used 
in bread 
(2000), and at 
follow-up 
(2008-2010) 
after IF.  
1417 women 
age range 18-
65y and men 











During follow-up (mean 11y) 
period, there was no change 
in median Tg in Copenhagen 
while Tg decreased 
significantly in Aalborg. 
Regional differences in Tg 
before IF disappeared after 
IF. After IF, median Tg in 
non-users of iodine 
supplements was still higher 
than median Tg in iodine 
supplement users, indicating 
that the moderate IF might 
be insufficient to secure 
adequate iodine intake in 
the entire study population.  
Rasmussen 




urine UIC was 
68 µg/L in 
Copenhagen and 





was 111 µg/d in 
Copenhagen and 
74 µg/d in 
Aalborg. 
Iodine intake 
from food and 
supplements 
was assessed by 
FFQ. 
Seven measures 
of iodine intake 
(based on UIC 
and FFQ) were 
evaluated for 
the two study 
cites combined.  
None 4649 women 
age range 18-
65y and men 









serum Tg, TSH 
and TgAb. 
All measures of iodine intake 
except one (an iodine intake 
index) were inversely 
associated with the thyroid 
volume outcomes. Likewise, 
all measures of iodine intake 
were inversely associated 
with Tg concentration. The 
association between iodine 
intake and the occurrence of 
thyroid nodules was less 
clear. Iodine measures most 
consistently and inversely 
related to thyroid nodules 
were iodine intake from 
diet/kg bw, milk intake, and 
total iodine intake (diet and 
supplements). 
A low total iodine intake and 
a low milk intake were both 






Table 5.4.2-3 Overview of prospective cross-sectional studies and included for assessment of mild to 









N, gender, age Thyroid function 
measures 
Main findings 




Median UIC from spot 
urine was 205 µg/L. 
UIC was  divided into 
four groups: UIC<100 
µg/L, 100≤UIC<200 
µg/L, 200≤UIC<300 
µg/L and UIC≥300 
µg/L. 
14230 men and 
women ≥15y, mean 
45y. 
5 outcomes: TgAb, 
and additionally 
TSH, TPOAb, fT4 
and fT3. 
UIC was inversely associated with 
the prevalence of isolated TgAb 
positivity but not seen with the 
prevalence of isolated TPOAb 
positivity or TSH. Both males and 
females with UIC<100 µg/L were 
more prone to have positive 
TgAbs. 




Median UIC was 90 
µg/L (95%CI: 38, 439) 
µg/L, and when 
adjusted for creatinine 
the median was 85 
µg/g (95%CI: 36, 
386) µg/g. 
2009 pregnant 
women in early 
pregnancy (median 
10 gestational 
weeks, 95%CI: 6-14 
weeks). 
7 outcomes, of 
which 5 thyroid 
function 
parameters (TSH, 
fT4, TT4, fT3, 






Gestational reference ranges for 
thyroid function tests did not differ 
substantially by iodine status. We 
show that a lower UI/Creat was 
associated with significantly lower 
TSH, higher TT4, and a higher risk 
of TPOAb positivity. A lower 
UI/Creat was also associated with 
a higher fT4, fT3, and TT3, but 
these associations did not reach 
statistical significance. The fT4/fT3 
and TT4/TT3 ratios were stable 
across the full range of 
UI/creatinine. 




Median UIC was 153.6 
µg/L.  
UIC was categorised 







(adequate (34.2%)),  
250-500 µg/L (more 
than adequate 
(14.4%)), and UIC ≥ 
500 µg/L (excessive 
(3.2%)).  
7073 pregnant 








Iodine deficiency (UIC < 100 μg/L) 
was associated with higher risks of 
TPOAb positivity and TgAb 
positivity. Women with isolated 
TPOAb positivity, isolated TgAb 
positivity, or both TPOAb and 
TgAb positivity increased risk of 
overt hypothyroidism, and 
increased risk of subclinical 
hypothyroidism. Moreover, the 
risks of overt and subclinical 
hypothyroidism in women with a 
high TPOAb were higher than in 
TPOAb-negative women. The risk 
of overt hypothyroidism in women 
with a high TgAb titer was higher 











N, gender, age Thyroid function 
measures 
Main findings 




Median UIC was 164.5 
µg/L.  
UIC was categorised 





200-299.9 µg/L (more 
than adequate 
(21.9%)),  
and UIC ≥ 300 µg/L 
(excessive (13.2%)). 





and TAI (defined 
as the presence of 
either TPOAb or 
TgAb or both)  
The median UIC was 165 µg/L. 
UIC was divided into four groups: 
UIC<100 µg/L (deficient), UIC 
100-199.9 µg/L (adequate), UIC 
200-299.9 µg/L (more than 
adequate), and UIC ≥ 300 µg/L 
(excess). UIC was not associated 
with TPOAb or TgAb positivity 
alone, but there was a U-shaped 
association between iodine status 
and thyroid autoimmunity (TAI). 
The findings showed that the U-
shaped relationships between 
iodine intake and TAI risk, and 
that both iodine deficiency and 
excessive iodine status were risk 
factors of TAI among adults. 




Median UIC in spot 
urine was 
59 µg/L in non-
supplement users and  
98 µg/L in 
supplements user at 
the time of urine 
sampling. 
FFQ: Median intake 
from food was 121 







5 outcomes: TSH, 
fT4, fT3, TPOAb 
and TgAb were 
measured in 
plasma samples. 
Iodine intake measured by FFQ 
was not associated with thyroid 
function while UIC was inversely 
associated with fT3 (p=0.002) and 
fT4 (p<0.001). Current iodine 
supplement use was not 
associated with the outcomes, but 
a recent initiation of iodine 
supplementation after GW 12 was 
significantly associated with lower 
mean fT4 (beta=-0.21) but not 
fT3 or TSH. 




Median UIC was 134 
µg/L (IQR: 79-208 
µg/L). There were 
35.6% of the subjects 
whose UIC was lower 
than 100 µg, and 
10.3% was higher 
than 300 µg/L. 
2647 adult 
men(1352) and 
women (1295), aged 





(TNs). In addition, 
potential 
influencing factors 
on TNs including 
sex, age, iodine 
status, Tvol, TSH, 
TPOAb and TgAb. 
In the range of urine iodine levels 
investigated, the relationship 
between UIC and the occurrence 
of TNs showed a U-shaped curve. 
Prevalence of TNs was 30.7% 
among subjects with UIC between 
50 and 99 µg/L, and 25.3% 
among subjects with UIC in the 
range of 100-300 µg/L. The results 
showed that the prevalence of TNs 
was significantly decreased when 
the UIC was over 150 µg/L. 




















Median UIC in 1st 
trimester was 117 g/L 
before and 103 µg/L 
after correction for Cr. 
Median UIC in 3rd 
trimester was 131 
µg/L before and 138 
µg/L after correction 
for Cr.  
Of 1311 pregnant 
women, UIC was 
available for 550 
healthy (negative for 
TPOAb and TgAb 
and no history of 
thyroid disease) 
women in 1st 
trimester and 616 








fT4, fT3, TSH, Tg, 
TPOAb, and TgAb. 
UIC/Cr was inversely associated 
with Tg, but not with fT4, fT3, 
TSH, TPOAb, and TgAb.  




Median UIC spot urine 
was 68 (IQR: 50-95) 
µg/L. 
1153 children 5-14y 
611 boys 




defined by serum 
Tg, serum TSH, 
plasma fT4 and 
fT3. 
UIC was inversely associated with 
Tg and fT3, but not with TSH and 
fT4. This was seen when groups 
were compared using a cut-off for 
UIC at 50 µg/L or a cut-off for UIC 





Median UIC in spot 
urine was 137 µg/L in 
all women. UIC was 
categorised as <50, 
50-99, 100-149, 150-
249, and 250+ µg/L in 
which 9, 23, 22, 25 




64% had iodine intake 
≥160 µg/d.  
Iodine intake from 
supplements was 
categorised as 0-99, 
100-199 and 
≥200 µg/d, with 51, 






and without thyroid 
pathology 
2 outcomes: TSH 
and fT4 
Consumption of  ≥200 µg/d 
supplemental iodine was 
associated with higher TSH levels 
(β=0.090 (95% CI: 0.003, 0.177) 
and increased risk of 
hyperthyrotropinemia (TSH>3 
µU/mL) compared to those 
consuming less than 100 µg/d 
(adjusted odds ratio=2.5 (95% CI; 
1.2-5.4). The results showed no 
association between urinary iodine 
and TSH levels. Pregnant women 
from the area with the highest 
median iodine (168 µg/L) and 
highest supplement coverage 
(93%) had the lowest values of 
serum fT4 (geometric mean 



















Average of two 
separate 24-h urine 
collections: 
Mean UIC was 59 
µg/L. Mean 24-h UIE 
was 86 µg/day. Mean 
I/Cr was 57 µg/g.  
233 subjects, 114 
men and 119 
women, 
mean age 32y 
enrolled 1997-98. 
4 outcomes: 





were analysed by 
three categories of 
I/Cr ratio divided 
according to the 
following cutoffs: 
Low (<40 µg/g 
Cr), medium (40-
60 µg/g Cr) and 
high (>60 µg/g 
Cr) corresponding 
to adequate, low 
and marginal 
iodine status.  
Tg concentrations and Tvols were 
higher in the low and marginal 
groups than in the adequate 
iodine status group, while serum 
TSH and T4 did not differ between 
groups.  
 
5.4.2.6 Grading of thyroid function – schoolchildren  
One cross-sectional study on iodine status and thyroid function in schoolchildren were 
identified. The study found elevated Tg and free triiodothyronine (T3) in schoolchildren with 
mild to moderate iodine deficiency. It is therefore concluded that the evidence is limited (no 
conclusion) that mild to moderate iodine deficiency in schoolchildren is associated with 
thyroid dysfunction. 
 Fertility and birth outcomes 
Six prospective cohort studies measuring iodine status and fertility and birth outcomes were 
identified, all categorised as B.  
In a prospective cohort study of pregnant women in US, the relationship between iodine 
status and pregnancy loss was measured in 329 women (Mills et al., 2019). The risk of loss 
was not elevated in the mildly, moderate or in the severe deficient group. Urinary iodine 
concentrations were in the deficiency range in 60% of the participants. The authors 
concluded that iodine deficiency at levels seen in many developed countries does not 
increase the risk of pregnancy loss. 
A prospective study including 541 pregnant women was conducted in London, Leeds, and 
Manchester between 2004 and 2008 (Snart et al., 2019). The median UIC was 134 µg/L and 
was between 100 and 150 in all three cities. Less than 20% had UIC < 50 µg/L. UIC was not 
associated with pregnancy outcomes including birth weight, growth restriction (SGA) and 




In a prospective cohort study of women (n=501) planning a pregnancy in US (Mills et al., 
2018), women with UIC <50 µg/L took significantly longer to become pregnant, experiencing 
a 46% decrease in probability of becoming pregnant over each cycle compared to women 
with UIC ≥100 μg/L (adequate iodine status in non-pregnant women). Women with UIC 50–
99 μg/L (the mildly deficient range group) had a smaller, non-significant increase in time to 
conception, suggesting that the risk, if any, is modest in this group.  
In a prospective cohort study from UK (Torlinska et al., 2018) on pregnant women with 
median UIC of 95 µg/L (moderate iodine deficiency in pregnant women) (n=3524), no 
associations were found between iodine status and seven different measures on adverse 
pregnancy outcomes including birth weight and preterm birth. 
In a cohort study from Thailand (Charoenratana et al., 2016) in pregnant women (n=410), 
UIC<150 µg/L was associated with increased rate of preterm birth and low birth weight. In 
addition, women with a UIC <100 µg/L (moderate iodine deficiency in pregnant women) had 
a significantly higher rate of foetal growth restriction. 
In a cohort study from Spain (Alvarez-Pedrerol et al., 2009) in pregnant women (n=657), 
higher birth weight and lower risk of having a small for gestational age (SGA) new-born was 
reported, in mothers with UIC between 100-149 µg/L (mild iodine deficiency in pregnant 





Table 5.4.3-1 Overview of six prospective cohort studies included for assessment of mild to 
moderate iodine deficiency in women and fertility and pregnancy/birth outcomes, all categorised as B 







iodine status  
N, age Fertility, pregnancy 
and birth outcome 
measures 
Main findings 




Spot urine samples at the first 
in-home interview prior to 
conception. Median UIC 170 
µg/d. Iodine was measured as 
µg/L and creatinine was used 
either as an independent 
variable or to use the ratio of 
iodine to creatinine (µg/g 
creatinine). The exposure was 
grouped into normal status 
(≥150 µg/L, n=133 (40%)), 
mild deficiency (100-149 µg/L, 
n=52 (16%)), moderate 
deficiency (50-99 µg/L, n=74 
(22.5%)) and severe deficiency 








the analyses.  
1 outcome: Pregnancy 
loss. Pregnancy was 
assessed by the 
Clearblue fertility 
monitor. Pregnancy 
was identified by a 
positive test and 
pregnancy loss 
identified by conversion 
to a negative test. 
The women with UIC in the 
deficiency range did not have 
a different loss rate than 
those in the sufficient group. 
Results were consistent in 
sensitivity analyses including 
creatinine adjustment or 
exclusion of women being 
treated for thyroid disease. 




Urinary iodine concentration 
was measured in two spot 
urines, one in 15 gw and one in 
20 gw. The mean UIC of both 
time points were the main 
exposure. Median UIC was 134 
µg/L, (139 µg/L in Manchester, 
130 µg/L in London and 116 
µg/L in Leeds. 
541 pregnant 
women. 
4 outcomes: Birth 
weight, birth weight 
centile (primary 
outcome), small for 
gestational age (SGA) 
and spontaneous 
preterm birth. 
No evidence of an association 
between UIC and birth weight 
centile, nor with odds of 
spontaneous preterm birth or 
SGA. Sensitivity analyses 
gave similar results (using 
creatinine adjusted UIC, µg/g 
Cr) and assessing iodine at 
the individual time points. 




Spot urine samples from 467 
women as UIC and I/Cr-ratio. 
Iodine status was sufficient 
(UIC≥100 μg/L) in 260 
(55.7%), mildly deficient (50–99 
μg/L) in 102 (21.8%), 
moderately deficient (20–49 
μg/L) in 97 (20.8%) and 
severely deficient (<20µg/l) in 8 
(1.7%). 
Median UIC was 112.8 µg/L in 
the entire population, 114.1 
µg/L in those who became 
pregnant, 97.2 µg/L in those 
who did not become pregnant, 








1 outcome: Time to get 
pregnant. Fertility 
monitoring, home 
digital pregnancy test. 
For women UIC in the 
moderate to severe deficiency 
range, it took significantly 
longer time to become 
pregnant, and they had a 
46% decrease in probability 
of becoming pregnant over 
each cycle compared to 
women who were iodine 
sufficient. The mildly deficient 
range group had a smaller, 
non-significant increase in 
time to conception, 
suggesting that the risk, if 










iodine status  
N, age Fertility, pregnancy 




al., 2018,  
UK,  
ST33 
Median UIC was 95 µg/L and 











7 adverse pregnancy 
outcomes: (i) 
hypertensive disorders 
in pregnancy; (ii) 
glucose derangement; 
(iii) anaemia; (iv) post-
partum haemorrhage; 
(v) preterm birth; (vi) 
mode of delivery; and 
(vii) birthweight 
No associations were found 
between iodine status and 
adverse pregnancy outcomes. 
Charoenrata




Repeated urine samples, UIC in 
1st (n=384), 2nd (n=325) and 3rd 
(n=221) trimesters. Median UIC 
151 µg/L.  The mean UIC of 
repeated measurements were 
categorised into ≥150 µg/L and 
<150 µg/L. The study also 
report the findings on foetal 
growth restriction using a cut-






data for 390. 
Gestational 
length/preterm birth, 
birth weight, foetal 
growth restriction, 







UIC <150 µg/L was 
associated with increased risk 
of preterm birth and low birth 
weight.  
UIC <100 µg/L was 
associated with higher risk of 
foetal growth restriction. 







Median UIC in the 1st trimester 
(n=251): 95 µg/L.  
Median UIC in the 3st trimester 
(n=528): 104 µg/L.  
UIC was categorised into five 
categories <50 µg/L, 50-99 
µg/L, 100-149µg/L, 150-249 








Women with 3rd trimester 
UICs between 100-149 µg/L 
had lower risk of having an 
SGA newborn than women 
with UICs below 50 µg/L 
(aOR (95%CI): 0.15 (0.03, 
0.76). The newborns in this 
group also had higher mean 
birth weights.  
Similar results were indicated 
for 1st trimester UICs, but did 
not reach statistical 
significance.  
 
5.4.3.1 Grading of fertility and birth outcomes  
Six cohort studies on fertility and birth outcomes were identified in the literature review. In 
four of the five studies on birth outcomes, no association between iodine status and birth 
outcomes were found. In one of the studies on birth outcomes, a higher prevalence of 
preterm birth and low birth weight was found in mild to moderate iodine deficient women. In 
one of the studies, lower birth weight and higher risk of having a small for gestational age 
(SGA) newborn was found in severe iodine deficient women. It is therefore concluded that 
the evidence is limited (no conclusion) that mild to moderate iodine deficiency prior to 
conception or during pregnancy is associated with negative birth outcomes.  
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5.5 Evidence table and grading of health effects related to mild to moderate iodine deficiency 
The systematic literature searches for evidence on health effects associated with mild- and moderate iodine deficiency resulted in 131 studies. 
As a result of quality assessment, one of these studies were categorised as an A-study, a total of 35 studies were categorised as B-studies, 
whereas a total of 95 studies were categorised as C-studies. The category C-studies (lowest quality score) were not considered further. The 
following sections are organised according to the health outcomes graded, starting with neurodevelopment, followed by thyroid function and 
finally birth outcomes. The grading of evidence for the outcomes neurodevelopment, thyroid function and birth outcomes is finally summarised 
in the evidence Tables in 5.5-1 and 5.5-2. 
Table 5.5-1 Evidence based on the systematic literature review of mild to moderate iodine deficiency graded as limited – suggestive for neurodevelopmental 















Outcomes measured.  
Findings in bold 
Findings associated with 
UIC 
Findings associated 
with iodine intake 
Findings associated with 













0 of 3 3 outcomes: Verbal and 
performance IQ and global executive 
composite score. 
Primary outcome - no 
effect. 
Effect in favor of 
placebo on expressive 









5 of 6 6 outcomes: Language skills, 
reading skills, writing skills, 
mapping test reading, mapping 
test mathematics and special 
education. 
No association between 
UIC and school 
performance tests 
Pos. association 
between iodine intake 
with language, 
reading, writing, 
school and spec. ed. 
No association with 
supplement and 
neurodevelopment 




78 µg/L 2 of 5 5 outcomes: Cognitive, receptive 
communication, expressive 
communication, gross motor and 
fine motor. 
Pos. association between 
UIC <100 µg/L and 
language (expressive and 
receptive) 



















Outcomes measured.  
Findings in bold 
Findings associated with 
UIC 
Findings associated 
with iodine intake 
Findings associated with 
iodine supplement use 
Murcia, 2018 Cohort, 
n=1803, 4-
5y 
123 µg/L 1 of 2 2 outcomes: Cognitive and motor 
function. 
No associations for raw 
UIC. After adj. for 
creatinine UIC < 150 µg/g 
Cr associated with reduced 
general cognitive score 
Neg. association with 
scores on motor scale, 
no association with 
general cognitive 
score 
No association with 
cognitive or motor scores 
Robinson, 2018 Cohort, 
n=654, 6-7y 
108 µg/L 1 of 4  4 outcomes: Full scale IQ and 
executive function (CANTAB DMS, 
CANTAB IED and CANTAB SSP). 
Pos. association between 
preconception UIC and full-
scale IQ 
  
Zhou, 2019 Cohort, 
n=699, 
18mo 
186 µg/L 3 of 3 3 outcomes: Cognitive, language 
and motor. 
No associations with 
Bayley-III scores 
Pos. associations with 
maternal intake (<220 
μg/day) and (391 
μg/day) on all 3 
subscales and higher 
odds of developmental 
delays. 
 





3 of 5 5 outcomes: Language delay, 
communication skills, motor 
milestone, fine motor skills and 
behavior problems. 
 Pos. association 
between iodine intake 
<160 μg/day and 
language, behaviour 
(ext/int) and fine 
motor skills.  
Neg. association with 
internal behavior 
Abel, 2017b Cohort, 
n=27945, 
8y 




1 of 2 2 outcomes: ADHD diagnosis and 
maternally-reported child ADHD 
symptoms. 
 Pos. association 
between maternal 
iodine intake <200 
μg/day and maternal 
reported ADHD scores 
Neg. association with ADHD 
symptoms and diagnoses  
Hynes, 2017 Cohort, 
n=228, 15y 
83 µg/L 1 of 4 4 outcomes: Reading, spelling, 
grammar and writing. 
Pos. associations between 





n=1525, 6 y 
296.5 μg/g 
creatinine 
0 of 2 2 outcomes: Non-verbal IQ and 
language comprehension. 
No associations   
Bath, 2013 Cohort, 
n=958, 8-9y 
91 µg/L 3 of 7 7 outcomes: Verbal and 
performance IQ, total IQ, words 
read per minute, reading 
accuracy, comprehension and 
reading scores. 
Pos. association between 
UIC<150 µg/L and verbal 
IQ, reading accuracy and 
comprehension 
  
Hynes, 2013 Cohort, 
n=228, 9y 
81 µg/L 3 of 7 7 outcomes: Literacy (reading, 
spelling, grammar, writing, 
Pos. association between 



















Outcomes measured.  
Findings in bold 
Findings associated with 
UIC 
Findings associated 
with iodine intake 
Findings associated with 
iodine supplement use 
numeracy, English-literacy score 
and mathematics-numeracy score. 







125 µg/L 0 of 2 2 outcomes: Cognitive and 
psychomotor development. 
  Neg. association with 
Bayley-II PDI in 1 of 3 
regions, and overall when 
including data from Murcia 
2011.  




0 of 2 2 outcomes: Mental and 
psychomotor scales. 
No associations No associations Neg. association with 
Bayley-II PDI 
 
Exposure in children 
Gordon, 2009 RCT, 
n=166, 
10-13y 
63 µg/L 2 of 4 4 outcomes: Picture concepts, 
matrix reasoning, symbol search, 
letter-number sequencing and 
overall cognitive.  
  Pos. associations with 







43 µg/L 4 of 7 7 outcomes: Rapid target 
marking, symbol search, rapid 
object naming, Raven’s 
Coloured Progressive Matrices, 
Bead threading, Digit span and 
Coding. 
  Pos. associations with rapid 
target marking, symbol 
search, rapid object naming, 
Raven’s Coloured 
Progressive Matrices  
 
Table 5.5-2 Evidence based on the literature review of mild to moderate iodine deficiency graded as limited – no conclusion for thyroid function and birth 







Study design, N, 
age 
Finding of total 
main outcomes 
measured 
Median UIC  
Median iodine 
intake  
Outcomes measured.  





















1 of 4 48 µg/L 4 outcomes: TSH, fT3, fT4 and Tg. 
 Chen, 2019 Cross-sectional, n=14230 1 of 5 205 µg/L 5 outcomes: TgAbs, serum TSH, TPOAbs, fT4 and fT3. 
 
 







Study design, N, 
age 
Finding of total 
main outcomes 
measured 
Median UIC  
Median iodine 
intake  
Outcomes measured.  
Findings in bold 
 Wang, 2019 Cross-sectional, n=2808 1 of 3 165 µg/L 3 outcomes: TPOAb positivity, TgAb positivity, Thyroid autoimmunity 
(TAI) defined as a combination of positivity for one or both of TPOAb or 
TgAb. 





1 of 1 61 µg/L (45) 
 





2 of 5 68 (53) µg/L 5 outcomes: Tvol, nodularity, Tg, TSH and TgAbs. 
 Thomson, 
2001 
Cross-sectional, n=233 2 of 4 54 µg/L 4 outcomes: Serum total T4, TSH, Tg and Tvol. 







2 of 5 51 µg/L 5 outcomes: Serum TSH, T4, fT4, Tg and Tvol. 
 Levie, 2019 Cross-sectional, n=2009 4 of 7  90 µg/L (1st 
trimester) 
TSH, fT4, TT4, fT3, TT3, TPOAb positivity, TgAb positivity, 
borderline significant for the rest (0.05>p<0.1). 
 Sun, 2019 Cross-sectional, n=7073 2 of 2 154 µg/L (1st  
trimester) 
TPOAb positivity, TgAb positivity. 
 Abel, 2018 Cross-sectional, n=2910 2 of 5 59 µg/L  
121 µg/d 
5 outcomes: TSH, fT4, fT3, TPOAb and TgAb. 
 Moreno-Reyes, 
2013 
Cross-sectional, n=1311 1 of 6 117 µg/L (1st 
trimester) 
6 outcomes: Tg, TSH, TPOAb, TgAb, fT3 and fT4. 
 Rebagliato, 
2010 
Cross-sectional, n=1844 0 of 2 137 µg/L (1st 
trimester) 
2 outcomes: fT4 and TSH. 
      
School 
children 
Skeaff, 2012 Cross-sectional, n=1153, 
5-14y 
2 of 4 68 µg/L 4 outcomes: Serum Tg, serum TSH, plasma fT4 and fT3. 





Mills, 2018 Cohort, n=501 1 of 1 113 µg/L 1 outcome: Time to get pregnant.  























Mills, 2019 Cohort, n=329 0 of 1 Not available 1 outcome: Pregnancy loss. 
 Snart, 2019 Cohort, n=541 0 of 4 134 µg/L 4 outcomes: Birth weight, birth weight centile (primary outcome), small 
for gestational age (SGA) and spontaneous preterm birth. 
 Torlinska, 
2018 











Study design, N, 
age 
Finding of total 
main outcomes 
measured 
Median UIC  
Median iodine 
intake  
Outcomes measured.  
Findings in bold 
 Charoenratana 
2016 
Cohort, n=410 3 of 12 151 µg/L 12 outcomes: Gestational week at birth, birthweight, stillbirth, 
Intrauterine growth restriction, preterm birth, LBW, Low Apgar 
score 1 min, Low Apgar score 5 min, antepartum haemorrhage, PIH, 
GDM and Caesarean delivery. 
 Alvarez-
Pederol 2009 
Cohort, n=657 2 of 2 95 µg/L (1st 
trimester) 
2 outcomes: Birth weight and SGA. 
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6 Best available evidence on the upper 
level (UL) of iodine intake 
Several scientific bodies have established ULs for iodine (described in chapter 4.2), the latest 
thorough evaluation of UL was, however, published back in 2002/2003. The literature search 
for adverse health effects from excessive iodine intakes for this report aimed at retrieving 
new literature after the year 2000 to possibly re-evaluate the existing ULs.  
The literature search, search terms, databases and inclusion/exclusion criteria, publication 
selection of the included studies for iodine excess is described in detail in Appendix I, and 
therefore only briefly described in this chapter. 
6.1 Literature search concerning the upper level (UL) of iodine 
intake 
Literature searches for studies investigating health outcomes related to excessive iodine 
intakes were performed in MEDLINE and EMBASE and aimed at retrieving publications on 
adverse effects caused by high intakes of iodine published after 1999 (meta-analyses and 
systematic reviews) or 2000 (original research articles) to re-evaluate the existing ULs 
described in chapter 4.2. Details about the search strategy and publication selection are 
given in Appendix I. Studies of chronic iodine exposure with a range that covered excess 
intake and that included at least one dose-response analysis with an health outcome, were 
considered suitable for investigating thresholds and for comparison with existing ULs. Studies 
with a prospective design were considered optimal, but cross-sectional studies were included 
if no prospective studies were found and the potential for reverse causation was considered 
limited. 
The literature search for meta-analyses and systematic reviews was conducted 
on September 21st 2017, and the systematic search for original research articles was 
conducted on November 23rd 2017. An updated search was conducted in May 2019 covering 
2017 and until May 14th 2019, and the latest update vas conducted November 18th 2019.  
The literature search for single studies performed in November 2017 identified 2919 articles, 
and the updated searches performed in May 2019 identified 466 articles and November 2019 
identified 234 articles. Both updated searches contained articles that were also found in the 
previous search. Consequently, the number of articles could not be summarised. Both human 
and animal studies were included in the search strategy, it was however, decided not to 




VKM Report 2020: 05  100 
In total, 5 studies were found relevant and included for evaluation of existing ULs in this 
opinion. Figure 6.1-1 shows a flow chart for the literature search and selection process for 















Figure 6.1-1 Flow chart for publication selection for literature concerning adverse health effects of 
excessive iodine intakes. 
6.2 Included studies concerning the upper level (UL) of iodine 
intake 
Few studies had a design suitable for investigating dose-response associations of chronic 
iodine intake in the excess range, with potential adverse health outcomes. Only five relevant 
human studies were identified and included from the literature search; one randomised, 
controlled dose response study in young adults and four cross-sectional studies in children 
and adolescents.  
 Study of upper level (UL) of iodine intake in adults 
An overview of the RCT in adults is given in Table 6.2.1-1. 
Main search 
The publications were identified searching 
Embase and Medline 
Titles and abstracts 
Human and animal studies:  
n=2919 + 466 + 234 
Full text 
Human studies:  
n=140 
Manual search 
2 human studies 
135 publications not suitable for the 
purpose of evaluating UL were 
excluded  
 
Publications not fulfilling the inclusion 
criteria were excluded 
n=2813 + 438 + 228 
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Number in study 
groups 
Doses Measures Duration of 
intervention 
Conclusions 






























fT4, fT3, and 
TSH, TPOAb and 
TgAb, thyroid 
size (Tvol), and 
UIC measured in 
fasting blood and 
urine samples 
obtained in the 
morning at 0, 2, 










appeared in the 
participants who took≥ 
400-µg I supplement, 
which provided a total 
iodine intake of 
800 µg/d or higher. 
Thus, the authors 
cautioned against a 
total daily iodine intake 
that exceeds 800 µg/d 
in China. 
The objective of this randomised controlled dose-response study was to explore the safe 
upper level of total daily iodine intake from diet and supplements among adults in China 
(Sang et al., 2012). A 4-week, double blind, placebo-controlled, randomised trial was 
conducted in 256 euthyroid adults (19-24 years old). In phase 1, 161 euthyroid participants 
met the inclusion criteria and were included in 2004. In phase 2 of the study, an additional 
115 participants were recruited in 2008 by using the same method, which resulted in 95 
eligible participants. In 2004, in the phase 1 trial, the study participants were randomised to 
one of seven groups and received supplements of 500, 750, 1000, 1250, 1500, 1750, or 
2000 µg iodine per day for 4 weeks. In 2008, phase 2 of the study was conducted, whereby 
95 euthyroid participants were randomly assigned to one of the following five groups: 0, 
100, 200, 300, or 400 µg iodine per day for 4 weeks. The 0 µg/day group was the control 
group and received a placebo. In total the participants were randomly assigned to 12 
intervention groups with various iodine supplement doses ranging from 0 to 2000 µg/day. 
Fasting blood and urine samples were obtained in the morning at 0, 2, and 4 weeks. Follow-
up in both phases was conducted after 1 and 3 months. Total iodine intake included iodine 
from both supplements and diet. Multiple outcome measures were used to evaluate possible 
adverse effects, including thyroid function (serum concentrations of fT4, fT3, and TSH, 
TPOAb and TgAb, thyroid size (Tvol), and UIC. The initial median UIC concentration was 291 
µg/L (272 µg/L in phase 1 and 304 µg/L in phase 2), all of which were within the 
recommendations of the WHO/UNICEF/ICCIDD (200–299 µg/L). Before supplementation, the 
mean dietary iodine intakes from food and iodized salt of the participants were 105 (mean 
intake range of 93 to 117 µg/day between supplementation groups) and 258 µg/day (mean 
intake assigned to all groups), respectively. The contribution from drinking water was 
analysed and found to be small (9.9 µg/day) and therefore excluded from estimates of total 
iodine intake. The mean total iodine intake between supplementation groups ranged from 
351 µg/day (placebo group) to 2375 µg/day (2000 µg supplement group). In comparison 
with the placebo group, all iodine supplemented groups responded with significant increases 
in median UICs (p<0.05) and in thyroid-stimulating hormone concentration (p<0.05). 
Thyroid volume decreased after 4 weeks in the high-iodine intervention groups (1500–2000 
µg). Subclinical hypothyroidism (TSH >5 mIU/L and normal fT4) appeared in the groups that 
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received 400 µg iodine (5%) and 500–2000 µg iodine (15–47%). A small decrease from 
baseline (0 wk) was observed in the fT3 concentration in the 500–2000-µg intervention 
groups (p < 0.05), but it remained within the normal range. Similar changing patterns were 
observed for fT4. This study showed that subclinical hypothyroidism appeared in the 
participants who took the 400 µg iodine supplement, which provided a total iodine intake of 
800 µg/day. Elevated TSH concentrations (TSH >5 mIU/L) remained in 5% of the 
participants who received 400 µg iodine per day 3 months after iodine withdrawal (Sang et 
al., 2012). 
 Studies of relevance to the upper level (UL) of iodine intake in 
children and adolescents 
Four cross-sectional studies investigating health outcomes from excessive iodine in children 
and adolescents were included. An overview is given in Table 6.2.2-1. 
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Table 6.2.2-1 An overview of the four cross-sectional studies investigating iodine and adverse health 















1288 children and 
adolescents, 6-
19y, with median 
UIC 449 µg/L. 
Thyroid function 
test in sub-sample 















In euthyroid individuals 10-19y, there was 
a weak, positive correlation between UIC 
and TSH that was more prominent for UIC 
>1000 µg/L. The prevalence of SCH was 
significantly higher in the iodine-deficient 
and iodine-excessive groups compared to 
UIC of 100–299.9 μg/L. Excess iodine 





14y with adequate 
to excessive iodine 
concentrations in 
drinking water, 







intake of 298 










The risk of total goiter significantly 
increased at iodine intakes ≥250–299 
μg/day in children 7-10 years and at iodine 
intakes ≥300–399 μg/day in children 11-
14 years. Similar to the publication in 
2017, the authors recommended 250 and 
300 μg/day as safe Tolerable Upper Intake 
Levels of iodine for children aged 7–10 





14y with adequate 
to excessive iodine 
concentrations in 
drinking water, 











(Tvol) and total 
goiter rate 
(TGR) 
Tvol began to increase in children with 
iodine intake ≥150 µg/d, and TGR 
exceeded 5% for daily iodine intake 
categories ≥250 µg/d in children 7-10 yrs, 
and ≥300 µg/d in children 11-14 yrs old. 
Authors conclude that 150-249 and 150-
299 µg/d appears to be safe upper iodine 
intake ranges for children aged 7-10 and 









12y from areas 
with adequate to 
excessive iodine 
intake. Median UIC 











UIC concentrations ≥500 µg/L were 
associated with increasing Tvol, which may 
reflect adverse effects of chronic iodine 
excess. 
TSH=thyrotropin, fT4=free thyroxine, fT3=free triiodothyronine, TPOAb= thyroperoxidase antibodies, Tg, 
thyroglobulin, SCH=subclinical hypothyroidism. 
6.2.2.1 Results based on changes in thyroid volume and risk of goiter 
Two studies (three publications) examined threshold effects of habitual dietary iodine intake 
on thyroid volume and goiter (Chen et al., 2017; Chen et al., 2018a; Zimmermann et al., 
2005). 
In the publication from 2017 (Chen et al., 2017), children (n=2089, 49% boys) were 
selected randomly from 1 to 6 primary schools in each of two cities with varying drinking 
water iodine concentrations. After adjusting for age, sex, height, and body weight, the 
results suggested a positive, nonlinear relation of total estimated iodine intake with Tvol, 
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with an iodine intake threshold of 150 µg/day. The TGR exceeded 5% for total estimated 
iodine intake ≥ 250 µg/day in children aged 7-10 and ≥ 300 µg/day in children aged 11-14 
years. Taken together the authors suggested safe, upper intake ranges of 150-249 µg/day 
for children aged 7-10 years and 150-299 µg/day for children aged 11-14 years. 
In the publication from 2018 (Chen et al., 2018a), the children (n=2224, 49% boys) were 
selected from 4 areas. After adjusting for age, sex, BMI, TSH, and Tg, the risk of goiter 
significantly increased at total estimated iodine intakes ≥250–299 μg/day in children 7-10 
years and at iodine intakes ≥300-399 μg/day in children 11-14 years. In line with the 
previous study (Chen et al., 2017), the authors recommended 250 and 300 μg/day as safe 
Tolerable Upper Intake Levels of iodine for Chinese children aged 7-10 years and 11–14 
years, respectively.  
A multi-center cross sectional study by (Zimmermann et al., 2005) examined the association 
between urinary iodine concentration (UIC) in spot urine and thyroid volume in a sample of 
school children aged 6-12 years (n=3319) from 5 continents (see Table 6.2.2-1) with iodine 
intakes ranging from adequate to excessive. The median (range) UIC was lowest in 
Switzerland (115 (2-450) µg/L) and highest in coastal Hokkaido, Japan (728 (28-
11,000) µg/L). In the combined sample, after adjustment for age, sex, and body surface 
area, log(Tvol) began to rise at log(UIC)>2.7 corresponding to 500 µg/L. The authors 
concluded that UIC ≥500 µg/L are associated with increasing Tvol. There was no significant 
correlation between UIC and Tvol in any single study site with the exception of coastal 
Hokkaido (r=0.24, p<0.0001). 
6.2.2.2 Results based on thyroid function 
Two studies examined threshold effects of habitual dietary iodine intake on thyroid function 
(Chen et al., 2018a; Kang et al., 2018). 
In (Chen et al., 2018a) the prevalence of hyperthyrotropinemia (defined as TSH >5.0 mIU/L 
with a normal fT4, reference range 13.4–20.6 pmol/L) was >10% in children at iodine 
intakes of 200–300 μg/day. However, there were no consistent differences in the risk of 
hyperthyrotropinemia with different iodine intakes over the range <100 µg/day to ≥ 
600 µg/day. Adjusted TSH values were not significantly correlated with iodine intake. The 
authors concluded that thyroid volume and goiter appear to be more sensitive indicators of 
thyroid stress than TSH in children with long-term excess iodine intakes. 
A study from the Korean National Health and Nutrition Examination Surveys (KNHANES) V 
(Kang et al., 2018) examined excessive iodine intake (based on the urinary iodine 
concentration (UIC) in spot urine) and subclinical hypothyroidism (SCH) in 1288 (55% male) 
euthyroid children. The median UIC was 449 µg/L (range 15-21,905 µg/L). Thyroid function 
tests were only performed on a sub-sample aged 10-19 years (n=1000, 56% male). SCH 
was defined as TSH >5.5 IU/mL with normal fT4 levels (0.89-1.76 ng/dL). The authors 
reported a positive, but weak correlation between UIC and TSH (r=0.09; p=0.004) that was 
more prominent for UIC >1000 µg/L. The prevalence of SCH was significantly higher in the 
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iodine-deficient group (8.5% for UIC <100 μg/L) and iodine-excessive groups (7-10% for 
UIC from 300-<600, 600-<1000, or ≥1000 μg/L) compared to 4% SCH in the group with an 
UIC of 100-299.9 μg/L. The authors conclude that excess iodine intake may be associated 
with SCH. 
 Discussion and summary of studies on excessive iodine intake and 
upper level 
The results of the systematic literature search were used to evaluate established tolerable 
upper intake levels (ULs) of iodine (IOM, 2001; NNR Project Group, 2012; SCF, 2002) in light 
of new scientific evidence on health effects of excess iodine intake. UL has been defined as 
the maximum level of total chronic daily intake of a nutrient (from all sources) judged to be 
unlikely to pose a risk of adverse health effects to humans (EFSA, 2010c). Existing UL values 
for iodine have predominantly been established based on changes in thyroid stimulating 
hormone (TSH) concentrations in studies of adults (Gardner (1988) and Paul (1988) cited in 
IOM, 2001 and SCF, 2002). Elevated TSH is considered to indicate an existing risk of induced 
hypothyroidism (SCF, 2002). ULs for children and adolescents have mainly been derived 
from adult values adjusted for body surface area.  
The literature search identified five relevant publications with TSH and subclinical 
hypothyroidism, or goiter rate as outcome, but only one dose-response study. The dose-
response study was limited to young adults from China (Sang et al., 2012) and had a short 
duration (4 weeks). Because dose-response studies in children are not available, four 
publications from three large, cross-sectional studies including populations from China, 
Korea, and Japan with high iodine exposures, were included (Chen et al., 2017; Chen et al., 
2018a; Kang et al., 2018; Zimmermann et al., 2005).  
In adults, the results from the dose-response study (Sang et al., 2012) were found to be in 
line with the UL of 600 µg/day in adults set by the SCF (2002) and later adopted by the NNR 
(2012). The study (Sang et al., 2012) included more participants (256 vs 20) with longer 
follow-up (4 vs 2 weeks) than previous studies underlying the current UL of 600 µg/day 
(Gardner (1988) and Paul (1988 cited in IOM, 2001 and SCF, 2002). This study showed that 
subclinical hypothyroidism appeared in the participants with a total iodine intake of 
800 µg/day. The project group therefore considered that an UF of 1.3 was sufficient to apply 
to the UL of 800 µg/day of iodine suggested by the authors (800/1.3 = 600 µg/day).  
In children, the cross-sectional studies were not considered sufficient to establish or re-
evaluate existing ULs. Two studies assessed iodine exposure from UIC in a single spot 
sample (Kang et al., 2018; Zimmermann et al., 2005) which may not reflect chronic iodine 
intake in individuals. Most weight was placed on the studies by Chen et al. (2017 and 2018) 
where iodine exposure was assessed from UIC in two 24-hour urine collections in an area 
with high iodine concentrations in drinking water, which reflects long-term exposure to high 
iodine intakes with more certainty.  
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The studies by Chen et al. (2017 and 2018) suggested safe, tolerable upper intake levels of 
iodine of 250 μg/day for ages 7-10 years and 300 μg/day for ages 11-14 years based on 
increased goiter rate (> 5%) in Chinese children. One of the studies by Chen et al. (2018) 
and the study by Kang et al. (2018) measured TSH in children. Chen et al. (2018) reported 
that the prevalence of hyperthyrotropinemia exceeded 10% for iodine intakes ≥ 200 μg/day 
in children 7-10 and 11-14 years, but there was no dose-response relationship across intake 
categories up to ≥ 600 μg/day. Kang et al. (2018) reported a significantly higher prevalence 
of subclinical hypothyroidism in children aged 10-19 years in the iodine deficient and iodine 
excess groups (8-10%) compared to those in the UIC 100-299.9 µg/L group (4%). These 
results suggest that goiter rate and subclinical hypothyroidism and hyperthyrotropinemia, 
may increase in children with iodine intakes below existing UL values derived from studies in 
adults (SCF, 2002). However, given the uncertainties of these studies, the project group 




VKM Report 2020: 05  107 
7 Exposure assessment 
In the terms of reference from the Norwegian Food Safety Authority, VKM is requested to 
estimate the iodine exposure in the general population and among specified potential risk 
groups. Imported foods that are fortified with iodine and sold on the Norwegian market 
should also be taken into account. In this benefit and risk assessment risk groups refer to 
subpopulations at risk for overly low or high iodine intakes, and include women of 
childbearing age, women who are pregnant and breastfeeding, men and children. Other risk 
groups such as vegans, individuals suffering from allergy to fish and dairy products, ethnic 
minorities which do not consume fish and dairy products, and individuals consuming iodine 
supplements are also requested to be included in the benefit and risk assessment of iodine, 
as is iodine fortified plant-based alternatives to cow’s milk. 
VKM is furthermore requested to estimate iodine exposures in the general population and 
among identified risk groups in scenarios according to graded concentrations of iodine added 
to household salt and industrial salt used in bread. The estimates are seen in conjunction 
with the Salt Strategy 2014-2018 (Helsedirektoratet, 2014). 
The iodine exposure estimates are based on available food composition data updated for 
iodine (Carlsen et al., 2018) and consumption data from national dietary surveys. Estimated 
exposures to iodine in the Norwegian population are described below. 
7.1 Food composition data 
Intakes of iodine were computed using the Norwegian Food Composition Database and the 
software system KBS developed at the Institute of Basic Medical Sciences, Department of 
Nutrition, at the University of Oslo.  
In 2017-2018, the Norwegian Food Composition Database was updated to include the iodine 
content of 3259 food items. The data were compiled using international guidelines and 
standards. Values were gathered from multiple sources, including analytical values, values 
from other food composition databases, estimated values, and values that were based on 
recipes (Carlsen et al., 2018). The KBS database version AE-18 (October 2019) containing 
the most recent iodine values for all foods were used. 
In this assessment the point estimates of iodine content in each food are used. This do not 
take the variation of iodine content for all foods into consideration. An example is iodine 
content in Atlantic cod where the iodine variation was from 22 to 720 µg/100 g (Nerhus et 
al., 2018). However, the long term intake will most likely even out the large variations. 
Mineral water has been analysed, and two brands had an iodine content of 30-40 µg/100 g. 
In the national surveys, the participants were not asked for brand name on mineral water, 
and these iodine values were therefore not included in the exposure calculations.  
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Foods from the marine environment, including some lean fish, seaweed, and sea salt have 
the highest content of iodine per 100 gram. In addition, Norwegian whey cheese have high 
iodine content.  
In Norway, iodization of cow fodder has been mandatory since 1959 to protect the health of 
the animal. The maximum limit for iodine in cow fodder is set at 5 mg I/kg in Norway 
(Forskrift om fôrvarer, 2002: https://lovdata.no/dokument/LTI/forskrift/2002-11-07-1290) 
and in the EU. This results in increased iodine content in milk and dairy products.   
Table 7.1-1 shows the average iodine content in selected foods in Norway. 





Cheese, white (gauda type) 27 
Cheese, whey, goat’s milk 342 
Cheese, whey, cow and goat milk 144 
Cheese, whey, cow’s milk 128 
Fish 
Atlantic cod 279 
Saithe 272 




7.2 Food consumption data 
As VKM was requested to evaluate scenarios of potential iodine exposure according to 
different levels of iodization of household salt and/or bread, the relevant food consumption 
data variables were iodine from all sources in the diet, the “background level”, household 
salt and salt in bread. The exposures to iodine were calculated using food consumption data 
from the national dietary surveys. Consumption data for the iodine exposure estimates were 
based on the national food consumption surveys listed below.  
Norkost 3 was based on two 24-hour recalls by telephone at least one month apart. Food 
amounts were presented in household measures or estimated from photographs (Totland et 
al., 2012). The Norkost 3 study was carried out by the University of Oslo, Norwegian Food 
Safety Authority, Norwegian Directorate of Health and Norwegian Institute of Public Health in 
2010/2011. A total of 1787 adults aged 18-70 years participated. The participation rate was 
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Consumption data on bread from the Norwegian Mother and Child Cohort Study (MoBa) for 
pregnant women was considered. However, consumption data for bread in Norkost 3 were, 
considered to be more solid for the purpose of this benefit and risk assessment, as the 
consumption data in MoBa were based on a FFQ with relatively few questions related to 
bread consumption.  
The exposures to iodine in 4-, 9- and 13-year-old children are calculated from the national 
food consumption survey Ungkost 3 (Hansen et al., 2017; Hansen et al., 2016). The Ungkost 
3 study was carried out by the University of Oslo, Norwegian Food Safety Authority, 
Norwegian Directorate of Health and Norwegian Institute of Public Health in 2015 for 4th and 
8th graders (8-9-year-olds and 12-13-year-olds), and in 2016 for 4-year-old children. The 
dietary assessment tool was a 4 days validated web-based food diary. A total of 399 4-year-
old, 636 9-year-old and 687 13-year-old children participated. 
The iodine exposures in 1-year-old children were estimated from the national food 
consumption survey Spedkost conducted in 2007 (Kristiansen et al., 2009), and the exposure 
in 2-year-olds were estimated from Småbarnskost 3, conducted in 2019 (Astrup et al., 2020). 
These food consumption surveys were based on semi-quantitative FFQs. The caretaker was 
asked to have the last two weeks in mind when answering the questionnaire. In addition to 
predefined household units, food amounts were also estimated from photographs. A total of 
1635 1-year-olds, and 1413 2-year-olds participated. The participation rate was 56%, and 
47% respectively.  
Figure 7.2-1 illustrates mean contribution to the total iodine intake from different food 
groups (not including food supplements) in adults, 13-year-olds and 2-year-olds in 
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Figure 7.2-1 Contribution to the total mean iodine intake from the most significant food groups (not 
including supplements) in adults, 13-year-olds and 2-year-olds in % of the total mean iodine intake. 
 Consumption of total salt and household salt 
Estimating salt (NaCl) intakes from dietary surveys has low validity due to a number of 
factors influencing the total salt intake. Processed foods may vary substantially in salt 
content. The same foods, e.g. cheese or bread, will differ in salt content depending on the 
producer. In addition, each producer will change recipes over time. Home cooked meals are 
prepared from a large variation of recipes, and both the recipes and the taste of the cook 
will influence how much salt was added. The individual amount of salt added to the food at 
the table varies depending on individual taste preferences. These variables are difficult to 
take into account in dietary surveys. Salt intake estimates from dietary surveys therefore 
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usually aim to cover salt added to processed foods, and standard amounts of salt added to 
home cooking. Use of household salt was not specifically asked for in the national dietary 
surveys.  
The best method for measuring habitual salt intake is by measuring sodium from several 24-
hour urine collections in the same person. The most recent sodium data from Norway are 
based on a single 24-hour urine collection in the seventh wave of the Tromsø study (Tromsø 
7), carried out in 2015-16 (www.tromsostudy.com). The Tromsø Study is a population based 
longitudinal multi-purpose study focusing on lifestyle-related diseases and their risk factors 
(Jacobsen et al., 2012). All citizens aged 40 years and above (32 591) living in the 
municipality of Tromsø in northern Norway were invited, and a total of 21 083 people 
participated. 24-hour urine was collected from 496 participants aged 40-69 years and 
analysed for sodium, potassium, creatinine and iodine (Meyer et al., 2019). The total daily 
intake of NaCl (g) was calculated by multiplying daily sodium excretion with a factor of 2.54. 
Mean (SD) estimated daily salt intake was 10.4 (4.1) g in men and 7.6 (2.8) g in women. 
There is a lack of knowledge about household salt use in the Norwegian population. Studies 
from England (Sanchez-Castillo et al., 1987), USA (Mattes and Donnelly, 1991), and 
Denmark (Andersen et al., 2009) have shown that household salt consumption is in the 
order of 10% of the total salt consumption. However, in studies from Italy (Leclercq and 
Ferroluzzi, 1991) household salt comprised close to 40% of total salt consumption. In 
addition to differences between countries, there is large individual variation.  
In our exposure estimates we have assumed that the intake of household salt constitutes 
10% of the total salt intake based on the Tromsø 7 study. In this assessment, the estimated 
daily intake of NaCl from Tromsø 7 was for men and women independently fitted with a log-
normal distribution. These distributions represented, to our knowledge, the best available 
charaterisation of daily salt intake for adult Norwegians. To transform these daily intakes into 
chronic intakes (i.e. long-term average intakes) used in the probabilistic exposure 
assessment for each individual exposure, a mean of 365 randomly drawn daily salt intakes 
from the relevant distribution was calculated for each of the individuals used in the scenario 
calculations (see Appendix IV). 
Data on salt consumption in Norwegian children or adolescents is, to our knowledge, lacking. 
In a study by Whelton et al. (2012) it was concluded that sodium intake was highly 
correlated with total energy intake, due to its inclusion in a wide variety of foods and 
meals (Whelton et al., 2012). To estimate salt intake in children and adolescents for our 
scenario estimates, we therefore have assumed that sodium intake scale linearly with energy 
intake across age classes. Sodium intake was scaled by calculating overall mean energy 
intakes for adults (Norkost 3)/ mean energy intakes children (2-, 4-, 9- and 13-year-olds) 
(Småbarnskost 3 and Ungkost 3), independently for boys and girls. Household salt is 
assumed to be 10% of total salt also in children and adolescents. The daily energy intakes 
used are means from the national dietary surveys, and are for men and boys 10.7 MJ 
(adults), 8.6 MJ (13 years), 7.8 MJ (9 years) and 6.1 MJ (4 years), 5.6 MJ (2 years), and for 
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women and girls 9.0 MJ (adults), 7.4 MJ (13 years), 6.9 MJ (9 years), 5.5 MJ (4 years), and 
5.3 MJ (2 years). 
The salt estimates used for the scenario calculations for adults, children and adolescents are 
given in Table 7.2.1-1. Daily salt intake for adults is assumed to follow a log-normal 
distribution (which means that the standard deviation of the log-normal distribution is the 
same for all groups within sexes). Parameters for the lognormal distributions of daily salt 
intake for adults are µfemales = log(7.1), σfemales = 0.381 and µmales = log(9.7), σmales=0.395. 
The variation is assumed to represent variability between days. Reported below (7.2.1.-1) 
are the assumed long-term intakes of household salt (i.e. mean of 365 daily intakes, set to 
10% of total salt intake). Note that for the scenario estimates, some variability in chronic salt 
intake is incorporated by sampling 365 ‘daily’ intakes of salt for each individual (see 
Appendix IV). 
One-year-olds consume less salt than adults, adolescents and children. The above 
assumption of a correlation between energy and salt intake was not presumed to be 
applicable for 1-year-olds, and no data on household salt are presented for this age group.  
Table 7.2.1-1 Assumed household salt intakes in adults, children and adolescents (g/day), based on 
approximations from Tromsø 7. These are long-term mean intake (i.e. the mean of a log-normal 












Males 1.0 0.8 0.8 0.6 0.5 
Females 0.8 0.6 0.6 0.5 0.5 
Present iodine fortification of household salt in Norway is 5 mg/kg salt, with both iodized and 
non-iodized salt are available in the Norwegian market. We do not have data on the iodized 
vs non-iodized salt consumption, and we assumed that the current intake of salt is only non-
iodized salt.  
 Consumption of bread 
VKM is requested to evaluate different iodization levels in industrialised salt used in bread 
production. We have categorised ‘bread’ as all whole grain and fine bread, rolls and 
baguettes, rusks, focaccia, crispbreads and other yeast bakings usually eaten with 
breadspreads, pizza or pie bottoms, tortilla wraps, naan, potato wraps (‘lompe’), hot dog 
bread, and hamburger bun. It was assumed that all salt used for commercial bread 
production were iodized at the given levels. Not included in the category “bread” for the 
scenario estimates were sweet and salt biscuits, scones, taco shells, sweet yeast bakery 
wares, and cakes. 
We do not have sales data regarding imported bread produce with iodized salt. If we assume 
that most of the imported bread is produced within Europe, the salt iodization levels could be 
as high as 75 mg iodine per kg salt. It should be noted that a noteworthy proportion of 
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bread products are imported, mostly as frozen breads, baguettes or rolls for home baking, or 
frozen doughs for in-store baking. 
Imported bread with iodized salt is not included in our iodine exposure estimates neither in 
the estimates for current intake levels nor in the bread scenarios. 
7.2.2.1 Salt content in bread 
As bread consumption in Norway generally has been high, bread has been a significant 
contributor to the total salt intake in the Norwegian population. The Norwegian food industry 
and the health authorities collaborate to reduce salt in processed foods, including salt 
reduction in bread. In this context, salt was monitored in 29 breads at the Norwegian market 
in 2016, and these are the most recent analysis available of salt in bread in Norway. The 
analysis includes bread and crispbreads, but not rolls or baguettes. The mean salt content in 
bread in these analyses, was 1.1 g salt per 100 g bread (NIFES, 2017) and unpublished 
analyses from 2018-2019. In the present assessment, 1.1 g salt per 100 g bread was used 
for all bread in the intake modelling of daily individual intakes of “salt in bread”.  
 Consumption of food supplements with iodine 
The iodine content in regular food supplements used in Norkost 3 range from 25 to 150 µg 
per dose, but most iodine supplements contain 150 µg iodine per recommended daily dose. 
In Norkost 3, 16% (n=145) of the women reported use of iodine supplements with a mean 
iodine contribution of 95 µg/day. Among women between 18-45 years of age, a total of 17% 
(n=77) reported use of iodine supplements, with at mean iodine contribution of 96 µg/day. 
Similarly, 11% (n=92) of the men reported use of iodine supplements with a mean iodine 
contribution of 117 µg/day. Iodine exposures including food supplement (users only) are 
presented in Appendix V. 
In 13-year-olds in Ungkost 3, 4% of the girls (n=14) and 3% (n=9) of the boys reported to 
use iodine supplements. In 9-year-olds, 4% of the girls (n=13) and 2% (n=6) of the boys 
reported to use iodine supplements. In 4-year-olds, 4% of the girls (n=8) and 5% (n=12) of 
the boys reported to use iodine supplements. In Småbarnskost 3, 10% of the 2-year-olds 
reported to use iodine supplements with at mean iodine contribution of 96 µg/day. In 
Spedkost-07 there were no reported use of iodine supplements among the 1-year-old 
infants.  
Kelp- and seaweed-based products and supplements may contain high concentrations of 
iodine. Duinker et al. at Institute of Marine Research has analysed 125 kelp and seaweed 
samples for iodine (personal communication Arne Duinker and (NIFES, 2016). The iodine 
content varies from 525 mg iodine per kg dry weight to 10094 mg iodine per kg dry weight. 
(Gundersen and Olsen, 2018) collected 40 different dried kelp products from shops in 
Norway, and also from internet sites. The highest iodine content was measured in a kelp 
product with 5500 mg iodine per kg dry weight, while the lowest content was measured to 
14 mg iodine per kg dry weight.  
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Consumption of kelp- and seaweed-based products and supplements may result in iodine 
intakes above UL. Vegetarians and vegans recruited to a study in the Oslo-area in 2014-2015 
showed excessively high UIC (>1000 µg/L) in three individuals who used kelp-supplements 
(Brantsaeter et al., 2013). Thyrotoxicosis due to ingestion of kelp has been widely reported 
(Leung and Braverman, 2014).  
Pregnant women participating in the Norwegian Mother and Child Cohort Study (MoBa) 
during years 1999-2008 provided information about dietary supplement use. The results 
showed that 10% of the women initiated iodine-supplement use prior to conception and 
9% initiated iodine-supplement use in the first trimester (Abel et al., 2019). Overall, 32-
37% of the women used iodine-containing supplements at some time during the first half of 
pregnancy (Abel et al., 2017a; Brantsaeter et al., 2013). The median amount of iodine intake 
from supplements (in iodine-supplement users) was 107 μg/day (Abel et al., 2017a; 
Brantsaeter et al., 2013). Information about consumption of kelp or kelp supplements is not 
available in MoBa.  
In a study among 804 pregnant women, 32.7% of the participants reported using iodine-
containing supplements (Henjum et al., 2018a). In a study in 175 lactating women 29% 
reported habitual iodine supplement use, whereas only 17.7% had actually consumed an 
iodine-containing supplement during the last 24-hours (Henjum et al., 2017). In a study in 
403 women of childbearing age 9.4% reported habitual intake of an iodine-containing 
supplement (Henjum et al., 2018b). In this study, the median amount of iodine contributed 
by the supplements was 129 µg/day, the mean (SD) contribution was 106±60 µg/day, and 
the median adjusted increase in UIC associated with iodine supplement use was 70 µg/L. 
7.3 Iodine exposure estimates 
Chapter 7.3 responds to the following question in the terms of reference: What is the iodine 
intake in the general population and among identified risk groups? Risk groups meaning 
subpopulations at risk for overly low or high iodine intake.  
The iodine exposure for the general population was estimated based on data from Norkost 3 
(adults), Ungkost 3 (4-, 9- and 13-year-olds), Småbarnskost 3 (2-year-olds) and Spedkost 
(1-year-olds). For Norkost 3 and Ungkost 3 data the estimates for iodine exposure have 
been calculated using two different approaches and statistical tools. Since the iodine 
exposure estimates are based on data from different dietary survey methods, they are 
presented in different sections or tables or at least separated with thick lines if presented in 
the same tables. 
Direct comparison between different dietary assessment methods in different age groups are 
challenging to interpret without validation and calibration studies. There is a tendency for 
FFQ (used for the 2-year-olds) to overreport the energy intake, and for recording methods 
(used for the other age groups) to underreport the energy intake (Andersen et al., 2004; 
Burrows et al., 2010; Medin et al., 2017a; Medin et al., 2017b). 
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1. Exposure calculations based on means of survey days. Two survey days for adults, and 
four survey days for adolescents and children (13-, 9- and 4-year-olds). This is generally 
referred to as observed individual means (OIMs). For 1- and 2-year-olds the reported 
intakes from the FFQs were also expressed as intake per day.  
2. Exposure modelling using Bayesian generalised linear mixed models. Models were 
developed and fitted to daily intakes of iodine and salt and used to simulate long-term 
exposures. The models were used to correct for unrepresentativeness in the surveys on 
both sex-ratio, age and level of education for adults, and only sex-ratio for 13-, 9- and 4-
year-olds. This was applied in the statistical environment R, using the Bayesian package 
MCMCglmm (Hadfield, 2010). These mixed models are in structure very similar to the 
Monte Carlo Risk Assessment Tool (MCRA), available from RIVM (van der Voet et al., 
2015), and a preliminary comparison of the tailor-made scripts and models in R with 
MCRA was performed showing very similar results (see Appendix IV). However, as MCRA 
does not allow for estimation of variance between individuals (nor covariance between 
two intake variables, iodine and bread), MCRA was not used for the full assessment. 
Appendix IV detail the modelling approach. We refer to results from this modelling 
approach as mixed models (MM). 
Exposure estimates based on OIMs (presented in Appendix V) can overestimate the variance 
in intake between individuals and lead to bias in the estimator, due to the low number of 
sampled days in the original survey as well as the degree of unrepresentativeness in survey 
respondents. The approach is particularly prone to overestimates of the tails of an intake 
distribution due to low number of sampled days. In general, the standard error of a mean 
decreases with the inverse of the square root of number of days (~1/sqrt(n_days)), which 
implies that using the mean of two (or 4) daily intakes as a long-term intake for each 
individual, is an estimate with a substantial standard error. When the population distribution 
then consists of a number of individual means with high standard error, the variance of long-
term intakes at the level of the population is overestimated. In an attempt to alleviate this 
problem, we apply statistical models through which we can directly estimate and account for 
different levels of variability. 
For long-term exposure, we wish to remove the day-to-day variability within individuals (to 
get long-term exposures at the individual level), but to correctly characterise the variability 
between individuals (accounting for the fact that individuals have different diets). One 
appropriate statistical framework for such an analysis is mixed models. A mixed model 
approach estimates the linear (fixed) effects of explanatory variables (sex, age, level of 
education) on daily iodine intake, but the variation in daily intakes is decomposed into 
within- and between-individual variability. This is possible when there are multiple 
‘observations’, in our case several days of iodine intake. For all individuals we also fitted 
multivariate models, i.e. for each individual and day we have calculated iodine intakes and 
intakes of salt from bread, and explicitly incorporated how individuals covary in their iodine 
and bread intake.  
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Fitted models are able to simulate daily exposures, and averaging over many such daily 
simulated intakes predict chronic exposures. When simulating exposures, we also corrected 
for fixed effects (sex, age, level of education). For adults in the Norkost 3 survey we use 
age-distributions from the Norwegian population from (StatisticsNorway, 2018) and not the 
study population, thus partially correcting for unrepresentativeness in age among 
respondents. We also corrected for the over-representation of highly educated individuals. 
For 4-, 9, and 13- year-olds we present simulated exposure for each sex, and no fixed effect 
besides sex was included in the models. A more thorough introduction to this modelling 
approach and the details of the models developed for this project is presented in Appendix 
IV.  
Simulated exposures of iodine are drawn together with simulated intake of salt from bread 
consumption and are then used to perform scenario analyses. The approach allows for direct 
analysis of correlation between intake of iodine and salt from bread, and scenarios 
incorporate this covariation, for each sex independently. This covariance is positive for males 
and females in all surveys modelled, except for 4-year-old boys. This implies that individuals 
that have an iodine intake above the population mean also have a bread intake above the 
population mean. For each scenario we also quantify the proportion of the (sub-) populations 
predicted to be below or above the estimated average requirements and tolerable upper 
intake levels. 
The impact of MM-approach on the exposure estimates would typically be a reduction in the 
tails, i.e. a narrower distribution of chronic intake, compared to OIMs or daily intakes. 
Furthermore, a reduction in the mean intake is expected, as the daily intake distributions are 
skewed and an increase in the number of days will reduce the impact of rare days of very 
high intake (i.e. the upper tail). 
Norkost 3, Ungkost 3, and Småbarnskost 3/Spedkost 07 have used different dietary 
assessment methods. Norkost 3 and Ungkost 3 have used recall and record methods that 
collect the food intake day by day for two non-consecutive days and four consecutive days 
respectively. The 2x24-hour recall method used in Norkost 3, and the 4-day precoded web-
based food diary used in Ungkost 3 are both methods that can give detailed information 
about the food intake over a short period of time. These methods aim to identify the food 
actually eaten, and do not ask the participant to do estimations on long term intakes. The 
FFQs that were used for 1- and 2-year-olds asked the caretaker to make estimates about 
foods usually eaten, and the frequencies range from per day to per month. The caretaker 
was also asked to have the last two weeks in mind when answering the questionnaire. In 
toddlers, food habits change relatively quickly compared to older children and adults, and 
the changes are especially rapid around 1 year of age. The FFQs ask for the caretaker to 
estimate an average intake, whereas in the recall and record methods, mean intake can be 
calculated as OIMs, or modelled with MM-method. Because we have different approaches to 
the calculations for adults, for 13-, 9-, 4-year-olds, and for the 2-year-olds, we present the 
data in separated chapters, and have marked the tables with thicker lines to visualise that 
the data arrive from different food survey methods and statistics. 
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Also, the number of foods reported used illustrate the differences between the methods in 
detail level. In Norkost 3 approximately 1800 different food codes were reported eaten with 
the 24-hour recalls. In Ungkost 3, approximately 800 food codes were used in the precoded 
food diary. In the FFQs for 1- and 2-year-olds the number of food codes used is 
approximately 180.  
As the three different methods have used different questions to assess dietary intake, the 
answers will also differ. Both the number of registration days, number of food items and 
level of details in the questions differ between methods used. Thus, comparison of iodine 
intakes based on data from the three different methods has methodological limitations.  
Only the estimates for intakes without iodine supplements have been described and 
commented in the text below. The project group considers that it is appropriate to base the 
evaluation of the scenarios with increasing iodization levels in household salt and bread on 
intakes without food supplements. However, iodine exposure including iodine from 
supplements are presented in some of the tables and in Appendix V. 
The project group decided to compare the iodine exposure estimates in the following 
sections with the AR/EAR for adults from NNR (2012) and EAR for children and adolescents 
from IOM (2001) and the ULs established by the SCF (2002). The rationale for this choice of 
dietary reference values for comparison with exposure estimates is given in section 4.3. 
 Exposures in adults, 13-, 9- and 4-year-olds 
7.3.1.1 Model-based iodine exposure estimates 
The MM iodine exposures are presented in Table 7.3.1.1-1. For each survey, models of daily 
(log) iodine intake were fitted together with daily (log) salt intake from bread. For Norkost 
models, fixed effects were included for age, sex and level of education. The simulated 
exposures were corrected for these biases by sampling age and level of education from 
Statistics Norway (SSB). For Ungkost data, only sex was used as fixed effect. For all models, 
individual level variance was implemented independently for each sex, and covariance 
between intake of salt from bread and iodine was explicitly modelled (this is used for 
scenario analyses, see section 6.5). Day-to-day variance was also estimated independently 
for each sex, but without explicit covariance. Values in the table are long-term exposures 
(mean of 365 simulated days) for 100 000 simulated individuals. In addition to summary 
statistics on the simulated population we also report the percentage of the groups that are 
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Table 7.3.1.1-1 MM iodine exposure estimates in adults and 13-, 9- and 4-year-olds, presented as 
mean and percentiles (µg/day) and percentages of population above the estimated average 
requirement (EAR) and under tolerable upper intake levels (UL). All groups are presented with or 
without supplement use when calculating all the daily intakes for all individuals. For each group, 
100 000 individuals were simulated. 














Wo 202 88 183 377 91 100 
Women, 
18-70y 
Wo 147 72 137 259 79 100 
Women, 
18-45y 
Wo 137 68 128 240 74 100 
Men,  
18-70y 
W 215 88 192 419 91 99 
Women, 
18-70y 
W 163 79 151 288 85 100 
Women, 
18-45y 












Wo 124 48 110 248 79 100 
Girls 
13y 
Wo 95 38 85 187 62 100 
Boys 
9y 












Wo 100 44 91 188 70 100 
Boys 
4y 
Wo 110 62 105 177 93 100 
Girls 
4y 
Wo 102 52 95 175 85 100 
Boys 
13y 
W 126 49 111 252 80 100 
Girls 
13y 
W 98 39 87 195 64 100 
Boys 
9y 
W 120 64 113 198 90 100 
Girls 
9y 
W 103 44 93 196 70 99 
Boys 
4y 
W 114 62 108 188 93 99 
Girls 
4y 
W 105 52 98 182 86 99 
Wo=without iodine supplements, W=with iodine supplements. 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 4-year-olds=65 µg/day 
(Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day (Source: 
SCF, 2002). 
The mean and median iodine intake in men is above the recommended intake of 
150 µg/day, and 91% of the men have intakes above the EAR of 100 µg/day. In women, the 
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mean and median intakes are below the recommended intake. 74-79% of women have 
intakes above the EAR, and women of childbearing age have the lowest intakes among 
adults.  
The mean and median iodine intakes in 13-year-old boys and girls are below the 
recommended intake of 150 µg/day, and the intakes in the girls are low; mean (median) 
intake is 95 (85) µg/day. Only 79% of the 13-year-old boys and 62% of the girls have 
intakes above the EAR of 73 µg/day.  
The mean and median iodine intakes in 9-year-old boys and girls are below the 
recommended intake of 120 µg/day. The iodine intake is lower in girls than in boys, and 
89% of the 9-year-old boys and 70% of the girls have intakes above the EAR of 73 µg/day. 
The mean and median iodine intakes in 4-year-old boys and girls are above the 
recommended intake of 90 µg/day. 93% of the 4-year-old boys and 85% of the girls have 
intakes above the EAR of 65 µg/day. 
Almost all (99-100%) of adults and 13-, 9- and 4- year-olds have intakes below the UL. 
The dietary assessment methods used in Norkost 3 and Ungkost 3 tend to underestimate the 
energy intake, and the tendency differ between the age groups. Based on the method 
proposed by (Black, 2000), Norkost 3 reports that there is a high probability that participants 
with a ratio for energy intake:basal metabolic rate (EI:BMR) below 0.96 underreport their 
true energy intakes. The proportion who underreported energy intake was 16% in Norkost 3, 
and similar in men and women (Totland et al., 2012). In Ungkost 3, the proportion who 
underreported energy intake was 33% in the 13-year-olds, 12% in the 9-year-olds and 5% 
in the 4-year-olds (Hansen et al., 2017; Hansen et al., 2016), whereas the proportions for 
overreporting was 1%, 2% and 2% in the same age groups (EI:BMR > 2.49). Inaccurate 
estimates of energy intake can to some extent be a proxy for inaccuracy in the estimated 
intake of nutrients. In Norkost 3 and Ungkost 3, energy and iodine intakes were medium 
correlated (correlation coefficients in the range of 0.3-0.5 in some tested groups). The 
explanation may be that only a few food sources have high content of iodine whereas the 
energy intake will be affected by all foods with energy. However, due to the relatively high 
proportion of underreporters of energy intake in adults and 13-year-old (16 and 33%, 
respectively), it is reasonable to assume that our estimated iodine intakes in adults and 
especially in the 13-year-olds are somewhat lower than true intakes. It should be noted that 
under- and overreporting of energy intake was not accounted for in the MM-modelling of the 
iodine exposure estimates. 
 Exposures in 1- and 2- year-olds 
Iodine exposure estimates for 1-year-olds are based on FFQ and collected in 2007. The 
differences in iodine intakes between boys and girls are small, and the intakes are given for 
boys and girls together. It should be noted that for breastfed infants, the iodine intake from 
breast milk consumption is not included in the estimates. New data for 1-year-olds will be 
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available in 2020. If the new data for the 1-year-olds differs substantially from the ones 
presented here for iodine, we will supplement this benefit and risk assessment with updated 
exposure estimates. 
Table 7.3.2-1 Iodine exposure estimates for 1- and 2-year-olds based on food frequency 
questionnaire, presented as mean and percentiles (µg/day) and percentages of population above the 
estimated average requirement (EAR) or under the tolerable upper intake level (UL). 2-year-olds are 
presented with or without supplement use when calculating all the daily intakes for all individuals. 




Boys (n=720), 2y, w 139 58 128 262 64 93 87 
Girls (n=693), 2y, w 137 57 129 244 59 92 87 
Boys (n=720), 2y, wo 129 56 122 215 52 92 92 
Girls (n=693), 2y, wo 128 56 122 214 50 91 92 
1y, both sexes, 
breastfed, n=722* 
100 28 84 227 66 65 93 
1y, both sexes, non-
breastfed, n=881 
147 54 139 259 69 92 82 
Wo=without iodine supplements. 
W=with iodine supplements. 
EAR: 1- and 2-year-olds=65 µg/day (Source: IOM, 2001). 
UL: 1- and 2-year-olds=200 µg/day (Source: SCF, 2002). 
*iodine from breastmilk is not included. 
The estimates for 1- and 2- year-olds show mean and median intakes well above the 
recommended intakes of 70 µg/day in 1-year-olds and 90 µg/day in 2-year-olds. 91-93% of 
the 2-year-olds have intakes above the EAR, and 65% of breastfed 1-year-olds and 92% of 
non-breastfed have intakes above the EAR of 65 µg/day. 
87-92% of 2-year-olds, and 93% of breastfed 1-year-olds and 82% of non-breastfed 1-year-
olds have intakes below the UL, i.e., 8-13% of the 2-year-olds who do not use iodine 
supplements exceed the UL. 
The iodine estimates for 1- and 2-year-olds are based on data from FFQ, and cannot be 
modelled as the estimates for adults and 13-, 9- and 4-year-olds have been done. Our iodine 
exposure estimates for non-breastfed 1-year-olds and the 2-year-olds, are higher than for 
the 4-year-olds also when comparing the mean intakes. To explore the differences between 
the dietary assessment methods used in 1-/2- and 4-year-old children, a comparison of 
energy intake was performed. The proportion of underreporters of energy intake in the 4-
year-olds is 5% (Totland et al., 2012). According to NNR (2012), energy requirement 
increases approximately 25% in children from 2 to 4 years of age. However, the increase in 
energy between 2-year-olds (Småbarnskost 3) and 4-year-olds (Ungkost 3) is only 4 and 9% 
in girls and boys, respectively. The calculated mean energy intake in the 4-year-olds in 
Ungkost 3 is in line with the estimated daily energy requirements given in Table 8.6 in NNR 
(2012), whereas the calculated energy intake in 2-year-olds in Småbarnskost 3 exceeds the 
daily energy requirements for this age group. E.g. for 2-year-old girls the estimated 
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requirement is 4.14 MJ/day and the intake in Småbarnskost 3 is 5.3 MJ/day, which indicate 
an overreporting of energy intakes in the 2-year-olds. We cannot conclude that the observed 
overreporting of energy also applies to iodine. Nevertheless, the mean iodine intake among 
the 2-year-olds is approximately 20% higher than in the 4-year-olds. Altogether it is 
therefore reasonable to assume that the estimated iodine intakes in the 2-year-olds are 
higher than the true intakes.  
 Groups at risk of too low or high intakes 
In the terms of reference, VKM is requested to identify groups/subpopulations at risk for low 
or overly high iodine intake. According to the benefit and risk assessment, these include 
vegans, individuals suffering from allergy to fish and dairy products, ethnic minorities which 
do not consume fish and dairy products and individuals consuming iodine supplements. 
Norkost 3 and the other national dietary surveys do not provide data to calculate iodine 
intake estimates for vegans, ethnic minorities, persons with milk or fish allergies. Our intake 
estimates show that iodine at the 5th percentile is 88 µg/day in men, 72 µg/day in women 
and 68 µg/day in women of childbearing age (Table 7.3.1.1-1), and population groups that 
for various reasons have diets with low consumption of food sources rich in iodine are at risk 
of having intakes far below recommended intake. This also applies to the younger age 
groups, and especially 13-year-old boys with intake in the 5th percentile at 48 µg/day and 
girls at 38 µg/day. 13-year-olds have the same recommendations for intake as adults i.e. 
150 µg/day (Table 7.3.1.1-1). 
Studies of iodine intake and UIC consistently show that women have lower iodine intake than 
men, a difference that is apparent from adolescence onwards and may be explained by 
differences in food habits and total energy intake (Brantsaeter et al., 2018; Henjum et al., 
2019). 
In a Norwegian study, the median UIC was 46 µg/L and the median calculated iodine intake 
was 31 µg/day in 19 vegans and the median UIC was 105 µg/L and the calculated iodine 
intake was 116 µg/day in 25 vegetarians (Brantsaeter et al., 2018). Milk and dairy products 
were the main iodine source in the vegetarians.  
Vegans are recommended to use iodine containing dietary supplements, and it should be 
noted that some of the vegans in the study had UIC above the UL due to use of a kelp-
supplement (Brantsaeter et al., 2018). 
Studies in women of non-Norwegian ethnic origin living in Oslo did not reveal lower iodine 
status in in these women than in women of Norwegian origin, although iodine status was 
generally low in all the women (Henjum et al., 2018b; Henjum et al., 2017). 
As showed in Table 7.3.1.1-1 very few adults and adolescents have iodine intakes that 
exceed UL, even in those who use regular iodine supplements. However, kelp- and seaweed-
based supplements, and also other foods made with kelp and seaweed may contain high 
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concentrations of iodine, and people who use these ingredients or supplements may be at 
risk of overly high iodine intakes. Consumption of kelp- and seaweed-based ingredients have 
not been reported in the national dietary surveys. 
Table 7.3.2-1 show that high intakes and exceedance of UL is most frequent in 1- and 2-
year-olds, and the iodine intake in the 95th percentile 2-year-olds without iodine 
supplements is 215 µg/day and in non-breastfed 1-year-olds 259 µg/day. The UL for this age 
group is 200 µg/day. 
 Plant-based alternatives to cow’s milk 
In the terms of reference, VKM is requested to evaluate what the iodine intake in the general 
population and among the specified potential risk groups (of both low and high iodine 
intakes) would be if plant-based milks were to be fortified with iodine levels comparable to 
those in cow’s milk i.e. 15 µg per 100 g. Plant-based milks may be produced from e.g. oat, 
rice, soy or almond. 
The national dietary surveys have not registered use of plant-based milk alternatives. The 
project group has, due to lack of intake data, assumed that consumption of plant-based milk 
alternatives replaces consumption of cow’s milk, and that consumption of plant-based 
alternatives have similar individual variations as for cow’s milk. The tables presenting iodine 
exposure in chapter 6.3 and 6.4 are therefore applicable for both cow’s milk users and users 
of the plant-based alternatives given that all plant based alternatives have the same iodine 
content and bioavailability as cow’s milk. Iodization of plant-based alternatives may 
contribute to increased iodine intake in vegans. Individuals with low consumption of plant-
based alternatives will receive only small amounts of iodine from this source, whereas high-
consumers will receive larger amounts. The risks related to high iodine intakes from iodized 
plant-based alternatives are not considered to be any larger than risks related to milk 
consumption in any age groups. Goitrogens in e.g. soy-milk may reduce the bioavailability of 
iodine, but the impact is considered to be low (Otun et al., 2019). 
7.4 Scenarios with different iodization levels 
Chapter 7.4 responds to the following question in the terms of reference: What would the 
iodine intake in the general population and among identified risk groups be if household salt 
and industrial salt used in bread were to be iodized and if plant-based milks were to be 
fortified with iodine levels comparable to those in cow milk? Table 7.4-1 shows the iodization 
levels in salt for which the potential effect on iodine intake is to be estimated. The iodine 
intake resulting of the various scenarios should be estimated both with and without the 
added effect of iodine fortification of plant-based alternatives to dairy products (milk 
16 μg/100 g). The estimates should also be considered in the context of the Salt Strategy 
2015 (governmental initiatives to reduce salt consumption). In addition to the requested 
scenarios from the NFSA, we have also made scenario estimates for iodization level at 15 mg 
iodine per kg salt. 
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Table 7.4-1 The estimated scenarios with increased iodization levels. 
Iodization levels 
Food items Abbreviation 
15 mg iodine/kg 
Household salt  Salt15-scenario 
 Industrial salt used in bread Bread15-scenario 
Household salt + Industrial salt used in bread Salt+bread15-scenario 
20 mg iodine/kg 
Household salt  Salt20-scenario 
 Industrial salt used in bread Bread20-scenario 
Household salt + Industrial salt used in bread Salt+bread20-scenario 
25 mg iodine/kg 
Household salt  Salt25-scenario 
 Industrial salt used in bread Bread25-scenario 
Household salt + Industrial salt used in bread Salt+bread25-scenario 
50 mg iodine/kg 
 
Household salt  Salt50-scenario 
 Industrial salt used in bread Bread50-scenario 
Household salt + Industrial salt used in bread Salt+bread50-scenario 
 
In Table 7.4-2 we have presented these iodization levels as iodine per 100 g bread if the salt 
concentration in bread is 1.1 g salt per 100 g bread (the salt concentration used in our 
exposure estimates) and if the salt concentration is reduced to 0.9 g salt per 100 g bread 
(goal in the salt strategy). 
Table 7.4-2 Iodine in bread at different iodization levels and different salt concentrations in bread. 
Iodization level in salt 
in bread 
Iodine (µg) per 100 g 
bread if bread 
contains 1.1 g salt per 
100 g 
Iodine (µg) per 100 g 
bread if bread contains 
0.9 g salt per 100 g 
(aim in the salt 
strategy) 
15 mg iodine/kg salt 16.5 13.5 
20 mg iodine/kg salt 22 18 
25 mg iodine/kg salt 27.5 22.5 
50 mg iodine/kg salt 55 45 
Model-based scenarios were conducted to estimate what the iodine intake would be if 
household salt and industrial salt used in bread were iodized up to 15 or 20 or 25 or 50 mg 
iodine per kg salt. The method for the scenario estimates for adults and 13-, 9- and 4-year-
olds are based on the MM-method described in section 7.3.1 and Appendix IV. However, the 
scenarios for 1- and 2- year-olds are not based on the MM-method, as data for these age 
groups are based on FFQ.  
The scenario estimates for the different iodization levels (scenarios), age groups and gender 
are presented in Tables 7.4-3 – 7.4-14. The scenario estimates in the tables are presented 
as mean, median, 5th and 95th percentiles, and as percent of the population estimated 
intakes above the estimated average requirements (EARs) and percent of the population 
with estimated intakes below the tolerable upper intake levels (ULs) (given in chapter 4).  
 
 
VKM Report 2020: 05  124 
The intake estimates presented below do not include iodine supplements. Scenarios 
including supplements (users only) indicate that these are not at high risk of exceeding the 
UL in adults and adolescent. 2-year-old iodine supplement users are at high risk of exceeding 
the UL. Full results for supplement users are presented in Appendix V. 
The 1-year-olds are not included in the scenarios for household salt. The intake of household 
salt in 1-year-olds is assumed to be low, and consequently the impact of increased iodization 
in household salt on the total intake of iodine in 1-year-olds is assumed to be low. 
Table 7.4-3 Estimated iodine exposures in adults, 13-, 9-, 4-and 2-year-olds if household salt contain 
15 mg iodine per kg salt (µg/day). For the age groups 4-70 years, 100 000 individuals were simulated. 














Men, 18-70y 218 104 199 396 96 100 
Women, 18-70y 159 83 148 270 87 100 
Women, 18-45y 149 79 139 253 83 100 
Boys, 13y 137 61 122 261 88 100 
Girls, 13y 105 48 94 196 72 100 
Boys, 9y 129 76 123 205 96 100 
Girls, 9y 109 53 100 197 79 100 
Boys, 4y 119 71 114 186 97 100 
Girls, 4y 109 59 102 182 91 99 
Boys (n=720), 2y 138 65 131 224 95 89 
Girls (n=693), 2y 135 63 130 221 95 91 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
 
In the scenario where only household salt is iodized, at the iodization level of 15 mg iodine 
per kg salt (salt15-scenario), the mean and median iodine intake in men and women varies 
between slightly below or well above recommended intake. 96% of the men and 83-87% of 
the women have intakes above the EAR in the salt15-scenario, and women of childbearing 
age have the lowest intakes among adults.  
In the salt15-scenario, the mean and median iodine intakes in 13-year-old boys and girls are 
below the recommended intake. The intakes in the girls are very low; mean (median) intake 
is 105 (94) µg/day. 88% of the 13-year-old boys and 72% of the girls have intakes above 
the EAR. 
Mean and median iodine intakes in 9-year-old boys and girls are at or below the 
recommended intake. The iodine intake is lower in girls than in boys, and 96% of the 9-year-
old boys and 79% of the girls have intakes above the EAR in the salt15-scenario. 
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In the salt15-scenario, the mean and median iodine intakes in 4-year-old boys and girls are 
above the recommended intake. 97% of the 4-year-old boys and 91% of the girls have 
intakes above the EAR.  
Mean and median iodine intakes in 2-year-old boys and girls are well above the 
recommended intake. The iodine intake is similar in boys and girls, and 95% of the 2-year-
olds have intakes above the EAR in the salt15-scenario. 
All adults and 13- and 9- year-olds in the salt15-scenario have intakes below the UL. 4-year-
olds have individuals (1%) that exceed the UL in this scenario, whereas in 2-year-olds, 9-
11% have iodine intakes above UL. 
Table 7.4-4 Estimated iodine exposures in all age groups if salt in bread contains 15 mg iodine per 
kg salt (µg/day). For the age groups 4-70 years, 100 000 individuals were simulated. 














Men, 18-70y 243 119 223 430 98 99 
Women, 18-70y 173 90 162 294 91 100 
Women, 18-45y 165 86 155 279 89 100 
Boys, 13y 158 75 144 291 96 100 
Girls, 13y 123 61 112 221 87 100 
Boys, 9y 148 88 142 232 99 99 
Girls, 9y 126 65 117 220 90 99 
Boys, 4y 133 81 127 202 99 99 
Girls, 4y 122 67 115 201 96 99 
Boys (n=720), 2y 149 73 142 243 97 85 
Girls (n=693), 2y 146 73 143 242 97 86 
Boys and girls, 1y, 
breastfed (n=722)* 
117 32 98 265 74 89 
Boys and girls, 1y, non-
breastfed (n=881) 
172 63 162 302 95 68 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
*Iodine from breastmilk is not included. 
In the scenario where only salt in bread is iodized, at the iodization level of 15 mg iodine per 
kg salt (bread15-scenario), the mean and median iodine intake in both men and women are 
above recommended intake. 98% of the men and 89-91% of women have intakes above the 
EAR.  
In the bread15-scenario, the mean and median iodine intakes in 13-year-old boys are above 
or just slightly below the recommended intake, whereas the intake in girls is still well below. 
96% of the 13-year-old boys and 87% of the girls have intakes above the EAR.  
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The mean and median iodine intakes in 9-year-old boys and girls are at or above the 
recommended intake. 96% of the 9-year-old boys and 87% of the girls have intakes above 
the EAR in the bread15-scenario. 
In the bread15-scenario, the mean and median iodine intakes in 4-year-old boys and girls 
are close to the recommended intake. 99% of the 4-year-old boys and 96% of the girls have 
intakes above the EAR.  
The mean and median iodine intakes in 1- and 2-year-olds are above the recommended 
intake. 97% of the 2-year-olds and 74/95% of the breastfed/ non-breastfed 1-year-olds 
have intakes above the EAR in the bread15-scenario. 
All adults and 13-year-olds in the bread15-scenario have intakes below the UL. Among 9-
year-olds (boys and girls) and 4-year-old boys there are individuals (1%) that exceed the UL 
in this scenario. In 2-year-olds 14-15% exceed the UL. In 1-year-olds 11-32% exceed the 
UL. 
Table 7.4-5 Estimated iodine exposures in adults, 13-, 9-, 4- and 2-year-olds if both household salt 
and salt in bread contain 15 mg iodine per kg salt (µg/day). For the age groups 4-70 years, 100 000 
individuals were simulated. 
Both household salt and 














Men, 18-70y 258 135 239 446 99 99 
Women, 18-70y 185 101 173 306 95 100 
Women, 18-45y 176 97 166 291 94 100 
Boys, 13y 171 87 157 304 99 99 
Girls, 13y 132 70 122 230 93 100 
Boys, 9y 160 99 153 243 100 99 
Girls, 9y 135 73 126 228 95 99 
Boys, 4y 142 90 136 211 100 99 
Girls, 4y 129 74 122 208 98 99 
Boys (n=720), 2y 158 82 151 252 98 81 
Girls (n=693), 2y 154 80 150 250 98 84 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
In the scenario where both household salt and salt in bread is iodized, at the iodization level 
of 15 mg iodine per kg salt (salt+bread15-scenario), the mean and median iodine intake in 
both men and women are above recommended intake. 99% of the men and 94-95% of 
women have intakes above the EAR.  
In the salt+bread15-scenario, the mean and median iodine intakes in 13-year-old boys are 
above the recommended intake, whereas the intake in the girls are still is below. 99% of the 
13-year-old boys and 93% of the girls have intakes above the EAR.  
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The mean and median iodine intakes in 9-year-old boys and girls are above the 
recommended intake. All the 9-year-old boys and 95% of the girls have intakes above the 
EAR in the salt+bread15-scenario. 
In the salt+bread15-scenario, the mean and median iodine intakes in 4-year-old boys and 
girls are well above the recommended intake. All the 4-year-old boys and 98% of the girls 
have intakes above the EAR.  
The mean and median iodine intakes in 2-year-old boys and girls are well above the 
recommended intake. 98% of the 2-year-olds have intakes above the EAR in the 
salt+bread15-scenario. 
All women and 13-year-old girls in the salt+bread15-scenario have intakes below the UL. 
Men, 13-year-old boys and 9-year-olds and 4-year-olds have individuals (1%) that exceed 
the UL in this scenario. In 2-year olds, 16-19% exceed the UL. 
Table 7.4-6 Estimated iodine exposures in adults, 13-, 9-, 4-and 2-year-olds if household salt contain 
20 mg iodine per kg salt (µg/day). For the age groups 4-70 years, 100 000 individuals were simulated. 














Men, 18-70y 223 109 204 398 97 100 
Women, 18-70y 163 87 152 275 89 100 
Women, 18-45y 153 83 143 255 86 100 
Boys, 13y 141 65 126 265 91 100 
Girls, 13y 108 51 97 199 76 100 
Boys, 9y 133 79 126 209 97 100 
Girls, 9y 112 56 103 200 82 100 
Boys, 4y 122 74 117 189 98 99 
Girls, 4y 111 61 105 185 93 99 
Boys (n=720), 2y 141 68 134 227 96 88 
Girls (n=693), 2y 138 66 132 224 96 91 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-
olds=65 µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
 
In the scenario where only household salt is iodized, at the iodization level of 20 mg iodine 
per kg salt (salt20-scenario), the mean and median iodine intake in both men and women 
are approximately at or above recommended intake. 97% of the men and 86-89% of the 
women have intakes above the EAR in the salt20-scenario, and women of childbearing age 
have the lowest intakes among adults.  
In the salt20-scenario, the mean and median iodine intakes in 13-year-old boys and girls are 
still below the recommended intake. The intakes in the girls are very low; mean (median) 
intake is 108 (97) µg/day. 91% of the 13-year-old boys and 76% of the girls have intakes 
above the EAR. 
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Mean and median iodine intakes in 9-year-old boys and girls are at or slightly below the 
recommended intake. The iodine intake is lower in girls than in boys, and 97% of the 9-year-
old boys and 82% of the girls have intakes above the EAR in the salt20-scenario. 
In the salt20-scenario, the mean and median iodine intakes in 4-year-old boys and girls are 
above the recommended intake. 98% of the 4-year-old boys and 93% of the girls have 
intakes above the EAR.  
Mean and median iodine intakes in 2-year-old boys and girls are well above the 
recommended intake. The iodine intake is similar in boys and girls, and 96% of the 2-year-
olds have intakes above the EAR in the salt20-scenario. 
All adults and 13- and 9- year-olds in the salt20-scenario have intakes below the UL. 4-year-
olds have individuals (1%) that exceed the UL in this scenario, whereas in 2-year-olds, 9-
12% have iodine intakes above UL. 
Table 7.4-7 Estimated iodine exposures in all age groups if salt in bread contains 20 mg iodine per 
kg salt (µg/day). For the age groups 4-70 years, 100 000 individuals were simulated. 














Men, 18-70y 256 129 237 446 99 99 
Women, 18-70y 182 95 170 306 93 100 
Women, 18-45y 174 92 164 292 92 100 
Boys, 13y 170 83 155 306 98 99 
Girls, 13y 132 67 121 232 92 100 
Boys, 9y 159 95 152 246 99 99 
Girls, 9y 135 71 126 231 94 99 
Boys, 4y 140 88 135 210 100 99 
Girls, 4y 129 72 122 210 97 98 
Boys (n=720), 2y 155 80 148 251 97 81 
Girls (n=693), 2y 152 77 149 249 98 84 
Boys and girls, 1y, 
breastfed (n=722)* 
122 34 102 277 77 87 
Boys and girls, 1y, non-
breastfed (n=881) 
180 66 169 316 95 64 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
*Iodine from breastmilk is not included. 
In the scenario where only salt in bread is iodized, at the iodization level of 20 mg iodine per 
kg salt (bread20-scenario), the mean and median iodine intake in both men and women are 
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In the bread20-scenario, the mean and median iodine intakes in 13-year-old boys are above 
the recommended intake, whereas the intake in girls is still below. 98% of the 13-year-old 
boys and 92% of the girls have intakes above the EAR.  
The mean and median iodine intakes in 9-year-old boys and girls are above the 
recommended intake. 99% of the 9-year-old boys and 94% of the girls have intakes above 
the EAR in the bread20-scenario. 
In the bread20-scenario, the mean and median iodine intakes in 4-year-old boys and girls 
are well above the recommended intake. All the 4-year-old boys and 97% of the girls have 
intakes above the EAR.  
The mean and median iodine intakes in 1- and 2-year-olds are above the recommended 
intake. 97-98% of the 2-year-olds and 77/95% of the breastfed/ non-breastfed 1-year-olds 
have intakes above the EAR in the bread20-scenario. 
All women and 13-year-old girls in the bread20-scenario have intakes below the UL. Men, 
13-year-old boys, 9-year-olds (boys and girls) and 4-year-old boys have individuals (1%) 
that exceed the UL in this scenario. In 4-year-old girls, 2% exceed the UL, and in 2-year-olds 
16-19% exceed the UL. In 1-year-olds 13-36% exceed the UL. 
Table 7.4-8 Estimated iodine exposures in adults, 13-, 9-, 4- and 2-year-olds if both household salt 
and salt in bread contain 20 mg iodine per kg salt (µg/day). For the age groups 4-70 years, 100 000 
individuals were simulated. 
Both household salt and 














Men, 18-70y 277 150 258 467 100 99 
Women, 18-70y 197 111 186 321 98 100 
Women, 18-45y 189 107 179 307 97 100 
Boys, 13y 187 100 172 323 100 99 
Girls, 13y 145 80 134 244 97 100 
Boys, 9y 174 110 167 261 100 98 
Girls, 9y 147 82 138 243 98 99 
Boys, 4y 152 100 147 222 100 98 
Girls, 4y 138 81 131 219 99 98 
Boys (n=693), 2y 167 92 160 263 99 77 
Girls (n=720), 2y 162 87 159 259 99 79 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
In the scenario where both household salt and salt in bread is iodized, at the iodization level 
of 20 mg iodine per kg salt (salt+bread20-scenario), the mean and median iodine intake in 
both men and women are above recommended intake. All the men and 97-98% of women 
have intakes above the EAR.  
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In the salt+bread20-scenario, the mean and median iodine intakes in 13-year-old boys are 
above the recommended intake, whereas the intake in the girls still is slightly below. All the 
13-year-old boys and 97% of the girls have intakes above the EAR.  
The mean and median iodine intakes in 9-year-old boys and girls are above the 
recommended intake. All the 9-year-old boys and 98% of the girls have intakes above the 
EAR in the salt+bread20-scenario. 
In the salt+bread20-scenario, the mean and median iodine intakes in 4-year-old boys and 
girls are well above the recommended intake. All the 4-year-old boys and 99% of the girls 
have intakes above the EAR.  
The mean and median iodine intakes in 2-year-old boys and girls are well above the 
recommended intake. 99% of the 2-year-olds have intakes above the EAR in the 
salt+bread20-scenario. 
All women and 13-year-old girls in the salt+bread20-scenario have intakes below the UL. 
Men, 13-year-old boys and 9-year-old girls have individuals (1%) that exceed the UL in this 
scenario. In 9-year-old boys and 4-year-old boys and girls, 2% exceed the UL. In 2-year 
olds, 21-23% exceed the UL. 
Table 7.4-9 Estimated iodine exposures in adults, 13-, 9-, 4- and 2-year-olds if household salt 
contains 25 mg iodine per kg salt (µg/day). For the age groups 4-70 years, 100 000 individuals were 
simulated. 














Men, 18-70y 228 114 209 404 98 100 
Women, 18-70y 166 91 156 278 91 100 
Women, 18-45y 157 87 147 259 88 100 
Boys, 13y 145 69 131 269 93 100 
Girls, 13y 111 54 100 202 79 100 
Boys, 9y 137 83 130 213 98 100 
Girls, 9y 115 59 106 203 85 100 
Boys, 4y 125 77 120 191 99 99 
Girls, 4y 114 63 107 187 94 99 
Boys (n=720), 2y 144 71 137 230 97 87 
Girls (n=693), 2y 140 68 135 226 97 90 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
In the scenario where only household salt is iodized, at the iodization level of 25 mg iodine 
per kg salt (salt25-scenario), the mean and median iodine intake in both men and women 
are approximately at or above recommended intake. 98% of the men and 88-91% of women 
have intakes above the EAR in the salt25-scenario, and women of childbearing age have the 
lowest intakes among adults. 
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In the salt25-scenario, the mean and median iodine intakes in 13-year-old boys and girls are 
still below the recommended intake, and the intakes in the girls are very low; mean (median) 
intake is 111 (100) µg/day. 93% of the 13-year-old boys and 79% of the girls have intakes 
above the EAR in the salt25-scenario.  
The mean and median iodine intakes in 9-year-old boys and girls are at or slightly below the 
recommended intake. The iodine intake is lower in girls than in boys, and 98% of the 9-year-
old boys and 85% of the girls have intakes above the EAR in the salt25-scenario. 
In the salt25-scenario, the mean and median iodine intakes in 4-year-old boys and girls are 
above the recommended intake. 99% of the 4-year-old boys and 94% of the girls have 
intakes above the EAR.  
The mean and median iodine intakes in 2-year-old boys and girls are well above the 
recommended intake, and 97% of the 2-year-olds have intakes above the EAR in the salt25-
scenario. 
All adults and 13- and 9- year-olds in the salt25-scenario have intakes below the UL. 4-year-
olds have individuals (1%) that exceed the UL in this scenario. In 2-year-olds, 10-13% 
exceed the UL. 
Table 7.4-10  Estimated iodine exposures in all age groups if salt in bread contains 25 mg iodine per 
kg salt (µg/day). For the age groups 4-70 years, 100 000 individuals were simulated. 














Men, 18-70y 269 138 250 465 99 99 
Women, 18-70y 190 101 179 319 95 100 
Women, 18-45y 183 98 172 306 94 100 
Boys, 13y 181 91 167 321 99 99 
Girls, 13y 141 74 131 244 95 100 
Boys, 9y 169 102 162 260 100 98 
Girls, 9y 144 76 134 242 96 99 
Boys, 4y 148 94 143 219 100 98 
Girls, 4y 136 77 129 219 98 98 
Boys (n=720), 2y 162 85 155 258 98 79 
Girls (n=693), 2y 159 80 155 258 98 81 
Boys and girls, 1y, 
breastfed (n=722)* 
128 35 107 290 79 85 
Boys and girls, 1y, non-
breastfed (n=881) 
188 69 177 330 96 62 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
*Iodine from breastmilk is not included. 
In the scenario where only salt in bread is iodized, at the iodization level of 25 mg iodine per 
kg salt (bread25-scenario), the mean and median iodine intake in both men and women are 
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above recommended intake. 99% of the men and 94-95% of women have intakes above the 
EAR in the bread25-scenario.  
In the bread25-scenario, the mean and median iodine intakes in 13-year-old boys are above 
the recommended intake, whereas the intake in girls still is slightly below. 99% of the 13-
year-old boys and 95% of the girls have intakes above the EAR.  
The mean and median iodine intakes in 9-year-old boys and girls are above the 
recommended intake. All the 9-year-old boys and 96% of the girls have intakes above the 
EAR in the bread25-scenario. 
In the bread25-scenario, the mean and median iodine intakes in 4-year-old boys and girls 
are well above the recommended intake. All the 4-year-old boys and 98% of the girls have 
intakes above the EAR.  
The mean and median iodine intakes in 1- and 2-year-olds are above the recommended 
intake. 98% of the 2-year-olds and 79/96% of the breastfed/non-breastfed 1-year-olds have 
intakes above the EAR in the bread25-scenario. 
All women and 13-year-old girls in the bread25-scenario have intakes below the UL. Men, 
13-year-old boys, 9-year-old girls) have individuals (1%) that exceed the UL. In 9-year-old 
boys and 4-year-old boys and girls, 2% exceed the UL, and in 2-year-olds 19-21% exceed 
the UL. In 1-year-olds 15-38% exceed the UL. 
Table 7.4-11 Estimated iodine exposures in adults, 13-, 9-, 4- and 2-year-olds if both household salt 
and salt in bread contain 25 mg iodine per kg salt (µg/day). For the age groups 4-70 years, 100 000 
individuals were simulated.  
Both household salt and 














Men, 18-70y 296 164 277 491 100 99 
Women, 18-70y 209 120 198 338 99 100 
Women, 18-45y 202 117 191 325 99 100 
Boys, 13y 202 112 188 342 100 99 
Girls, 13y 157 90 146 259 99 100 
Boys, 9y 188 121 181 279 100 97 
Girls, 9y 158 91 149 257 99 98 
Boys, 4y 163 109 158 234 100 97 
Girls, 4y 147 88 140 230 100 97 
Boys (n=720), 2y 177 100 170 273 100 70 
Girls (n=693), 2y 171 92 167 271 100 75 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
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In the scenario where both household salt and salt in bread is iodized, at the iodization level 
of 25 mg iodine per kg salt (salt+bread25-scenario), the mean and median iodine intake in 
both men and women are well above recommended intake. All the men and 99% of women 
have intakes above the EAR. 
In the salt+bread25-scenario, the mean and median iodine intakes in 13-year-old boys and 
girls are at or above the recommended intake. All the 13-year-old boys and 99% of the girls 
have intakes above the EAR.  
The mean and median iodine intakes in 9-year-old boys and girls are above the 
recommended intake. All the 9-year-old boys and 99% of the girls have intakes above the 
EAR in the salt+bread25-scenario. 
In the salt+bread25-scenario, the mean and median iodine intakes in 4-year-old boys and 
girls are well above the recommended intake. All the 4-year-old boys and girls have intakes 
above the EAR.  
The mean and median iodine intakes in 2-year-old boys and girls are well above the 
recommended intake. All the 2-year-olds have intakes above the EAR in the salt+bread25-
scenario. 
All women and 13-year-old girls in the salt+bread25-scenario have intakes below the UL. 
Men and 13-year-old boys have individuals (1%) that exceed the UL. In 9-year-old girls, 2% 
exceed the UL, whereas in 9-year-old boys and in 4-year-old boys and girls, 3% exceed the 
UL. In 2-year-olds, 25-30% have intakes that exceed the UL. 
Table 7.4-12 Estimated iodine exposures in adults, 13-, 9-, 4- and 2-year-olds if household salt 
contains 50 mg iodine per kg salt (µg/day). For the age groups 4-70 years, 100 000 individuals were 
simulated. 














Men, 18-70y 254 141 235 430 100 99 
Women, 18-70y 185 110 175 298 98 100 
Women, 18-45y 176 106 166 278 97 100 
Boys, 13y 166 90 152 290 99 100 
Girls, 13y 127 70 116 218 93 100 
Boys, 9y 156 102 149 232 100 99 
Girls, 9y 130 74 120 217 95 99 
Boys, 4y 140 91 135 206 100 99 
Girls, 4y 125 75 119 199 99 99 
Boys (n=720), 2y 159 86 152 245 99 82 
Girls (n=693), 2y 153 81 147 239 99 85 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
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In the scenario where only household salt is iodized, at the iodization level of 50 mg iodine 
per kg salt (salt50-scenario), the mean and median iodine intake in both men and women 
are above recommended intake. All the men and 97-98% of women have intakes above the 
EAR. 
In the salt50-scenario, the mean and median iodine intakes in 13-year-old boys are above, 
and the intakes in girls are still below the recommended intake. 99% of the 13-year-old boys 
and 93% of the girls have intakes above the EAR.  
The mean and median iodine intakes in 9-year-old boys and girls are at or above the 
recommended intake. The iodine intake is lower in girls than in boys, and all the 9-year-old 
boys and 95% of the girls have intakes above the EAR in the salt50-scenario. 
In the salt50-scenario, the mean and median iodine intakes in 4-year-old boys and girls are 
above the recommended intake. All the 4-year-old boys and 99% of the girls have intakes 
above the EAR.  
The mean and median iodine intakes in 2-year-old boys and girls are well above the 
recommended intake, and 99% of the 2-year-olds have intakes above the EAR in the salt50-
scenario. 
Women and 13-year-olds in the salt50-scenario have intakes below the UL. Men and 9- and 
4-year-olds have individuals (1%) that exceed the UL in this scenario. In 2-year-olds, 15-
18% have intakes that exceed the UL. 
Table 7.4-13 Estimated iodine exposures in all age groups if salt in bread contains 50 mg iodine per 
kg salt (µg/day). For the age groups 4-70 years, 100 000 individuals were simulated. 














Men, 18-70y 337 181 317 561 100 97 
Women, 18-70y 233 126 220 385 99 100 
Women, 18-45y 229 124 216 378 99 100 
Boys, 13y 239 128 224 401 100 97 
Girls, 13y 188 106 176 305 100 100 
Boys, 9y 220 134 212 335 100 89 
Girls, 9y 187 104 177 305 100 94 
Boys, 4y 185 122 180 267 100 92 
Girls, 4y 169 99 162 265 100 93 
Boys (n=720), 2y 195 107 189 305 100 57 
Girls (n=693), 2y 189 102 184 301 100 62 
Boys and girls, 1y, 
breastfed (n=722)* 
155 43 130 353 86 74 
Boys and girls, 1y, non-
breastfed (n=881) 
228 84 215 401 98 44 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
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year-olds=200 µg/day (Source: SCF, 2002). 
*Iodine from breastmilk is not included. 
In the scenario where only salt in bread is iodized, at the iodization level of 50 mg iodine per 
kg salt (bread50-scenario), the mean and median iodine intake in both men and women are 
well above recommended intake All the men and 99% of women have intakes above the 
EAR. 
In the bread50-scenario, the mean and median iodine intakes in 13-year-old boys and girls 
are above the recommended intake. All the 13-year-old boys and girls have intakes above 
the EAR.  
The mean and median iodine intakes in both 9- and 4- year-old boys and girls are well above 
the recommended intake. All the 4-year-olds (boys and girls) and all 9-year-old boys and 
96% of the girls have intakes above the EAR in the bread50-scenario. 
The mean and median iodine intakes in 1- and 2-year-olds are also above the recommended 
intake. All the 2-year-olds and 86/98% of the breastfed/non-breastfed 1-year-olds have 
intakes above the EAR in the bread50-scenario. 
All women and 13-year-old girls in the bread50-scenario have intakes below the UL. In men 
and 13-year-old boys, 3% exceed the UL, whereas 7-8% of the 4-year-old boys and girls 
and 11% of the 9-year-old boys exceed the UL. In 2-year-olds, 38-43% have intakes above 
UL in this scenario. In 1-year-olds 26-56% exceed the UL. 
Table 7.4-14 Estimated iodine exposures in adults, 13-, 9-, 4- and 2-year-olds if both household salt 
and salt in bread contain 50 mg iodine per kg salt (µg/day). For the age groups 4-70 years, 100 000 
individuals were simulated. 
Both household salt and 














Men, 18-70y 389 233 369 614 100 94 
Women, 18-70y 271 164 258 423 100 100 
Women, 18-45y 267 162 254 416 100 100 
Boys, 13y 281 170 266 443 100 95 
Girls, 13y 219 138 208 337 100 99 
Boys, 9y 259 173 250 373 100 78 
Girls, 9y 216 133 206 334 100 90 
Boys, 4y 215 152 210 297 100 80 
Girls, 4y 193 123 185 288 100 87 
Boys (n=720), 2y 225 137 219 335 100 37 
Girls (n=693), 2y 214 127 209 326 100 43 
EAR adults=100 µg/day (Source: NNR, 2012), EAR 9- and 13-year-olds=73 µg/day, 1-, 2- and 4-year-olds=65 
µg/day (Source: IOM, 2001). 
UL adults=600 µg/day, 13-year-olds=450 µg/day, 9-year-olds=300 µg/day, 4-year-olds=250 µg/day, 1- and 2-
year-olds=200 µg/day (Source: SCF, 2002). 
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In the scenario where both household salt and salt in bread is iodized, at the iodization level 
of 50 mg iodine per kg salt (salt+bread50-scenario), the mean and median iodine intake in 
all adults, 13-, 9-, 4- and 2-year-olds are well above recommended intake, and all have 
intakes above the EAR.  
All women in the salt+bread50-scenario have intakes below the UL. In the other groups, UL 
is exceeded in 1-20% with the highest exceedance percentage in the 9-year-old boys and 4-
year-olds. However, in 2-year-olds 57-63% have intakes that exceed UL in this scenario. 
We cannot calculate from the national dietary surveys how the different scenarios affect 
iodine intakes in other vulnerable groups mentioned in the assignment, such as persons with 
allergies or intolerance to fish or milk and dairy products, vegetarians, vegans or ethnic 
minorities. However, as salt consumption is assumed to be correlated with energy intake, the 
increase in iodine intake in the various scenarios with increased levels of iodine in salt may 
be the same in these potential risk groups as in the rest of the population, clearly with large 
individual variations within the different groups. Neither can we extract data on bread 
consumption among persons in these potential risk groups. The variation in bread 
consumption among persons with allergy or intolerance to fish, milk or dairy products, 
vegans, vegetarians and also some ethnic minorities might be similar to the variation in 
bread consumption in the rest of the population. Consequently, for persons with few iodine 
sources in the diet (vegans and people with allergy or intolerance), the increase in iodine 
intake from increased iodization of salt and bread may be the same as in the lower 
percentiles (e.g. the 5th percentiles) in the scenarios in Tables 7.4-3 - 7.4-14.  
Figures 7.4-1-7.4-5 show the scenario estimates for iodization in males (blue lines) and 
females (red lines) in adults, 13-, 9-, 4- and 2-year-olds (dark red for females 18-45 and 
light red for all females in Figure 7.4.1). The three boxes in the top row show total iodine 
intake (µg/day) if household salt, bread and both household salt and bread are iodized (0-50 
mg iodine per kg salt). The curves represent the intakes in the 5th percentiles (lower dashed 
lines), median (full lines) and 95th percentile (upper dashed lines). The horisontal lines 
represent the age specific EAR and UL given in Table 4.3-1. The three boxes in the middle 
row show percent of population group with iodine intakes above EAR (upper lines) and 
above UL (lower lines). The bottom boxes show percentage of males and females with 
intakes both above EAR and below UL, and thus represent the percentage of the target 
population deemed to be within the dietary reference values.  
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Figure 7.4-1 Scenario estimates for iodization in adult males (blue lines), females (light red lines) 
and females 18-45 years old. The three plots in the top row show total iodine intake (µg/day) if 
household salt, bread and both household salt and bread are iodized (0-50 mg iodine per kg salt). The 
curves represent the intakes in the 5th percentiles (lower dashed lines), median (full lines) and 95th 
percentile (upper dashed lines). The horisontal lines represent the age specific EAR (100 µg/day) and 
UL (600 µg/day) given in Table 4.3-1. The three plots in the middle row show percent of population 
group with iodine intakes above EAR (upper lines) and above UL (lower lines). The bottom plots show 
percentage of males and females with intakes both above EAR and below UL, and thus represent the 
percentage of the target population deemed to be within the dietary reference values. 
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Figure 7.4-2 Scenario estimates for iodization in 13-year-olds boys (blue lines) and girls (red lines). 
The three plots in the top row show total iodine intake (µg/day) if household salt, bread and both 
household salt and bread are iodized (0-50 mg iodine per kg salt). The curves represent the intakes in 
the 5th percentiles (lower dashed lines), median (full lines) and 95th percentile (upper dashed lines). 
The horisontal lines represent the age specific EAR (73 µg/day) and UL (450 µg/day) given in Table 
4.3-1. The three plots in the middle row show percent of population group with iodine intakes above 
EAR (upper lines) and above UL (lower lines). The bottom plots show percentages of boys and girls 
with intakes both above EAR and below UL, and thus represent the percentage of the target 
population deemed to be within the dietary reference values. 
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Figure 7.4-3 Scenario estimates for iodization in 9-year-olds boys (blue lines) and girls (red lines). 
The three plots in the top row show total iodine intake (µg/day) if household salt, bread and both 
household salt and bread are iodized (0-50 mg iodine per kg salt). The curves represent the intakes in 
the 5th percentiles (lower dashed lines), median (full lines) and 95th percentile (upper dashed lines). 
The horisontal lines represent the age specific EAR (73 µg/day) and UL (300 µg/day) given in Table 
4.3-1. The three plots in the middle row show percent of population group with iodine intakes above 
EAR (upper lines) and above UL (lower lines). The bottom plots show percentage of boys and girls 
with intakes both above EAR and below UL, and thus represent the percentage of the target 
population deemed to be within the dietary reference values. 
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Figure 7.4-4 Scenario estimates for iodization in 4-year-olds boys (blue lines) and girls (red lines). 
The three plots in the top row show total iodine intake (µg/day) if household salt, bread and both 
household salt and bread are iodized (0-50 mg iodine per kg salt). The curves represent the intakes in 
the 5th percentiles (lower dashed lines), median (full lines) and 95th percentile (upper dashed lines). 
The horisontal lines represent the age specific EAR (65 µg/day) and UL (250 µg/day) given in Table 
4.3-1. The three plots in the middle row show percent of population group with iodine intakes above 
EAR (upper lines) and above UL (lower lines). The bottom plots show percentage of boys and girls 
with intakes both above EAR and below UL, and thus represent the percentage of the target 
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Figure 7.4-5 Scenario estimates for iodization in 2-year-olds boys (blue lines) and girls (red lines) 
(without supplements). The three plots in the top row show total iodine intake (µg/day) if household 
salt, bread and both household salt and bread are iodized (0-50 mg iodine per kg salt). The curves 
represent the intakes in the 5th percentiles (lower dashed lines), median (full lines) and 95th 
percentile (upper dashed lines). The horisontal lines represent the age specific EAR (65 µg/day) and 
UL (200 µg/day) given in Table 4.3-1. The three plots in the middle row show percent of population 
group with iodine intakes above EAR (upper lines) and above UL (lower lines). The bottom plots show 
percentage of boys and girls with intakes both above EAR and below UL, and thus represent the 
percentage of the target population deemed to be within the dietary reference values. Please note 
that these estimates are not modelled in the same manner as Norkost and Ungkost (Figures 7.4-1 
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 Effect of potential salt reduction on the scenario estimates for iodine 
This section responds to the following task in the terms of reference: The scenario estimates 
should also be considered in the context of the Salt Strategy 2015 (governmental initiatives 
to reduce salt consumption).  
The main goals in the Salt Strategy are 30% relative reduction in mean population intake of 
salt/sodium within year 2025 and a long-term target of mean salt consumption of 5 g/day. 
An intermediate objective is to reduce salt in bread to 0.9 g salt per 100 g bread. This 
corresponds to approximately 18% reduction in salt in bread compared to our scenario 
calculations. 
A 30% reduction in salt consumption would imply a need for approximately 43% increased 
iodization levels to achieve the same levels of daily iodine intake as given in the scenario 
Tables 7.4-3-7.4-14 for all the age groups (1/(1-0.3) = 1.43). This estimate assumes a 
uniform 30% reduction, and no consideration is given to if the salt reduction is unevenly 
distributed between various food groups. Similarly, a reduction of salt in bread to 0.9 g salt 
per 100 g bread, would imply a need for approximately 22% increased iodization levels to 
achieve the same levels of daily iodine intake as given in the scenarios. 
7.5  Discussion and summary of exposure/intake 
Generally, in Norway, iodine intake estimates are considered to be reliable as few food 
products have been iodized and drinking water contains only small amounts of iodine. 
However, there are methodological concerns and limitations related to the various dietary 
survey methods for adults, adolescents and toddlers and infants. 
Comparison of data from different dietary surveys 
Norkost 3, Ungkost 3 and Småbarnskost 3/Spedkost 07 have all used different dietary 
assessment methods. Norkost 3 and Ungkost 3 have used recall and record methods that 
collect the food intake day by day, while FFQs were used in Småbarnskost 3/Spedkost-07. 
The iodine exposure estimates for 1- and 2-year-olds are based on individual intakes 
whereas the exposure estimates for adults, 13-, 9- and 4-year-olds are based on a mixed 
models (MM) method. Modelling to correct for day to day variation could not be carried out 
for iodine intakes in 1- and 2-year-olds, since the underlying data are based on FFQ. Day-to-
day variation is partially accounted for in the FFQ method, as the dietary intakes estimated 
from an FFQ reflect habitual intakes over a longer period of time.  
The impact of a mixed model approach on the exposure estimates is typically a reduction in 
the tails, i.e. a narrower distribution of chronic intake, compared to OIMs or daily intakes. 
Furthermore, a reduction in the mean intake is expected, as the daily intake distributions are 
skewed and an increase in the number of days will reduce the impact of rare days of very 
high intake (i.e. the upper tail). 
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The mean iodine intake estimates for 2-year-olds (Table 7.3.2-1) and non-breastfed 1-year-
olds are higher than the mean iodine intake for 4-year-olds (Table 7.3.1-1), and it is 
therefore reasonable to assume that the estimated iodine intakes in the 2-year-olds are 
higher than the true intakes. Due to the relatively large proportion of underreporters of 
energy in adults and 13-year-old (16 and 33%, respectively), it is reasonable to assume that 
our estimated iodine intakes in adults and especially in the 13-year-olds are somewhat lower 
than true intakes. It should be noted that under- and overreporting of energy was not 
accounted for in the MM-modelling of the iodine exposure estimates.  
The intake estimates and scenarios presented here in chapter 7 do not include intakes from 
food supplements. Scenarios including supplements (users only) are presented in 
Appendix V. 
It has recently been proposed that comparison of population intakes with recommended 
intakes will yield an overestimate of inadequacy as the recommended intake is set to cover 
almost all individuals (Allen et al., 2019). We have commented on whether mean and median 
intakes are below or above the recommended intakes, but this information is not used to 
evaluate the adequacy of the intake in the benefit and risk characterisation. 
Current iodine intake 
Iodine intakes in adults are higher in men than in women and increase with age for both 
sexes. Women of childbearing age have the lowest estimated intakes among adults, and 
74% have intakes above the EAR. 13-year-old girls have the lowest intake, and only 62% of 
these girls have intakes above the EAR. All adults and 13-, 9- and 4- year-olds have intakes 
below the UL (presented in Table 7.3.1-1). 
The estimates for 1- and 2- year-olds show that 92% of the 2-year-old boys and 91% of the 
girls have intakes above the EAR, and 65% of breastfed 1-year-olds and 92% of non-
breastfed have intakes above the EAR of 65 µg/day. The estimated iodine intake in the 95th 
percentile is 215 µg/day, slightly above the UL of 200 µg/day, and 8% of the 2-year-olds 
exceed the UL (presented in Table 7.3.2-1). However, excessive iodine intakes above the UL 
seem to be less frequent in the older age groups (from 4-years and older), and may 
therefore be described as transient. 
The scenarios 
Scenarios (presented in Tables 7.4-3 – 7.4-14) were conducted to estimate what the iodine 
intake would be if household salt and salt used in bread were iodized up to 15, 20, 25 or 
50 µg iodine per kg salt. 
The model-based scenarios in adults and 13-, 9- and 4-year-olds show impact at increasing 
iodization levels and naturally more impact if both household salt and salt in bread was 
iodized. We have presented 12 scenario tables, three scenarios (household salt alone, salt in 
bread alone and both household salt and salt in bread) for four iodization levels (15, 20, 25 
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and 50 mg iodine per kg salt). The percentages of the population groups with intakes above 
the EAR increases with increasing iodization levels, but so does the percentages with intakes 
above UL. In the scenario with both household salt and salt in bread at level 25 µg iodine 
per kg salt at least 99% of all the subjects in these age groups have iodine intakes above 
EAR and in all age groups the percentage of subjects exceeding UL is ≤ 3%. 
For 2-year-olds all scenarios lead to an increase in both the proportion of toddlers with 
estimated intakes above EAR and intakes above UL. As increasing iodization levels of both 
household salt and bread elevates the children with low iodine intake above the EAR, a 
larger portion will have intakes exceeding the UL. At the iodization scenarios with 25 or 50 
mg iodine per kg salt, including iodization of household salt and salt in bread, the proportion 
of 2-year-olds expected to exceed the UL rises to 30-63%.  
Supplement use and population groups at risk of low or high intakes 
Scenarios including supplements (users only) are presented in Appendix V. Adult and 
adolescent iodine supplement users (regular supplements – not seaweed and kelp based 
supplements) are not at special risk of high intakes, even in the scenarios with increased 
iodization levels, compared to the general population. 2-year-old supplement users are at 
high risk of exceeding UL. Kelp-, tare- and seaweed-based supplements may contain 
significantly higher concentrations of iodine than regular iodine supplement users. 
A total of 16% of the women and 11% of the men participating in Norkost 3 reported use of 
supplements containing iodine, with a mean iodine contribution of 95 and 117 µg/day, 
respectively. In Småbarnskost 3, 10% of the 2-year-olds reported use of iodine-containing 
supplements with a mean iodine contribution of 96 µg/day. In MoBa, 32-37% of the 
pregnant women reported use of iodine-containing supplement during the first half of 
pregnancy (Brantsaeter et al., 2013). The median amount of iodine contributed by 
supplements was 107 μg/day in iodine-supplement users (Brantsaeter et al., 2013). 
Individuals omitting all foods of animal origin receive very little iodine through their diet. 
Subjects with allergy to milk and/or fish-products and vegans are likely to have low iodine 
intakes. For persons with few iodine sources in the diet, the increase in iodine intake from 
increased iodization of salt and bread may be the same as for the lower percentiles (e.g. the 
5th percentiles) in the scenarios in Tables 7.4-3 - 7.4-14. Vegans are recommended to use 
iodine-containing dietary supplements, and some vegans have iodine intakes above the UL 
due to use of a kelp-supplements. 
Some ethnic minorities have been suggested to be at risk of low iodine intakes. However, a 
study on iodine status in women from the Oslo area, found no association between iodine 
status and ethnicity (Henjum et al., 2018a). 
Effect of potential salt reduction on the scenario estimates for iodine 
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A uniform 30% reduction in average salt consumption implies a need for 43% increased 
iodization levels to achieve the same levels of daily iodine intake as given in the scenario 
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8 Benefit and risk assessment  
This benefit and risk assessment is based on 1) established knowledge about health 
consequences from severe iodine deficiency, 2) evidence based systematic literature review 
of health consequences of mild to moderate iodine deficiency, 3) literature review of studies 
on adverse health effects from excessive iodine intakes to re-evaluate existing ULs, 4) 
evaluation of estimated iodine intake levels in different population groups in Norway 
compared to established dietary reference values, specifically estimated average requirement 
(EAR) and tolerable upper intake levels (UL), and finally 5) an estimation of the effect of 
different scenarios of increasing iodization levels in household salt and salt in bread on iodine 
intake levels in different population groups compared to the established dietary reference 
values. 
This chapter attempts, in a systematic way, to bring all previous chapters and sections 
together to address possible benefits and risks from iodization of household salt and salt 
used in industrial bread and bakery products.  
8.1 Benefit and risk assessment - guidelines 
In 2010, the EFSA Scientific Committee developed “Guidance on human health risk-benefit 
assessment of foods” (EFSA, 2010a). EFSA recommended a stepwise approach for the risk- 
and benefit assessment, i.e. 1) an initial assessment, addressing the question whether the 
health risks clearly outweigh the health benefits or vice versa, 2) a refined assessment, 
aiming at providing semi-quantitative or quantitative estimates of risks and benefits at 
relevant exposure levels by using common metrics, and 3) a comparison of risks and benefits 
using a composite metric such as disability-adjusted life years (DALYs) or quality-adjusted 
life years (QALYs) to express the outcome of the risk-benefit assessment as a single net 
health impact value. For the current assessment, step 3) was not employed.  
8.2 Benefit and risk characterisation 
The recommended daily iodine intake for adults is 150 µg/day, for pregnant women 175 
µg/day and for lactating women 200 µg/day (NNR, 2012). The recommendations for children 
and adolescents are in the range between 90 and 120 µg/day depending on age. Estimated 
average requirement (EAR) for children ≥ 10 years and adults is 100 µg/day (NNR Project 
Group, 2012). In the Nordic Nutrition Recommendations 2012 (NNR) an EAR was not set for 
children < 10 years and adolescents. The US Institute of Medicine (IOM, 2001) set the EAR 
for children and adolescents (1 to 18 years) between 65 to 95 µg/day. The tolerable upper 
intake level (UL) set by the SCF (2002) for adults is 600 µg/day, 450 µg/day for 13-years-old 
and 200 µg/day for 2-years-old.  
The project group decided to use EAR and UL as comparison values, and this is in line with 
the recent proposal for harmonised dietary reference values from WHO, FAO, and NASEM, 
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where AR and UL are considered the core values for evaluating population intakes (Allen et 
al., 2019). UL should by definition protect most of the population, whereas EAR is assumed 
to be sufficient for 50% of the population.  
 Groups at risk of low and high iodine intakes 
VKM was requested to estimate iodine exposure from the diet in the general population and 
among specified risk groups at current intake level (no iodization).  
VKM was furthermore requested to estimate iodine exposures in the general population and 
among specified risk groups in scenarios with graded levels of iodine added to household salt 
and industrial salt used in bread (20, 25 or 50 mg iodine per kg salt). In addition to the 
requested scenarios, we have estimated scenarios with 15 mg iodine per kg salt because 
according to national dietary surveys, 8% of 2-years-olds and 18% of non-breastfed 1-year-
olds had iodine intakes above UL at current intake levels (no iodization). In the text below, 
we present the scenarios for iodine added to both household salt and industrial salt used in 
bread, since the scenarios with iodine added to household salt alone or industrial salt used in 
bread alone did not increase the estimated iodine intakes sufficiently in the groups at risk of 
low intakes. 
The estimated effects of the different iodization levels and scenarioson iodine intakes in 
various age groups, are presented in Tables 7.4-3 - 7.4-14 and Figures 7.4-1 - 7.4-5. 
Scenarios for iodine-containing supplement users (users only) are presented in Appendix V 
Tables V-2 and V-3 and Figures V-1 and V-2. 
It should be noted that the iodine intake estimates for 13-year-olds and women of 
childbearing age (18-45 years) are modelled using a mixed model approach (MM-approach), 
whereas the estimates for the 1- and 2-year-olds are based on reported intakes. 
8.2.1.1 Groups at risk of low intakes – current level and scenarios 
At current intake levels (no iodization), women of childbearing age (18-45 years) have the 
lowest estimated intakes among adults, and 26% have intakes below the EAR at 100 µg/day. 
The mean (median) iodine intake is 147 (128) µg/day for those who do not use iodine 
supplements, and the estimated intake in the 5th percentile is 68 µg/day. 13-year-old girls 
have the lowest estimated iodine intake, and 38% of these girls have intakes below the EAR 
at 73 µg/day. The mean (median) estimated iodine intake in 13-year-old girls is 95 
(85) µg/day, and the estimated intake in the 5th percentile is 38 µg/day. It is reasonable to 
assume that our estimated iodine intakes in adults and especially in the 13-year-olds may be 
somewhat lower than true intakes. The rationale for this assumption is given in section 
7.3.1.   
The findings that especially young girls and women of childbearing age have low iodine 
intakes are in accordance with a recent review on iodine status in Norway, where all studies 
involving women in childbearing age, including pregnant and lactating women, found that 
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the median UIC was lower than the WHO cut-off for adequate iodine status (Henjum et al., 
2019).  
In Tables 8.2.1.1-1 and 8.2.1.1-2 we have presented how the estimated iodine intakes in the 
groups at risk of low intakes increase with the increasing iodization level scenarios. In the 
13-year-olds, only the data for the girls are presented, as girls have lower intakes than boys. 
The estimates in these tables do not include contribution from iodine containing 
supplements. 
In the with 15 mg iodine/kg added to both household salt and salt in bread (scenario 
salt+bread15), 94% of the women 18-45 years have iodine intakes above EAR and 
estimated mean (median) iodine intake is 176 (166) µg/day. The intake in the 5th percentile 
is 97 µg/day. In the scenario with 20 mg iodine/kg added to both household salt and salt in 
bread (salt+bread20), 97% have iodine intakes above EAR and estimated mean (median) 
iodine intake is 189 (179) µg/day. The intake in the 5th percentile is 107 µg/day. At the 
scenarios adding 25 or 50 mg iodine/kg (salt+bread25 and salt+bread50), 99-100% of the 
women 18-45 years have estimated iodine intakes above EAR, and estimated mean and 
median intakes are slightly below or above 200 µg/day. 
The EAR in 13-year-olds is 73 µg/day. At scenario salt+bread 15, 93% have estimated iodine 
intakes above EAR and estimated mean (median) iodine intake is 132 (122) µg/day. The 
intake in the 5th percentile is 70 µg/day. At scenario salt+bread20, 97% are above EAR, and 
estimated mean (median) intake is 145 (134) µg/day. The intake in the 5th percentile is 
80 µg/day. At scenario salt+bread25, the estimated intake in the 5th percentile has 
increased to 90 µg/day. 
Table 8.2.1.1-1 Estimated iodine intakes in women 18-45 years in the different scenarios, sorted by 













Current intake – 
no iodization 
137 68 128 240 74 100 
Salt15 149 (+12) 79 (+11) 139 (+11) 253 (+13) 83 (+9) 100 
Salt20 153 (+16) 83 (+15) 143 (+15) 255 (+15) 86 (+12) 100 
Salt25 157 (+20) 87 (+19) 147 (+19) 259 (+19) 88 (+14) 100 
Bread15 165 (+28) 86 (+18) 155 (+27) 279 (+39) 89 (+15) 100 
Bread20 174 (+37) 92 (+24) 164 (+36) 292 (+52) 92 (+18) 100 
Salt+bread15 176 (+39) 97 (+29) 166 (+38) 291 (+51) 94 (+20) 100 
Salt50 176 (+39) 106 (+38) 166 (+38) 278 (+38) 97 (+23) 100 
Bread25 183 (+46) 98 (+30) 172 (+44) 306 (+66) 94 (+20) 100 
Salt+bread20 189 (+52) 107 (+39) 179 (+49) 307 (+67) 97 (+23) 100 
Salt+bread25 202 (+65) 117 (+49) 191 (+61) 325 (+85) 99 (+25) 100 
Bread50 229 (+92) 124 (+56) 216 (+86) 378 (+138) 99 (+25) 100 
Salt+bread50 267 (+130) 162 (+94) 254 (+124) 416 (+176) 100 (+26) 100 
EAR adults=100 µg/day 
UL adults=600 µg/day 
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Table 8.2.1.1-2 Estimated iodine intakes in 13-year-old girls in the different scenarios, sorted by 













Current intake – 
no iodization 
95 38 85 187 62 100 
Salt15 105 (+10) 48 (+10) 94 (+9) 196 (+9) 72 (+10) 100 
Salt20 108 (+13) 51 (+13) 97 (+12) 199 (+12) 76 (+14) 100 
Salt25 111 (+16) 54 (+16) 100 (+15) 202 (+15) 79 (+17) 100 
Bread15 123 (+28) 61 (+23) 112 (+27) 221 (+34) 87 (+25) 100 
Salt50 127 (+32) 70 (+32) 116 (+31) 218 (+31) 93 (+31) 100 
Bread20 132 (+37) 67 (+29) 121 (+36) 232 (+45) 92 (+30) 100 
Salt+bread15 132 (+37) 70 (+32) 122 (+37) 230 (+43) 93 (+31) 100 
Bread25 141 (+46) 74 (+36) 131 (+46) 244 (+57) 95 (+33) 100 
Salt+bread20 145 (+50) 80 (+42) 134 (+49) 244 (+57) 97 (+35) 100 
Salt+bread25 157 (+62) 90 (+52) 146 (+61) 259 (+72) 99 (+37) 100 
Bread50 188 (+93) 106 (+68) 176 (+91) 305 (+118) 100 (+38) 100 
Salt+bread50 219 (+124) 138 (+100) 208 (+123) 337 (+150) 100 (+38) 99 (-1) 
EAR 13-year-olds=73 µg/day 
UL 13-year-olds=450 µg/day 
8.2.1.2 Groups at risk of high intakes – current level and scenarios 
At current intake level (no iodization), almost all adults, adolescents and children above 2-
years of age have individual iodine intakes below UL. Men and 4-year-olds are groups at risk 
of high intakes with increasing iodization levels, however, in all the 15, 20 and 25 mg iodine 
per kg salt scenarios, the percentage above UL is 1% at the most in the population groups 
above 2 years. In the scenarios with 50 mg iodine per kg salt scenarios including both 
household salt and bread (bread50 and salt+bread50), several population groups are at risk 
of intakes above UL. 
In Tables 8.2.1.2-1 and 8.2.1.2-2 we have presented how the estimated iodine intakes in the 
groups at risk of high intakes increase with the increasing iodization level scenarios. The 
estimates in these tables and the text below do not include contribution from iodine 
containing supplements. It is reasonable to assume that the estimated iodine intakes in the 
2-year-olds are higher than the true intakes. The rationale for this assumption is given in 
section 7.3.2. 
The presentation of groups at risk of high estimated intakes is limited to the 1- and 2-year-
olds. 18% of non-breastfed 1-year-olds and 8% of the 2-year-olds have iodine intakes above 
the UL of 200 µg/day at current intake level. The 95th percentile for iodine intake is 
259 µg/day in non-breastfed 1-year-olds and 215 µg/day in 2-year-olds (UL in both 1- and 2-
year-olds is 200 µg/day).  
In 1-year-olds, only data for the non-breastfed are presented. We could not estimate iodine 
intake in breastfed infants as we do not have information about breast milk consumption, 
and therefore breastfed 1-year-olds are not included in this assessment. In the scenarios for 
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1-year-olds, only iodine in salt from bread has been estimated. Iodine in household salt was 
not included because salt consumption data in 1-year-olds were considered to be too 
uncertain. Furthermore, the general advice is to keep the salt intake in toddlers low, and to 
avoid adding extra salt to the food. It is reasonable to assume that consumption of 
household salt in 1-year-olds is low.  
While currently available data on dietary intake in 1-year olds were collected in 2007, data 
from a new dietary survey in 1-year-olds are expected to be available before summer 2020. 
If the new upcoming data and new data differs substantially from the exposure estimates for 
1-year-olds presented in chapter 7, this benefit and risk assessment will be supplemented 
with an updated evaluation for this group 
In the 2-year-olds, only the data for the boys are presented, as the boys have slightly higher 
intakes than the girls. The group at absolutely highest risk of high intakes is 2-year-old 
iodine supplement users. Exposure estimates for this group is presented separately in Table 
V-3 in Appendix V. 
In the scenarios (salt+bread15 or salt+bread20) that could elevate the estimated iodine 
intakes in the 5th percentile of women 18-45 years and 13-year-old girls up to the EAR or 
above the EAR, the proportion of 2-year-old boys exceeding the UL increases from 8% to 19 
or 23%, respectively. In the salt+bread15-scenario, the estimated iodine intake in the 95th 
percentile of 2-year-old boys is 252 µg/day, and in the salt+bread20-scenario, the iodine 
intake in the 95th percentile of 2-year-old boys is 263 µg/day. At scenario salt+bread25, 
30% exceeds UL and at scenario salt+bread50, 63% of the 2-years-old boys exceeds UL. 
In the scenarios with 15 or 20 mg iodine per kg salt added to salt in bread alone (bread15 or 
bread20-scenario), the proportion of non-breastfed 1-year-olds exceeding the UL increases 
from 18% to 32 or 36%, respectively. In the bread15-scenario, the estimated iodine intake 
in the 95th percentile of 1-year-olds is 302 µg/day, and in the bread20-scenario, the iodine 
intake in the 95th percentile of 1-year-olds is 316 µg/day.  
Few adults and adolescents have estimated iodine intakes that exceed UL, even in those who 
use regular iodine containing supplements. However, kelp- and seaweed-based supplements, 
and other foods made with kelp and seaweed may contain high concentrations of iodine. 
People who use these ingredients or supplements may be at risk of overly high iodine intakes 
at the estimated current intake level or in any given increased iodization level scenario. In 
the national dietary surveys, consumption of kelp- and seaweed-based ingredients has only 
been reported in the most recent dietary survey in 2-year-old children (Småbarnskost 3). 
Table 8.2.1.2-1 Estimated iodine intakes in 2-year-old boys in the different scenarios, sorted by 













Current intake – 
no iodization 
129 56 122 215 92 8 
 
 













Salt15 138 (+9) 65 (+9) 131 (+9) 224 (+9) 95 (+3) 11 (+3) 
Salt20 141 (+12) 68 (+12) 134 (+12) 227 (+12) 96 (+4) 12 (+4) 
Salt25 144 (+15) 71 (+15) 137 (+15) 230 (+15) 97 (+5) 13 (+5) 
Bread15 149 (+20) 73 (+17) 142 (+20) 243 (+28) 97 (+5) 15 (+7) 
Bread20 155 (+26) 80 (+24) 148 (+26) 251 (+36) 97 (+5) 19 (+11) 
Salt+bread15 158 (+29) 82 (+26) 151 (+29) 252 (+37) 98 (+6) 19 (+11) 
Salt50 159 (+30) 86 (+30) 152 (+30) 245 (+30) 99 (+7) 18 (+10) 
Bread25 162 (+33) 85 (+29)  155 (+33) 258 (+43) 98 (+6) 21 (+13) 
Salt+bread20 167 (+38) 92 (+36) 160 (+38) 263 (+48) 99 (+7) 23 (+15) 
Salt+bread25 177 (+48) 100 (+42) 170 (+48) 273 (+58) 100 (+8) 30 (+22) 
Bread50 195 (+66) 107 (+51) 189 (+67) 305 (+90) 100 (+8) 43 (+35) 
Salt+bread50 225 (+96) 137 (+81) 219 (+97) 335 (+120) 100 (+8) 63 (+55) 
EAR 2-year-olds=65 µg/day 
UL 2-year-olds=200 µg/day 
 
Table 8.2.1.2-2 Estimated iodine intakes in non-breastfed 1-year-olds in the different scenarios, 













Current intake – 
no iodization 
147 54 139 259 69 18 
Bread15 172 (+25) 63 (+9) 162 (+23) 302 (+43) 95 (+26) 32 (+14) 
Bread20 180 (+33) 66 (+12) 169 (+30) 316 (+57) 95 (+26)  36 (+18) 
Bread25 188 (+41) 69 (+15) 177 (+38) 330 (+71) 96 (+27) 38 (+20) 
Bread50 228 (+81) 84 (+30) 215 (+75) 401 (+142) 98 (+29) 56 (+38) 
EAR 1-year-olds=65 µg/day 
UL 1-year-olds=200 µg/day 
 Risk characterisation 
For the purpose of this benefit and risk assessment of iodization in household salt and salt 
used in bread and bakery products, risk may be understood as risk of adverse health effects 
related to too high or too low iodine intakes.  
8.2.2.1 Risks related to low iodine intakes  
Women of childbearing age and 13-year-old girls have low iodine intakes. In addition, people 
who for various reasons include few iodine rich sources in their diet (e.g. people with 
allergies and intolerances to fish or milk/dairy products, vegans/vegetarians and certain 
ethnic minorities), have increased risk of low intakes.  
Severe iodine deficiency during foetal life, infancy, or early childhood may lead to permanent 
intellectual disability. Severe maternal iodine deficiency in pregnancy may also result in 
miscarriages, preterm delivery, stillbirth, and congenital abnormalities. These effects are 
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mediated through the thyroid hormones on the developing tissues. For 13-year-old girls, an 
inadequate iodine intake might affect thyroid hormone production negatively. Severe iodine 
deficiency and reduced thyroid function during adolescence increase the risk of developing 
goiter, juvenile hypothyroidism, impaired mental function, and retarded physical 
development. Data for the prevalence of severe iodine deficiency or mild or moderate iodine 
deficiency in Norway are not available. 
Several studies have found poorer neurodevelopmental outcomes in children born to 
mothers with seemingly mild to moderate iodine deficiency. However, based on our 
systematic literature review and use of WCRF’s criteria for grading of evidence, the evidence 
was not judged strong enough to meet the criteria for probable evidence. We concluded that 
there is limited suggestive evidence to support that mild to moderate iodine deficiency prior 
to, or during pregnancy, causes poor neurodevelopment in children. Limited suggestive 
means that the evidence is too limited to permit a probable or convincing causal judgement 
but shows a generally consistent direction of effect. 
After carefully reviewing the articles on the other outcomes relevant for women of 
childbearing age (thyroid function and birth outcomes), it was concluded that there is limited 
(no conclusive) evidence to support that mild to moderate iodine deficiency causes thyroid 
dysfunction or has negative effects on birth outcomes. Limited (no conclusive) means that 
the evidence is so limited that no firm conclusion can be made. The evidence may be limited 
by the amount of evidence in terms of the number of studies available, by inconsistency of 
direction of effect, and by methodological flaws (lack of adjustment for known confounders).  
As for schoolchildren, it was also concluded that the evidence is limited suggestive that mild 
to moderate iodine deficiency in schoolchildren causes poor neurodevelopment. Only one 
study included in our systematic review investigated thyroid function, and no conclusion 
could be made. 
For more detailed information about the grading of evidence from the systematic review on 
health effects related to mild to moderate iodine deficiency, see Tables 5.5-1 and 5.5-2. 
Recommendations for nutrients are set to secure adequate growth, development, 
maintenance of health, and to reduce the risk of chronic illnesses. An adequate iodine intake 
is essential for synthesis of thyroid hormones and is critically important for the foetus and 
infant by affecting the development and maturation of the nervous system, skeletal muscles, 
and lungs. An adequate iodine intake is particularly important for women in childbearing age 
because their future children may be susceptible to the adverse effects of iodine deficiency. 
Women with intakes below EAR have a relatively high probability of inadequate iodine 
intakes and therefore a higher risk of adverse health effects from iodine deficiency. For 13-
year-old girls iodine intake in the 5th percentile is 38 µg/day (EAR 73 µg/day) and for 
women of childbearing age 70 µg/day (EAR 100 µg/day). 
Current iodine intake in certain population groups is worryingly low, and trend studies 
indicate that consumption of milk and dairy products in Norway, the most significant iodine 
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sources in the diet, is declining, especially among young women (Brantsaeter et al., 2013; 
Gunnarsdottir and Dahl, 2012). 
8.2.2.2 Risks related to high iodine intakes  
The 2-year-olds are at risk of high iodine intakes, in addition to kelp or seaweed supplement 
users. Few studies with designs suited for risk assessment have investigated adverse health 
outcomes in relation to excessive iodine. However, excessive iodine intake has been 
associated with poor regulation of thyroid hormones and increased (hyperthyroidism) and 
decreased (hypothyroidism) thyroid hormone production. Whether excessive iodine 
exposure, acute or chronic, is a significant cause of poor neurodevelopment or other adverse 
health outcomes is still a matter of debate.  
The clinical consequence of excessive intakes in young children is uncertain, and the studies 
found relevant for comparison with the existing UL (chapter 6.2.2) only include children at or 
above the age of 6 years. In our updated literature review, we included four publications 
from three large, cross-sectional studies including children from China, Korea, and Japan 
with high iodine exposures,  
The prevalence of subclinical hypothyroidism in Chinese children (7-10 years old and 11-14 
years old) was increased with iodine intakes ≥ 250 μg/day (Chen et al., 2017; Chen et al., 
2018a). The ULs in these age groups are ranging from 300-450 µg/day. Kang et al. (2018) 
reported a significantly higher prevalence of subclinical hypothyroidism in Korean children 
aged 10-19 years in the group with UIC above 300 µg/L, corresponding to an estimated 
iodine intake of 333 µg/day. The ULs in this age groups are ranging from 450-600 µg/day. 
However, the study quality from these cross-sectional studies were not considered sufficient 
to establish new ULs. The project group therefore proposed to keep the existing ULs in 
children, including the UL of 200 µg/day for 1- and 2-year-olds, set by SCF in 2002.  
A recent non-systematic review of iodine excess and thyroid function in children aged 6-24 
months concluded that the long-term effects of chronic excessive iodine on thyroid function 
and somatic growth and development in infants and young children remain uncertain 
(Farebrother et al., 2019a). One of the studies included in this review assessed thyroid 
function and Tg concentrations in 6-24 month old infants, and observed an increase in Tg in 
infants consuming iodine above the UL (>230 µg/day) (Farebrother et al., 2019b). Two other 
studies were carried out in groups with higher iodine intakes (median UIC > 400 µg/L, 
corresponding to estimated iodine intake > 444 µg/day) and reported an increased 
prevalence of subclinical hypothyroidism (Aakre et al., 2016; Nepal et al., 2015).  
In adults (19-24 years old), results from a randomised controlled dose-response study (12 
intervention groups with various iodine supplement doses ranging from 0 to 2000 µg/day 
and total iodine intakes ranging from 351 µg/day (placebo group) to 2375 µg/day (2000 µg 
supplement group ) (Sang et al., 2012) were found to be in line with the UL of 600 µg/day in 
adults set by the SCF (2002) and later adopted by the NNR (2012) and a recent proposal 
from NASEM (Allen et al., 2019). This study showed that subclinical hypothyroidism 
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appeared in participants with a total iodine intake of 800 µg/day (around 400 µg/day from 
food and 400 µg/day from supplements). No increase in TSH concentrations (TSH >5 mIU/L) 
or thyroid hormones appeared at lower intakes. However, according to findings in new 
studies, the lowest-observed-adverse-effect levels (LOAEL) for excessive iodine intake may 
be lower than previously assumed, and the uncertainty factor inherent in the established ULs 
is reduced from three to 1.3 for adults. It should be noted that elevated TSH concentrations 
(TSH >5 mIU/L) remained in 5% of the participants with a total intake of 800 µg iodine per 
day 3 months after iodine withdrawal (Sang et al., 2012).  
It should be noted that in subclinical hypothyroidism, the production of the thyroid hormones 
T3 and T4 are within normal ranges, whether these findings have clinical or developmental 
consequences is uncertain, but subclinical hypothyroidism may progress to overt 
hypothyroidism (Cooper and Biondi, 2012). 
In the salt+bread15 and salt+bread20-scenarios, 19 and 23% of the 2-year-olds have 
intakes above UL of 200 µg/day. The estimated intakes in the 95th percentiles are 252 and 
263 µg/day, respectively. In the bread15- or bread20-scenario, the proportion of 1-year-olds 
exceeding the UL increases from 18% to 32% or 36%, respectively. In the bread15-
scenario, the estimated iodine intake in the 95th percentile of 1-year-olds is 302 µg/day, and 
in the bread20-scenario, the iodine intake in the 95th percentile of 1-year-olds is 316 µg/day. 
These are intake levels that have been associated with an increase in TSH or Tg, without a 
change in the thyroid hormones T3 or T4. 
According to the benefit and risk assessment, other groups at risk for overly high iodine 
intake are individuals consuming dried kelp or kelp supplements. In pregnant women, an 
abrupt moderate increase in iodine intake may cause transient thyroid dysfunction (Bath, 
2019; Moleti et al., 2011). Data from the MoBa showed that the pregnant women were 
mildly to moderately iodine deficient. This might indicate that a high proportion of infants in 
Norway have been exposed to low iodine exposures during foetal life. From 4-6 months of 
age and through early childhood, the infants and toddlers probably increase their iodine 
intakes. Abrupt increase in iodine intakes in individuals with a previously mild to moderate 
iodine deficiency might disturb normal iodine metabolism and increase the risk of altered 
thyroid function.  
 Benefit characterisation  
Benefit may be understood as reduction or avoidance of adverse health effects related to too 
high or too low iodine intakes. For iodine, this is a challenging maneuver, as the range 
between too low and too high intakes is narrow. The subjects with iodine intakes above EAR 
and below UL have less risk for developing iodine deficiency disorders or having excessive 
iodine intakes associated with thyroid dysfunction.  
 
 
VKM Report 2020: 05  155 
8.3 Summary of benefit and risk assessment  
It is well established that severe iodine deficiency has adverse effects on thyroid function, 
neurodevelopment and birth outcomes. Several single studies described impaired 
neurodevelopmental outcomes related to mild to moderate iodine deficiency prenatally, 
during pregnancy and in schoolchildren. However, based on our systematic literature review 
and use of guidelines for grading of evidence, the project group concluded that there is 
limited - suggestive evidence for a causal relationship between mild to moderate iodine 
deficiency and adverse neurodevelopmental outcomes. The evidence was limited (no 
conclusion) that mild to moderate iodine deficiency causes thyroid dysfunction or affect 
fertility or birth outcomes. 
At current intake level (no iodization), 26% of women 18-45 years of age and 38% of 13-
year-olds girls have intakes below the estimated average requirement (EAR). It is, 
reasonable to assume that our estimated iodine intakes in adults and especially in the 13-
year-olds are somewhat lower than the true intakes (section 7.3.1). The findings that 
especially young girls and women of childbearing age have low intakes are, however, in 
accordance with studies in Norway on iodine status in women of childbearing age (Henjum 
et al., 2019).  
An adequate iodine intake is essential for synthesis of thyroid hormones and is critically 
important for the foetus and infant by affecting the development and maturation of the 
nervous system, skeletal muscles, and lungs. Subjects with intakes below EAR have a 
relatively higher probability of inadequate iodine intakes and therefore a higher risk of 
adverse health effects from severe iodine deficiency. An adequate iodine intake is particularly 
important for women in childbearing age because their future children may suffer adverse 
effects from iodine deficiency. The scenario (salt+bread 15 mg) that could adequately 
increase the iodine intakes of women 18-45 years and 13-year-old girls above EAR for 94%, 
put 19% of the 2-year-old boys at risk of intakes above UL. 
Excessive iodine interferes with normal regulation of thyroid hormones and may lead to both 
increased (hyperthyroidism) and decreased (hypothyroidism) thyroid hormone production 
(Burgi, 2010; Farebrother et al., 2019a; Katagiri et al., 2017; Laurberg et al., 2010). 
However, the evidence for excessive iodine intakes leading to poorer neurodevelopmental 
outcomes is limited.  
In regard to high iodine intakes, at estimated current intake level (no iodization), 8% of the 
2-year-old children and 18% of the non-breastfed 1-year-olds exceed UL of 200 µg/day. 
With the intake scenarios of 15, 20 and 25 mg iodine per kg salt in household salt and 
bread, 19%, 23% and 30% of the 2-year-olds, respectively will exceed UL. It is, however, 
reasonable to assume that the estimated iodine intakes in the 2-year-olds are higher than 
the true intakes (section 7.3.2). Subclinical hypothyroidism (changes in TSH without changes 
in T3 or T4) have been reported in children with iodine intakes at or below the existing ULs. 
It should be noted that in subclinical hypothyroidism, the production of the thyroid hormones 
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T3 and T4 are within the normal range, and whether these findings have clinical or 
developmental consequences is uncertain, but subclinical hypothyroidism may progress to 
overt hypothyroidism (Cooper and Biondi, 2012). 
The value for comparison in the upper intake range (UL) should by definition protect most of 
the population, whereas the chosen value for comparison in the lower intake range (EAR) is 
assumed sufficient for 50% of the population. It may therefore be argued that the chosen 
value for comparison in the upper intake range is more conservative than the chosen value 
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9 Uncertainties 
9.1 Uncertainties related to the evidence for health impact of 
insufficient or excessive iodine intakes 
The project group assessed the quality and risk of bias of all studies included in the literature 
reviews, but there will still be uncertainty related to the evidence. The uncertainties pertain 
to validity and precision of the exposure (iodine intake) and outcome measurements, as well 
as to the number and relevance of the available studies. 
Table 9.1-1 Uncertainties related to the evidence for mild to moderate iodine deficiency and 
health outcomes. 
Source of uncertainty Consequences for our evaluation 
Iodine status (UIC) 
As an indicator of regular iodine intake in the diet, a single UIC 
measurement provides only a snapshot of recent intake. This 
measurement may provide information about median iodine intake in a 
population, while several repeated measurements are required to 
reliably estimate individual iodine status and to classify individuals as 
iodine deficient or sufficient. Yet, the classification of populations into 
subgroups of deficiency or sufficiency in most published studies are 
based on UIC in a single urine sample. This leads to a high degree of 
misclassification and incorrect estimates for: 
 the prevalence of iodine deficiency, insufficiency, sufficiency, 
and excess in individuals 
 the effect of mild and moderate iodine deficiency, or excess, on 
health outcomes in individuals 
Neurodevelopmental 
outcomes and iodine 
deficiency 
Neurodevelopmental tests might not capture the domain sensitive to 
iodine deficiency or excess. This might result in false negative results 
(type II errors). 
The results from neurodevelopmental tests in young children (i.e. early 
child development before approximately 3 years of age) are poor 
predictors for cognitive functions later. The reliability of the study results 
is poor which decreases the precision of the effect estimates.  
The results obtained from neurodevelopmental tests might be influenced 
by socioeconomic factors that increases the risk of confounding.  
The subjective nature of many of these tests increases the risk of both 
random and systematic errors. 
Thyroid function and 
iodine deficiency 
Although cross-sectional studies are generally not appropriate for causal 
inference, such studies were included due to the rapid response of the 
thyroid to increased iodine intakes 
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Source of uncertainty Consequences for our evaluation 
Tg is a marker of iodine status rather than thyroid function. Increased 
Tg is an early sign of increased thyroid activity, but should not be 
regarded as a clinically relevant endpoint for thyroid dysfunction if 
thyroid hormone production is still within the normal range. 
Decreases in thyroid hormone concentrations and TSH occur during 
pregnancy as a consequence of the normal physiological changes in 
blood volume (hemodilution) in pregnancy. Consequently, it is difficult to 
distinguish between normal changes and changes that may result from 
mild or moderate iodine deficiency. 
Detecting effects of changing iodine intakes on thyroid function can be 
challenging since auto-regulatory processes are initiated in the thyroid 
gland, when the iodine intake increases or decreases, to maintain 
normal thyroid function.  
EAR as reference 
value in this benefit 
and risk assessment 
EAR in adults is based on studies of thyroid iodine accumulation and 
turnover in euthyroid adults, and supported by balance studies. There is 
more uncertainty related to EAR for children and for pregnant women, 
than for non-pregnant adults. 
Balance studies for deriving EAR have limitations, e.g. differences in 
long-term iodine intake prior to inclusion, iodine equilibrium relies on 
thyroidal store and not only intake and excretion, the studies were 
conducted at a time when key indicators such as serum TSH were not 
available. 
By definition, the iodine requirement is covered for only 50% of the 
population at EAR.  
UL as reference value 
in this benefit and 
risk assessment 
The UL from 2002 is based on small pharmacokinetic dose-response 
studies evaluating the effects of relatively short-term iodine exposures in 
euthyroid adults. Results from more recent studies suggest that the 
inherent uncertainty factor is lower for the existing UL in both adults, 
adolescents and children. 
UL is based on increase in TSH and later studies on subclinical 
hypothyroidism. There is uncertainty regarding the clinical relevance of 
changes in TSH and subclinical hypothyroidism. 
Only cross-sectional studies were available as a basis for appraising UL 
in children, which makes the uncertainty for the younger age groups 
even larger than for adults. This applies particularly for the extrapolation 
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9.2 Uncertainties related to iodine exposure 
The main sources of uncertainty in the exposure estimates are presented in Table 9.2-1. The possible impact of the uncertainty on the 
exposure estimates was evaluated by expert judgement, and both the main sources to uncertainty and the possible effect on the exposure 
estimates are presented in the table. 



















Scenarios on brand 
loyal consumers are 
not included in this 
assessment. 
 
na1 Two brands of mineral water were analysed to contain iodine between 30-40 
µg/100g. For those who consume mineral water only from the brands with the 
highest iodine content, the exposure will be higher than estimated. 




Iodine concentrations in white fish vary substantially. We have used one single mean concentrations from the 
Norwegian Food Composition Table. In a long term perspective this is not assumed to affect the iodine 
estimates in any specific direction. 
Import of bread 
Imported bread 
could include 
iodized salt, but 
was not taken into 
account. 
In the presented exposure estimates current intake could be underestimated.  
Scenarios of salt in bread could be overestimated. 
 
 






















foods was not 
taken into account. 
In the presented exposure estimates, sampled foods were assumed to represent consumed foods, which 
could lead to both over- and underestimation. 
Use of household salt 
Gender- and 
energy-adjusted 
salt intake based 
on 10% of urinary 
iodine excretion 
data from Tromsø 




individuals, and will 
also correlate with 
intake of different 
types of foods. This 
correlation was not 
taken into account 
in this assessment, 
due to lack of data. 
na1 
Presented household salt scenarios will have a lower level of variation. 
 
 




















Short period of 
food registration 
provides dietary 
data on group 




        
 
Food frequency 
questionnaire will give 
an estimate with a 
higher degree of 
variance in both 
current intake and 
scenarios. 
Four days web food diary; Iodine 
containing foods like milk and milk 
products, fish and for the scenarios 
bread consumption, are common 
food groups that is probably well 
captured by the survey. However, 
four days will not capture the 
impact of rarely eaten foods with 
high iodine concentrations. 
Two recording days; some foods/food groups 
have high concentrations of iodine, and the 
long term consumption of these high iodine 
concentration products (e.g. brown weigh 
cheese, cod) will not be reflected in two days 
recalls for one person. 




overly low intake of 
iodine. 
     
In the presented current intake and 
scenarios, persons not eating milk and/or fish 
will have an iodine intake in the lower 
percentiles. However, the largest uncertainty 
is lack of food intake data for these groups. 
1na – not applicable 
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 Uncertainties related to the modelling method (Mixed Models 
approach) 
Models in general have different types of uncertainties: data/input uncertainties (detailed 
above for the different surveys), structural uncertainties (do the parameters and structure of 
the model represent the true nature of the data), parametric uncertainties (are the 
parameters properly estimated, e.g. how iodine intake increases with age). Our MM-
approach is Bayesian and all models were evaluated for convergence and stability of 
parameter estimates (by inspecting the effective sample sizes and plotting their trace and 
distribution), and therefore it is reasonable to assume that the parametric uncertainty is well 
captured by our approach.  
The MM-methods applied here assume (for adults) that both iodine intake and bread 
consumption are linearly impacted by sex, age and level of education on a logarithmic scale. 
It is well known that intake distributions are often skewed (particularly since they are 
bounded by 0), and a log transformation is often performed. In our preliminary comparison 
with Monte Carlo Risk Assessment (MCRA) (see appendix IV) the log-transformation of iodine 
intake was favoured by the selection procedure within the MCRA software (which performs a 
comparison with various Box-Cox transformations), so the assumptions of normality on a log 
scale is probably justified.  
The structural uncertainty in the MM-approach relates to whether or not the appropriate 
kinds of explanatory variables are included, and that the variance/covariance structure in the 
mixed model is justified. We did apply models using more covariates, including testing for 
sex-specific age-dependencies (i.e. that men and women differ in how age impacts the 
iodine intake in Norkost 3), and these models did not outperform the models with age-effect 
for both men and women. We also fitted models to several related, but slightly different 
data-sets (e.g. including and excluding supplements for all adults, as well as for users-only) 
and for ease of comparison between these, we assumed the same structure for them all. 
There are some indications that iodine intake is geographically structured in Norway (Medin 
et al., 2020), but we did not include this as a covariate. 
For the iodine exposure estimates, including the scenarios, the combined uncertainty 
deriving from data and modelling the uncertainty is largest in the 2-year-olds (since no 
modelling was performed), substantially less for adults (Norkost 3), and thought to be even 
smaller for Ungkost 3 (4-, 9- and 13-year-olds), mostly due to the higher number of days (4 
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10 Answers to the terms of reference 
and concluding remark 
The Norwegian Scientific Committee on Food and Environment (VKM) was requested by the 
Norwegian Food Safety Authority (NFSA) to conduct a benefit-risk assessment of iodization 
of household salt and industrial salt used in bread. The assessment should include 
subpopulations that are at risk of overly low or high intake of iodine, including women of 
childbearing age, women who are pregnant and breastfeeding, men and children. Other risk 
groups such as vegans, individuals suffering from allergy or intolerance to fish and dairy 
products, relevant ethnic minorities that do not consume fish and dairy products and 
individuals consuming iodine supplements should also be considered. Iodization of plant-
based alternatives to cow milk products should also be considered. Imported foods that are 
fortified with iodine and sold on the Norwegian market should be taken into account. 
The VKM Panel on Nutrition, Dietetic Products, Novel Food and Allergy has discussed several 
draft opinions and has evaluated and approved the final opinion drafted by the project 
group. The VKM Panel supports and agrees with the assumptions and conclusions drafted by 
the project group. The answers to the Terms of Reference from the VKM Panel are given 
below. 
10.1 Current iodine intake 
This section answers question 1 in the terms of reference: What is the iodine intake in the 
general population and among identified risk groups? Risk groups are subpopulations at risk 
for overly low or high iodine intake.  
The four nationwide dietary surveys Norkost 3, Ungkost 3, Småbarnskost 3 and Spedkost-07, 
have used different dietary assessment methods; 2x24h-recall, 4 days web-based food diary 
and food frequency questionnaire (FFQ), respectively.  
The iodine exposure estimates for adults, 13-, 9- and 4-year-olds are based on a mixed 
models (MM) method, whereas the exposure estimates for 1- and 2-year-olds are based on 
FFQ.  
The impact of a mixed models approach on the exposure estimates is typically a reduction in 
the tails, i.e. a narrower distribution of chronic intake, compared to observed individual 
means or daily intakes.  
It should be noted that it is reasonable to assume that our estimated iodine intakes in adults 
and especially in the 13-year-olds are lower than the true intakes, both at the current level 
and in the scenarios. The rationale for this assumption is given in section 7.3.1. Furthermore, 
it is reasonable to assume that our estimated iodine intakes in the 2-year-olds are higher 
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than the true intakes, both at the current level and in the scenarios, and the rationale for 
this assumption is given in section 7.3.2. 
The iodine exposure estimates and the scenarios have been compared to the reference 
values EAR and UL. The rationale for this choice of reference values is given in section 4.3. 
Current intakes in adults, 13-, 9- and 4-year-olds, the general population 
The estimated iodine intakes in adults, 13-, 9- and 4-year-olds not using iodine-containing 
supplements are presented in Table 7.3.1.1-1. 
91% of the men and 79% of the women have estimated intakes above the EAR of 
100 µg/day. Estimated mean (median) intakes are 202 (183) µg/day and 147 (137) µg/day, 
in men and women, and the intakes in the 5th percentiles are 88 and 72 µg/day, 
respectively. In women of childbearing age, 74% have intakes above EAR and the estimated 
intake in the 5th percentile is 68 µg/day. 
79% of the 13-year-old boys and 62% of the girls have estimated intakes above the EAR of 
73 µg/day. The estimated mean (median) intakes in girls are 95 (85) µg/day, whereas the 
intake in the 5th percentile for girls is 38 µg/day. 
89% of the 9-year-old boys and 70% of the girls have estimated intakes above the EAR of 
73 µg/day. 93% of the 4-year-old boys and 85% of the girls have estimated intakes above 
the EAR of 65 µg/day. 
All adults and 13-, 9- and 4- year-olds have estimated intakes below the UL at current intake 
level. The ULs for these age groups are 600, 450, 300 and 250 µg/day, respectively. 
Estimated intake in adults including iodine containing supplements (users only) are 
presented in Table V-2 and Figure V-1 in Appendix V. In Norkost 3, 16% of the women and 
11% of the men reported use of iodine supplements with a mean iodine contribution of 95 
and 117 µg/day, respectively. In 4-, 9- and 13-year-olds, 2-5% reported use of iodine 
supplements.  
Current intakes in 1- and 2-year-olds, the general population 
The estimated iodine intakes in 1- and 2-year-olds are presented in Table 7.3.2-1. 
91-92% of the 2-year-olds have estimated intakes above the EAR of 65 µg/day. The 
estimated mean (median) intakes are 128 (122) µg/day, whereas the intake in the 5th 
percentile is 56 µg/day. 92% of non-breastfed 1-year-olds have estimated intakes above the 
EAR of 65 µg/day. 
8% of 2-year-olds, and 18% of non-breastfed 1-year-olds have estimated intakes above the 
UL of 200 µg/day. The estimated iodine intakes in the 95th percentile is 215 µg/day in 2-
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year-olds and 259 µg/day in non-breastfed 1-year-olds. Excessive iodine intakes above the 
UL seem to be less frequent in the older age groups (from 4-years and older). 
10% of the 2-year-olds have reported use of iodine containing supplements, and mean 
iodine contribution from supplements is 96 µg/day in users only. The estimated intakes in 2-
year-old supplement users (users only) are presented in Table V-3 and Figure V-2 in 
Appendix V.  
There is no reported use of iodine supplements in 1-year-olds. 
Current intakes in groups at risk of low and high intakes 
As presented above, 13-year-olds and women of childbearing age (18-45 years) are at 
particular risk of iodine intakes below EAR. One- and 2-year-olds are at special risk of intakes 
above UL. Norkost 3 and the other national dietary surveys do not provide enough data to 
calculate iodine intake estimates for vegetarians, vegans, ethnic minorities, and persons with 
milk or fish allergy or intolerance. 
As shown in Table 7.3.1.1-1 very few adults and adolescents have estimated iodine intakes 
that exceed the UL, even in those who use regular iodine containing supplements (Table V-2 
in Appendix V). However, kelp- and seaweed-based supplements, and other foods made with 
kelp and seaweed may contain high concentrations of iodine, and individuals who use these 
ingredients or supplements may be at risk of overly high iodine intakes. Consumption of 
kelp- and seaweed-based ingredients has not been reported in Norkost 3 or Ungkost 3, but 
five 2-year-olds reported use of kelp and seaweed in Småbarnskost 3. 
10.2 The scenarios - the iodine intake if household salt and 
industrial salt used in bread were to be iodized  
This section answers question 2 in the terms of reference: What would the iodine intake in 
the general population and among identified risk groups be if household salt and industrial 
salt used in bread were to be iodized and if plant-based milks were to be fortified with iodine 
levels comparable to those in cow’s milk? The iodine intakes resulting from the various 
scenarios should be estimated both with and without the added effect of iodine fortification 
of plant-based alternatives to dairy products (milk 15 μg/100 g). The estimates should also 
be considered in the context of the Salt Strategy 2015 (governmental initiatives to reduce 
salt consumption). 
The scenario estimates for all age groups not using iodine containing supplements are 
presented in Tables 7.4-3 - 7.4-14.  
We have presented 12 scenario tables, three scenarios (household salt alone, salt in bread 
alone and both household salt and salt in bread) for each iodization level (15, 20, 25 and 50 
mg iodine per kg salt). In the text below, we present only the scenarios for iodine added to 
both household salt and industrial salt used in bread, since the scenarios with iodine only in 
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household salt or only in industrial salt used in bread do not increase the iodine intakes in 
the groups at risk of low intakes, sufficiently. 
The percentages of the population groups with intakes above the EAR increase with 
increasing iodization levels, but so do also the percentages with intakes above the ULs for 
iodine.  
The scenarios –adults, 13-, 9- and 4-year-olds, the general population 
In Tables 8.2.1.1-1 and 8.2.1.1-2 we have presented how the estimated iodine intakes in the 
groups at risk of low intakes (women 18-45 years and 13-year-old girls) increase with the 
increasing iodization level scenarios. 
The iodization option yielding the combined lowest proportions of the population below EAR 
and above UL, is the scenario of adding 15 µg iodine per kg salt to both household salt and 
salt in bread. At this iodization level, 93-100% of all adults and adolescents have iodine 
intakes above EAR and the proportion exceeding UL is ≤ 1%. 
At this scenario, 94% of women 18-45 years have estimated iodine intakes above EAR. 
Estimated mean (median) intakes are 176 (166) µg/day, and the estimated iodine intake in 
the 5th percentile is 97 µg/day.  
In the same scenario, 93% of the 13-year-old girls have estimated iodine intakes above EAR. 
Estimated mean (median) intakes are 132 (122) µg/day and the estimated intake in the 5th 
percentile is 70 µg/day.  
At the scenario of adding 20 µg iodine per kg salt to both household salt and salt in bread, 
97% of the women (18-45 years) and 13-year-old girls have estimated intake levels above 
EAR. The estimated mean intakes are 189 and 145 µg/day in women (18-45 years) and 13-
year olds, respectively, and the intakes in the 5th percentiles are 107 and 80 µg/day.  
At the scenario of adding 25 µg iodine per kg salt to both household salt and salt in bread, 
the estimated intake in the 5th percentile has increased to 90 µg/day in the 13-year-old girls. 
At the scenario of adding 50 µg iodine per kg salt to both household salt and salt in bread, 
all age-groups have estimated iodine intakes above the EAR. All the women still have 
estimated intakes below the UL, however, 1-20% of the men and children are exceeding UL.  
The scenario estimates for the different iodization levels in adults including iodine 
supplements (users only) are presented in Table V-2 in Appendix V. 
The scenarios – 2-year-olds, the general population 
For 2-year-olds, all scenarios lead to a decrease in the proportion of children expected to be 
within the acceptable range. While iodization of both household salt and bread lifts the 
children with low iodine intake over the EAR, a larger part will have intakes exceeding the 
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UL. At the highest iodization scenarios including iodization of salt in bread (salt+bread50), 
the proportion of children expected to exceed the UL rises to 63%. 
At the scenario of adding 15 µg iodine per kg salt to both household salt and salt in bread, 
17-19% of the 2-years-olds have iodine intakes exceeding UL, and the estimated iodine 
intake in the 95th percentile is 250 and 252 µg/day in girls and boys, respectively. At the 
scenario of adding 20 µg iodine per kg salt to both household salt and salt in bread, 21-23% 
of the 2-year-olds exceed UL, and the estimated iodine intake in the 95th percentile is 259 
and 263 µg/day in girls and boys, respectively. At the scenario of adding 25 µg iodine per kg 
salt to both household salt and salt in bread, 25-30% of the 2-year-olds exceed UL, and the 
estimated iodine intake in the 95th percentile is 271 and 273 µg/day in the girls and boys, 
respectively. At the scenario of adding 50 µg iodine per kg salt to both household salt and 
salt in bread, 57-63% of the 2-year-olds exceed UL. 
In the bread15 or bread20-scenario, the proportion of 1-year-olds exceeding the UL 
increases from 18% to 32 or 36%, respectively. In the bread15-scenario, the estimated 
iodine intake in the 95th percentile of 1-year-olds is 302 µg/day, and in the bread20-
scenario, the iodine intake in the 95th percentile of 1-year-olds is 316 µg/day. 
The scenarios – other specified risk groups of low and high iodine intakes. 
There was no information available from the national dietary surveys to calculate the effect 
of the different iodization levels on the iodine intakes in the other specified groups at risk of 
low iodine intakes levels such as e.g. persons with allergy or intolerance to fish, milk or dairy 
products, vegans, vegetarians and some ethnic minorities. However, as salt consumption is 
assumed to be correlated with energy intake, the increase in iodine intake with increasing 
levels of iodized salt may be expected to be similar in these potential risk groups as in the 
rest of the population, although with large individual variations within the different groups. 
In addition, we do not have exact data on bread consumption among persons in these 
specified groups at risk. The variation in bread consumption among persons with allergy or 
intolerance to fish, milk or dairy products, vegans, vegetarians and some ethnic minorities 
may be assumed to be fairly similar to the variation in bread consumption in the general 
population. Consequently, for persons with few iodine sources in the diet (low milk in take), 
vegans and people with allergy or intolerance), the increase in iodine intake in these 
potential risk groups may be the same as the increase in the lower percentiles in the 
scenarios, e.g. the 5th percentiles in the scenarios in Tables 7.4-3 - 7.4-14. 
Groups at risk of high iodine intake might be individuals consuming dried kelp or kelp 
supplements. In pregnant women, an abrupt moderate increase in iodine intake may cause a 
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Plant-based alternatives to cow’s milk 
This section responds to the following in the terms of reference: The iodine intake resulting 
of the various scenarios should be estimated both with and without the added effect if plant-
based alternatives were to be fortified with iodine levels comparable to those in cow’s milk 
i.e. 15 µg per 100 g. 
The suggested iodine level in plant-based alternatives to cow’s milk corresponds to the 
concentration in cow’s milk. The national dietary surveys have not collected information on 
use of plant-based milk alternatives. The project group has, due to lack of intake data, 
assumed that consumption of plant-based milk alternatives replaces consumption of cow’s 
milk, and that consumption of plant-based alternatives have similar individual variations as 
for cow’s milk. The tables presenting iodine exposure in sections 7.3 and 7.4 are therefore 
applicable for both cow’s milk users and users of the plant-based alternatives given that all 
plant-based alternatives have the same iodine content and bioavailability as cow’s milk. 
Iodization of plant-based alternatives may contribute to increased iodine intake in vegans. 
Individuals with low consumption of plant-based alternatives will receive only small amounts 
of iodine from this source, whereas high-consumers will receive larger amounts. The risks 
related to high iodine intakes from iodized plant-based alternatives are not considered to be 
any larger than risks related to milk consumption in any age groups.  
Effect of potential salt reduction on the scenario estimates for iodine 
This section responds to the following in the terms of reference: The iodine intake estimated 
should also be considered in the context of the Salt Strategy 2015 (governmental initiatives 
to reduce salt consumption). 
The main goals in the Salt Strategy are 30% relative reduction in mean population intake of 
salt/sodium within year 2025 and a long-term target of mean salt consumption of 5 g/day. 
An intermediate objective is to reduce salt in bread to 0.9 g salt per 100 g bread. This 
corresponds to approximately 18% reduction in salt in bread compared to our scenario 
calculations. 
A 30% reduction in salt consumption would imply a need for approximately 40-45% 
increased iodization levels to achieve the same levels of daily iodine intake as given in the 
scenario Tables 7.4-3-7.4-14 for all the age groups (1/(1-0.3) = 1.43). This estimate 
assumes a uniform 30% reduction, and no consideration is given to whether the salt 
reduction is unevenly distributed between various food groups. Similarly, a reduction of salt 
in bread to 0.9 g salt per 100 g bread, would imply a need for approximately 22% increased 
iodization levels to achieve the same levels of daily iodine intake as given in the scenarios. 
10.3 Health effects related to the various iodization levels 
This section answers question 3 in the terms of reference: What potential health effects will 
the various iodization levels have for the general population and the identified risk groups? 
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We do not have enough dose-response data to evaluate the health effects for the various 
iodization levels. We have, however, evaluated possible health consequences of iodine 
intakes related to intakes below EAR and above UL in the various age-/ life stage-groups.  
In addition, the systematic literature review on mild to moderate iodine deficiency in relation 
to neurodevelopment, thyroid function and birth outcomes provides support to this 
assessment. We have also reviewed the literature on excessive intakes of iodine and re-
evaluated the existing UL. 
Adequate iodine intake is essential for normal thyroid function. Thyroid hormones are crucial 
for the foetus and infant by affecting the development of the nervous system, skeletal 
muscles and lungs. Adequate iodine intake is especially important in women of childbearing 
age in order to secure optimal thyroid hormone production before pregnancy.  
Severe iodine deficiency during foetal life, infancy, or early childhood may lead to permanent 
intellectual disability. Severe maternal iodine deficiency in pregnancy may also result in 
miscarriages, preterm delivery, stillbirth, and congenital abnormalities. All these effects are 
mediated through a lack of thyroid hormones. However, we do not know the prevalence of 
severe iodine deficiency in Norway.  
The recommendations for vitamins and minerals generally aim to secure adequate growth 
and development and to maintain good health and prevent chronic illnesses. VKM 
generally assumes that intakes above EAR and below UL are beneficial to health, and that 
both too low and too high intakes, operationally defined as intakes below EAR and above UL 
in the current assessment, may entail increased risk of illness.  
The recommendations for iodine are set to prevent goiter and to maintain normal thyroid 
function. Average requirements (AR or EAR) are intake levels that are estimated to meet the 
requirement of half the healthy individuals in a population.  
Both too little and too much iodine can affect thyroid hormone production. Generally, UL is 
the maximum level of total chronic daily intake judged unlikely to pose any risk of adverse 
health effects. UL is derived from often sparsely available evidence of toxicity in humans or, 
if unavailable, in animals, by dividing the lowest-observed-adverse-effect level (LOAEL) by an 
uncertainty factor (UF). The choice of UF varies with the quality and relevance of the toxicity 
data, but it usually involves a several-fold safety margin between the intake levels potentially 
associated with health risks. In the case of iodine, the UL for adults is the maximum daily 
intake where changes in TSH are unlikely to occur, and the UL for iodine set by SCF in 2002 
was based on a LOAEL for TSH alterations and used an uncertainty factor of three, resulting 
in an UL at 600 µg iodine/day. After reviewing new literature, VKM suggest to maintain this 
UL. However, a recent dose-response study in young adults showed that elevated TSH 
(subclinical hypothyroidism) appeared from a total iodine intake of 800 µg/day. Maintaining 
the UL at 600 µg/day therefore implies a reduction of the uncertainty factor to approximately 
1.3, which is considered by the VKM to represent an acceptable safety margin due to a well-
designed randomised controlled dose-response study. Furthermore, in the same RCT, 
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although a small decrease from baseline was observed in the fT3 concentration in the 500–
2000-µg iodine from supplements-intervention groups, it remained within the normal range. 
Similar changing patterns were observed for fT4. It should be noted that in subclinical 
hypothyroidism, the production of the thyroid hormones T3 and T4 are within the normal 
range, whether these findings have clinical or developmental consequences is uncertain, but 
subclinical hypothyroidism may progress to overt hypothyroidism (Cooper and Biondi, 2012).  
The actual comparison of estimated iodine intakes with EAR and UL is presented above in 
sections 10.1 and 10.2. 
In addition to a comparison of intakes with the reference values, we performed a systematic 
literature review to summarise the evidence for effect of mild to moderate iodine deficiency 
and health outcomes specifically relevant for iodine. Many studies described a negative 
association between UIC and different adverse neurodevelopmental outcomes. Negative 
health outcomes of mild to moderate iodine deficiency cannot be excluded, but based on the 
existing literature and the use of guidelines for grading the evidence, the VKM Panel 
concludes that there is limited suggestive evidence to support that mild to moderate iodine 
deficiency prenatally or during pregnancy is associated with reduced neurodevelopment in 
children. The VKM Panel also concludes that there is limited suggestive evidence to support 
that mild to moderate iodine deficiency in schoolchildren is associated with poorer 
neurodevelopmental outcomes. Limited suggestive means that the evidence is too limited to 
permit a probable or convincing causal judgement but is suggestive of a direction of effect. 
The evidence may be limited in amount or by methodological flaws but shows a generally 
consistent direction of effect. After carefully reviewing the articles on thyroid function and 
birth outcomes, the VKM Panel concludes that there is limited – no conclusion evidence to 
support that mild to moderate iodine deficiency is associated with thyroid dysfunction or has 
negative effects on birth outcomes. Limited (no conclusion) means that the evidence is so 
limited that no firm conclusion can be made. The evidence may be limited by the amount of 
evidence in terms of the number of studies available, by inconsistency of direction of effect, 
by methodological flaws (lack of adjustment for known confounders). For a detailed overview 
of the findings in the included articles, see Tables 5.5-1 and 5.5-2. 
10.4 Concluding remarks 
Low estimated iodine intakes in adolescents (13-year-olds) and women of childbearing age 
(18-45 years) i.e. intakes below EAR cannot be sufficiently corrected by the proposed 
increased iodization levels of salt and/or bread without imposing iodine intakes above UL in 
other population groups, particularly 1- and 2-year-old children.  
Based on the scientific evidence and the data presented in this benefit and risk assessment it 
cannot be concluded that a specific iodization level benefits all age and gender groups 
without posing increased risk of harm to others or that the benefits in one population group 
outweigh the risks in others.  
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Several studies show that especially adolescents and women of childbearing age have 
insufficient iodine intakes, which may leave a number of individuals at risk of severe 
deficiency. There are, to our knowledge no data on the prevalence of severe iodine 
deficiency in Norway nor data on excessive iodine intakes. In other words, we do not know 
how many, if any, there are who may have clinical consequences due to inadequate or 
excessive iodine intakes.  
Recommendations for daily intakes of nutrients are set to secure adequate growth, 
development, maintenance of health, and to reduce the risk of chronic illnesses. Thus, iodine 
intakes below EAR will decrease the possibilities of achieving the beneficial effects of 
adequate intake. It must be assumed that population groups with estimated iodine intakes 
below EAR, especially women of childbearing age and 13-year-olds, will benefit from 
increased iodine intakes. This will also benefit other groups that, for various reasons, have 
few iodine-rich sources in their diet, e.g., people who do not eat lean fish or consume milk or 
other dairy products. The scenarios that seem to raise the iodine intakes in women of 
childbearing age and 13-year-olds (the groups at highest risk of low intakes) to a sufficient 
intake level are iodization up to 15 or 20 mg iodine per kg salt, including iodization of salt in 
bread. Above these iodization levels, no increased benefit would be expected in women of 
childbearing age and 13-year-olds, whereas several population groups will be at risk of 
exceeding UL, and especially 1- and 2-year-olds. 
The WHO recommends salt as a vehicle for correcting iodine deficiency in a population, 
followed by a close monitoring of the iodization program (UNICEF, 2018; WHO, 2007). Any 
increased iodization levels of household salt or salt in bread might lead to excessive intakes 
that may be associated with negative health effects in certain subgroups. It is therefore 
important that any increased levels of iodization are to be followed by a monitoring program 
to surveil both the benefits in the groups at risk of low intakes and the risks in groups with 
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11 Data gaps 
Iodine status  
 Good biomarkers for iodine status: In the absence of a gold standard biomarker for 
iodine status, UIC is endorsed as the best available biomarker at group level. Due to 
its dependence on recent iodine and fluid intake, UIC has a high day-to-day variability 
and is accordingly not a good marker for long-term status. Other biomarkers such as 
thyroglobulin and breast milk iodine concentrations (BMIC) have been less used and 
have some of the same limitations as UIC. 
 Data on iodine status in all age groups in Norway is lacking: Especially population 
groups at risk of low or high iodine intakes (e.g. adolescents, women of fertile age 
and infants and toddlers). 
 Prevalence of iodine deficiency and excess in all age groups: We do not have good 
estimates of the prevalence of the different categories of iodine deficiency and excess 
in Norway. 
Dietary food surveys and iodine intake 
 Future dietary surveys should be designed to include participants from special groups 
at risk of low and high intakes of iodine; e.g. vegetarians, vegans, persons that do 
not eat milk/milk products and/or fish. Enough participants are needed from these 
groups to enable estimations of intake that are statistically robust.  
 Similar dietary survey methods are needed to be able to compare intake, across age 
groups. In the age groups 1- and 2-year-olds, more detailed information at a day to 
day level are needed.  
 To get a more precise estimate of iodine intake, brand specific information are 
needed for foods high in iodine 
Dietary reference values 
 Estimated average requirements for children and adolescents: The estimated average 
requirements for children and adolescents are interpolated from adults. This 
interpolation assumes a certain proportionality between the EAR and body weigh 
which might not be accurate.  
 Updated ULs for all age groups: The UL for adults is well defined, but new evidence 
might be available after 2002. The values for other age- and life stage groups are 
also interpolated from the adult estimates.  
 The clinical relevance of the thyroid “stunning effect”: Some individuals are more 
sensitive to the “stunning effect” caused by high intakes of iodine. This has been 
demonstrated in those who have had thyroid disorders and those with poor iodine 
status. 
Iodine intake and health outcomes – associations and dose-response 
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The knowledge about severe iodine deficiency as a cause of impaired neurodevelopment, 
thyroid dysfunction and adverse birth outcomes is well established. It is, however, lack of 
data on at what level of iodine status or iodine intake the various adverse effects occur: 
 Consequences of mild to moderate iodine deficiency: Several observational studies 
suggest that mild to moderate iodine deficiency can result in various health outcomes 
related to poor thyroid functioning. However, the value of the evidence is limited due 
to the lack of good biomarkers of iodine status that can be used to define mild to 
moderate deficiency.  
 Limitations in the assessment tools for neurodevelopment: Different aspects of 
neurodevelopment can be measured in various ways, and there is no consensus on 
the optimal measure.  
 Timing of the exposure: Iodine deficiency, through impaired thyroid functioning, 
might have different consequences according to the timing and severity of the 
exposure.   
 Reference values for thyroid hormones in different age groups and life stages: The 
consequences of very low or very high thyroid hormone levels are well described. The 
extent to which slightly elevated or lower levels of T3 and T4 have consequences in 
different populations is less certain. In other words, the reference limits for when 
thyroid function disturbances start to have consequences for human health in various 
populations is not well defined.  
 Dose response studies for iodine intake and thyroid functioning: Iodine excess results 
in altered thyroid functioning. It is not clear, however, at which level of iodine intake 
adverse effects occur. Furthermore, it is also not known why the susceptibility to high 
doses of iodine varies between individuals. Evidence for excessive iodine intakes in 
children and adults, including during lactation and pregnancy is lacking. 
 Health outcomes related to acute high intakes: E.g. kelp and seaweed based 
products. 
Salt consumption 
 There is limited information on total salt consumption in children and adults. This can 
be measured with sodium analyses of repeated 24 h urine in the different age 
groups. 
 There is limited information from representative population studies on the 
consumption of household salt and the proportion of total salt consumption in 
children and adults that are from household salt. Household salt consumption is 
difficult to measure. If this is a priority for future RBA, designated studies with 
weighing of salt used in the household need to be designed. The number of 
participants need to be from different age groups, and large enough to be statistically 
robust.  
 There were few analyses of salt content in different categories of bread and bakery 
products. A larger number of salt analyses in different bread and bakery categories 
will give more precise intake estimate for iodine.  
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 For the scenario estimates with iodized salt, we need updated data on the actual salt 
reduction resulting from the Salt Strategy.  
Consumption of plant-based alternatives to cow’s milk 
 Data on consumption of plant-based alternatives to cow’s milk in different population 
groups are lacking.  
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Appendix I - Literature searches 
a) Search strategy for health outcomes mild and moderate 
iodine deficiency 
Searches for health outcomes related to mild and moderate iodine deficiency were 
conducted 4 July 2018 and updated 14 May and 18 November 2019. 
# Database: Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid 
MEDLINE® Daily and Ovid MEDLINE® 1946 to Present 
1 Iodine/  
2 (“iodine” or “iodide”).tw,kf.  
3 Urine/  
4 (“urin*” or “status” or “intake*” or “deficiency” or “condition*” or “lack” or “concentration”).tw,kf.  
5 1 or 2  
6 3 or 4  
7 5 and 6  
8 Goiter/  
9 Goiter, endemic/  
10 Goiter, nodular/  
11 Hypothyroidism/  
12 Thyrotropin/  
13 exp Thyroid Diseases/  
14 Thyroid Hormones/  
15 Triiodothyronine/  
16 Cognition/  
17 Child development/  
18 Cognitive dysfunction/  
19 Developmental disabilities/  
20 Child development deviations/  
21 Brain injuries/  
22 Neurocognitive disorders/  
23 exp Neurodevelopmental disorders/  
24 exp Autism Spectrum Disorder/  
25 Intelligence/  
26 Language Development Disorders/  
27 Language Disorders/  
28 Academic Performance/  
29 Memory, Short-Term/  
30 Memory Disorders/  
31 Fertility/  
32 Abortion, Spontaneous/  
33 Birth Weight/  
34 Infant, Premature/  
35 Reproduction/  
36 Pregnancy complications/  
37 (“goit*” or “idd” or “hypothyroidism?” or “thyroid stimulating hormone?” or “ths” or “thyroid-stimulating 
hormone?” or “thyroxin” or “triiodothyronine” or liothyronine or “thyrotropin” or “tri iodothyronine” or “tri 
iodo thyronine” or “triiodo l thyronine” or “lio thyronine” or “T3” or ((“Thyroid*” or “thyreoid”) adj2 
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# Database: Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid 
MEDLINE® Daily and Ovid MEDLINE® 1946 to Present 
38 ((“cognitive” adj3 (“function” or “decline” or “dysfunction” or “impairment” or “deterioration” or 
“Deficit*”)) or ((“child*” or “infant?” or “psychomotor*”) adj3 “development*”) or ((“neurocognitive” or 
“neurodevelopmental” or “neurological”) adj2 (“dysfunction?” or “disorder?” or “impact*”)) or 
(“development*” adj3 (“deviation?” or “disorder?” or “disabili*”)) or (“brain” adj2 (“damage?” or “injur*” 
or “development” or “disorder?”)) or ((“neurological” or “mental” or “intellectual” or “learning” or 
“memory”) adj3 (“disorder?” or “retardation” or “disabilit*” or “disturbance?” or “impairment?” or 
“defianc*” or “short-term”)) or “idiocy” or “IQ” or “intelligence deficit” or ((“mental” or “intellectual”) adj2 
(“development” or “deficien*”)) or “autism” or “autistic” or “kanner*” or “Asperger*” or “attention deficit” 
or “h#peractiv*” or “ADDH” or “ADHD”).tw,kf.  
39 (“language” or “speech” or ((“academic” or “school” or “educational”) adj3 (“performance?” or 
“underachievement” or “adjustment” or “behavior*” or “behaviour*” or “score?”)) or “fertility” or 
“fecund*” or (“abortion?” adj2 “spontaneous”) or “miscarriage?” or ((“birth” or “neonatal” or “newborn”) 
adj2 “weight?”) or “preterm” or “premature*” or “reproducti*” or “pregnancy complication?”).tw,kf.  
40 or/8-39  
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# Database: Embase 1974 to dates for searches 
1 Iodine/  
2 (“iodine” or “iodide”).tw,kw.  
3 urine/  
4 (“urin*” or “status” or “intake*” or “deficiency” or “condition*” or “lack” or “concentration”).tw,kw.  
5 1 or 2  
6 3 or 4  
7 5 and 6  
8 iodine deficiency/  
9 7 or 8  
10 goiter/ or endemic goiter/ or nodular goiter/  
11 hypothyroidism/  
12 thyroid function/  
13 thyroid disease/  
14 thyroid hormone/  
15 liothyronine/  
16 Cognition/  
17 Child development/  
18 Cognitive dysfunction/  
19 Developmental disorder/  
20 cognitive development/  
21 brain injury/  
22 nervous system malformation/  
23 intellectual impairment/  
24 nervous system development/  
25 attention deficit disorder/  
26 brain development/  
27 Intellectual disability/  
28 Learning disorders/  
29 working memory/  
30 literacy/  
31 exp Autism/  
32 Asperger syndrome/  
33 Intelligence/  
34 developmental language disorder/  
35 language disability/  
36 academic achievement/  
37 fertility/  
38 spontaneous abortion/  
39 birth weight/  
40 prematurity/  
41 pregnancy complication/  
42 (“goit*” or “idd” or “hypothyroidism?” or “thyroid stimulating hormone?” or “ths” or “thyroid-stimulating 
hormone?” or “thyroxin” or “triiodothyronine” or liothyronine or “thyrotropin” or “tri iodothyronine” or 
“tri iodo thyronine” or “triiodo l thyronine” or “lio thyronine” or “T3” or ((“Thyroid*” or “thyreoid”) adj2 
(“function” or “disease?” or “dysfunction?” or “abnorm*” or “anomal*” or “disorder?” or “hormone?” or 
“agent?”))).tw,kw.  
43 ((“cognitive” adj3 (“function” or “decline” or “dysfunction” or “impairment” or “deterioration” or 
“Deficit*”)) or ((“child*” or “infant?” or “psychomotor*”) adj3 “development*”) or ((“neurocognitive” or 
“neurodevelopmental” or “neurological”) adj2 (“dysfunction?” or “disorder?” or “impact*”)) or 
(“development*” adj3 (“deviation?” or “disorder?” or “disabili*”)) or (“brain” adj2 (“damage?” or 
“injur*” or “development” or “disorder?”)) or ((“neurological” or “mental” or “intellectual” or “learning” 
or “memory”) adj3 (“disorder?” or “retardation” or “disabilit*” or “disturbance?” or “impairment?” or 
“defianc*” or “short-term”)) or “idiocy” or “IQ” or “intelligence deficit” or ((“mental” or “intellectual”) 
adj2 (“development” or “deficien*”)) or “autism” or “autistic” or “kanner*” or “Asperger*” or “attention 
deficit” or “h#peractiv*” or “ADDH” or “ADHD”).tw,kw.  
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# Database: Embase 1974 to dates for searches 
44 (“language” or “speech” or ((“academic” or “school” or “educational”) adj3 (“performance?” or 
“underachievement” or “adjustment” or “behavior*” or “behaviour*” or “score?”)) or “fertility” or 
“fecund*” or (“abortion?” adj2 “spontaneous”) or “miscarriage?” or ((“birth” or “neonatal” or 
“newborn”) adj2 “weight?”) or “preterm” or “premature*” or “reproducti*” or “pregnancy 
complication?”).tw,kw.  
45 reproduction/  
46 or/10-45  
47 9 and 46  
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 Database: PsycINFO 1806 to Year and week for searches 
1 (“iodine” or “iodide”).tw.  
2 Urine/  
3 (“urine*” or “status” or “intake*” or “deficiency” or “condition*” or “lack” or “concentration”).tw.  
4 2 or 3  
5 1 and 4  
6 exp Thyroid Disorders/  
7 Thyrotropin/  
8 thyroid hormones/ or triiodothyronine/  
9 Cognition/  
10 exp Cognitive Development/  
11 Childhood Development/  
12 Cognitive Impairment/  
13 Developmental Disabilities/  
14 Brain Damage/  
15 Neurocognition/  
16 Neurodevelopmental Disorders/  
17 Autism Spectrum Disorders/  
18 Intelligence/  
19 Language Development/  
20 Language Disorders/  
21 Academic Achievement/  
22 Short Term Memory/  
23 Fertility/  
24 Spontaneous Abortion/  
25 Birth Weight/  
26 Premature Birth/  
27 (“goit*” or “idd” or “hypothyroidism?” or “thyroid stimulating hormone?” or “ths” or “thyroid-stimulating 
hormone?” or “thyroxin” or “triiodothyronine” or liothyronine or “thyrotropin” or “tri iodothyronine” or “tri 
iodo thyronine” or “triiodo l thyronine” or “lio thyronine” or “T3” or ((“Thyroid*” or “thyreoid”) adj2 
(“function” or “disease?” or “dysfunction?” or “abnorm*” or “anomal*” or “disorder?” or “hormone?” or 
“agent?”))).tw.  
28 ((“cognitive” adj3 (“function” or “decline” or “dysfunction” or “impairment” or “deterioration” or 
“Deficit*”)) or ((“child*” or “infant?” or “psychomotor*”) adj3 “development*”) or ((“neurocognitive” or 
“neurodevelopmental” or “neurological”) adj2 (“dysfunction?” or “disorder?” or “impact*”)) or 
(“development*” adj3 (“deviation?” or “disorder?” or “disabili*”)) or (“brain” adj2 (“damage?” or “injur*” 
or “development” or “disorder?”)) or ((“neurological” or “mental” or “intellectual” or “learning” or 
“memory”) adj3 (“disorder?” or “retardation” or “disabilit*” or “disturbance?” or “impairment?” or 
“defianc*” or “short-term”)) or “idiocy” or “IQ” or “intelligence deficit” or ((“mental” or “intellectual”) adj2 
(“development” or “deficien*”)) or “autism” or “autistic” or “kanner*” or “Asperger*” or “attention deficit” 
or “h#peractiv*” or “ADDH” or “ADHD”).tw.  
29 (“language” or “speech” or ((“academic” or “school” or “educational”) adj3 (“performance?” or 
“underachievement” or “adjustment” or “behavior*” or “behaviour*” or “score?”)) or “fertility” or 
“fecund*” or (“abortion?” adj2 “spontaneous”) or “miscarriage?” or ((“birth” or “neonatal” or “newborn”) 
adj2 “weight?”) or “preterm” or “premature*” or “reproducti*” or “pregnancy complication?”).tw.  
30 or/6-29  
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Database: Web of Science. Timespan: All years. Indexes: SCI-EXPANDED, SSCI, A&HCI, 
ESCI 
((TOPIC: (“iodine” OR “iodide”) AND TOPIC: (“urine*” OR “status”) OR “intake*”) OR “deficiency”) OR 
“condition*”) OR “lack”) OR “concentration”)) AND TOPIC: (“goit*” OR “idd”) OR “hypothyroidism?”) OR “thyroid 
stimulating hormone?”) OR “ths”) OR “thyroid-stimulating hormone?”) OR “thyroxin”) OR “triiodothyronine”) OR 
liothyronine) OR “thyrotropin”) OR “tri iodothyronine”) OR “tri iodo thyronine”) OR “triiodo l thyronine”) OR “lio 
thyronine”) OR “T3”) OR ((“Thyroid*” OR “thyrsoid”) NEAR (((((((“function” OR “disease?”) OR “dysfunction?”) 
OR “abnorm*”) OR “anomal*”) OR “disorder?”) OR “hormone?”) OR “agent?”))) OR (“cognitive” NEAR 
(((((“function” OR “decline”) OR “dysfunction”) OR “impairment”) OR “deterioration”) OR “Deficit*”))) OR 
(((“child*” OR “infant?”) OR “psychomotor*”) NEAR “development*”)) OR (((“neurocognitive” OR 
“neurodevelopmental”) OR “neurological”) NEAR ((“dysfunction?” OR “disorder?”) OR “impact*”))) OR 
(“development*” NEAR ((“deviation?” OR “disorder?”) OR “disabili*”))) OR (“brain” NEAR (((“damage?” OR 
“injur*”) OR “development”) OR “disorder?”))) OR (((((“neurological” OR “mental”) OR “intellectual”) OR 
“learning”) OR “memory”) NEAR ((((((“disorder?” OR “retardation”) OR “disabilit*”) OR “disturbance?”) OR 
“impairment?”) OR “defianc*”) OR “short-term”))) OR “idiocy”) OR “IQ”) OR “intelligence deficit”) OR ((“mental” 
OR “intellectual”) NEAR (“development” OR “deficien*”))) OR “autism”) OR “autistic”) OR “kanner*”) OR 
“Asperger*”) OR “attention deficit”) OR “h#peractiv*”) OR “adds”) OR “ADHD”) OR “language”) OR “speech”) OR 
(((“academic” OR “school”) OR “educational”) NEAR (((((“performance?” OR “underachievement”) OR 
“adjustment”) OR “behavior*”) OR “behaviour*”) OR “score?”))) OR “fertility”) OR “fecund*”) OR (“abortion?” 
NEAR “spontaneous”)) OR “miscarriage?”) OR (((“birth” OR “neonatal”) OR “newborn”) NEAR “weight?”)) OR 
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b) Search strategy for single studies excessive iodine 
# 
Database: Embase <1974 to 2017 November 22 and updated 14 May and 18 
November 2019>, Ovid MEDLINE® In-Process & Other Non-Indexed Citations, Ovid 
MEDLINE® Daily and Ovid MEDLINE® <1946 to Present> 
1 iodine*.ti.  
2 high intak*.ti.  
3 high iodine intake*.ti.  
4 high iodine concentrat*.ti.  
5 excess*.ti.  
6 hypothyroidism*.tw.  
7 thyroid volume.tw.  
8 safe upper*.tw.  
9 tolerable upper*.tw.  
10 thyrotoxic*.tw.  
11 iodized salt.tw.  
12 iodised salt.tw.  
13 seaweed.tw.  
14 iodine-induc*.tw.  
15 iodine induc*.tw.  
16 risk*.ti.  
17 safety*.ti.  
18 side-effect*.ti,ab.  
19 side effect*.ti,ab.  
20 harm*.tw.  
21 contraindicat*.ti,ab.  
22 contra-indicat*.ti,ab.  
23 toxic*.tw.  
24 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 
or 22 or 23  
25 1 and 24  
26 limit 25 to yr=”2000 -Current”  
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c) Search strategy for meta-analyses and systematic reviews 
excessive iodine 
Database: Embase <1974 to 2017 September 21>, Ovid MEDLINE® In-Process & Other 
Non-Indexed Citations, Ovid MEDLINE® Daily and Ovid MEDLINE® <1946 to Present> 
1. “iodin*”.m_titl. (47983) 
2. limit 1 to human (28053) 
3. limit 2 to yr=”1999 -Current” (13592) 




VKM Report 2020: 05  196 
Publication selection and data extraction 
The search terms for defining health outcomes were predefined and based on knowledge 
about consequences of mild and moderate iodine deficiency (see chapter 3). 
The literature searches were performed in the MEDLINE, Embase, Web of Science and 
PsycINFO databases in July 2018.  
Updated search was conducted May 2019 covering 2018 and until 14 May 2019 and 
November, covering 14 May until 18 November 2019. The librarian had some difficulties in 
limiting the May update to specific dates, weeks or months, and consequently there was an 
overlap between these searches. 
Publication selection and data extraction for articles relevant for iodine 
deficiency 
The July 2018 search resulted in 13 399 records after automatical and manual duplicate 
removal. It should however be noted that due to the vast number of articles, a large number 
of duplicates remained. The number of original records in this search is therefore lower than 
13 399. The May 2019 search resulted in 899 records, and the last update in November 2019 
resulted in 622 records. Both the updated searches contained articles that were also found in 
the previous search. Consequently, the number of articles could not be summarised. 
The titles and/or abstract of every record retrieved were screened independently in Rayyan 
QCRI by two reviewers to determine which studies required further assessment. Full text 
articles were retrieved when the information given in the titles and/or abstracts seemed to 
fulfil the inclusion criteria. If one of the two reviewers included the article, the paper was 
retrieved in full text. When there was any doubt regarding these criteria from screening the 
titles and abstracts, the full article was retrieved for clarification. Disagreements were 
resolved by discussion.  
The criteria for inclusion were studies investigating mild or moderate iodine deficiency in 
combination with a predefined health outcome within the categories: thyroid function, 
neurodevelopment, and fertility and birth outcomes. The study types for inclusion in this 
opinion were human randomised controlled trials, prospective cohort studies presenting data 
for iodine intake or status in at least one subgroup, case-control studies and cross-sectional 
studies. An overview of the inclusion and exclusion criteria for studies with mild to moderate 
iodine deficiency is given in Table I-1. 
 
 
VKM Report 2020: 05  197 
Table I-1 Inclusion and exclusion criteria for publication selection iodine deficiency in this opinion. 
Criteria for 
inclusion 
 Studies investigating iodine status (mild or moderate deficiency) in relation 
to one or more health outcomes 
 RCTs, cohorts, cross-sectional and case-control studies 
Criteria for 
exclusion 
 Studies investigating iodine status or iodine intake without any relation to 
specific health outcomes 
 Studies in populations with severe iodine deficiency 
 Studies including other vitamins or minerals than iodine (if the effect from 
various nutrients could not be separated from each other) 
 Studies with iodine containing drugs/medications including iodine 
containing contrast medium 
 Studies with radioactive iodine 
 Studies investigating thyroid status and health outcomes if the thyroid 
status is not related to iodine status, e.g. studies investigating 
environmental contaminants 
 Studies investigating excessive iodine 
 Reviews and case histories 
 Animal model studies 
 In vitro-studies 
 
Studies on iodine deficiency fulfilling the inclusion criteria were obtained and evaluated in full 
text by two reviewers. 
To assess the relevance and quality of included studies a three-category (A-B-C) rating 
system based on the NNR5 AMSTAR Quality Assessment Tool (QAT) was applied (NNR5 
working group, 2011; Shea et al., 2007), slightly modified for our purposes. By using QAT, 
the studies were rated according to study characteristics presented in the published papers. 
The rating system included questions for evaluating several aspects of a study, e.g. study 
design, population characteristics, assessment of dietary intervention, assessment of 
outcome, confounding factors, methods, results etc. Only studies categorised as A or B are 
included in the results. Studies categorised as A or B are listed in Appendix IIa. Each study 
with A or B rating has been summarised in a summary table (Appendix III) and are 
described in chapter 5.4. Studies categorised as C are listed in Appendix IIb were also the 
most common reasons for category C are mentioned.  
The systematic literature searches on mild and moderate iodine deficiency resulted in 131 
studies which were rated for quality (A-B-C). Of these, 1 study was categorised as A, while 
35 studies qualified for category B, and 95 category C. The category C-studies were not 
considered further.  
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Publication selection and data extraction for articles relevant for iodine 
excess 
Literature searches for studies investigating health outcomes related to excessive iodine 
intakes were performed in MEDLINE and EMBASE and aimed at retrieving publications on 
adverse effects caused by high intakes of iodine published after 1999 (meta-analysis and 
systematic reviews) or 2000 (original research articles). Both databases were searched to 
ensure comprehensive study retrieval. The literature search for meta-analysis and systematic 
reviews was conducted on 21 September 2017, and the search for original research articles 
was conducted on 23 November 2017. Updated search was conducted May 2019 covering 
2017 and until 14 May 2019 and November 2019 covering 14 May and until 18 November 
2019. Both the updated searches contained articles that were also found in the previous 
search. Consequently, the number of articles could not be summarised. 
The titles and/or abstract of every record retrieved were screened independently by two 
reviewers to determine which studies required further assessment. The strategies for the 
searches are outlined in Appendix Ic. 
Initially, to get an overview of the literature and relevant search terms, a literature search 
for meta-analysis and systematic reviews addressing health outcomes related to excessive 
iodine intakes was conducted. The literature search for excessive iodine intakes for this 
report aimed at retrieving new literature after year 2000 to re-evaluate the existing ULs. The 
literature search for single studies November 2017 identified 2919 articles, and the updated 
searches identified 466 articles in May 2019 and 234 articles in November 2019. Both human 
and animal studies were included in the search strategy, it was however decided not to 
include animal studies as human and animal iodine metabolism and thyroid hormone 
production may be difficult to compare. In the primary screening, titles and abstracts of all 
unique publications retrieved were independently screened against the inclusion criteria.  
An overview of the inclusion and exclusion criteria for studies with excessive iodine intakes is 
given in Table I-2. 
Table I-2 Inclusion and exclusion criteria for publication selection excessive iodine in this opinion. 
Criteria for 
inclusion 
 Chronic excess iodine exposure is addressed 
 Adverse effects from iodine are addressed 
 Route of exposure for humans is oral 
 Human studies are performed in apparently healthy individuals or patient 
groups assumed to have normal iodine absorption and metabolism 
Criteria for 
exclusion 
 In vitro studies 
 Animal studies 
 Cross-sectional studies unless no other evidence is available  
Titles and abstracts that did not fulfil the inclusion criteria were excluded from further 
screening. The primary screening was performed by two persons.  
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The papers that passed the primary screening were reviewed in full text by one project 
member. 
In the search aimed at retrieving original research articles, the primary screening of titles 
and abstracts resulted in 138 full-text articles fulfilling the inclusion criteria. In addition, 2 
publications from manual search of relevant reference lists were identified and reviewed. 
From these 140 papers, 135 were not considered relevant for the purpose of assessing risk 
related to excessive iodine and evaluation of UL because of lack of dose-response analysis or 
focus on food survey methods or pathology, and not health effects. Thus, in total, 5 studies 
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Appendix II – List of papers 
categorised as A, B or C 
a) List of papers categorised as A or B 
The following 36 studies were categorised as A or B in accordance with the Quality 
Assessment Tool (QAT) tables adapted for variable study designs in A guide for conducting 
Systematic Literature Reviews for the 5th edition of the Nordic Nutrition Recommendations. 
Manuals for the QAT-tables for the various study designs are presented in Appendix VI. 
Data from all A and B papers are extracted in Summary Tables 1-36 in Appendix III. 
ST nr Reference list for papers categorised as A or B Category  
1 Abel M.H., Brandlistuen R.E., Caspersen I.H., Aase H., Torheim L.E., Meltzer 
H.M., Brantsaeter A.L. (2019) Language delay and poorer school performance 
in children of mothers with inadequate iodine intake in pregnancy: results 
from follow-up at 8 years in the Norwegian Mother and Child Cohort Study. 
European Journal of Nutrition 12:12.  
B 
2 Abel M.H., Korevaar T.I.M., Erlund I., Villanger G.D., Caspersen I.H., 
Arohonka P., Alexander J., Meltzer H.M., Brantsaeter A.L. (2018) Iodine 
Intake is Associated with Thyroid Function in Mild to Moderately Iodine 
Deficient Pregnant Women. Thyroid 28:1359-1371. DOI: 
B 
3 Abel M.H., Caspersen I.H., Meltzer H.M., Haugen M., Brandlistuen R.E., Aase 
H., Alexander J., Torheim L.E., Brantsaeter A.L. (2017a) Suboptimal Maternal 
Iodine Intake Is Associated with Impaired Child Neurodevelopment at 3 Years 
of Age in the Norwegian Mother and Child Cohort Study. Journal of Nutrition 
147:1314-1324. 
B 
4 Abel M.H., Ystrom E., Caspersen I.H., Meltzer H.M., Aase H., Torheim L.E., 
Askeland R.B., Reichborn-Kjennerud T., Brantsaeter A.L. (2017b) Maternal 
Iodine Intake and Offspring Attention-Deficit/Hyperactivity Disorder: Results 
from a Large Prospective Cohort Study. Nutrients 9:13. 
B 
5 Alvarez-Pedrerol M., Guxens M., Mendez M., Canet Y., Martorell R., Espada 
M., Plana E., Rebagliato M., Sunyer J. (2009) Iodine levels and thyroid 
hormones in healthy pregnant women and birth weight of their offspring. 
European Journal of Endocrinology 160:423-9. 
B 
6 Bath S.C., Steer C.D., Golding J., Emmett P., Rayman M.P. (2013) Effect of 
inadequate iodine status in UK pregnant women on cognitive outcomes in 
their children: results from the Avon Longitudinal Study of Parents and 
Children (ALSPAC). Lancet 382:331-7. 
B 
7 Charoenratana C., Leelapat P., Traisrisilp K., Tongsong T. (2016) Maternal 
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ST nr Reference list for papers categorised as A or B Category  
8 Chen Y., Chen W., Du C., Fan L., Wang W., Gao M., Zhang Y., Cui T., Hao Y., 
Pearce E.N., Wang C., Zhang W. (2018) Iodine Nutrition and Thyroid Function 
in Pregnant Women Exposed to Different Iodine Sources. Biological Trace 
Element Research.  
B 
9 Fan L.L., Tan L., Chen Y.T., Du C., Zhu M., Wang K.L., Wei H.Y., Wang W., 
Gao M., Zhang Y.X., Cui T.K., Chen W., Shen J., Zhang W.Q. (2018) 
Investigation on the factors that influence the prevalence of thyroid nodules 
in adults in Tianjin, China. Journal of Trace Elements in Medicine and Biology 
50:537-542. 
B 
10 Ghassabian A., Steenweg-de Graaff J., Peeters R.P., Ross H.A., Jaddoe V.W., 
Hofman A., Verhulst F.C., White T., Tiemeier H. (2014) Maternal urinary 
iodine concentration in pregnancy and children's cognition: results from a 
population-based birth cohort in an iodine-sufficient area. Erratum appears in 
BMJ Open. 2017 Feb 8;7(2). 
B 
11 Gordon R.C., Rose M.C., Skeaff S.A., Gray A.R., Morgan K.M., Ruffman T. 
(2009) Iodine supplementation improves cognition in mildly iodine-deficient 
children. American Journal of Clinical Nutrition 90:1264-71. 
B 
12 Gowachirapant S., Jaiswal N., Melse-Boonstra A., Galetti V., Stinca S., 
Mackenzie I., Thomas S., Thomas T., Winichagoo P., Srinivasan K., 
Zimmermann M.B. (2017) Effect of iodine supplementation in pregnant 
women on child neurodevelopment: a randomised, double-blind, placebo-
controlled trial. Lancet Diabetes & Endocrinology 5:853-863. 
B 
13 Hynes K.L., Otahal P., Burgess J.R., Oddy W.H., Hay I. (2017) Reduced 
Educational Outcomes Persist into Adolescence Following Mild Iodine 
Deficiency in Utero, Despite Adequacy in Childhood: 15-Year Follow-Up of the 
Gestational Iodine Cohort Investigating Auditory Processing Speed and 
Working Memory. Nutrients 9:13. 
B 
14 Hynes K.L., Otahal P., Hay I., Burgess J.R. (2013) Mild iodine deficiency 
during pregnancy is associated with reduced educational outcomes in the 
offspring: 9-year follow-up of the gestational iodine cohort. Journal of Clinical 
Endocrinology & Metabolism 98:1954-62. 
B 
15 Krejbjerg A., Bjergved L., Pedersen I.B., Carle A., Knudsen N., Perrild H., 
Ovesen L., Rasmussen L.B., Laurberg P. (2015) Serum thyroglobulin before 
and after iodization of salt: an 11-year DanThyr follow-up study. European 
Journal of Endocrinology 173:573-81. 
B 
16 Levie D., Derakhshan A., Shu H., Broeren M.A.C., de Poortere R.A., Peeters 
R.P., Bornehag C.G., Demeneix B., Korevaar T.I.M. (2019) The Association of 
Maternal Iodine Status in Early Pregnancy with Thyroid Function in the 
Swedish Environmental Longitudinal, Mother and Child, Asthma and Allergy 
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ST nr Reference list for papers categorised as A or B Category  
17 Markhus M.W., Dahl L., Moe V., Abel M.H., Brantsaeter A.L., Oyen J., Meltzer 
H.M., Stormark K.M., Graff I.E., Smith L., Kjellevold M. (2018) Maternal 
Iodine Status is Associated with Offspring Language Skills in Infancy and 
Toddlerhood. Nutrients 10.  
B 
18 Mills J.L., Ali M., Louis G.M.B., Kannan K., Weck J., Wan Y.J., Maisog J., 
Giannakou A., Sundaram R. (2019) Pregnancy Loss and Iodine Status: The 
LIFE Prospective Cohort Study. Nutrients 11. 
B 
19 Mills J.L., Buck Louis G.M., Kannan K., Weck J., Wan Y., Maisog J., Giannakou 
A., Wu Q., Sundaram R. (2018) Delayed conception in women with low-
urinary iodine concentrations: a population-based prospective cohort study. 
Human Reproduction 11:11. 
B 
20 Moreno-Reyes R., Glinoer D., Van Oyen H., Vandevijvere S. (2013) High 
prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient 
country: a population-based study. Journal of Clinical Endocrinology & 
Metabolism 98:3694-701. 
B 
21 Murcia M., Espada M., Julvez J., Llop S., Lopez-Espinosa M.J., Vioque J., 
Basterrechea M., Riano I., Gonzalez L., Alvarez-Pedrerol M., Tardon A., 
Ibarluzea J., Rebagliato M. (2018) Iodine intake from supplements and diet 
during pregnancy and child cognitive and motor development: the INMA 
Mother and Child Cohort Study. Journal of Epidemiology & Community Health 
72:216-222. 
B 
22 Murcia M., Rebagliato M., Iniguez C., Lopez-Espinosa M.J., Estarlich M., Plaza 
B., Barona-Vilar C., Espada M., Vioque J., Ballester F. (2011) Effect of iodine 
supplementation during pregnancy on infant neurodevelopment at 1 year of 
age. American Journal of Epidemiology 173:804-12. 
B 
23 Pedersen K.M., Laurberg P., Iversen E., Knudsen P.R., Gregersen H.E., 
Rasmussen O.S., Larsen K.R., Eriksen G.M., Johannesen P.L. (1993) 
Amelioration of some pregnancy-associated variations in thyroid function by 
iodine supplementation. Journal of Clinical Endocrinology & Metabolism 
77:1078-83. 
B 
24 Rasmussen L.B., Ovesen L., Bulow I., Jorgensen T., Knudsen N., Laurberg P., 
Perrild H. (2002) Relations between various measures of iodine intake and 
thyroid volume, thyroid nodularity, and serum thyroglobulin. American 
Journal of Clinical Nutrition 76:1069-76. 
B 
25 Rebagliato M., Murcia M., Alvarez-Pedrerol M., Espada M., Fernandez-
Somoano A., Lertxundi N., Navarrete-Munoz E.M., Forns J., Aranbarri A., Llop 
S., Julvez J., Tardon A., Ballester F. (2013) Iodine Supplementation During 
Pregnancy and Infant Neuropsychological Development INMA Mother and 
Child Cohort Study. American Journal of Epidemiology 177:944-953. 
B 
26 Rebagliato M., Murcia M., Espada M., Alvarez-Pedrerol M., Bolumar F., Vioque 
J., Basterrechea M., Blarduni E., Ramon R., Guxens M., Foradada C.M., 
Ballester F., Ibarluzea J., Sunyer J. (2010) Iodine intake and maternal thyroid 
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ST nr Reference list for papers categorised as A or B Category  
27 Robinson S.M., Crozier S.R., Miles E.A., Gale C.R., Calder P.C., Cooper C., 
Inskip H.M., Godfrey K.M. (2018) Preconception Maternal Iodine Status Is 
Positively Associated with IQ but Not with Measures of Executive Function in 
Childhood. Journal of Nutrition 148:959-966. 
B 
28 Skeaff S.A., Thomson C.D., Wilson N., Parnell W.R. (2012) A comprehensive 
assessment of urinary iodine concentration and thyroid hormones in New 
Zealand schoolchildren: a cross-sectional study. Nutrition Journal 11:31. 
B 
29 Snart C.J.P., Keeble C., Taylor E., Cade J.E., Stewart P.M., Zimmermann M., 
Reid S., Threapleton D.E., Poston L., Myers J.E., Simpson N.A.B., Greenwood 
D.C., Hardie L.J. (2019) Maternal Iodine Status and Associations with Birth 
Outcomes in Three Major Cities in the United Kingdom. Nutrients 11.  
B 
30 Sun J., Teng D., Li C., Peng S., Mao J., Wang W., Xie X., Fan C., Li C., Meng 
T., Zhang S., Du J., Gao Z., Shan Z., Teng W. (2019) Association between 
iodine intake and thyroid autoantibodies: a cross-sectional study of 7073 
early pregnant women in an iodine-adequate region. J Endocrinol Invest. 
DOI: 10.1007/s40618-019-01070-1. 
B 
31 Thomson C.D., Campbell J.M., Miller J., Skeaff S.A., Livingstone V. (2009) 
Selenium and iodine supplementation: effect on thyroid function of older New 
Zealanders. American Journal of Clinical Nutrition 90:1038-46. 
B 
32 Thomson C.D., Woodruffe S., Colls A.J., Joseph J., Doyle T.C. (2001) Urinary 
iodine and thyroid status of New Zealand residents. European Journal of 
Clinical Nutrition 55:387-92. 
A 
33 Torlinska B., Bath S.C., Janjua A., Boelaert K., Chan S.Y. (2018) Iodine Status 
during Pregnancy in a Region of Mild-to-Moderate Iodine Deficiency is not 
Associated with Adverse Obstetric Outcomes; Results from the Avon 
Longitudinal Study of Parents and Children (ALSPAC). Nutrients 10:01. 
B 
34 Wang B., He W.W., Li Q., Jia X., Yao Q.M., Song R.H., Qin Q., Zhang J.A. 
(2019) U-shaped relationship between iodine status and thyroid 
autoimmunity risk in adults. European Journal of Endocrinology 181:255-266. 
B 
35 Zhou S.J., Condo D., Ryan P., Skeaff S.A., Howell S., Anderson P.J., McPhee 
A.J., Makrides M. (2019) Maternal iodine intake in pregnancy and childhood 
neurodevelopment at 18 months. Journal of Paediatrics and Child Health 55 
(Supplement 1):55.  
B 
36 Zimmermann M.B., Connolly K., Bozo M., Bridson J., Rohner F., Grimci L. 
(2006) Iodine supplementation improves cognition in iodine-deficient 
schoolchildren in Albania: a randomized, controlled, double-blind study. 
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b) List of studies categorised as C 
The following 95 studies were categorised as C in accordance with the Quality Assessment 
Tool (QAT) tables adapted for variable study designs in A guide for conducting Systematic 
Literature Reviews for the 5th edition of the Nordic Nutrition Recommendations. Manuals for 
the QAT-tables for the various study designs are presented in Appendix VI. Most of these 
articles were categorised as C because they provided inadequate statistical analysis for our 
purpose or was not designed to test our research hypothesis. 
Reference list for articles categorised as C 
Aghini Lombardi F., Pinchera A., Antonangeli L., Rago T., Chiovato L., Bargagna S., Bertucelli B., 
Ferretti G., Sbrana B., Marcheschi M., Vitti P. (1995) Mild iodine deficiency during fetal/neonatal life 
and neuropsychological impairment in Tuscany. Journal of Endocrinological Investigation 18:57-62. 
Bienertova-Vasku J., Grulichova M., Mikes O., Zlamal F., Prusa T., Pohorala A., Andryskova L., 
Pikhart H. (2018) Estimated dietary iodine intake as a predictor of placental size: Evidence from the 
ELSPAC study. Nutrition and Metabolism 15 (1) (no pagination).  
Blazewicz A., Makarewicz A., Korona-Glowniak I., Dolliver W., Kocjan R. (2016) Iodine in autism 
spectrum disorders. Journal of Trace Elements in Medicine & Biology 34:32-7. 
Blumenthal N., Byth K., Eastman C.J. (2012) Iodine Intake and Thyroid Function in Pregnant 
Women in a Private Clinical Practice in Northwestern Sydney before Mandatory Fortification of 
Bread with Iodised Salt. Journal of Thyroid Research 2012:798963. 
Brucker-Davis F., Ferrari P., Gal J., Berthier F., Fenichel P., Hieronimus S. (2012) Iodine status has 
no impact on thyroid function in early healthy pregnancy. Journal of Thyroid Research 
2012:168764. 
Caron P., Hoff M., Bazzi S., Dufor A., Faure G., Ghandour I., Lauzu P., Lucas Y., Maraval D., Mignot 
F., Ressigeac P., Vertongen F., Grange V. (1997) Urinary iodine excretion during normal pregnancy 
in healthy women living in the southwest of France: correlation with maternal thyroid parameters. 
Thyroid 7:749-54. 
Casey B. (2017) Impact of iodine status in women with subclinical hypothyroidism or 
hypothyroxinemia on child neurodevelopment. American Journal of Obstetrics and Gynecology 
216:S436-S437. 
Censi S., Watutantrige-Fernando S., Groccia G., Manso J., Plebani M., Faggian D., Mion M.M., 
Venturini R., Andrisani A., Casaro A., Vita P., Avogadro A., Camilot M., Scaroni C., Bertazza L., 
Barollo S., Mian C. (2019) The Effects of Iodine Supplementation in Pregnancy on Iodine Status, 
Thyroglobulin Levels and Thyroid Function Parameters: Results from a Randomized Controlled 
Clinical Trial in a Mild-to-Moderate Iodine Deficiency Area. Nutrients 11.  
Chan S.S.Y., Hams G., Wiley V., Wilcken B., McElduff A. (2003) Postpartum maternal iodine status 
and the relationship to neonatal thyroid function. Thyroid 13:873-876. 
Eltom A., Elnagar B., Elbagir M., Gebre-Medhin M. (2000) Thyroglobulin in serum as an indicator of 
iodine status during pregnancy. Scandinavian Journal of Clinical & Laboratory Investigation 60:1-7. 
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Etemadi A., Amouzegar A., Mehran L., Tohidi M., Azizi F., Moradi K., Delshad H. (2019) Isolated 
hypothyroxinemia in Iranian pregnant women, the role of iodine deficiency; a population based 
cross-sectional study. Thyroid. DOI: 10.1089/thy.2019.0047. 
Farebrother J., Zimmermann M.B., Assey V., Castro M.C., Cherkaoui M., Fingerhut R., Jia Q., Jukic 
T., Makokha A., San Luis T.O., Wegmuller R., Andersson M. (2019b) Thyroglobulin Is Markedly 
Elevated in 6- to 24-Month-Old Infants at Both Low and High Iodine Intakes and Suggests a Narrow 
Optimal Iodine Intake Range. Thyroid 29:268-277.  
Gebreegziabher T., Woltamo T., Thomas D.G., Kennedy T.S., Stoecker B.J. (2019) Iodine 
supplementation of lactating women and assessment of infant visual information processing and 
maternal and infant thyroid function: A randomized trial. PLoS One 14:e0223348.  
Gerasimova L.I., Denisov M.S., Samoilova A.V., Gunin A.G., Denisova T.G. (2016) Role of iodine 
deficiency in the development of menstrual disorders in young females. Sovremennye Tehnologii v 
Medicine 8:104-106. 
Gulaboglu M., Borekci B., Delibas I. (2010) Urine iodine levels in preeclamptic and normal pregnant 
women. Biological Trace Element Research 136:249-57. 
Hampel R., Gordalla A., Zollner H., Klinke D., Demuth M. (2000) Continuous rise of urinary iodine 
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1993 to 1997. Experimental and Clinical Endocrinology and Diabetes 108:197-201. 
Hamza R.T., Hewedi D.H., Sallam M.T. (2013) Iodine deficiency in Egyptian autistic children and 
their mothers: relation to disease severity. Archives of Medical Research 44:555-61. 
Heydarian P., Ordookhani A., Azizi F. (2007) Goiter rate, serum thyrotropin, thyroid autoantibodies 
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Laurberg P., Pedersen I.B., Pedersen K.M., Vestergaard H. (1999) Low incidence rate of overt 
hypothyroidism compared with hyperthyroidism in an area with moderately low iodine intake. 
Thyroid 9:33-38. 
Laurberg P., Pedersen K.M., Hreidarsson A., Sigfusson N., Iversen E., Knudsen P.R. (1998) Iodine 
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ST1 Summary table iodine 
Reference details, first 
author, year, country 
Abel et al. (2019) Language delay and poorer school performance in children of mothers with inadequate iodine intake in 
pregnancy: results from follow-up at 8 years in the Norwegian Mother and Child Cohort Study, Norway 
Study design Prospective cohort study 
Population, subjects This study is based on the Norwegian Mother and Child Cohort study (MoBa) in which women pregnant in their first trimester were 
recruited from all over Norway during the years 1999-2008. More than 99% of participants are of Caucasian origin. Pregnancy and birth 
records from the Medical Birth Registry of Norway are linked to the MoBa database. The women consented to participation in 41% of the 
pregnancies and the cohort now includes 114, 500 children, 95,200 mothers and 75,200 fathers. Exclusion criteria in the present study 
included; twins or triplets, maternal report of thyroid medication in pregnancy, missing food frequency questionnaire (FFQ), energy intake 
<4.5 or >20 MJ, or >3 blank FFQ pages and missing data on outcomes at child age 8 years.  
Outcome measures The questions about language and learning in the MoBa questionnaire at child 8 years was designed for the Language and Learning Sub-
study (Språk og Læring Studien - SOL) within MoBa. The aim SOL is to provide the best possible knowledge base for the understanding 
of causes and developmental trajectories of language difficulties. Specific instruments answered by the mothers included *Child language 
difficulties from the Children’s communication checklist-Short (CCC-S), *Reading and writing: 3 items selected from sub-scale of Vineland 
Adaptive Behaviour Scale-II, *Reading and mathematics: *Mandatory mapping tests (based on information from teachers on how the 
child had performed, and *whether the child received Special education due to language or learning difficulties (extra educational 
services). 
Time between baseline 
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Reference details, first 
author, year, country 
Abel et al. (2019) Language delay and poorer school performance in children of mothers with inadequate iodine intake in 
pregnancy: results from follow-up at 8 years in the Norwegian Mother and Child Cohort Study, Norway 
Exposure assessment/ Dietary 
assessment method 
Maternal iodine intake was measured by 1) a food frequency questionnaire (FFQ) to capture dietary habits and use of dietary 
supplements during the first half of pregnancy, and 2) as iodine concentration in a spot urine sample (UIC) measured in gestational week 
18. 




Follow-up period, drop-out 
rate 
This study was based on information of maternal iodine intake from the first half of pregnancy and information of child language and 
learning at age 8 years. Based on the total number of participants in the MoBa-study the number of participants included in the present 
study (n=39,471) yielded a response rate was 35%. 
Results The calculated median iodine intake from food was 122 µg/day (IQR: 89-161 µg/day), and median UIC in gestational week 18 was 67 
µg/L (n=2001). The children had adequate iodine status with median UIC of 110 μg/L in a subsample of 279 children at age 8 years). 
For all outcomes, maternal iodine intake was modelled flexibly (continuous variable). The curve-shaped associations indicated that 
habitual iodine intakes from food lower than approximately 150 µg/day were associated poorer outcomes. Point estimates using the EAR 
of 160 µg/day as reference showed that intakes at or below 100 µg/day were associated with the child having 0.05-0.10 SD 
(standardised z-score) poorer skills in language, reading, and writing, 9-43% increased likelihood of scoring low on mapping test in 
reading, 6-13% (non-significant) increased risk of scoring low on mapping test in mathematics, and a 10-29% increased likelihood of the 
child receiving special education services. The study showed no protective effect of supplemental iodine during pregnancy on 
neurodevelopment. The effect sizes were modest, but still relevant at the population level (public health effect) because the majority of 
mothers had low iodine intakes. 
Comments  
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ST1 Dietary information* 
SI  
Author, year, study name Abel et al. (2019) Language delay and poorer school performance in children of mothers with inadequate iodine intake in 
pregnancy: results from follow-up at 8 years in the Norwegian Mother and Child Cohort Study, Norway. 
Exposure Iodine intake and UIC 
Dietary assessment method** A validated Food Frequency Questionnaire (FFQ) designed to capture intake of foods and dietary supplements during the first half of 
pregnancy. 
Food composition database*** 
Definition of relevant nutrient**** 
The Norwegian food composition table 
Internal calibration (or validity) of 
dietary assessment (y/n) - if yes -  
provide data 
Yes. Previously, iodine has been validated separately and iodine intake by the FFQ, including supplemental iodine, agreed well with 
the reference methods 24-h UIE and 4 days weighed-food dairy, triangular validity coefficient for total iodine intake by the FFQ was 
0.62 (95% CI: 0.46, 0.77). 
Biomarker assay***** Urinary iodine concentration (UIC) 
Analytical validity of biomarker data 
reported? (y/n) – if yes – provide 
data 
No 
Time between biomarker sampling 
and analysis 
No information provided 
Season/ date when biomarker 
samples were drawn 
No information provided 
Background exposure data  
* write “nd” if there was no data reported. Please do not leave blank 
** please refer to brief name indicated in dietary assessment method table. If other method was used, please describe the detail 
*** specify database used to calculate nutrient intakes. Other nutrient analysis, please specify 
**** E.g. are carbohydrates expressed as available carbohydrates by difference, is fibre included in the carbohydrates or not, retinol equivalent or retinol activity etc. Chemical 
form of the nutrient 
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ST2 Summary table iodine 
Reference details, first 
author, year, country 
Abel et al. (2018) Iodine Intake is Associated with Thyroid Function in Mild to Moderately Iodine Deficient Pregnant 
Women, Norway 
Study design Cross-sectional study 
Population, subjects A population-based pregnancy cohort including pregnant women participating in The Norwegian Mother and Child Cohort Study. 
Outcome measures Plasma thyroid hormones and antibodies, i.e. thyroid stimulating hormone (TSH), free T4 (FT4), free T3 (FT3), thyroid peroxidase 
antibodies (TPOAb), and thyroglobulin antibodies (TgAb). 
Time between baseline 
exposure and outcome 
assessment 
NA 
Exposure assessment/ Dietary 
assessment method 
Maternal iodine intake was measured by 1) a food frequency questionnaire (FFQ), and 2) as iodine concentration in a spot urine sample. 




Follow-up period, drop-out 
rate 
NA 
Results Median iodine intake from food was 121 µg/day (IQR: 90-160 µg/day), and 40% reported use of iodine-containing supplements in 
pregnancy. Median urinary iodine concentration (UIC) was 59 µg/L among those who did not use supplements and 98 µg/L in those 
reporting current use of iodine-containing supplements. 
Iodine intake measured by FFQ was not associated with the outcome measures, while UIC was inversely associated with fT3 (p=0.002) 
and fT4 (p<0.001). Current iodine supplement use was not associated with the outcomes, but a recent initiation of iodine 
supplementation after GW 12 was significantly associated with lower mean fT4 (beta=-0.21, p=0.027), but not fT3 or TSH. 
Comments  
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ST2 Dietary information* 
SI  
Author, year, study name Abel et al. (2018) Iodine Intake is Associated with Thyroid Function in Mild to Moderately Iodine Deficient Pregnant Women, Norway 
Exposure Iodine intake and UIC 
Dietary assessment method** Food Frequency Questionnaire (FFQ). 
Food composition database*** 
Definition of relevant nutrient**** 
The Norwegian food composition table. 
Internal calibration (or validity) of 
dietary assessment (y/n) - if yes -  
provide data 
Yes. Previously, iodine has been validated separately and iodine intake by the FFQ, including supplemental iodine, agreed well with 
the reference methods 24-h UIE and 4 days weighed-food dairy, triangular validity coefficient for total iodine intake by the FFQ was 
0.62 (95% CI 0.46, 0.77). 
Biomarker assay***** TSH, free T4 (FT4), free T3 (FT3), thyroid peroxidase antibodies (TPOAb), and thyroglobulin antibodies (TgAb) were measured in 
plasma samples. 
Analytical validity of biomarker data 
reported? (y/n) – if yes – provide 
data 
Yes. The coefficient of variation (CV) of control samples for measuring UIC was 2.0-4.8%. The CV of control samples for measuring 
urinary creatinine was 1.4-1.7%. The CV of control samples for measuring plasma TSH, FT3, FT4, TPOAb, and TGAb was 1.8-8.5%. 
The CV of control samples for measuring plasma ferritin was 2.7-3.7%. The CV of control samples for measuring whole blood 
selenium was 1.5%. 
Time between biomarker sampling 
and analysis 
No information provided 
Season/ date when biomarker 
samples were drawn 
No information provided 
Background exposure data  
* write “nd” if there was no data reported. Please do not leave blank 
** please refer to brief name indicated in dietary assessment method table. If other method was used, please describe the detail 
*** specify database used to calculate nutrient intakes. Other nutrient analysis, please specify 
**** E.g. are carbohydrates expressed as available carbohydrates by difference, is fibre included in the carbohydrates or not, retinol equivalent or retinol activity etc. Chemical 
form of the nutrient 
***** ONLY biomarker of interest for outcome  
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ST3 Summary table iodine 
Reference details, first 
author, year, country 
Abel et al. (2017a) Suboptimal Maternal Iodine Intake Is Associated with Impaired Child Neurodevelopment at 3 Years 
of Age in the Norwegian Mother and Child Cohort Study, Norway 
Study design Prospective cohort study 
Population, subjects This study is based on the Norwegian Mother and Child Cohort study (MoBa) in which women pregnant in their first trimester were 
recruited from all over Norway during the years 1999-2008. More than 99% of participants are of Caucasian origin. Pregnancy and birth 
records from the Medical Birth Registry of Norway are linked to the MoBa database. The women consented to participation in 41% of the 
pregnancies and the cohort now includes 114, 500 children, 95,200 mothers and 75,200 fathers. Exclusion criteria in the present study 
included; multiple pregnancies, maternal report of thyroid medication in pregnancy, missing food frequency questionnaire(s) (FFQ) filled 
out around 1) week 17 (general questionnaire), 2) gestational week 22, and 3) when the child was 3 years of age, energy intake <4.5 or 
>20 MJ, or >3 blank FFQ pages and missing data on outcomes at child age 3 years. 
Outcome measures Child neurodevelopment at age 3 years. Language delay (a six-point ordinal language grammar rating scale developed by Dale & Bishop), 
communication skills (Ages and Stages Questionnaire, ASQ), motor milestones (ASO), motor skills (ASO) and behaviour problems at 3y 
(Child Behaviour Check List/ 11/2-5/LDS). 
Time between baseline 
exposure and outcome 
assessment 
Three years 
Exposure assessment/ Dietary 
assessment method 
A validated FFQ designed to capture dietary habits and use of dietary supplements during the first half of pregnancy.  
 
No. of subjects analysed A total of 48,297 mother-child pairs were included in this study. For the main analysis which excluded iodine supplement users, 33,047 




Follow-up period, drop-out 
rate 
This study was based on information of maternal iodine intake from the first half of pregnancy and information of child language and 
motor development and behaviour problems at age 3 years. Based on the total number of participants in the MoBa-study, the number of 
participants included in the present study (n=48,297) yielded a response rate was 42%. 
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author, year, country 
Abel et al. (2017a) Suboptimal Maternal Iodine Intake Is Associated with Impaired Child Neurodevelopment at 3 Years 
of Age in the Norwegian Mother and Child Cohort Study, Norway 
Results The calculated median iodine intake from food was 122 µg/day (IQR: 89-161 µg/day).  
Maternal iodine intake was associated in a curvilinear dose-response with child language delay (p=0.024), externalising and internalising 
behaviour problems (both p<0.001), and fine motor skills (p=0.002) but not gross motor skills or the risk of not walking unaided at 17 
mo of age. In the 74% of participants who did not use iodine-containing supplement and had an iodine intake <160 g/d (median: 105 
mg/d; IQR: 80, 129 mg/d), intakes <100 µg/day were estimated to account for;12% (95% CI:22%, 23%) of cases of language delay; 
31% (95% CI: 5%, 50%) of cases of severe language delay; 24% (95% CI: 17%, 31%) of cases of externalising behaviour problems 
>1.5 SD; and 24% (95% CI: 17%, 31%) of cases of internalising behaviour problems >1.5 SD in children at age 3 years. The results for 
iodine from food remained statistically significant after adjusting for multiple comparisons.  
There was no beneficial effect of iodine supplement use. When iodine supplement use was initiated in gestational weeks 0–12, 
supplement use was associated with an increased risk of externalising behaviour problems (adjusted OR of scoring >1.5 SD: 1.28; 95% 
CI: 1.09, 1.49), and initiation of supplement use in gestational week ≥13 was associated with an increased risk of internalising behaviour 
problems (adjusted OR of scoring >1.5 SD: 1.27; 95% CI: 1.10, 1.46). The results for supplement use did not remain statistically 
significant after adjusting for multiple comparisons. 
Comments  
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SI  
Author, year, study name Abel et al. (2017a) Suboptimal Maternal Iodine Intake Is Associated with Impaired Child Neurodevelopment at 3 Years of Age in the 
Norwegian Mother and Child Cohort Study, Norway 
Exposure Iodine intake  
Dietary assessment method** Food Frequency Questionnaire (FFQ). 
Food composition database*** 
Definition of relevant nutrient**** 
The Norwegian food composition table. 
Internal calibration (or validity) of 
dietary assessment (y/n) - if yes -  
provide data 
Yes. A validation study showed that relative to a dietary reference method (4-d weighed food diary) and several biological markers, 
the MoBa FFQ produces a realistic estimate of habitual intake and is a valid tool for ranking pregnant women according to high and 
low intakes of energy, nutrients, and foods. The relative validity of total iodine intake from food and supplements and the intake of 
specific food groups such as dairy products and seafood were evaluated separately. The total iodine intake calculated from the FFQ 
correlated well with the iodine intake reported from the 4-d food diaries at mid-pregnancy and with 24-h urinary iodine excretion 
data. 
Biomarker assay***** NA 
Analytical validity of biomarker data 
reported? (y/n) – if yes – provide 
data 
NA 
Time between biomarker sampling 
and analysis 
NA 
Season/ date when biomarker 
samples were drawn 
NA 
Background exposure data  
* write “nd” if there was no data reported. Please do not leave blank 
** please refer to brief name indicated in dietary assessment method table. If other method was used, please describe the detail 
*** specify database used to calculate nutrient intakes. Other nutrient analysis, please specify 
**** E.g. are carbohydrates expressed as available carbohydrates by difference, is fibre included in the carbohydrates or not, retinol equivalent or retinol activity etc. Chemical 
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Reference details, first 
author, year, country 
Abel et al. (2017b) Maternal Iodine Intake and Offspring Attention-Deficit/Hyperactivity Disorder: Results from a Large 
Prospective Cohort Study, Norway 
Study design Prospective cohort study 
Population, subjects This study is based on the Norwegian Mother and Child Cohort study (MoBa) in which women pregnant in their first trimester were 
recruited from all over Norway during the years 1999-2008. More than 99% of participants are of Caucasian origin. Pregnancy and birth 
records from the Medical Birth Registry of Norway are linked to the MoBa database. The women consented to participation in 41% of the 
pregnancies and the cohort now includes 114, 500 children, 95,200 mothers and 75,200 fathers. Exclusion criteria in the present study 
included; multiple pregnancies, maternal report of thyroid medication in pregnancy, missing food frequency questionnaire(s) (FFQ) filled 
out around 1) week 17 (general questionnaire), and 2) gestational week 22, energy intake <4.5 or >20 MJ, or >3 blank FFQ pages and 
missing data on outcomes at child age 8 years. 
Outcome measures Child attention-deficit/hyperactivity disorder (ADHD) diagnosis, registered in the Norwegian Patient Registry and maternally-reported child 
ADHD symptoms of eight years of age. Child ADHD symptoms were assessed in the eight-year-old questionnaire from MoBa on a four-
point Likert scale (never/rarely, sometimes, often, or very often) covering inattention problems (nine items) and hyperactivity/impulsivity 
(nine items) from the ADHD Rating Scale. 
Time between baseline 
exposure and outcome 
assessment 
Eight years 
Exposure assessment/ Dietary 
assessment method 
Maternal iodine intake was measured by 1) a food frequency questionnaire (FFQ) to capture dietary habits and use of dietary 
supplements during the first half of pregnancy, and 2) as iodine concentration in a spot urine sample (UIC). 





Follow-up period, drop-out 
rate 
This study was based on information of maternal iodine intake from the first half of pregnancy and information of child ADHD diagnosis at 
age 8 years. Based on the total number of participants in the MoBa-study the number of participants included in the present study 
(n=77,164) yielded a response rate was 67%. 
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author, year, country 
Abel et al. (2017b) Maternal Iodine Intake and Offspring Attention-Deficit/Hyperactivity Disorder: Results from a Large 
Prospective Cohort Study, Norway 
Results Median iodine intake from food was 121 µg/day (IQR: 89-162 µg/day), and 31% reported use of iodine-containing supplements in 
pregnancy (median intake: 107 µg/day (IQR: 58-150 µg/day). Iodine intake from food did not differ between iodine supplement users 
and non-users. 
Median urinary iodine concentration (UIC) in non-users of iodine supplements and thyroid medication was 61 µg/L (IQR: 32-104 µg/L) 
and in iodine supplement users, the median UIC was 86 µg/L (IQR: 43-140 µg/L). 
In non-users of iodine supplements, the results showed no association between iodine intake from food and risk of child ADHD diagnosis, 
while low intake of iodine from food (<200 µg/day) was associated with higher child ADHD symptom scores (adjusted difference in score 
up to 0.08 standard deviation, p<0.001). In the total sample, there was no evidence of beneficial effects of maternal use of iodine-
containing supplements on child ADHD diagnosis or symptom score.  
In participants with low iodine intakes from food, iodine supplement use initiated in GW 0-12 was associated with a ~29% increased risk 
of ADHD diagnosis (95%CI: 0%, 67%) and a 0.06 SD higher average score on ADHD symptoms at eight years of age (95% CI: 0.01, 
0.11).  
Comments  
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ST4 Dietary information 
SI  
Author, year, study name Abel et al. (2017b) Maternal Iodine Intake and Offspring Attention-Deficit/Hyperactivity Disorder: Results from a Large Prospective 
Cohort Study, Norway 
Exposure Iodine intake 
Dietary assessment method** Food Frequency Questionnaire (FFQ). 
Food composition database*** 
Definition of relevant nutrient**** 
The Norwegian food composition table. 
Internal calibration (or validity) of 
dietary assessment (y/n) - if yes - 
provide data 
Yes. Previously, iodine has been validated separately and iodine intake by the FFQ, including supplemental iodine, agreed well with 
the reference methods 24-h UIE and 4 days weighed-food dairy, triangular validity coefficient for total iodine intake by the FFQ was 
0.62 (95% CI 0.46, 0.77). Less than 5% were grossly misclassified. 
Biomarker assay***** NA 
Analytical validity of biomarker data 
reported? (y/n) – if yes – provide 
data 
NA 
Time between biomarker sampling 
and analysis 
NA 
Season/ date when biomarker 
samples were drawn 
NA 
Background exposure data  
* write “nd” if there was no data reported. Please do not leave blank 
** please refer to brief name indicated in dietary assessment method table. If another method was used, please describe the detail 
*** specify database used to calculate nutrient intakes. Other nutrient analysis, please specify 
**** E.g. are carbohydrates expressed as available carbohydrates by difference, is fibre included in the carbohydrates or not, retinol equivalent or retinol activity etc. Chemical 
form of the nutrient 
***** ONLY biomarker of interest for outcome  
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Reference details, first 
author, year, country 
Alvarez-Pederol et al. (2009) Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their 
offspring, Sabadell, Spain  
Study design Prospective study of maternal thyroid function (including UIC) measured in first and third trimester and birth weight in 657 mother infant 
pairs.  
Population, subjects Healthy pregnant women recruited in first trimester in a public health clinic in Sabadell. Of 657 recruited, 619 were followed until delivery 
and 568 remained after exclusion of women with thyroid disorders, preterm deliveries or missing data.  
Outcome measures Birth weight (continuous) and adjusted SGA. SGA was defined as i) birth weight <10th percentile birth weight distribution of the 
population based corresponding gestational age and as ii) <10th percentile weight according to a customised predicted birth weight 
accounting for maternal and newborn characteristics to better identify intrauterine growth restriction from constitutionally small infants. 
Only infants classified as SGA in both definitions were considered as SGA in the analyses.   
Time between baseline 
exposure and outcome 
assessment 
Analysis 1: First trimester to delivery 
Analysis 2: Third trimester to delivery 
Exposure assessment/ Dietary 
assessment method 
Median UIC in the 1st trimester: 95 µg/L. Free T4 (fT4) and TSH was measured in 557 pregnant women. 
Median UIC in the 3st trimester: 104 µg/L.  
UIC was categorised into five categories <50 µg/L, 50-99 µg/L, 100-149µg/L, 150-249 µg/L and >249 µg/L. 
No. of subjects analysed N=251 mother had UIC measured in 1st trimester, n=528 had UIC measured in 3rd trimester and n=243 had both 
Intervention None 
Follow-up period, drop-out 
rate 
Follow up till delivery, no dropouts 
Results Women with 3rd trimester UICs between 100-149 µg/L had lower risk of having an SGA newborn than women with UICs below 50 µg/L 
(aOR (95%CI): 0.15 (0.03, 0.76). The newborns in this groups also had higher mean birth weights. Higher TSH levels were associated 
with higher risk of SGA and lower birth mean birth weight. 
Comments The lowest risk of SGA and highest mean birth weight was seen in mothers with UIC in the range 100-149 µg/L. The study has some 
limitations such as relatively low sample size and a large number of tests. 
Study quality, A-C B 
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Reference details, first 
author, year, country 
Bath et al. (2013) Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: 
results from the Avon Longitudinal Study of Parents and Children (ALSPAC), UK 
Study design Prospective study of maternal iodine status in pregnancy and neurodevelopmental outcomes in children.  
Population, subjects Pregnant women and their children at age 8 years (n=1040 mother-child pairs) in the Avon Longitudinal Study of Parents and Children 
(ALSPAC). Inclusion criteria: first pregnancy, singleton delivery, availability of a urine sample from the first trimester, and a measure of 
intelligence quotient at 8 years. 
Outcome measures At age 8 years, IQ was assessed in the ALSPAC research clinic using an abbreviated form of the Weschler Intelligence Scale for Children 
IIIUK (WISC-IIIUK) and included verbal IQ, performance IQ and total IQ. At age 9 years, trained psychologist assessed children’s reading 
by four outcomes: speed (words read per minute), accuracy, comprehension, and reading score. 
Time between baseline 
exposure and outcome 
assessment 
Baseline in first trimester (≤13 gw, median 10 gw), outcome assessment in children at 8 years (IQ) and 9 years (reading ability).  
Exposure assessment/ Dietary 
assessment method 
Maternal urinary iodine concentration (UIC) was analysed in spot urine samples and examined in all models as the ratio of iodine to 
creatinine (µg/g Cr). Median (IQR) UIC was 110 µg/g Cr (IQR 74-170), while the median unadjusted UIC was 91.1 µg/L (IQR: 53.8-143).  




Follow-up period, drop-out 
rate 
Study sample only included mother-child pairs with available follow-up data. 
Results In statistical analyses, maternal UIC (iodine-to-creatinine-ration) was dichotomised into ≥150 µg/g (sufficient) or <150 µg/g (deficient). 
In additional analyses, the <150 µg/g category was divided onto <50 µg/g (severe) and 50-150 µg/g (mild-to-moderate). Seven 
associations were studied (3 for IQ, 4 for reading ability) using three regression models for each cognitive outcome to adjust for potential 
confounders. The second model included variables associated with at least one of the outcomes, while third model included variables that 
were potentially on the causal pathway. Irrespective of statistical testing, the results showed that children from the maternal low-iodine 
group (UIC<150 µg/g) were more likely to have scores in the lowest quartile for verbal IQ (OR: 1.58; 95%CI: 1.09, 2.30), reading 
accuracy (OR:1.69; 95%CI: 1.15, 2.49) and reading comprehension (OR: 1.54; 95%CI: 1.06, 2.23) than those from the sufficient group. 
Further stratification of the low-iodine mothers showed that children from the group with urinary iodine (<50 µg/g) had lower scores than 
those from the group with iodine 50–150 µg/g (dose-response). 
Comments The study provides evidence that mild-to-moderate iodine deficiency (inadequate iodine status during early pregnancy) is adversely 
associated with child cognitive development.  
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Bath et al. (2013) Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: 
results from the Avon Longitudinal Study of Parents and Children (ALSPAC), UK 
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Reference details, first 
author, year, country 
Charoenratana et al. (2016) Maternal iodine insufficiency and adverse pregnancy outcomes, Thailand 
Study design Prospective cohort study: to compare the pregnancy outcomes between women with iodine insufficiency (UIC<150 µg/L) and iodine 
sufficiency (UIC ≥150 µg/L). 
Population, subjects 410 pregnant Thai women with a median iodine concentration of 151 µg/L (across all three trimesters), complete data for 390. 
Outcome measures Pregnancy outcomes: Gestational week at birth, birth weight, stillbirth, intrauterine growth restriction, preterm birth, low birth weight, low 
Apgar score 1 min, Low Apgar score 5 min, antepartum haemorrhage, pregnancy induced hypertension, gestational diabetes, and 
Caesarean delivery. Adjusted analyses only reported for preterm birth and low birth weight. 
Time between baseline 
exposure and outcome 
assessment 
Exposures were measured during pregnancy and outcome at birth. I.e. duration of known pregnancy is maximum follow up time. 
Exposure assessment/ Dietary 
assessment method 
UIC in 1st (n=384), 2nd (n=325) and 3rd (n=221) trimesters. The mean UIC of repeated measures were categorised into ≥150 µg/L and 
<150 µg/L. They also report the findings on foetal growth restriction using a cut-off of 100 µg/L  




Follow-up period, drop-out 
rate 
Follow up during antenatal visits in pregnancy to delivery, of 410 recruited, 390 had complete data on pregnancy outcomes. 
Results The duration of pregnancy was one week longer and birth weight was 150g higher in the iodine sufficient group than in the group with 
UIC <150 µg/l. UIC < 150 µg/L was associated increased risk of preterm birth (adjusted OR 2.69, 95%CI: 1.38, 5.24) and increased risk 
of low birth weight (a OR 2.66; 95%CI: 1.40, 5.05). UIC<100 was associated with increased risk of intrauterine growth restriction.  
Comments The main finding was that insufficient iodine status (UIC<150 µg/L) was associated with increased rate of preterm birth and low birth 
weight. A weakness of this study is that it is not clear about the main objectives, the description of the statistics and rationale for 
adjustment is weak.  
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Reference details, first 
author, year, country 
Chen et al. (2019) Iodine Nutrition and Thyroid Function in Pregnant Women Exposed to Different Iodine Sources, China 
Study design Cross-sectional study 
Population, subjects This study included 15,008 adult men and women, aged 15 years or older (mean age 45 years) and was undertaken between 2011 and 
2012 in 10 cities located in the eastern and central parts of China.  
Outcome measures Primary outcome: Presence of thyroglobulin antibodies (TgAbs).  
In addition, serum thyrothropin (TSH) and thyroid perioxidase antibodies (TPOAbs) were measured for each participant. If TSH was not 
within the reference range, free thyroxine (fT4) and free triiodothyronine (fT3) levels were measured. 
Time between baseline 
exposure and outcome 
assessment 
NA  
Exposure assessment/ Dietary 
assessment method 
Concentration of urinary iodine (UIC) from spot urine samples.  
No. of subjects analysed A total of 14,230 participants (6017 males and 8213 females) with complete data were enrolled in the final analyses. 
Follow-up period, drop-out 
rate 
NA 
Results Median UIC was 205 µg/L (5% and 95% percentiles: 66 and 538 µg/L). The participants were classified into four groups according to UIC 
level: UIC<100 µg/L, 100≤UIC<200 µg/L, 200≤UIC<300 µg/L and UIC≥300 µg/L. A total of 2508 participants (17.6%) had iodine 
deficiency (UIC<100 µg/L). The results showed that with the increase in UIC, the prevalence of isolated TgAb positivity decreased 
gradually (for TgAb: 6.14%, 5.62%, 5.34%, and 5.15%). The same trend was not seen with the prevalence of isolated TPOAb positivity 
or TSH. Thus, the result showed that both males and females with UIC<100 µg/L were more prone to have positive TgAbs. 
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Reference details, first 
author, year, country 
Fan et al. (2018) Investigation on the factors that influence the prevalence of thyroid nodules in adults in Tianjin, China. 
Study design Cross-sectional study 
Population, subjects This study included 2647 adult men and women, aged 18 years or older (mean age 43 years), and was undertaken between March and 
October 2015 in Tianjin, China. Random cluster sampling was used to select one district in city and country respectively.  
Outcome measures Primary outcome: Presence of thyroid nodules (TNs), defined as areas of greatly reduced or absent echogenicity on thyroid 
ultrasonography. In addition, potential influencing factors on TNs including sex, age, iodine status, thyroid volume, thyroid hormone 
(TSH), thyroid antoantibody TPOAb, TgAb and living habits were analysed. 
Time between baseline 
exposure and outcome 
assessment 
NA 
Exposure assessment/ Dietary 
assessment method 
Concentration of urinary iodine (UIC) from spot urine samples.  




Follow-up period, drop-out 
rate 
NA 
Results Median UIC was 134 µg/L (interquartile range 79-208 µg/L). There were 35.6% of the subjects whose UIC was lower than 100 µg, and 
10.3% was higher than 300 µg/L. In the range of urine iodine levels investigated (10 levels: 0 µg/L ~, 50 µg/L ~, 100 µg/L ~, 150 µg/L 
~, 200 µg/L ~, 250 µg/L ~, 300 µg/L ~, 350 µg/L ~, 400 µg/L ~, and 500 µg/L ~), the relationship between UIC and the occurrence of 
TNs showed a U-shaped curve. Prevalence of TNs was 30.7% among subjects with UIC between 50 and 99 µg/L, and 25.3% among 
subjects with UIC in the range of 100-300 µg/L. The results showed that the prevalence of TNs was significantly decreased when the UIC 
was over 150 µg/L. 
Comments  
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Reference details, first 
author, year, country 
Ghassabian et al. (2014) Maternal urinary iodine concentration in pregnancy and children's cognition: results from a 
population-based birth cohort in an iodine-sufficient area, Netherland 
Study design Prospective study of maternal iodine status in pregnancy (UIC measured < 18 gestational weeks) and neurodevelopmental outcomes in 
children at age 6 years.  
Population, subjects Pregnant women and their children at age 6 years (n=1525 mother–child pairs) participating in Generation R, a multiethnic birth cohort in 
Rotterdam. The population was iodine sufficient with a median UIC of 296.5 μg/g creatinine (229.6 µg/L). Only 188 (12.3%) had UIC < 
150 µg/g creatinine.  
Inclusion criteria: singleton live birth, data on UIC and on child cognitive measures at age 6 years. 
Outcome measures Non-verbal IQ and language comprehension were assessed during a visit to the research centre using Dutch test batteries when the 
children were 6 years. 
Time between baseline 
exposure and outcome 
assessment 
Baseline in first trimester (≤18 gw, median 10 gw), outcome assessment in children at 6 years.  
Exposure assessment/ Dietary 
assessment method 
Maternal iodine intake assessed by urinary iodine analysed in spot urine samples and modelled as the ratio of iodine to creatinine (µg/g 
Cr). Median UIC in all women: 296.5 μg/g creatinine (UIC=229.6 μg/L) and were iodine sufficient at the group level. UIC was 
dichotomised into <150 µg/g (n=188 (12.3%)) and ≥150 µg/g (n=1337 (87.7%)). Median UIC in the 188 women with UIC<150 μg/g 
was 119.3 μg/g creatinine.   




Follow-up period, drop-out 
rate 
Study sample only included mother-child pairs with available follow-up data. 
Results Children of mothers with UIC<150 µg/g had higher likelihood of suboptimum (lowest quartile, scores <93) non-verbal IQ in crude 
analysis (OR=1.44, 95% CI 1.02, 2.02), but no significant association for either non-verbal IQ or language comprehension in adjusted 
analyses (adj OR: 1.33 (95% CI: 0.92, 1.92) and adj OR 0.82 (95% CI: 0.56, 1.19), respectively).    
Comments The study included few women with low UIC.  
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Reference details, first 
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Gordon et al. (2009) Iodine supplementation improves cognition in mildly iodine-deficient children, New Zealand 
Study design Randomised double-blind placebo-controlled trial to determine the effect of iodine supplementation with 150 µg daily in mildly iodine 
deficient 10-13-year-old children. Median UIC in children at baseline was 63 µg/L and 32% had UIC<50 µg/L.  
Population, subjects Children (n=184) were recruited through schools and advertisement in 2007 and 2008. Inclusion criteria were: age 10-13 years, no 
known history of thyroid condition, and not taking iodine-containing dietary supplement. 
Outcome measures Primary outcome was a difference in cognitive test scores between the iodine and placebo groups. Cognitive performance was assessed 
by four tests from the Wechsler Intelligence Scale for Children, fourth edition (WISC-IV): Picture concepts and Matrix reasoning (both 
assessing perceptual reasoning), Letter-number sequencing (working memory), and Symbol search (processing speed). 
Time between baseline 
exposure and outcome 
assessment 
28 weeks 
Exposure assessment/ Dietary 
assessment method 
The exposure was iodine-supplementation or placebo. At baseline, iodine intake from iodine rich foods, iodized salt and iodine-containing 
dietary supplements was assessed. 
No. of subjects analysed Total n=166 
Intervention 
Intervention/ exposure 
Intervention with 150 µg I daily (n=84) or placebo (n=82). 
Follow-up period, drop-out 
rate 
Follow up for 28 weeks (6 mo). Of 184 included in the study, 166 completed. 
Results In statistical analysis, the effect of supplementation was evaluated by using multiple linear regression for each of the 4 cognitive tests 
and biochemical indexes. Supplementation with 150 µg I/day corrected iodine deficiency by increasing median UIC from 66 to 145 µg/L 
and decreasing thyroglobulin from 16.5 to 8.5 µg/L.  
Iodine supplementation improved performance on 2 of the 4 cognitive tests relative to the placebo. The age standardised score obtained 
in picture concepts increased by 0.81 points (8.6%) and the score in matrix reasoning by 0.63 points (6.5%). 
Comments The study provides evidence that daily supplementation with 150 µg iodine improved perceptual reasoning, but not working memory or 
processing speed in mildly iodine deficient children. The study was limited by a small study population.  
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Gowachirapant et al. (2017) Effect of iodine supplementation in pregnant women on child neurodevelopment: a 
randomised, double-blind, placebo-controlled trial, Thailand and India  
Study design A randomised double-blind placebo-controlled trial with iodine supplementation in mild-to-moderate iodine deficient pregnant women and 
cognitive measures in their children. (Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development, MITCH-
trial). 
Population, subjects Pregnant women were recruited in Bangkok, Thailand and Bangalore, India. At each site, recruitment took place in a large, well-run 
antenatal clinic serving mainly middle-income families. To be included, women had to be 18-40 years, have singleton pregnancy less than 
or equal to 14 weeks of gestation, no thyroid disease or major illnesses, and not be taking iodine-containing dietary supplements. Median 
UIC in first trimester in all participants combined was 131 µg/L.  
Outcome measures Primary outcome: child neurodevelopment at age 5-6 years assessed by 3 outcomes; the Wechsler Preschool and Primary Scale of 
Intelligence (WPSSI-III) verbal IQ and performance IQ, and the Behavior Rating Inventory of Executive Function-Preschool Version 
(BRIEF-P) global executive composite score.  
Secondary outcomes at age 5-6 years: externalising and internalising behaviour problems assessed a by the Strengths and Difficulties 
Questionnaire (SDQ), auditory tests, anthropometrics (weight and length), and thyroid function parameters (TSH and T4).  
Secondary outcomes at earlier ages: child neurodevelopment assessed 6 weeks after birth using the Neonatal Behavioral Assessment 
Scales (NBAS) and at 1 and 2 years using the Bayley Scales of Infant Development (BSID)-III, pregnancy outcomes and maternal and 
infant thyroid volume and thyroid function parameters. 
Time between baseline 
exposure and outcome 
assessment 
From early pregnancy (≤14 gw) to children at age 5-6 years. 
Exposure assessment/ Dietary 
assessment method 
Intervention with 200 µg iodine or placebo daily throughout pregnancy.  
No. of subjects analysed In total n=832 women entered the trial, of which 412 were assigned to iodine and 420 assigned to placebo. Cognitive outcome 
measurements were available for 330 children at 5.4 years, 166 in the intervention group and 134 in the placebo group. 
Intervention Intervention with 200 µg iodine or placebo daily from first trimester (mean 10.7 gw) throughout pregnancy. 
Follow-up period, drop-out 
rate 
Follow up from pregnancy to age 5-6 years of children. Of the 832 women enrolled, 330 children (40%) were available at age 5-6. 
Results Statistical tests at 5-6 years for primary and secondary outcomes showed no differences between the groups receiving supplement and 
placebo for the primary outcomes at age 5-6 years. Moreover, except for a higher score on expressive language in favour of placebo at 1 
year, there were no differences in any of the secondary outcomes at age 5-6 years or at earlier ages. 
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Gowachirapant et al. (2017) Effect of iodine supplementation in pregnant women on child neurodevelopment: a 
randomised, double-blind, placebo-controlled trial, Thailand and India  
Comments Although women were mildly iodine deficient at baseline (median UIC 131 µg/L), women in India were iodine sufficient (UIC 188 µg/L) 
and only women in Thailand were deficient (UIC: 112 µg/L). Both study sites were in regions with reasonable coverage of iodized salt, 
and the UIC was sufficient in both the intervention and placebo group from 2. trimester onwards. Therefore, this study does not provide 
the evidence required to know whether mild-to-moderate iodine deficiency affects brain development and child cognition. 
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Hynes et al. (2017) Reduced Educational Outcomes Persist into Adolescence Following Mild Iodine Deficiency in Utero, 
Despite Adequacy in Childhood: 15-Year Follow-Up of the Gestational Iodine Cohort Investigating Auditory Processing 
Speed and Working Memory, Australia (Tasmania)  
Study design Prospective cohort in pregnant women. Follow up of children in Hynes et al. 2013. 
Population, subjects Exposure (UIC) was measured in pregnancy during a period with moderate iodine deficiency in the population. The population iodine 
status substantially improved during the follow-up period of the study participants, thus this represent exposure to poor iodine status 
during early life only. In years 1999 to 2000, 449 pregnant women were recruited from antenatal clinics in Australia. Median UIC was 83 
µg/L. The previous study (Hynes et al. 2013) examined associations between prenatal iodine and educational outcomes at 8-9 years, 
while this study examined associations between prenatal iodine and educational outcomes at later ages using mixed models of repeated 
NAPLAN-outcomes assessed in school year/grade 3 (i.e. 9 years of age), 5, 7 and 9 (i.e.15/6 year of age) years and gestational UIC as 
continuous variables, and in addition examined associations between gestational iodine and two outcomes (language delay and 
hearing/auditory processing) in a subsample of 45 participants at age 14-15 years. 
Outcome measures Standardised School tests (National Assessment Program—Literacy and Numeracy (NAPLAN) tests for spelling, grammar, reading, writing, 
numeracy) from grade 3 (age 9 y) up to and including grade 9 (15/16 y). In a subsample of adolescents at 14-15 years (n=45), 
additional outcomes included the “Comprehensive Evaluation of Language Fundamentals» (CELF-4) and A Central Auditory Processing 
Disorder (CAPD) assessment. These tests assess language development and hearing/auditory processing.  
Time between baseline 
exposure and outcome 
assessment 
14-15 years 
Exposure assessment/ Dietary 
assessment method 
None 
No. of subjects analysed 266 children for mixed model analysis of repeated measures at grade 3 (8-9 years), grade 5, grade 7 and grade 9 (14-15 years), and 45 




Follow-up period, drop-out 
rate 
Of 449 recruited, n=266 (59%) were included in the longitudinal analysis. 
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Hynes et al. (2017) Reduced Educational Outcomes Persist into Adolescence Following Mild Iodine Deficiency in Utero, 
Despite Adequacy in Childhood: 15-Year Follow-Up of the Gestational Iodine Cohort Investigating Auditory Processing 
Speed and Working Memory, Australia (Tasmania)  
Results The study showed that the association between UIC dichotomised at 150 µg/L and performance on standardised school test for spelling 
persisted to grade 9 (14-15 years). The outcomes were modelled using repeated measurements (NAPLAN measured in school years 3, 5, 
7 and 9). In the fully adjusted model, children whose mothers had UIC < 150 µg/L exhibited persistent reductions in spelling from year 3, 
age 8-9 years (10%, -41.4 points (95% Confidence Interval -65.1 to -17.6, p = 0.001)) to year 9, age 14-15 years (5.6%, -31.6 (-57.0 to 
-6.2, p = 0.015)) compared to children whose mothers had UIC ≥150 µg/L. For grammar and reading, differences at year 3 continued 
into year 5 but decreased by year 9 (an initial 6.5% difference in grammar reduced to 2.8% by year 9 and a 7.1% difference in reading 
reduced to 2.5% by year 7). 
At age 15 years, there were no differences in CELF-4 (language development) or CAPD (hearing/auditory processing) scores. However, all 
CELF-4 measures were lower for offspring of mothers with UIC<150 µg/L than for those of mothers with UIC≥150 µg/L (not significant). 
The statistical power was extremely low as the groups that were compared had only 30 and 15 participants respectively. 
Comments This is a follow up study of maternal iodine status and educational outcomes in the same cohort as Hynes 2013 with repeated measures 
in the following years. The study population for the repeated measures (266 mother-child pairs) is about 50% of the original cohort. The 
study population for the two additional outcomes at 14-15 years of n=45 mother-child pairs is clearly underpowered.  
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Hynes et al. (2013) Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the 
offspring: 9-year follow-up of the gestational iodine cohort, Australia (Tasmania) 
Study design Prospective cohort study 
Population, subjects Exposure (UIC) was measured in pregnancy during a period with moderate iodine deficiency in the population. The population iodine 
status substantially improved during the follow-up period of the study participants, thus this represent exposure to poor iodine status 
during early life only. A total of 433 pregnant women were recruited between 1999 and 2000. 
Outcome measures Standardised School tests (Australian national curriculum and Tasmanian state curriculum educational assessment data for children) at 9 
years. National Assessment Program—Literacy and Numeracy (NAPLAN) tests are standardised criteria-referenced measures of individual 
student’s performance in literacy (reading, writing, and language conventions [spelling, grammar, and punctuation]) and numeracy. 
Student Assessment and Reporting Information System (SARIS) used by Tasmanian State Government schools to record individual 
student’s academic achievement in assessments in English-literacy and Mathematics-numeracy. 
Time between baseline 
exposure and outcome 
assessment 
9-10 years 
Exposure assessment/ Dietary 
assessment method 
Some women but not all donated more than one UIC and the average value was assigned to those with more than one UIC. The median 
UIC was 81 µg/L.  UIC was categorised into <150µg/L and ≥ 150 µg/L.  




Follow-up period, drop-out 
rate 
433 were included in the original cohort, and outcomes were available in 228 so almost 50% were lost during the follow-up period of nine 
year.  
Results There was a significant association between UIC (categorised at 150 µg/L) and spelling (NAPLAN) in the full model, and a borderline 
association between with grammar (NAPLAN) and English-literacy score (SARIS), but not with reading, writing or numeracy scores 
(NAPLAN). In comparison with children whose mothers had UIC≥150 µg/L, children whose mothers had UIC<150 µg/L had 10% 
reduction in spelling (-38; 95%CI: -65.5, -11.5, p=0.005), 7% reduction in grammar (-29.1; 95%CI; -59.9, -1.8, p=0.065), and 5% 
reduction in English grammar (-0.30; 95%CI: -0.62, 0.01, p=0.059). Significant effect sizes were also seen in the crude analyses and in 
the models with fewer (only biological, birth size, gestation age, sex etc.) variables. 
Comments There were significant and substantial associations in the crude analyses. Only one out of the 7 tests (spelling) remained statistically 
significant when all potential confounders were adjusted for, while two were borderline significant. The main weaknesses are the low 
sample size, too few adjustment variables, and high losses to follow-up. 
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Hynes et al. (2013) Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the 
offspring: 9-year follow-up of the gestational iodine cohort, Australia (Tasmania) 
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Krejbjerg et al. (2015) Serum thyroglobulin before and after iodization of salt: an 11-year DanThyr follow-up study, 
Denmark 
Study design A longitudinal population-based study (DanThyr) in two regions with different iodine intake at baseline: Aalborg (moderate iodine 
deficiency (ID) and Copenhagen (mild ID). Median UIC Aalborg: 45 g/L in non-supplement users and 53 µg/L in iodine-supplement users. 
Median UIC Copenhagen 61 µg/L in non-supplement users and 68 µg/L in iodine supplement users. 
Population, subjects Participants were chosen at random within specific age and sex groups using the Danish civil registration system: women aged 18–22 
years, 25–30 years, 40–45 years and 60–65 years and men aged 60–65 years. A total of 4649 subjects participated (50% of the invited): 
2429 participants in Copenhagen and 2220 participants in Aalborg. At follow-up, of the 4649 participants, 72 subjects had emigrated (out 
of the country) and 403 subjects deceased, allowing 4174 subjects to be invited for participation. 2465 subjects participated, 
corresponding to 59% of the invited, and 1417 participants with no previous thyroid disease and without Tg-autoantibodies were included 
in the analyses.  
Outcome measures Serum Tg was measured by immunoradiometric method. A daily intake of iodine from supplements in addition to iodine fortification (IF) 
was measured.  
Time between baseline 
exposure and outcome 
assessment 
Tg was assessed at baseline in 1997-1998 and at follow up in 2008-2010. The mean follow-up time was 11.2 years (range: 10.1–12.8 
years).  
Exposure assessment/ Dietary 
assessment method 
Food frequency questionnaire was collected but not presented in this paper, only information about iodine supplements. 
No. of subjects analysed Total n=1417 
Intervention 
Intervention/ exposure 
Participants were examined at baseline (1997-98) before the mandatory IF of salt (2000), and again at follow-up (2008-2010) after IF. 
The IF was initiated in year 2000 and consisted of adding 13 µg iodine/g salt in household salt and into salt for the production of bread. 
The program was designed to increase the average daily iodine intake among adult Danes by 50 µg/day. 
Follow-up period, drop-out 
rate 
72 subjects had emigrated (out of the country) and 403 subjects deceased. 
Results Overall, the follow-up period saw no change in median Tg in Copenhagen (9.1/9.1 µg/L, p=0.67) while Tg decreased significantly in 
Aalborg (11.4/9.0 µg/L, p<0.001). Living in Aalborg (p<0.001) and not using iodine supplements at baseline (p<0.001) predicted a 
decrease in Tg whereas baseline thyroid enlargement (p<0.02) and multinodularity (p<0.01) were associated with an individual increase 
in Tg during follow-up. 
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Krejbjerg et al. (2015) Serum thyroglobulin before and after iodization of salt: an 11-year DanThyr follow-up study, 
Denmark 
Comments The iodization of salt initiated in 2000 (13 mg/g) was cautious in order to minimise side effects. The results raise the question if a 
moderate increase in the level of iodine added to the salt, bringing median urinary iodine values to a level around 100 mg/L as found in 
2004–2005 could be beneficial for the Danish population and further increase the population iodine intake. This conclusion is in 
accordance with the results of urinary iodine measurements, indicating that at follow up in 2008–2010 the participants were in general 
suffering from mild ID. 
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Levie et al. (2019) The Association of Maternal Iodine Status in Early Pregnancy with Thyroid Function in the Swedish 
Environmental Longitudinal, Mother and Child, Asthma and Allergy Study, Sweden 
Study design Cross-sectional study embedded within the Swedish Environmental Longitudinal Mother and child Asthma and Allergy (SELMA) study, 
aiming to investigate the association of maternal urinary iodine concentration with thyroid function and autoantibodies in a mild-to-
moderate iodine deficient pregnant population.  
Population, subjects Pregnant Swedish women (n=2009) with data on UIC, creatinine and thyroid function parameters collected at median gestation age 10 
weeks (95%CI: 6-14 weeks). Mean (SD) maternal age was 30 (5.2) years.  
Outcome measures Thyroid function: Thyrotropin (TSH), free thyroxine (fT4), free triiodothyronine (fT3), total T4 (TT4 and total T3 (TT3).  
Thyroid autoantibodies: positive test for thyroid peroxidase autoantibodies (TPOAb>34 IU/mL), positive test for Thyroglobulin 
autoantibodies (TgAb>115 IU/mL).  
Time between baseline 






The median UI/creat was 85 (95%CI: 36, 386) µg/g and UI/creat was <150 µg/g in 80.1% of women. Without correction for creatinine 
median UIC was 90 (38, 439 µg/L) and UIC was <150 µg/L in 78.6% of women. 




Follow-up period, drop-out 
rate 
 
Results UI/Creat was modelled as a continuous variable and the results showed significant curvilinear associations of low UI/Creat (lower than 
~100 µg/g) with lower TSH (p=0.027) and higher TT4 (p=0.032). There was also a trend toward an association of a lower UI/Creat with 
higher fT4 (p=0.081), fT3 (p=0.079), and TT3 (p=0.10), but no association of UI/Creat with the TT4/TT3 and fT4/fT3 ratios. In the 
whole study population, TPOAb positivity occurred more often in women with low or high UI/Creat; an increase of one unit in the natural 
logarithm of UI/Creat was associated with a 27% lower risk of TPOAb positivity (odds ratio (OR) 0.73; 95%CI: 0.56, 0.98, p=0.034), but 
not with TgAb positivity (OR 0.83; 95%CI 0.61, 1.14, p = 0.25). The results for thyroid function and autoantibodies were similar when 
examining UIC without adjusting for creatinine. 
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Levie et al. (2019) The Association of Maternal Iodine Status in Early Pregnancy with Thyroid Function in the Swedish 
Environmental Longitudinal, Mother and Child, Asthma and Allergy Study, Sweden 
Comments The analyses were adjusted for TPOAb, hCG, gestational age, maternal, age, maternal ethnicity, maternal education, parity, maternal 
BMI, smoking status based on the serum cotinine concentration, and child sex. 
The findings of lower TSH and higher TT4, and of (borderline) higher fT4, TT3 and fT3 were contra-intuitive to an expected increase in 
TSH and shift from T4 to T3, but is in line with results from other studies.  
Study quality and 
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Markhus et al. (2018) Maternal Iodine Status is Associated with Offspring Language Skills in Infancy and Toddlerhood, 
Norway 
Study design A population-based prospective cohort.  
Population, subjects During 2011-2012, pregnant women were enrolled at nine public health clinics across all four Norwegian health regions. The clinics were 
chosen after considering demographic characteristics and size of the population to include participants from both cities and rural districts 
with a wide distribution of socioeconomic conditions. Midwives at the public health clinics approached pregnant women at 16–26 weeks 
gestation with an invitation to participate; however, some women were asked as late as weeks 31–34. Inclusion criteria for analysis in the 
present study were available data on UIC and on child development, singleton pregnancy, no thyroid medication in pregnancy, and no 
severe genetic disorder. 
Outcome measures Five developmental outcomes (domains) at 6, 12 and 18 months (Bayley Scales of Infant and Toddler Development, third). At six and 12 
months, the screening version of the test was used measuring all five domains: cognitive, receptive communication, expressive 
communication, gross motor and fine motor. At 18 months, the full-scale version was used measuring cognitive and language skills. 
Health care nurses, trained under supervision of clinical psychologists specialised in infant and child development, administered the test 
at the public health clinics. 
Time between baseline 
exposure and outcome 
assessment 
NA 
Exposure assessment/ Dietary 
assessment method 
Maternal UIC was the main exposure. Questions on supplement use were embedded in a short web-based food frequency questionnaire 
explained elsewhere. 




Follow-up period, drop-out 
rate 
Data collection up to age 18 months ended in November 2014. 1063 pregnant women included, 212 excluded due to multiple births, 
reported thyroid hormone drug therapy, Downs syndrome and missing data on the outcome or exposure variable.  
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Markhus et al. (2018) Maternal Iodine Status is Associated with Offspring Language Skills in Infancy and Toddlerhood, 
Norway 
Results The median UIC in pregnancy was 78 µg/L (IQR 46–130), classified as insufficient iodine intake according to the WHO. Eighteen percent 
reported use of iodine-containing multi supplements. A UIC below 100 was associated with reduced receptive (p = 0.025) and expressive 
language skills (p = 0.002), but not with reduced cognitive or fine- and gross motor skills. A lower UIC was associated with lower 
standardised receptive language scores (difference between values above 100 µg/L and lowest values: -0.2 SD) and a lower expressive 
language score (difference between values above 100 µg/L and lowest values: -0.3 SD), but there was no association with cognitive 
score, fine motor skills, or gross motor skills. These associations showed a curvilinear pattern, which indicates that the negative 
associations of UIC with receptive and expressive language scores starts to occur from a value of 100 µg/L or lower. 
Maternal use of iodine-containing supplements was associated with lower gross motor skills (b = -0.18, 95% CI = -0.33, -0.03, p = 0.02), 
but not with the other outcome measures. 
Comments An insufficient iodine intake in pregnancy, reflected in UIC below 100 µg/L, was associated with lower infant language skills measured at 
6, 12 and 18 months (mixed model, repeated measure). Iodine-containing supplements was not associated with beneficial (protective) 
effects.  
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Mills et al. (2019) Pregnancy Loss and Iodine Status: The LIFE Prospective Cohort Study, USA 
Study design A study of iodine status and pregnancy loss in women participating in a prospective population based study who had discontinued 
contraception within two months to become pregnant. Urinary iodine status was assessed at recruitment. The participants were followed 
up for 12 months and those who became pregnant were followed until the end of pregnancy. 
Population, subjects 501 women/couples were recruited, of which 347 (69%) became pregnant. After exclusion of multiple births (n=3) and those with 
missing UIC (n=15), 329 women were included in the analyses. Of these, 196 (59.5%) had live births, 92 (28%) had pregnancy losses, 
and 41 (12.5%) withdrew or were lost to follow up.  
Outcome measures Pregnancy loss and time to pregnancy loss. Pregnancy was assessed by the Clearblue fertility monitor. Pregnancy was identified by a 
positive test and pregnancy loss identified by conversion to a negative test.  
Time between baseline 
exposure and outcome 
assessment 
From the time of positive pregnancy test to loss, delivery or withdrawal. 
Exposure assessment/ Dietary 
assessment method 
Spot urine samples at the first in-home interview prior to conception. Iodine was measured as µg/L and creatinine was used either as an 
independent variable or to use the ratio of iodine to creatinine (µg/g creatinine). The exposure was grouped into normal status (≥150 
µg/L, n=133 (40%)), mild deficiency (100-149 µg/L, n=52 (16%)), moderate deficiency (50-99 µg/L, n=74 (22.5%)) and severe 
deficiency (<50 µg/L, n=70 (21%)). 




Follow-up period, drop-out 
rate 
From the time of positive pregnancy test to loss, delivery or withdrawal/drop out. Dropout rate: 12.5% 
Results The women with UIC in the deficiency range did not have a different loss rate than those in the sufficient group. The adjusted hazard 
ratio for pregnancy loss was 0.69 (95% CI 0.34, 1.38) in the mild iodine deficiency group, 0.81 (95% CI 0.43, 1.51) in the moderate 
deficiency group, and 0.69 (95% CI 0.32, 1.50) in the severe deficiency group. Results were consistent in sensitivity analyses including 
creatinine adjustment or exclusion of women being treated for thyroid disease. 
Comments The authors used weighted analysis to account for dropouts due to couples not getting pregnant, but the overall study sample was fairly 
small, and the majority of participants had UIC in the sufficient or mildly deficient range (56%). However, a major strength of this study 
is that the couples were recruited before conception making it possible to assess early pregnancy losses. This is not possible in pregnancy 
cohorts that usually recruit pregnant women well into pregnancy.  
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Mills et al. (2019) Pregnancy Loss and Iodine Status: The LIFE Prospective Cohort Study, USA 
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Mills et al (2018) Delayed conception in women with low-urinary iodine concentrations: a population-based prospective 
cohort study, USA 
Study design The LIFE Study, a population-based prospective cohort study, enrolled women who had discontinued contraception within 2 months to 
become pregnant. 
Population, subjects 501 couples were recruited from a defined area of 16 counties in Michigan and Texas. Couples planning a pregnancy were initially 
contacted by letter, then by a telephone screening interview. After obtaining full and informed consent, couples who wished to participate 
were seen at their homes for in depth interviews and training. Women were eligible if they were planning a pregnancy; were married or 
in a committed relationship; were between 18 and 40 years of age; had self-reported menstrual cycles ranging from 21 to 42 days; had 
not used injectable hormonal contraception in the past 12 months; were not off contraception for more than 2 months; were able to 
communicate in English or Spanish; and had a partner aged 18 or older. Of the 501 women enrolled, 467 (93%) had sufficient urine 
available for iodine analysis. 
Outcome measures Women reported on risk factors for infertility by interview then kept daily journals of relevant information. Women used fertility monitors 
to time intercourse relative to ovulation then used home digital pregnancy tests to identify pregnancies on the day of expected 
menstruation. Urine samples were obtained. 
Time between baseline 
exposure and outcome 
assessment 
12-month study period. 
Exposure assessment/ Dietary 
assessment method 
Spot urine samples from 467 women as UIC and I/Cr-ratio. Iodine status sufficient (UIC≥100 μg/L) in 260 (55.7%), mildly deficient (50–
99 μg/L) in 102 (21.8%), moderately deficient (20–49 μg/L) in 97 (20.8%) and severely deficient (<20µg/L) in 8 (1.7%) samples. 
Median UIC was 112.8 (IQR 53.6-216.9) µg/L in the entire population, 114.1 (IQR 103.1-126.3) in those who became pregnant, 97.2 
(IQR 73.5-128.5) µg/L in those who did not become pregnant, and 113.6 (IQR 92.9-138.9) µg/L in those who withdrew. 




Follow-up period, drop-out 
rate 
332 (71%) became pregnant; 47 (10%) did not become pregnant and 88 (19%) withdrew or were lost to follow-up. 
Results The group whose iodine–creatinine ratios were below 50 μg/g (moderate to severe deficiency) had a 46% reduction in fecundity (p = 
0.028) compared with the group whose iodine–creatinine ratios were in the adequate range: adjusted fecundability odds ratio of 
becoming pregnant per cycle, 0.54 (95% confidence interval 0.31–0.94). 
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Mills et al (2018) Delayed conception in women with low-urinary iodine concentrations: a population-based prospective 
cohort study, USA 
Comments Significant delays in becoming pregnant occur at iodine concentrations that are common in women in the USA and parts of Europe. 
Replicating these findings will be important to determine whether improving iodine status could be beneficial in improving fecundability. 
However, iodine concentrations vary within individuals over time, so the data must be interpreted by group as we have done; residual 
confounding is possible. The group between 50 and 100 μg/g or μg/L may be at risk, but if they are, the risk is much smaller. 
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Moreno-Reyes et al. (2013) High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: 
a population-based study, Belgium 
Study design Cross-sectional: national population-based survey of pregnant women, selected by a multistage stratified (by region: North vs South 
Belgium) and clustered sampling design, with the antenatal clinics as unit of cluster. 
Population, subjects Target population: all pregnant women in Belgium within the 1st and 3rd trimesters of pregnancy during survey period (between 
September 2010 and June 2011). National representative sample from 55 obstetric clinics.  
A random sample of 1311 women was included: 215 from Brussels, 641 from Flanders, and 455 from Wallonia. 
Mean (SD) age all participants from both trimesters (n=1311): 28.5 (5.1) yrs. 
Ethnicity (Caucasian, Asiatic, African, North African, and Hispanic) adjusted for in analysis, but % distribution not reported in paper.  
Outcome measures Prevalence of thyroid disorders in 1st and 3rd trimesters: maternal serum free T4 (fT4), free T3 (fT3), TSH, Tg, thyroid peroxidase 
antibodies (TPOAb), and thyroglobulin antibodies (TgAb). 
Time between baseline 
exposure and outcome 
assessment 
Cross-sectional. Not described in paper, but assumed that urine samples and blood samples were collected at the same time during visit 
to antenatal clinic in 1st or 3rd trimester. 
Exposure assessment/ Dietary 
assessment method 
Urinary iodine concentration before (UIC, ug/L) and after correction for creatinine (UIC/Cr, ug/g Cr) in 1st or 3rd trimester. 
Reported in paper that a questionnaire about sociodemographic and socioeconomic characteristics, smoking and alcohol drinking 
behavior, thyroid diseases, use of iodine-containing supplements and food consumption, and use of iodized household salt was completed 
face to face with the study nurse. But method/data not described. 
No. of subjects analysed A random sample of 1311 pregnant women was included. Urinary iodine concentration (UIC) available for n=550 women in 1st trimester 
and n=616 women in 3rd trimester who were negative for TPO-Ab and Tg-Ab and without known history of thyroid disease.  






Follow-up period, drop-out 
rate 
Cross-sectional study. No follow-up or drop out. 
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Moreno-Reyes et al. (2013) High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: 
a population-based study, Belgium 
Results Iodine status 
Median (IQR) UIC in 1st trimester= 117 (70-189) ug/L before and 103 (71-172) after correction for Cr. 
(Median (IQR) UIC in 3rd trimester= 131 (74-239) ug/L before and 138 (81-234) after correction for Cr – increase form 1st trimester 
probably reflects intake of iodine supplements). 
Multivariable linear regression analysis with log serum TSH and log serum Tg as outcomes 
UIC/Cr was a significant predictor of Tg (β= - 0.134, P=0.001), but not TSH (β= - 0.038, P=0.57). Other predictors in models were 
gestational age, maternal age, ethnicity, and season (winter, spring, summer autumn). Analysis probably combines women in 1st and 3rd 
trimesters. 
Main finding highlighted by authors in Abstract is that women with an adequate iodine status (UIC/Cr=150–249 µg/g) had significantly 
lower median Tg concentration compared to moderately iodine deficient women (UIC/Cr <=49µug/g), 19 µg/L and 25 µg/L, respectively. 
But, these results are unadjusted for potential confounders.  
Comments Reported that most women, but not how many, started taking iodine supplements (approximately 150 µg/d) during pregnancy. So higher 
UIC in 3rd compared with 1st trimesters probably reflects supplement use. Different women were assessed in 1st and 3rd trimesters, so 
changes between trimesters also includes other inter-individual variations. 
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SI  
Author, year, study name Moreno-Reyes et al. (2013) High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-
based study, Belgium 
Exposure Urinary iodine concentration before (UIC, µg/L) and after correction for creatinine (UIC/Cr, µg/g Cr). 
Dietary assessment method** ND 
Food composition database*** 
Definition of relevant 
nutrient**** 
ND 
Internal calibration (or validity) 
of dietary assessment (y/n) - if 
yes -  provide data 
ND 
Biomarker assay***** UIC measured in duplicate by a modification of the Sandell-Kolthoff reaction using spectrophotometric detection.  
Analytical validity of biomarker 
data reported? (y/n) – if yes – 
provide data 
The sensitivity of UIC assay was 12 µg/L 
Time between biomarker 
sampling and analysis 
ND 
Season/ date when biomarker 
samples were drawn 
All seasons (winter, spring, summer autumn). 
Background exposure data  
* write “nd” if there was no data reported. Please do not leave blank 
** please refer to brief name indicated in dietary assessment method table. If other method was used, please describe the detail 
*** specify database used to calculate nutrient intakes. Other nutrient analysis, please specify 
**** E.g. are carbohydrates expressed as available carbohydrates by difference, is fibre included in the carbohydrates or not, retinol equivalent or retinol activity etc. Chemical 
form of the nutrient 
***** ONLY biomarker of interest for outcome 
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Murcia et al. (2018) Iodine intake from supplements and diet during pregnancy and child cognitive and motor 
development: the INMA Mother and Child Cohort Study, Spain 
Study design INMA (Infancia y Medio Ambiente (Environment and Childhood)) pregnancy cohort, multicentre, 4 regional centres 
Population, subjects 2644 women enrolled between 2003 and 2008 after consecutive sampling at first routine specialised antenatal care visit in the 
geographical areas of Valencia, Sabadell, Asturias and Gipuzkoa. 2506 women (95%) delivered a live infant, and 2007 children (80%) 
were followed until the age of 4–5 years and tested between March 2009 and January 2013. The final study sample included 1803 
children (72%) with valid neuropsychological assessment. 
No report of maternal age. Maternal country of birth (measure of ethnicity) included in analysis, but % distribution not reported. 
Outcome measures A version of the McCarthy Scales of Children’s Abilities (MSCA) adapted to the Spanish population. 
The MSCA includes both a general cognitive scale (GCS) and the motor scale. 
The cognitive function included four additional subscales (verbal, perceptual-performance, quantitative and memory). 
The motor function was disaggregated into gross and fine motor subscales. 
Time between baseline 
exposure and outcome 
assessment 
3 maternal baseline exposures reflect different time points: 
1) Spot urine (and blood samples) collected before 24 gestational weeks: mean (SD) 13.5 (2.0) weeks. 
2) FFQ (intake of iodine, dairy and seafood) administered twice (11-13 wks and 28-32 wks gestation) and used to estimate average 
dietary intake from last menstrual period to 3rd trimester. 
3) Iodine supplement intake estimated as mean of months used, but unclear timing in pregnancy (se Comments to Murcia et al 2011). 
Children were tested at mean (SD) age 4.8 (0.6) yrs (range 4.0-6.4 yrs). 
Exposure assessment/ Dietary 
assessment method 
Semi-quantitative FFQ (100 items) administered twice. 
Structured questionnaire for intake of iodised salt (no, yes) and iodine containing supplements (brand name, composition, daily dose, and 
timing of consumption. Mean calculated for months of consumption). 
No. of subjects analysed Final study sample included 1803 children (72% of births) with valid neuropsychological assessment. 




Follow-up period, drop-out 
rate 
Children were followed for a mean (SD) period of 4.8 (0.6) yrs (range 4.0-6.4 yrs) after birth. 80% of live borne children were followed 
until the age of 4–5 years. Drop out (%) was 20%. 
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Results Iodine status in pregnancy (at mean (SD) 13.5 (2.0) weeks gestation 
Median (IQR) UIC in pregnant women was 123 (73, 208) µg/L before correction for creatinine. 
General cognitive score (GCS) as outcome (multivariable linear regression) 
Iodine intake (dietary iodine g/day, salt use, or iodine supplementation) was not associated with GSC. 
Urinary iodine excretion was not associated with GCS before adjusting for creatinine, but after. After adjusting by the residual method, 
children of women with UIC~Cr <100 μg/L had lower GCS scores (beta:-3.93, 95% CI: −6.18 to –1.69) compared with the reference 
category (150–249 μg/L). Similarly, a UIC/Cr <100 μg/g creatinine was associated with a lower score (beta:- 4.26, 95% CI: −6.57 to –
1.96) compared with 150–249 μg/g. By using the UIC/Cr ratio, the category 100–149 μg/g was also associated with reduced scores 
(beta: -5.28, 95% CI: -7.70 to -2.87). However, when missing creatinine values were imputed in sensitivity analysis, the associations with 
GCS lost significance (UIC~Cr <100 μg/L, beta=–1.85; 95% CI −3.78 to 0.08), or coefficients for the ratios UIC/Cr <100 μg/g and 100–
149 μg/g were attenuated. 
Motor development as outcome (multivariable linear regression) 
Dietary iodine intake was inversely associated with motor development: a 100 μg/day increase was associated with a 2.41 decrease in 
score (beta: -2.41; 95% CI: −3.98 to –0.85). Dairy intake and, specifically, milk intake (not other dairy products or seafood) accounted 
for the association (beta: −1.36; 95% CI: −2.12 to –0.61; per one daily serving of milk).  
Urinary iodine excretion was not associated with motor skills, before or after adjustment for creatinine.  
All models were adjusted for psychologist, child’s age at evaluation and gender, and maternal history of thyroid disorder and education. 
GCS models were additionally adjusted for birth order, main care provider at evaluation, occupational social class, paternal education, 
maternal intelligence proxy. 
No interaction was found between iodine from supplements and iodised salt use and iodine status from diet, or between child’ gender 
and GCS or motor scores. 
Number of tests: A total of 8 maternal iodine exposures (UIC, UIC adjusted for creatinine by 2 methods, iodized salt intake, iodine 
supplementation, iodine intake, dairy intake, and seafood intake) were tested against two main scales; general cognitive scale (GCS) and 
the motor scale, and 4 subscales of GCS and 2 subscales of the motor scale (fine and gross). 
Without considering sub-scales, significant inverse associations were reported for two of eight iodine exposures with motor scores; iodine 
intake and dairy intake (due to milk when disaggregated). 
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Reference details, first 
author, year, country 
Murcia et al. (2018) Iodine intake from supplements and diet during pregnancy and child cognitive and motor 
development: the INMA Mother and Child Cohort Study, Spain 
Without considering sub-scales, significant associations were reported for two of eight iodine exposures with cognitive scores; low UIC 
after adjustment for creatinine with either method, was associated with lower scores. 
Comments The sub-cohorts are from four iodine-sufficient or mildly iodine-deficient regions in Spain, according to paper. But it is not described 
which regions are considered deficient (or sufficient). Results could/should have been stratified or meta-analysed according to 
region/sub-cohort to account for differences in baseline status of iodine. Timing of iodine supplement use not clearly defined in this 
paper.  
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ST22 Summary table iodine 
Reference details, first 
author, year, country 
Murcia et al. (2011) Effect of iodine supplementation during pregnancy on infant neurodevelopment at 1 year of age, 
Spain 
Study design INMA (Infancia y Medio Ambiente (Environment and Childhood)) pregnancy cohort, multicentre, but only one centre included (Valencia) 
in current study. The study examined associations between maternal iodine nutrition and child neurodevelopmental outcomes using 
maternal UIC grouped into <100, 100-149, 150-249 and ≥250 µg/L, maternal use of iodized salt (yes/no), maternal intake of iodine rich 
foods by FFQ, and maternal iodine intake from supplements (µg/day) grouped into <100, 100-149 and ≥ 150 µg/day. 
Population, subjects 855 women enrolled during first prenatal visit to Le Fe hospital in Valance before 13 wks gestation, of which 691 mother-child pairs with 
data on maternal UIC and child mental and motor development. Mean (SD) age of mothers: 30.1 (4.4) yrs 
Ethnicity of mothers: 83/691 (12%) had country of origin other than Spain. 
Outcome measures Bayley Scales of Infant Development tested at age 1 yr (range 11-16 mths). 
Only Mental Scale (163 items) and Motor Scale (81 items) used. 
Mental Development Index (MDI) and Psychomotor Development Index (PDI) obtained by adjusting raw scores for psychologist and 
child’s age at testing.  
PDI score < 85 (No/Yes) – corresponds to PDI < 1 SD of mean (outcome for logistic regression). 
Time between baseline 
exposure and outcome 
assessment 
3 maternal baseline exposures at different time points: 
1) Spot urine (and blood samples) taken at end of 1st trimester (mean week 12.4, SD=0.66). 
2) FFQ intake (dairy and seafood) estimated twice (11-13 wks and 28-32 wks gestation) and used to estimate average intake from last 
menstrual period to 3rd trimester. 
3) Iodine supplement use estimated as mean of months used, but unclear timing (se Comments further down). 
Outcome assessment 1 yr (11-16 mths) after birth. 
Exposure assessment/ Dietary 
assessment method 
Semi-quantitative FFQ (100 items, 11 dairy, 11 fish), adapted from Willett, translated and validated. 
Structured questionnaire for intake of iodised salt (no, yes) and iodine containing supplements (brand name, composition, daily dose, and 
timing of consumption. Mean calculated for months of consumption). 
No. of subjects analysed 691 children included in regression models with MDI and PDI as outcomes, excluding children tested at older age (n=4), incomplete 
neuropsychological assessment (n=8), clinical conditions=5 (preterm=2, Down syndrome=1, epilepsy=1, autism=1). 
Note: 2 outliers for mental and 2 outliers for psychomotor scores (<4 SD or > 4SD from mean) excluded from analysis according to 
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Reference details, first 
author, year, country 





Follow-up period, drop-out 
rate 
Follow-up: from 1st trimester of pregnancy (inclusion) to infant neurodevelopmental testing at 1 yr (11-16 mths). 
Drop out: from inclusion (n=855 mothers) to child testing at age 1 yr (n=708 children)=(855-708)/855=17%. 
Results Statistically significant results related to maternal supplement intake, reported in Table 3: 
Maternal intake of ≥150 μg/day, compared with <100 μg/day, of iodine from supplements associated with a 5.2-point decrease in PDI 
(ꞵ=-5.2, 95% CI: -8.1, -2.2, linear regression, F-test overall p-value 0.002) and 1.8-fold increase in odds of having a PDI <85 (OR=1.8, 
95% CI: 1.0, 3.3, logistic regression, Likelihood ratio overall p-value 0.013). 
Sig p-value for interaction between iodine supplements and child’s sex of having PDI <85 (p=0.01).  
When stratified by sex, the association was intensified for girls, but not sig in boys: 
Girls (n=325): ꞵ=-8.7 95% CI: -13.0, -4.4, p<0.001 overall; OR=4.0, 95% CI: 1.4, 11.4, p=0.017 over all categories) 
Boys (n=357: ꞵ=-1.8, 95% CI: -6.0, 2.5, p=0.56 overall; OR=1.1, 95% CI: 0.5, 2.2, p=0.013 over all categories). 
Results on iodine supplements were adjusted for child’s sex, maternal age, mother’s cohabitant (father or other), social class, day-care 
attendance, and maternal history of thyroid disease. ORs also adjusted for country of origin. 
No sig associations found for other exposures (maternal UIC categories, intake of iodized salt, intake of dairy foods, or seafood) 
with PDI score. No sig associations found for any of the exposures (maternal UIC, iodine from supplements, intake of iodized salt, intake 
of dairy foods, and seafood) and MDI (Mental development index). Multivariable model results presented in Web Table 2. 
Number of tests: the main study objective was related to maternal iodine supplementation, but five maternal iodine exposures (UIC, 
iodized salt intake, iodine supplementation, dairy intake, and seafood intake) were tested against two outcomes in infants; the mental 
development index (MDI) and psychomotor development index (PDI). A statistically sig inverse association was reported for maternal 
iodine supplementation and PDI (lower PDI with higher supplement dose) regardless of scale (continuous or categorical) but was limited 
to girls. No other association reached statistical significance (p<0.05). 
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Reference details, first 
author, year, country 
Murcia et al. (2011) Effect of iodine supplementation during pregnancy on infant neurodevelopment at 1 year of age, 
Spain 
Comments Note: Valencia region described as iodine sufficient in later publication Murcia et al. 2018. Maternal iodine status (median UiC for group) 
not reported, but 55% of women had UIC <150 µg/L (Table 2). 
Main findings relate to iodine supplement intake, but unclear timing. Stated in paper that starting time of supplement intake (before or 
after the end of the first trimester of pregnancy) was not associated with neurodevelopment (data not shown). 
No estimate of dietary iodine. Typical iodine content of salt not reported. Strict cut-off value for sig statistical interactions (p<0.05). 
Interaction between iodine from reported main sources (supplements and salt) were tested for (reported in text) but not results found in 
paper so p-value was probably not statistically sig. 
Association maternal iodine supplement intake with infant neurodevelopment also investigated in remaining 3 study centres in separate 
publication: Rebagliato M et al. Am J Epidemiol 2013;177:944–53. 
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Reference details, first 
author, year, country 
Pedersen et al. (1993) Amelioration of some pregnancy-associated variations in thyroid function by iodine 
supplementation, Denmark 
Study design RCT of daily iodine supplementation (200 µg/day) in pregnant women from weeks 17-18 of pregnancy to 12 mths after delivery.  
Population, subjects Participants were normal pregnant Caucasian women attending the out-patient clinic of the Department of Obstetrics and Gynecology, 
Randers Centralsygehus, early in pregnancy as part of local routine. 
None had previous thyroid disease, and none took iodine supplementation or medication that could affect thyroid function. 
Of 74 women willing to participate, 20 left the study after first visit and 54/70=77% participated.  
Of the 54 women, 28 received iodine supplements and 26 were controls. 
The median age of women was 25.0 yrs in supplemented group and 26.3 yrs in control group. 
Outcome measures Maternal thyroid volume (ml - sonography) at gestational weeks 17-18, 28, 37; and 5 days, 26 wks, 52 wks after delivery. 
Thyroid function in women: serum TSH (mU/L), Tg (µg/L), T4 (nmol/L), T3 (nmol/L), free T4 (pmol/L), ratio T4/T3. 
Thyroid function in newborns (cord blood serum): TSH (mU/L), Tg (µg/L), T4 (nmol/L), T3 (nmol/L), free T4 (pmol/L). 
Iodine in morning spot urine samples. Urine sample at 52 weeks postpartum was taken after women had stopped taking iodine. 
Time between baseline 
exposure and outcome 
assessment 
Repeated measurements of the same women. Blood and urine samples were obtained at the time of measurement of thyroid volume and 
at 13 and 39 weeks after delivery.  
Exposure assessment/ Dietary 
assessment method 
None 
No. of subjects analysed Data available for 54 women during pregnancy and 49 women in the postpartum period. 
Intervention 
Intervention/ exposure 
Daily intake of 200 µg of iodine as 10 drops of KI solution from weeks 17-18 of pregnancy to 12 months after delivery. 
Probably no placebo control. 
Follow-up period, drop-out 
rate 
During the year after delivery, 5 women left the area (3 from the iodine supplementation group and 2 from the control group). They were 
excluded from the postpartum part of the investigation. 
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author, year, country 
Pedersen et al. (1993) Amelioration of some pregnancy-associated variations in thyroid function by iodine 
supplementation, Denmark 
Results Iodine status at baseline 
Median (95% CI) for UIC in pregnant women at initial visit was 51 (32-58) µg/L in controls and 55 (30-73) µg/L in group that later 
received supplements. 
Thyroid volume (Fig 3) 
Thyroid volume increased more in controls than supplemented group during pregnancy (p<0.05). 
T4, T3, T4/T3, free T4 in supplemented vs control group (Fig 1) 
 No significant differences were found between the control group than supplemented group in the developments of T4, T3, ratio T4/T3 or 
free T4 during pregnancy or postpartum.  
Tg and TSH in supplemented vs control group (Fig 2)  
Maternal Tg values were significantly higher in controls at all time points, except before initiation of iodine supplementation. Tg in cord 
blood was also sig higher in children of control mothers (p=0.005). 
In the control group, there was a sig increase in TSH during pregnancy (P <0.01), whereas no sig increase was found in the iodine 
supplemented group (P = 0.29, by Friedman’s test). During the postpartum period, there was no significant difference in TSH between 
groups. 
Authors’ interpretation: low iodine intake/status during pregnancy creates thyroidal stress (increases in thyroid size, higher Tg) which 
was ameliorated by iodine supplementation. Hormone levels did not change, suggesting that the thyroid gland was able to adapt under 
the (normal) circumstances in the study. 
Comments Unclear randomisation process, probably no placebo given to controls, relatively small but solid. 
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Reference details, first 
author, year, country 
Rasmussen et al. (2002) Relations between various measures of iodine intake and thyroid volume, thyroid nodularity, 
and serum thyroglobulin, Denmark 
Study design Study uses baseline data from the DanThyr (Danish Investigation of Iodine Intake and Thyroid Diseases) cohort study. 
Participants met for clinical examination at baseline. Inclusion period from 10 March 1997 to 1 June 1998. 
Population, subjects Recruitment from 2 cities: Aalborg and Copenhagen. 
Random samples drawn from civil registration system of all inhabitants of the regions around the 2 cities. 
Study population included women aged 18–22, 25–30, 40–45, and 60–65 y and men aged 60–65 y. 
Younger subjects and women were oversampled.  
Response rate (enrolled/invited) = 4649/9274= 50.1%. 
Of 4649 subjects studied at baseline, 62 (1.3 %) were pregnant and 85 (1.8 %) were lactating. Ethnicity not reported. 
Stated in paper that children were not included because unpublished observations did not show cases of goiter in schoolchildren. 
Outcome measures Thyroid volume (ultrasonography): calculated as the max length × width × depth × 𝜋/6 of each lobe. 
Thyroid enlargement (thyroid volume >18 mL for women and > 25 mL for men). 
Thyroid nodules (ultrasonography): presence of all solitary nodules > 5 mm against no nodules; all solitary nodules > 10 mm against no 
nodules; all multiple nodules > 5 mm against no nodules; multiple nodules > 10 mm against no nodules. 
Serum thyroglobulin (Tg) and thyroid stimulating hormone (TSH): immunoluminometric assays (Lumitest). 
Thyroglobulin antibodies: radioimmunoassay (DYNOtest) with a functional assay sensitivity < 20 kU/L.  
Time between baseline 
exposure and outcome 
assessment 
All data from clinical baseline examination. FFQ completed while waiting for examination. Not possible to determine time period covered 
by FFQ from paper. Supplement use appears to be current use. 
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Reference details, first 
author, year, country 
Rasmussen et al. (2002) Relations between various measures of iodine intake and thyroid volume, thyroid nodularity, 
and serum thyroglobulin, Denmark 
Exposure assessment/ Dietary 
assessment method 
Iodine intake from foods: semi-quantitative, validated FFQ, 53 items, iodine rich foods, described more elsewhere (Rasmussen LB et al. 
Eur J Clin Nutr 2001;55:287–92). 
Iodine intake from supplements: subjects were asked to bring in all dietary supplements, and brand names, dosage, and frequency of use 
were recorded. If they forgot to bring the supplements (< 5% did so), they were interviewed about current supplement use. 
7 measures/models of iodine intake were analysed 
1. Iodine excretion, spot urine (µg/L): <20, 20–49.9, 50–99.9, >= 100 
2. Estimated 24-h iodine excretion (µg/d): <50, 50-99.9, 100-149.9, >=150 
3. Total iodine intake (from the diet plus supplements, µg/day, quintiles): <= 80, 81-126, 127-187, 188-256, >256 
4. Iodine intake from the diet (ug/day, quintiles): <=70, 71-98, 99-130, 131-175, >175 
5. Iodine intake from the diet/kg body wt (µg/kg): <=1.1, 1.1–1.4, 1.5-1.9, 2.0-2.5, > 2.5 
6. Iodine intake index (low, medium, high) 
7. Milk intake (glasses/day): 0–0.2, 0.3–1.0, 1.1–2.0, 2.1–3.0, >3.0 
A low iodine intake index was < 75 g fish/wk and < one-half glass of milk/d and a high iodine intake index was > 200 g of fish/wk and ≥ 
0.5 L milk/d. Medium iodine intake index presented in paper, but not defined. 
Note: Iodized salt was illegal in Denmark at the time the study took place. 
Note: All milk and milk products were included in milk intake according to Methods, but presented as glasses in Tables. 
No. of subjects analysed Multivariate models for Tvol and thyroid enlargement as outcome included around 4100-4300 participants, depending on iodine exposure. 
Multivariate models for nodules as outcome included from 3412 to 3819 participants, depending on iodine exposure and nodule outcome 
(all, multiple, or solitary nodules). 
Subjects being treated for thyroid disease (n = 77) were not included in the analysis. 






Follow-up period, drop-out 
rate 
Cross-sectional, no follow-up. 
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Results Iodine status: 
Median (IQR) UIC (spot urine) was 68 (38–112) µg/L in Copenhagen and 53 (30–90) µg/L in Aalborg. 
Median (IQR) estimated 24-h iodine excretion was 111 (74–180) µg/d in Copenhagen and 74 (48–126) µg/d in Aalborg. 
Results from 7 multivariable regression models (each iodine exposure) per outcome: 
Notes regarding estimates: the paper reports estimates for 7 different iodine exposures (categorised) with each of 5 outcomes (mean 
Tvol; thyroid enlargement (no, yes); multiple nodules (no,yes), solitary nodules (no,yes), or mean Tg). Selected estimates (highest vs 
lowest) have been extracted for exposure models 1-3 which are considered most relevant (sport urine, estimated 24-h iodine excretion, 
and total iodine intake). Results are based on the two cities combined; Copenhagen with mild ID and Alborg with moderate ID. The 
reference categories (lowest) for odds ratios (ORs) are quite low (as specified under exposure models).  
Log Tvol/geometric means (Table 2, linear reg) or thyroid enlargement (Table 3, logistic reg) as outcome: Significant 
(P<0.05) inverse relations with 4 of 7 iodine measures (24-h urinary iodine, total iodine intake from diet and supplements, iodine from 
diet/kg body wt, milk intake in glasses/day), but not urinary iodine excretion (µg/L), iodine from diet only (excl supplements), and iodine 
index. Risk estimates (ORs) for the highest categories of iodine from diet only, and the iodine index were significant although overall p-
value was not.Log serum Tg as outcome (Table 5): All 7 iodine measures were significantly inversely related (p<=0.002) to log 
serum Tg concentration 
Occurrence of thyroid nodules as outcome (Table 4, logistic reg): Results less clear than for Tvol and Tg. Iodine measures most 
strongly and inversely related to nodules were iodine intake from diet/kg body wt, milk intake, and total iodine intake (diet and 
supplements). 
Models 1,2,3 
High-low effect estimates 
Thyroid enlargement 
(>18 mL for W, > 25 mL for M) 
OR (95% CI) 
Nodules, multiple or solitary 
OR (95% CI) 
Model 1: UIC spot urine 
≥ 100 vs < 20 µg/L (ref) 
0.81 (0.61, 1.08) 
Non-sig 
Reported as NS,  
multiple and solitary 
Model 2: 24-h urinary iodine 
excr. ≥150 vs <50 µg/d (ref) 
0.54 (0.41, 0.70) Reported as NS for multiple.  
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Rasmussen et al. (2002) Relations between various measures of iodine intake and thyroid volume, thyroid nodularity, 
and serum thyroglobulin, Denmark 
 Solitary (all): 
0.90 (0.66, 1.22) 
Model 3: total iodine (diet + 
suppl) intake >256 vs. ≤ 80 
µg/d (ref) 
0.68 (0.51, 0.89) 
 
Multiple (all): 0.64 (0.47, 0.88) 
Solitary (all): 0.70 (0.51, 0.95) 
 
Models 1,2,3 
High-low effect estimates 
Predicted geometric mean (95% CI),  
Tvol, ml 
Predicted geometric mean (95% CI), 
serum Tg, µg/L 
Model 1: UIC spot urine ≥ 
100 vs < 20 µg/L 
13.8 (13.4, 14.2) vs 14.0 (13.5, 14.6) 19.4 (17.0, 22.1) vs 29.0 (24.9, 33.6) 
Model 2: 24-h urinary iodine 
excr. ≥150 vs <50 µg/d 
13.3 (13.0, 13.7) vs 14.4 (13.9, 14.9) 18.9 (16.5, 21.6) vs 33.0 (28.7, 38.0) 
Model 3: total iodine intake 
(diet + suppl) >256 vs. ≤ 80 
µg/d 
13.7 (13.3, 14.2) vs 14.7 (14.2, 15.2) 20.0 (17.4, 23.0) vs 29.2 (25.4, 33.6) 
All models were adjusted for city, subject group (age and sex), smoking (daily smoker or not daily smoker), drinking (≥8 drinks/wk or < 
8 drinks/wk), and thyroid disease in the family.  
Comments Statistical notes: Can’t tell which tests were used to calculate p-values. Total iodine intake (diet and supplements) more strongly 
associated with Tvol than iodine intake from diet adjusted for iodine supplement intake (Table 2 footnote).  
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Reference details, first 
author, year, country 
Rebagliato et al. (2013) Iodine Supplementation During Pregnancy and Infant Neuropsychological Development INMA 
Mother and Child Cohort Study, Spain 
Study design Prospective cohort study 
Population, subjects This multicentre mother and child cohort study was established in Spain between 2003 and 2008, and the present analyses is based on 
data from the regions of Sabadell (Catalonia), Asturias, and Gipuzkoa (Basque County). Women were enrolled during their first visit to the 
main public hospital or a regional health centre and were followed through pregnancy. A total of 1789 women agreed to participate and 
met the following inclusion criteria; ≥16 years of age, singleton pregnancy, intention to deliver at the reference hospital, no 
communication handicap, and no assisted conception. After excluding the women who withdrew from the study, were lost to follow-up, 
had induced or spontaneous abortions, or foetal deaths, the study sample comprised 1719 women who delivered a live infant between 
October 2004 and August 2008. 
Outcome measures Infant neuropsychological development. Cognitive and psychomotor development  was assessed using the Bayley Scales of Infant 
Development in infants median age 16 mo. 
Time between baseline 
exposure and outcome 
assessment 
From enrolment of pregnant women during their first routine antenatal care visit and until outcome assessment at child age 1 year. 
Exposure assessment/ Dietary 
assessment method 
- A FFQ was administered twice, at 10-13 weeks and 28-32 weeks of gestation, to assess the usual dietary intake of 100 food items 
and beverages from the last menstrual period until the third trimester of pregnancy.  
- Information of the consumption of iodized salt and the use of specific potassium iodine supplements or vitamin/mineral preparations 
containing iodine was collected using a structured questionnaire. Iodine intake from supplements was estimated based on the 
supplement brand name and composition, daily dose, and timing of consumption. 
- Urinary iodine concentration (UIC) was measured in spot samples. 




Follow-up period, drop-out 
rate 
From baseline to follow-up at child age 1 year. Among the pregnant women who agreed to participate in the present study (n=1789), 
89% of their children (n=1532) were evaluated or neuropsychological development at 1 year of age. 
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Rebagliato et al. (2013) Iodine Supplementation During Pregnancy and Infant Neuropsychological Development INMA 
Mother and Child Cohort Study, Spain 
Results Median iodine intake from diet was 162 µg/day (IQR:133-191 µg/day).  
Mean supplementary iodine intake during the months of consumption was classified as a mean dose <100 µg/day, 100-149 µg/day, or 
≥150 µg/day (range, 150-400 µg/day). A total of 45, 15.2, and 39.8% of the participants belonged to the different categories, 
respectively.  
Median UIC was 125 µg/L (IQR:72-212 µg/L) in the total sample.  
Maternal consumption of 150 µg/day or more of iodine from supplements was associated with a non-significant decrease of 1.8 (95% CI: 
−5.6, 2.0) in mental scores and of 0.9 points (95% CI: −6.9, 5.0) in psychomotor scores. The corresponding risks of low mental and 
psychomotor scores (<85) when compared with supplemental iodine <100 µg/day was 1.7 (95% CI: 0.9, 3.0) for mental scores and 1.5 
(95%CI: 0.8, 2.9) for psychomotor scores. However, these associations did not reach statistical significance. Findings previously reported 
in the Valencia cohort (Murcia et al. 2011) were only partially verified. However, when the results from Murcia et al. (2011) were included 
in a meta-analyses with results from the other three sub-cohorts, there was a 1.7-fold increase in the odds of a psychomotor score less 
than 85. 
In conclusion, maternal UIC, iodized salt consumption, and dietary iodine intake during pregnancy were not associated with 
neuropsychological development. 
Comments  
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SI  
Author, year, study name Rebagliato et al. (2013) Iodine Supplementation During Pregnancy and Infant Neuropsychological Development INMA Mother and 
Child Cohort Study, Spain. 
Exposure Iodine intake 
Dietary assessment method** Food Frequency Questionnaire (FFQ) 
Food composition database*** 
Definition of relevant nutrient**** 
The iodine contents of the food items were primarily obtained from food composition tables from the US Department of Agriculture 
and from additional information available for iodized salt in Spain. 
Internal calibration (or validity) of 
dietary assessment (y/n) - if yes -  
provide data 
The authors confirm that the questionnaire has previously been used and validated in the general population in Valencia, Spain. 
Biomarker assay***** Iodine in spot urine and serum thyroid hormones (TSH and free thyroxine). 
Analytical validity of biomarker data 
reported? (y/n) – if yes – provide 
data 
No 
Time between biomarker sampling 
and analysis 
No information provided. 
Season/ date when biomarker 
samples were drawn 
No information provided. 
Background exposure data  
* write “nd” if there was no data reported. Please do not leave blank 
** please refer to brief name indicated in dietary assessment method table. If other method was used, please describe the detail 
*** specify database used to calculate nutrient intakes. Other nutrient analysis, please specify 
**** E.g. are carbohydrates expressed as available carbohydrates by difference, is fibre included in the carbohydrates or not, retinol equivalent or retinol activity etc. Chemical 
form of the nutrient 
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Reference details, first 
author, year, country 
Rebagliato et al. (2010) Iodine intake and maternal thyroid function during pregnancy, Spain 
Study design Cross-sectional study 
Population, subjects Between 2004 and 2008, pregnant women were recruited at their first routine antenatal care visit in the main public hospital or health 
centre of reference in the regions of Sabadell (Catalonia) , Asturias, and Gipuzkoa (Basque County). A total of 2137 women agreed to 
participate and met the inclusion criteria. The study included participants being at least 16 years old, having a singleton pregnancy, and 
not following any program of assisted reproduction. In addition, only women providing a serum sample available for thyroid hormone 
testing and questionnaire data on iodine intake before 24 weeks of gestation were included in the study. Those who reported having 
been diagnosed with thyroid pathology, regardless of whether or not they continued in treatment, were excluded from the analyses. 
Outcome measures Thyroid hormones (TSH and free thyroxine). 
Time between baseline 
exposure and outcome 
assessment 
NA 
Exposure assessment/ Dietary 
assessment method 
- A FFQ  was used to assess the usual dietary intake of 100 food items and beverages from the last menstrual period to the time of 
interview.  
- Iodine concentrations were measured in a spot urine sample. 
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Rebagliato et al. (2010) Iodine intake and maternal thyroid function during pregnancy, Spain 
Results In the total sample, 64% of the participants reported adequate iodine intake (≥160 µg/day) and 96% of the iodized salt consumers 
reported adequate iodine intake. Iodine intake from supplements was categorised as 0-99, 100-199 and ≥200 µg/day, in which 51, 16 
and 33% of the total sample belonged to the different categories, respectively. 
Urinary iodine concentration was categorised as <50, 50-99, 100-149, 150-249, and 250+ µg/L in which 9, 23, 22, 25 and 21% of the 
total sample belonged to the different categories, respectively. 
Consumption of ≥200 µg/d supplemental iodine was associated with higher TSH levels (β=0.090 (95% CI: 0.003, 0.177) and increased 
risk of hyperthyrotropinemia (TSH>3 µU/mL) compared to those consuming less than 100 µg/d (adjusted odds ratio=2.5 (95% CI; 1.2-
5.4). The results showed no association between urinary iodine and TSH levels. Pregnant women from the area with the highest median 
iodine (168 µg/L) and highest supplement coverage (93%) showed the lowest values of serum free thyroxine (geometric mean = 10.09 
pmol/L (9.98-10.19). 
Comments  
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SI  
Author, year, study name Rebagliato et al. (2010) Iodine intake and maternal thyroid function during pregnancy, Spain 
Exposure Iodine intake 
Dietary assessment method** Food Frequency Questionnaire (FFQ). 
Food composition database*** 
Definition of relevant nutrient**** 
Iodine values were obtained primarily from food composition tables from the US Department of Agriculture and from additional 
information available for iodized salt in Spain. 
Internal calibration (or validity) of 
dietary assessment (y/n) - if yes -  
provide data 
The authors confirm that the questionnaire has previously been used and validated in the general population in Valencia, Spain. 
Biomarker assay***** Iodine in spot urine and serum thyroid hormones (TSH and free thyroxine). 
Analytical validity of biomarker data 
reported? (y/n) – if yes – provide 
data 
No 
Time between biomarker sampling 
and analysis 
No information provided. 
Season/ date when biomarker 
samples were drawn 
No information provided. 
Background exposure data  
* write “nd” if there was no data reported. Please do not leave blank 
** please refer to brief name indicated in dietary assessment method table. If other method was used, please describe the detail 
*** specify database used to calculate nutrient intakes. Other nutrient analysis, please specify 
**** E.g. are carbohydrates expressed as available carbohydrates by difference, is fibre included in the carbohydrates or not, retinol equivalent or retinol activity etc. Chemical 
form of the nutrient 
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Reference details, first 
author, year, country 
Robinson et al. (2018) Preconception Maternal Iodine Status Is Positively Associated with IQ but Not with Measures of 
Executive Function in Childhood, UK 
Study design Prospective mother-offspring cohort: The Southampton Women’s Survey (SWS). 
Population, subjects A cohort of 12,583 non-pregnant women aged 20-34 were recruited through GPs in Southampton 1998-2002. These were interviewed at 
home by study nurses and provided blood and urine samples. The 3158 women who became pregnant within the study period and had a 
live singleton infant were followed up in pregnancy and their children have been assessed in ongoing follow-up studies. Ethnic 
background is not stated, but may be assumed to be predominantly Caucasian (Approximately 94% of the Southampton population are 
white according to the SWS Cohort profile paper (Inskip, 2006)). 
Outcome measures Offspring cognitive ability at age 6-7 was assessed by full scale IQ and executive function measured at home visit in 2010, supervised by 
educational psychologist. Full-scale IQ was assessed by the 2-subtest form of the Wechsler Abbreviated Scale of Intelligence (WASI). 
Executive function by three tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB). 
To reduce the likelihood of chance findings only the following three subscores of CANTAB were applied: 1: Delayed Matching to Subject 
(DMS) memory test: total correct (12 s delay); 2: Spatial Span (SSP) memory test assessing working memory capacity: span length 
(longest sequence successfully recalled); 3: Intra-Extra Dimensional Set Shift (IED) test: total errors (adjusted for each stage not 
attempted due to failure). Maternal (full-scale IQ) was also assessed using WASI.  
Data was analysed with linear regression using standardised z-scores of the respective outcome measures as dependent variables and 
maternal preconception iodine status (iodine:creatinine ratio) as independent variable. 
Time between exposure and 
outcome assessment 
Exposure assessed median 3.3 years (interquartile range 2.2-4.7 years) before conception, outcome assessed in offspring at age 6-7 
years. 
Exposure assessment/ Dietary 
assessment method 
Maternal preconception iodine status measured by iodine:creatinine ratio (I/Cr) in spot urine samples at enrolment  
Maternal diet was assessed by an administered FFQ before conception and in early and late pregnancy. Detailed information on 
supplement use was collected; supplementary iodine intakes were calculated with the use of manufacturers’ composition data, together 
with participants’ reported supplement frequency, dose, and duration of use. (The maternal iodine intake in pregnancy was included as a 
covariate in the main analysis to improve the accuracy of the model.) 
No. of subjects analysed Of the 942 children who had an assessment of cognitive function at age 6-7 years, 58 (6%) were preterm (born before gestation week 
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Robinson et al. (2018) Preconception Maternal Iodine Status Is Positively Associated with IQ but Not with Measures of 
Executive Function in Childhood, UK 
Results Median maternal preconception UIC was 108 (IQR: 62-168) μg/L and median I/Cr was 114 (IQR: 76-164) μg/g.  
In statistical analysis, four different associations were studied, i.e. the associations of preconception urinary I/Cr ratio with the four 
respective outcome parameters in the offspring at age 6-7 years: IQ determined by WASI, and the executive function subtests DMS, SSP 
and IED determined by CANTAB. Altogether 16 statistical tests appear to have been performed, i.e. associations of urinary I/Cr ratio with 
the 4 outcome parameters x 2 analyses according to covariate adjustment (crude and adjusted) x 2 analyses according to the nature of 
the exposure variable (continuous and in categories according to predefined cutoffs). Corrections for multiple testing were not made. 
One statistically significant finding: There was a statistically significant positive linear association between preconception I/Cr and 
offspring IQ. Beta-coefficient 0.13 (95% CI 0.04, 0.21) SD (standardised z-score) higher IQ z score per z score higher I/Cr after 
adjustment for maternal IQ, maternal education, and maternal pre-pregnancy BMI, breastfeeding duration, smoking in pregnancy, sex, 
age, and maternal iodine intakes in pregnancy. In comparison with children of women with an I/Cr ≥150 μg/g, children of women with 
preconception urinary I/Cr <50 μg/g (moderate iodine pre-pregnant iodine deficiency) had 0.49 (95% CI: 0.79, 0.18) SD lower IQ, which 
is equivalent to a difference of 7.5 IQ points. 
Three null findings: Maternal I/Cr was not associated with any of the three executive function outcomes assessed using CANTAB. 
Comments  
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Reference details, first 
author, year, country 
Skeaff et al. (2012) A comprehensive assessment of urinary iodine concentration and thyroid hormones in New Zealand 
schoolchildren: a cross-sectional study, New Zealand 
Study design Cross-sectional 
Population, subjects “Children‘s Nutrition Survey”; cross-sectional survey of a nationally representative sample of New Zealand school children aged 5-14 
years, carried out 2002. Two-stage school-based sampling frame with over-sampling of Māori and Pacific children to allow for ethnic 
specific analysis. Schools were randomly selected from the Ministry of Education rolls and children from these schools were randomly 
selected in proportion to the number of children on the school roll. Blood and urine samples were collected from a subset of children 
during school hours (urban schools only, to avoid long transport affecting stability). Of 200 invited schools, 172 schools (86%) agreed. Of 
4728 invited children in the participating schools, 3275 (69%) participated. Urine was collected from 1796 children (55% of participants). 
Blood was collected from 1927 children (59% of participants). Finally, 1153 children had available measurement data for exposure and 
outcomes and were included in the analysis (35% of participants; 24% of the invited children in the schools that had agreed). 611 were 
boys and 542 were girls. Children were categorised into three ethnic groups based on parental report; Māori (n=338; 29%), Pacific 
(n=482; 42%), and New Zealand European & all Other ethnicities (“NZEO”: n=333; 29%). 
Outcome measures Thyroid function defined by serum thyroglobulin (Tg), serum Thyroid Stimulating Hormone (TSH), plasma free thyroxine (fT4) and free 
triiodothyronine (fT3). Regression analysis was performed to estimate mean and 95 confidence intervals of the four blood biomarkers 
according to iodine status categories defined by UIC cutoffs of 50 µg/L and 100 µg/L, respectively. The data analysis took into account 
the clustering (school-based design), weighting (urban children and ethnic groups), socioeconomic status (based on deprivation index of 
residential address), age, sex and ethnicity. 
Time between exposure and 
outcome assessment 
Cross sectional design; the urine samples for exposure assessment (UIC) and the blood samples for outcome assessment (Tg, TSH, fT4 
and fT3) were collected at the same time. 
Exposure assessment/ Dietary 
assessment 
Iodine status defined by urinary iodine concentration (UIC) in a spot urine sample (µg/L). 
A 24-hour diet recall was collected from participating children, but iodine intakes were not determined since the iodine content of foods 
was neither complete nor reliable in the New Zealand Food Composition Database. 
No. of subjects analysed n=1153 children 
Follow-up, drop-out See “population and subjects” for attendance rate. 
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Skeaff et al. (2012) A comprehensive assessment of urinary iodine concentration and thyroid hormones in New Zealand 
schoolchildren: a cross-sectional study, New Zealand 
Results Median UIC was 68 (IQR: 50-95) µg/L. Tg was lower at UIC ≥100 µg/L (estimated mean 10.3 (95% CI 8.8, 12.1) µg/L) and higher at UIC 
<50 µg/L (estimated mean 15.6 (95% CI 14.0, 17.3) µg/L) while there were only minor differences in the other outcome parameters. 
Compared with children who had UIC ≥50 µg/L, those with UIC <50 µg/L had statistically significantly higher Tg (estimated mean 15.6 
vs. 12.3 µg/L) and fT3 (estimated mean 6.1 vs. 5.9 pmol/L), while TSH and fT4 did not differ according to this cutoff. Correspondingly, 
compared with children who had UIC ≥100 µg/L, those with UIC <100 µg/L had statistically significantly higher Tg (estimated mean 13.9 
vs. 10.3 µg/L) and fT3 (estimated mean 6.0 vs. 5.9 pmol/L), while TSH and fT4 did not differ between the groups. 
Comments  
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author, year, country 
Snart et al. (2019) Maternal Iodine Status and Associations with Birth Outcomes in Three Major Cities in the United 
Kingdom, UK 
Study design Data from pregnant women in London, Manchester and Leeds participating in the Screening for Pregnancy Endpoints (SCOPE) birth 
cohort (n=541) were used to assess prospective associations between maternal iodine status (UIC) in two spot urines (donated in 
gestational weeks 15 and 20) and birth outcomes.  
Population, subjects  
Outcome measures Pregnancy outcomes: primary outcome: birth weight and birth weight centile, secondary outcomes: birth weight, small for gestational 
age (SGA, defined as<10th customised centile adjusted for maternal height, weight, parity, ethnicity, gestational age and sex), and 
spontaneous preterm birth (<37 completed weeks). 
Time between baseline 
exposure and outcome 
assessment 
15 gw to delivery 
Exposure assessment/ Dietary 
assessment method 
Urinary iodine concentration was measured in two spot urines, one in 15 gw and one in 20 gw. The mean UIC of both time points were 
the main exposure. Median UIC was 134 µg/L, (139 µg/L in Manchester, 130 µg/L in London and 116 µg/L in Leeds), and the proportion 
with UIC <50 µg/L was <20% in all three cities. 




Follow-up period, drop-out 
rate 
Follow up from recruitment (antenatal visit) in week 15 to delivery. 
Results No evidence of an association between UIC and birth weight centile (-0.2% per 50 µg/L increase in UIC), nor with odds of spontaneous 
preterm birth (odds ratio: 1.00; 95%CI: 0.84, 1.20) or SGA (odds ratio: 1.09,; 95%CI: 1.00, 1.20). Sensitivity analyses gave similar 
results (using creatinine adjusted UIC, µg/g Cr) and assessing iodine at the individual time points.  
Comments The study population was small and the participants were only mildly iodine deficient (median UIC was 134 µg/L and <20% had UIC 
below 50 µg/L). The participants were not sufficiently iodine deficient to detect associations.  
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Reference details, first 
author, year, country 
Sun et al. (2019) Association between iodine intake and thyroid autoantibodies: a cross-sectional study of 7073 early 
pregnant women in an iodine-adequate region, China 
Study design Cross-sectional study examining associations between UIC and thyroid autoantibodies in pregnant women in two Chinese cities. 
Population, subjects 7073 pregnant women recruited in gestational weeks 4-8 (mean 7.2) in the cities Dalian and Shenyang in 2012-2014. Age range 19-40 
years. 
Outcome measures Thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) positivity defined by TPOAb > 34 IU/mL and TgAb > 115 IU/mL.  
The prevalence of TPOAb positivity was 8.8% and of TbAb was 12.2%. In total, 15.5% were positive to TPOAb, TgAb or both.  
Time between baseline 
exposure and outcome 
assessment 
None 
Exposure assessment/ Dietary 
assessment method 
Median UIC was 153.6 µg/L. UIC was categorised into five groups based on WHO criteria for pregnant women: UIC<100 µg/L (deficient), 
UIC 100-149.9 µg/L (borderline deficient), UIC 150-249.9 µg/L (adequate), 250-500 µg/L (more than adequate), and UIC ≥ 500 µg/L 
(excess). The distribution was 20.8% deficient, 27.4% borderline deficient, 34.2% adequate, 14.4% more than adequate, and 3.2% 
excessive. 




Follow-up period, drop-out 
rate 
 
Results Low urinary iodine (UIC<100 µg/L) was significantly associated with higher TPOAb as well as TgAb positivity. The adequate iodine group 
had the lowest antibody rates. Compared to individuals with UIC in the adequate group (150-249.9 µg/L), the adjusted odds of TPOAb 
positivity in those with UIC <100 µg/L was 1.64 (95%CI 1.29, 2.08) and the aOR for TgAb was 1.44 (95%CI 1.16, 1.80). The 
associations were not significant for the other iodine groups. 
Comments The associations were adjusted for age, weeks of gestation, BMI and mutual adjustment for TPOAb positivity and TgAb positivity.  
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Reference details, first 
author, year, country 
Thomson et al. (2009) Selenium and iodine supplementation: effect on thyroid function of older New Zealanders, New 
Zealand 
Study design Double-blind, randomised, placebo-controlled trial (RCT). 
Population, subjects This RCT was carried out with older male and female residents of Dunedin in the South Island of New Zealand from August to November 
2005. Participants were aged between 60 and 80 y; noninstitutionalised, were free from serious medical illness such as cancer, diabetes, or 
cardiovascular disease; were not using medications form thyroid function or with any known thyroid problems and were not taking 
multivitamin-multimineral or other dietary supplements that contained selenium or iodine. Block randomisation with stratification for sex was 
used to assign 76 participants into 1 of 3 treatment groups. 
Outcome measures Thyroid-stimulating hormone (TSH), free triiodothyronine (T3) free thyroxine (T4), thyroglobulin, plasma selenium, whole-blood glutathione 
peroxidase (GPx) activity, and urinary iodine concentration (UICs) were measured. 
Time between baseline 




Dietary assessment method 
- Blood and urine samples were collected in order to examine plasma selenium concentrations and urinary iodine concentration (UIC). 
- For dietary assessment, participants also completed a brief questionnaire that included questions on dietary habits, supplements and 
medication use, and consumption of foods high in selenium or iodine such as seafood and Brazil nuts. 
No. of subjects analysed A total of 100 participants at baseline, and 97 participants who completed the trial. 
Intervention 
Intervention/ exposure 
A population with moderate iodine deficiency (median UIC 48 µg/L) received 100 µg Se/d, 80 µg I, 100 µg Se + 80 µg I, or placebo for 3 
months. 
Follow-up period, drop-out 
rate 
From baseline to follow-up. Of the 102 participants initially randomly assigned to treatment groups, 1 participant was excluded from all 
analyses because her test indicated thyroid disease, 1 participant did not attend the baseline clinic, leaving 100 participants from whom 
baseline characteristics are reported. By week 12, a further 3 participants had dropped out, leaving 97 participant who completed the trial 
(23,25,24,25 in the placebo, selenium, iodine, and selenium plus iodine groups, respectively). A further 9 participants did not provide urine 
samples for reasons that include difficulty in passing urine or were unwilling to provide a sample. Compliance with supplement use was 
excellent with 90% of all participants consuming all supplements and 10% consuming between 97% and 99% of their supplements. 
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Thomson et al. (2009) Selenium and iodine supplementation: effect on thyroid function of older New Zealanders, New 
Zealand 
Results Median UIC at baseline was 48 µg/L (IQR:31-79 µg/L) in the total sample. 
Plasma selenium (p<0.0001) and whole-blood GPx activity (p<0.0001) increased from baseline to week 12 in the selenium and selenium 
plus iodine groups in comparison with the placebo group. UIC increased in the iodine and selenium plus iodine groups and was significant 
only form the iodine group (p=0.0014). Thyroglobulin concentration decreased by 24% and 13% of baseline in the iodine and selenium plus 
iodine groups in comparison with the placebo group (p=0.009 and p=0.108, respectively). No significant treatment effects were found for 
TSH, free T3, free T4, or ratio of T3 to T4. 
Comments  
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Reference details, first 
author, year, country 
Thomson et al. (2001) Urinary iodine and thyroid status of New Zealand residents, New Zealand 
Study design Cross-sectional 
Population, subjects Adult population in a low soil iodine area of the South Island of New Zealand. 350 Otago residents aged 18-49 years were recruited 1997-98. 
Initially recruitment was by random selection from the electoral roll and later by non-random selection from blood donors at the Dunedin 
Blood Bank. Of these, 233 subjects (114 men and 119 women, mean age 32 years) were recruited for assessment of thyroid hormone status 
in a blood sample and for thyroid volume by ultrasonography.  
Outcome measures Thyroid status determined from serum total thyroxine (T4), Thyroid Stimulating Hormone (TSH) and thyroglobulin (Tg), and thyroid volumes 
measured by ultrasonography. Thyroid hormone levels and thyroid volume of subjects were analysed according to three categories of I/Cr 
ratio divided according to the following cutoffs: Low (<40 µg/g Cr), medium (40-60 µg/g Cr) and high (>60 µg/g Cr). The cutoffs were 
chosen in order to give approximately equal numbers in each group, and were close to the criteria adapted from Clugston and Hetzel (1994) 
for adequate, low and marginal status. Comparisons of outcomes between the groups were done using multiple regression controlling for 
gender and weight. 
Time between baseline 
exposure and outcome 
assessment 
Cross sectional design; no time span between exposure and outcome measurements. 
Exposure assessment/ 
Dietary assessment method 
Iodine status measured by two 24-hour urine collections. Complete 24 h urine collections were done by all subjects on two occasions. An 
average of the two results was used to assess urinary iodine status. The following three measures are presented: 24 h urinary iodide 
excretion (µg/day), iodide/creatinine ratio (µg/g Cr) and urinary iodide concentration (µg/L). 
Diet was not assessed, but subjects completed a questionnaire on use of supplements and iodine-containing medications. 
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Thomson et al. (2001) Urinary iodine and thyroid status of New Zealand residents, New Zealand 
Results Mean (SD) 24-h UIE was 86 (49) µg/day. Mean (SD) UIC was 59 (33) µg/L. Mean I/Cr was 57 (35) µg/g. 
Thyroid status: In multiple regression analysis of thyroglobulin controlling for gender and weight showed a significant difference among the 
three groups categorised according to 24-hour excretion (P=0.019) and I/Cr ratio. 
(P=0.005), with higher thyroglobulin concentrations at lower iodine status: Low (<40 µg I/g Cr): Mean 8.0 (95% CI 6.2, 9.8) ng/ml. Medium 
(40-60 µg I/g Cr): Mean 6.6 (95% CI 5.3, 7.9) ng/ml. High (>60 µg I/g Cr): Mean 6.2 (95% CI 4.8, 7.5) ng/ml. No associations with plasma 
TSH or T4 were observed. 
Thyroid volume: In multiple regression analysis controlling for gender and weight there was a significant difference in thyroid volume 
between the three groups when categorising according to 24-hour iodide excretion (P=0.029) and when categorising according to I/Cr ratio 
(P=0.035), with larger thyroid volume at lower iodine status. Low (<40 µg/g Cr): mean 16.7 (95% CI 15.0, 18.4) ml. Medium (40-60 µg/g 
Cr): mean 14.5 (95% CI 13.3, 15.8) ml. High (>60 µg/g Cr): mean 12.2 (95% CI 11.3, 14.2) ml. No differences were observed when 
subjects were categorised according to UIC in µg/L. 
Comments  
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Torlinska et al. (2018) Iodine Status during Pregnancy in a Region of Mild-to-Moderate Iodine Deficiency is not Associated 
with Adverse Obstetric Outcomes; Results from the Avon Longitudinal Study of Parents and Children (ALSPAC), UK 
Study design Mother-and-child cohort 
Population, subjects ALSPAC recruited pregnant women from Avon county in South-Western UK, with expected dates of delivery April 1991 through December 
1992. Of 14,541 women enrolled, 13,988 had offspring surviving for at least 12 months. The current study was based on 3524 women with a 
singleton pregnancy who had a urinary I/Cr measure during pregnancy (already available from ongoing substudies examining maternal 
iodine status and child IQ at age 8 years). In addition, 46 women who had experienced pregnancy/infant loss up to the age of 1 year and 
who had an available antenatal urine sample were selected. Women with excessively high UIC (>500 mg/L) and/or high I/Cr ratio (>700 
mg/g) were excluded due to concern that the samples had been contaminated with iodine from urine test strips (child alive at 1 year: n=414, 
11.7%; pregnancy/infant loss n=5, 10.9%). If a woman had a later urine sample (with result that could be considered uncontaminated) that 
was used to replace the contaminated result (child alive at 1 year n=50; pregnancy/infant loss n=1). Those using thyroid hormone 
medication during pregnancy were excluded (child alive at 1 year n=20, 0.5%; pregnancy/infant loss, n=0). The resulting sample included in 
the analysis was 3140 women with a child alive at 1 year, and 42 women with a pregnancy/infant loss. Median age was 29 years 
(interquartile range 26-32) and similar in the two groups. Mean BMI was 22 kg/m2 and similar in the two groups. The distribution of ethnic 
background is not presented but it is stated with reference to the cohort profile paper (Fraser et al., Int J Epidemiol 2013) that the majority 
of ALSPAC participants were white and had indicators of high SES. 
Outcome measures Seven different adverse pregnancy outcomes: (i) hypertensive disorders in pregnancy; (ii) glucose derangement; (iii) anaemia; (iv) post-
partum haemorrhage; (v) preterm birth; (vi) mode of delivery; and (vii) birthweight. Details of obstetric outcomes were extracted from 
hospital records following delivery. Associations between I/Cr grouped in four categories and odds of each pregnancy outcome was examined 
in logistic regression, with the highest I/Cr (150–249 µg/g) as reference category. Adjustment was made for pre-pregnancy BMI, age, parity, 
cigarette smoking in early pregnancy, and trimester of urine sample. 
Time between exposure and 
outcome assessment 
Exposure assessed in early pregnancy (see details in “Exposure”), outcomes assessed later in pregnancy or at birth. 
Exposure assessment/ Dietary 
assessment 
Iodine status measured in spot urine samples, reported both as UIC (µg/L) and I/Cr ratio (µg/g). I/Cr ratio was categorised into: <50 µg/g, 
50-149.9 µg/g, 150-249.9 µg/g, and ≥250 µg/g, broadly speaking related to severely deficient, mildly-to-moderately deficient, sufficient, and 
more-than adequate iodine. For women with a repeat urine sample, the earliest available sample was used, as the authors postulated that 
impact of iodine status on pregnancy outcome is greatest in early pregnancy. 
Dietary data were not included. 
No. of subjects analysed n=3140 women with a child alive at 1 year, and n=42 women with a pregnancy/infant loss. 
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Torlinska et al. (2018) Iodine Status during Pregnancy in a Region of Mild-to-Moderate Iodine Deficiency is not Associated 
with Adverse Obstetric Outcomes; Results from the Avon Longitudinal Study of Parents and Children (ALSPAC), UK 
Results Median UIC was 95 (IQR 57-153) µg/L and median I/Cr was 124 (IQR 82-198) µg/g. No associations were found between iodine status and 
adverse pregnancy outcomes. 
Comments The study was underpowered to detect associations with rare outcomes (pregnancy and infant losses).  
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Wang et al. (2019) U-shaped relationship between iodine status and thyroid autoimmunity risk in adults, China 
Study design Cross-sectional study examining associations between iodine status and thyroid antibodies in adults. 
Population, subjects 2808 adult men and women recruited in Shanghai in 2016. 
Outcome measures Thyroid autoimmunity defined by the presence of positive thyroid peroxidase antibody (TPOAb) defined as TPOAb>34 IU/mL, or 
thyroglobulin antibody (TgAb) defined as TgAb>50 IU/mL, or thyroid autoimmunity (TAI) defined as a combination of positivity of one or 
both. 
Time between baseline 
exposure and outcome 
assessment 
None 
Exposure assessment/ Dietary 
assessment method 
Median UIC was 164.5 µg/L. UIC was divided into four groups: UIC<100 µg/L (deficient), UIC 100-199.9 µg/L (adequate), UIC 200-299.9 
µg/L (more than adequate), and UIC ≥ 300 µg/L (excess). The distribution of the different categories was 20.2% deficient, 44.6% 
adequate, 21.9% more than adequate, and 13.2% excessive. 




Follow-up period, drop-out 
rate 
 
Results No association for TPOAb or TgAb alone, but a U-shaped association between iodine status and TAI. Compared to individuals with UIC in 
the more than adequate range (200-299.9 µg/L), the adjusted odds of thyroid autoimmunity in those with UIC <100 µg/L was 1.50 
(95%CI 1.03, 2.17). The corresponding aOR was 1.50 (95%CI 1.09-2.07) in those with UIC in the adequate range (100-199 µg/L) and 
1.68 (95%CI 1.11-2.53) in those with excessive iodine (≥ 300 µg/L). 
Comments The associations were adjusted for age, sex, smoking, diabetes, BMI, hypertension and mutual adjustment for TPOAb and TgAb.  
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Zhou et al. (2019) Maternal iodine intake in pregnancy and childhood neurodevelopment at 18 months, Australia 
Study design Prospective cohort design 
Population, subjects Iodine intake (primary), UIC during pregnancy in 699 women with available data on outcome in children at 18 months in Adelaide, 
Australia. This population was categorised as mildly iodine deficient before mandatory bread- iodine fortification was implemented in 
2009, but at the time of this study, the population was iodine sufficient (median UIC was 186 µg/l (IQR 108–308 µg/L). The pregnant 
women were included between 2011 and 2013. 
Outcome measures Cognitive, language and motor skills assessed by the Bayley Scale of Infant Development (BSID) III. 
Time between baseline 
exposure and outcome 
assessment 
Main exposures were measured at wk 20 and 28 of pregnancy. BSID was measured at 19.5 months of age. I.e. approximately 22-24 
months between exposure and outcome  
Exposure assessment/ Dietary 
assessment method 
An iodine-specific FFQ measured twice in pregnancy (wk 20 and 28). Items with iodine 5% of the RDI were included. They also recorded 
table salt and iodine supplement use. Iodine from food and supplements were summed. The intake was averaged between the two time 
points and the difference in BSID scores were compared between the iodine intake quartiles. In addition, UIC was examined as the 
exposure. 




Follow-up period, drop-out 
rate 
24 months. > 90% of the mother-infant dyads could be included in the analyses. 
Results The relationship between iodine intake and BSID had an inverted U shape; those with the lowest and highest intakes had lower BSID 
scores and were at a higher risk of a BSID score of <85. In comparison to children born to mothers in the second quartile (reference 
group, intakes 220-316 µg/day), children of mothers with iodine intakes in the lowest quartile <220 µg/day had 4.3 points lower scores 
on cognitive, 6.3 points lower scores on language, and 3.5 lower scores on motor. The corresponding odds of low scores (Bayley III-
scores<85) for children of mothers in the lowest quartile was 2.8 (95%CI 1.3, 5.7) for cognitive, 2.4 (95%CI 0.9, 5.8) for language and 
2.2 (95%CI: 0.9, 5.2). There were no associations between UIC in pregnancy and the Bayley-III outcomes. 
Comments The study participants had in general adequate iodine intake and status. Several confounders were adjusted for including maternal IQ 
(WAIS), SES, Home stimulation environment, and pregnancy related factors.  
Study quality, A-C B 
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SI  
Author, year, study name Zhou et al. (2019) Maternal iodine intake in pregnancy and childhood neurodevelopment at 18 months, Australia. 
Exposure Iodine intake and UIC 
Dietary assessment method** A validated iodine food frequency questionnaire (I-FFQ) which included 44 food items and assessed intake over the previous month. 
The I-FFQ also asked participants whether they used salt in cooking or at the table and if the salt added was iodized salt. Iodine 
intake from supplements was calculated by multiplying the average daily number of tablets consumed and the level of iodine per 
tablet provided by the manufacturers. Iodine intake from foods and supplements was summed as iodine intake in pregnancy. 
Food composition database*** 
Definition of relevant nutrient**** 
The most up-to-date Australian food composition database, NUTTAB 2010 
Internal calibration (or validity) of 
dietary assessment (y/n) - if yes -  
provide data 
A validation study that showed a moderate correlation in iodine intake assessed using the I-FFQ and a 4-day weighed food record, 
with good reproducibility and a fair agreement in classifying adequate or inadequate iodine intake. 
Biomarker assay***** NA 
Analytical validity of biomarker data 
reported? (y/n) – if yes – provide 
data 
NA 
Time between biomarker sampling 
and analysis 
NA 
Season/ date when biomarker 
samples were drawn 
NA 
Background exposure data  
* write “nd” if there was no data reported. Please do not leave blank 
** please refer to brief name indicated in dietary assessment method table. If other method was used, please describe the detail 
*** specify database used to calculate nutrient intakes. Other nutrient analysis, please specify 
**** E.g. are carbohydrates expressed as available carbohydrates by difference, is fibre included in the carbohydrates or not, retinol equivalent or retinol activity etc. Chemical 
form of the nutrient 
***** ONLY biomarker of interest for outcome 
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ST36 Summary table iodine 
Reference details, first 
author, year, country 
Zimmermann et al. (2006) Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: a 
randomized, controlled, double-blind study, Albania 
Study design A double-blind randomised controlled intervention trial with iodine versus placebo and follow up for 24 weeks. 
Population, subjects Children (10-12 years) recruited in primary schools in Albania in an area with severe iodine deficiency (87% had goiter).  
Intervention group n=159, placebo n=151. 166 boys and 144 girls. Median UIC indicated moderate iodine deficiency (43 µg/L) while 87% 
had goiter, and nearly one-third had low concentrations of circulating TT4. 
Outcome measures Cognitive and motor performance tests at baseline and after 24 weeks (Raven’s Coloured Progressive Matrices (intelligence), Bead 
threading (fine motor), Rapid target marking, Digit span (short-term memory from WISC), Symbol search (visual from WISC), Coding 
(from WISC), and Rapid object naming (speed/time at which a child is able to name a series of familiar objects)). 
Time between baseline 
exposure and outcome 
assessment 
24 weeks 
Exposure assessment/ Dietary 
assessment method 
Urinary iodine concentration, thyroid volume, TSH, total thyroxine TT4 (hypothyroxinemia) measured at baseline and at the time of 
outcome. 
No. of subjects analysed 159 in the intervention group, 151 in the control group. 
Intervention A 400 mg iodine as iodized poppy seed oil capsule vs. placebo sunflower-oil capsules (swallowed with water under direct supervision). 
Follow-up period, drop-out 
rate 
24 weeks, dropout: 6 children (1.9 %), 4 in the I group and 2 in the placebo group. 
Results The iodine intervention group significantly improved performance (adjusted treatment effect (95%CI)) on 4 of the 7 tests; Raven’s 
Coloured Progressive Matrices (4.7 (95%CI: 3.8, 5.8) points), Rapid target marking (2.8 (95%CI: 1.4, 4.0) points), Symbol search (2.8 
(95%CI: 1.9, 3.6) points), and Rapid object naming (4.5 (95%CI: 2.3, 6.6) points).  
Comments The results showed improvement on some cognitive tests, but no improvement on test relying on working memory.  
Study quality, A-C B 
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Appendix IV – Exposure – 
supplementary methodological 
information 
This appendix describes the approaches to exposure estimates and scenarios presented in 
chapter 7. The mixed models approach for exposure estimates is detailed, and some simple 
comparisons between the three different methods for calculating exposure estimates; 
observed individual means (OIMs), mixed models approach (MM) and Monte Carlo risk 
assessment (MCRA) is presented. 
Details about the MM-method 
The main goal of a chronic intake calculation is to arrive at some characterisation of the 
long-term mean intake for many individuals. Classical approaches to intake analysis and 
exposure estimation usually consists of summary statistics (mean, percentiles, median etc.) 
on observed individual means (OIM); i.e. the means of intake for each individual in the 
survey. The standard error, i.e. a measure of the accuracy with which we can estimate all 
these individual means, is inversely related to the number of days from which we have 
intakes (se = sd/sqrt(n_days)). Firstly, this implies that, regardless of methodology, a lower 
number of days will lead to an overestimation of the variation between individuals, since 
there will be much more noise in the calculation of the means for each individual. Secondly, 
since most intake distributions have long upper tails (i.e. they are bounded by 0, and the 
distribution is highly skewed), using OIMs will particularly lead to an overestimation of the 
upper intake percentiles. 
In this report we also apply generalised linear mixed models (MM) and use them to simulate 
long-term exposures and implement scenarios. In addition to directly addressing the problem 
with overestimation of outer (and particularly upper) percentiles compared to OIMs, there 
are several other benefits of using mixed models to analyse individual level exposures: 1) 
MM allows for a flexible decomposition of variance, 2) MM can take into account covariance 
of variables (e.g. for daily iodine intake and bread consumption) in a multivariate model, 3) 
MM can easily be used to correct for (part of) the bias in the survey. In our approach the 
data for the models is the individual level daily intakes of iodine and bread.   
Flexible decomposition of variance – not all subgroups vary in the same 
way 
In contrast to OIMs a statistical model of daily exposures can also decompose variability in 
selected subgroups. For instance, we can define the model structure such that males and 
females exhibit different levels of variability within individuals. This is of particular 
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importance when interested in the exposure of high-risk sub-groups; they might not only 
differ in the mean exposure compared to the whole population, but also exhibit a different 
level of variability. For iodine intake in the Norkost 3 survey this holds; women do not only 
get less iodine through their diet, but there is also a much lower level of variability between 
individual women. A mixed model is especially applicable for data with repeated 
observations, which survey data is. Explicitly estimating the between individual variability and 
the between day variability within individuals yields more robust inferences on the long-term 
exposures in which we wish to factor out daily variability, but keep variability between 
individuals. 
Multivariate models – bread and iodine intake are correlated 
In addition to decompose variability in a mixed model, a multivariate model can also be 
constructed - a model with more than one response variable. Such multivariate analyses is 
especially important for iodization of salt in bread, as there can be a correlation between 
iodine intake and bread consumption. In case of implementing measures it is of crucial 
importance to assess the degree to which a particular measure will reach the intended sub-
group. In all surveys analysed in this benefit and risk assessment (except for 4-year-old 
boys), there is a positive correlation between intake of bread (and thus salt in bread) and 
intake of iodine. This means that individuals with low iodine levels also have a low intake of 
salt and thus the effect of iodization will to a large degree only increase intake in those with 
already high intakes of iodine. This positive correlation/covariance is exactly what we find in 
all our models and is accounted for in all MM scenarios. Without such accounting the effect 
of iodization of salt in bread would be overestimated. 
Using a MM for exposures and scenarios - correcting for bias in survey 
respondents 
When constructing the statistical models, we have included predictors (i.e. fixed effects) sex, 
age and level of education (for Norkost 3), and only sex (Ungkost 3: 4- ,9- and 13-year-
olds). Therefore, we can also correct for some of the biases in the survey.  
Exposure estimates are performed as simulations; essentially we draw a large number of 
‘individuals’ of different ages, levels of education and sex, and for each of these individuals 
we draw a large number of individual days of intake of iodine (and bread). For each of these 
individuals we then calculate a mean iodine intake which, over many individuals, is our 
estimated population level exposure. 
For Norkost 3 we directly estimated the effect of age on the intake of both iodine and bread. 
When simulating exposures we used a different age-distribution when sampling the 
population level exposure from the fitted model. In other words, instead of sampling the age 
of the focal individual from the Norkost 3 recipients, we sampled the age of this individual 
from the age-distribution of Norwegians in general. Our estimates are therefore more likely 
to fit the general population, rather than to describe the intake of the particular group that 
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was part of the survey. We also corrected for level of education in the Norkost 3 survey, 
which also has an effect on both bread consumption and iodine intake. 
Our use of MM here consisted of two steps. First, we constructed a suitably parameterised 
model for the exposures and then we used Monte Carlo sampling/simulation to draw 
exposures from the fitted model. Assumptions on the intake of household salt enters when 
using the models to evaluate the scenarios. This is in principle similar to some of the parts of 
MCRA (Monte Carlo Risk Assessment-tool) from the Netherlands National Institute for Public 
Health and the Environment (RIVM) (van der Voet et al., 2015). However, the models in 
MCRA does not allow for the more complex nesting of individual level effects within sexes, 
i.e. allowing males to have a different level of variation than females. Nor does MCRA allow 
for multivariate analysis necessary for properly including correlation of iodine and salt intake. 
Results from MCRA is therefore only shown for Norkost 3, estimated iodine intake for women 
of childbearing age (18-45 years), see Table IV-1 and also for comparison of the three 
exposure methods used in this benefit and risk assessment. 
Household salt consumption 
None of the surveys have reliable data on use of household salt. We therefore estimated the 
long-term intake of salt based on data from Tromsø 7 (see section 7.2.1). For all the 
scenarios and for all simulated individuals we drew household salt consumption as detailed in 
Table 7.2.1-1. We do not have any information about the potential covariance between 
household salt usage and intake estimates and assume they are independent. 
Model setup for iodine or bread/salt in bread intake 
Data in this section refer to intakes (either iodine or bread/salt in bread) for a given 
individual for a given day. We have no individual level data for household salt intake.  
For Norkost 3 we have 1767 individuals whose diet is coded for two days, giving multiple 
observations (one per day) for two variables (iodine intake and bread/ salt intake from 
bread). The fixed predictors included were sex, level of education (binary: more or less than 
13 years of schooling) and age. The logarithm of exposure is denoted with yij  (for individual 
i, on day j). Explanatory variables (sex, age, education) are denoted by xil.. Random effects 
are incorporated in a design matrix Z, where membership in the groups for which the 
random effects are calculated is coded. The exposure is log-transformed to improve the 
estimation of the parameters and since exposures are bounded by 0 (but the log is 
unbounded). In our case the link function is the identity. The basic model is 
𝑌 = 𝑋𝛽 + 𝑍𝑏 + 𝜀 
Where Y, X and Z, is the matrices of exposures (composed of all yij’s), the fixed effects 
design matrix (composed of all xij’s) and the random effects design matrix (composed of 
coded membership in groups), respectively. The simplest mixed model would be one with no 
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predictors and only one group of random effects. In such a case the log exposures are 
modelled as 
𝑦𝑖𝑗 = 𝛽1 + 𝑏𝑖 + 𝜀𝑗 
Thus the observed log exposure yij, of individual i on day j, is a sum of the overall mean (β1), 
this particular individual’s deviation from the mean (𝑏𝑖), and a residual term capturing the 
deviation for this particular day. All b’s are assumed to come from a normal distribution with 
mean 0 and variance σ1, and similarly all 𝜀𝑗 are assumed to come from a different normal 
distribution with mean 0 and variance σ2.  
To apply Monte Carlo sampling on such a model we would draw a ‘new’ individual level 
deviation (𝑏𝑛𝑒𝑤) from N(0, σ1), and several (say 365), daily deviations (𝜀𝑗) from a N(0, σ2). 
Then we back-transform these 365 daily exposures to the original scale and calculate the 
mean. This is the long-term exposure from one unobserved individual. This is repeated a 
large number of times to get a distribution of exposures. If this is performed in a Bayesian 
setting then formally these posterior predictive numbers correspond to the estimated 
probability distribution of exposure in the population given the original data, the priors and 
the structure of the model.  
For the models applied herein, both the random effects (i.e. between-individual variability) 
as well as the residuals (i.e. the day-to-day variation within individuals) were assumed 
different between the sexes. In other words, we directly estimated the degree to which 
males and females vary between days and between individuals independently. In 
multivariate models, where two or more intakes or exposures are modelled in concert, the 
covariance in the between-individual variability can be estimated independently for males 
and females. This captures the degree to which individuals with a high intake of iodine also 
have a high intake of salt from bread-products. Characterising this covariance is crucial for 
generating robust fortification scenarios. For all models, four different sets of priors were 
designed to test for prior-dependence, but both fitted parameters and simulated exposures 
were almost identical between priors, indicating strong signal from the data.  
These mixed models were all implemented in the computing environment R, using the 
Bayesian MCMCglmm package (Hadfield, 2010). Code to conduct the analysis is available 
upon request  
The model detailed above is in structure relatively similar to the main component of the 
MCRA tool developed by the Netherlands National Institute for Public Health and the 
Environment (RIVM) (van der Voet et al., 2015). However, more customisable approaches 
are readily available when using the R environment. For instance, a MM-model can easily be 
defined to estimate both individual differences and day-to-day difference in iodine exposure 
to be different for females and males.  
We applied statistical modelling of iodine and salt from bread using data from Norkost 3 and 
Ungkost 3.  
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Models 
For each survey we constructed eight models: iodine intakes with or without supplements 
combined with four different types of priors for the covariance structure to check for 
sensitivity of the prior. Priors for fixed effects were defaults (wide normal distributions 
centered on 0). All models response variables were iodine intake and salt from bread 
consumption (using 1.1 g salt per 100 g bread). Response variables were logged before 
analysis, and thus impacts are proportional.  
Data 
As detailed above, the raw data for these modelling exercises is the coded diets from the 
National Dietary Surveys listed above, together with the newly established concentrations of 
iodine in Norwegian Food Composition Table. For each individual-day in the surveys, the 
intake of iodine was calculated. Additionally, we extracted the consumption of bread-
products and assumed an average salt concentration of bread product to be 1.1 g salt per 
100 g bread. Covariates of sex, age and level of education were also extracted.  
Software/ statistical environment 
Performed using the MCMCglmm package (version 2.26) in Rstudio, running R version 3.5.2. 
Custom made functions were defined to simulate exposures.  
Model results 
Note that the intakes discussed here correspond to daily intakes. Long-term intakes are 
higher, since the day-to-day variability is modelled on the log-scale. Long-term intakes and 
scenarios are presented in the next section. 
Norkost 3:  
The four different priors for the variance components had negligible effects on parameter 
estimates and are not further discussed.  
For daily intakes, men have approximately a 25% higher intake of iodine than women 
(impact of being male on a log scale: 0.25 (0.19-0.31, credibility interval)). Men have about 
48% (42-53%) higher daily intake of salt from bread. While iodine intake increases with age 
for adults (0.7% increase per year, 0.5-0.9), salt intake from bread decreases (-0.6% per 
year, -0.7 to -0.3%). Individuals with low level of education (i.e. < 3 years of higher 
education), have a lower (but uncertain) daily intake of iodine (-4%, -12% - 1%), and a 
higher intake of salt through bread (6%, 0.1-10%). Men vary more between individuals in 
iodine intake but vary less in salt (on a log scale). Both men and women with high intake of 
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4-year-old girls had about 10% (2-20%) lower daily iodine intake than boys, and about 20% 
(11-28%) lower intake of salt from bread. For 9-year-olds, girls had about 17% (9-27%) 
lower iodine intake and 20% (12-27%) lower salt intake from bread. 13-year-old girls had 
17% lower daily intake of iodine (8-27%) and 24% (17-30%) lower intake of salt from 
bread. In general boys varied more between individuals, and for all except 4-year-old girls, 
there was a positive covariance between iodine intake and bread intake. 
Model-based exposure (Monte Carlo Risk Assessment software) 
The web-based Monte Carlo Risk Assessment software (MCRA 8.2) was employed to 
estimate the dietary exposure of iodine in food for women between the ages of 18 to 45 in 
Norway. MCRA was run on this population subsets with gender as cofactor and age as a 
covariate. A custom exposure model was fitted using logistic normal-normal with a 
logarithmic transformation. The MCRA was run using the earlier version of the AE database, 
for which the iodine concentrations in coffee and whey cheese were different, and the 
numbers are therefore not comparable to the ones presented in the main text in chapter 6. 
The reason for presenting them here is to show that the exposure estimates are almost 
identical between the MCRA model and our R based MM-method. The distribution of daily 
iodine exposures is presented in Figure IV-1, and the exposure estimates from MCRA are 
presented in Table IV-1 below. 
 
Figure IV-1 MCRA-model output showing frequency distribution of daily iodine exposures in women 
between the ages of 18 to 45 in Norway.  
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Comparing the estimates from OIMs, MM and MCRA 
Exposure estimates for women of childbearing age (18-45 years) were performed using the 
MM-method, means of survey days (OIMs) and MCRA, and relevant statistics are presented 
in Table IV-1. As expected, both the lower and upper tails are less extreme with model-
based estimates. The differences between MCRA estimates and MM estimates are minor, 
showing that the outcome of our tailor-made R models are in line with a more established 
software. 
The comparisons below was using the early version of the AE database, for which the iodine 
concentrations in coffee and whey cheese were slightly different, and the numbers are 
therefore not identical or comparable to the ones presented in the main text in chapter 6. 
The reason for presenting them here is to show that the exposure estimates are almost 
identical between the MCRA model and our R based MM-method. Furthermore, we wanted 
to show the differences between these two models and the OIMs estimates.  
Table IV-1 Iodine exposures in Norwegian women 18-45 years (n=466) based on tree different 
methods (OIMs, MM and MCRA 8.2 software,), using an earlier version of the AE database, µg/day. 
Method Mean P5 P10 P20 P25 P30 P40 P50 P75 P95 
OIM 164 48 59 78 86 95 111 129 207 415 
MM 160 83 94 111 118 124 137 150 191 280 
MCRA 164 87 99 116 122 129 142 155 195 273 
 
Comparing MM-method with MCRA 
The software MCRA was utilised for a preliminary comparison of our mixed-model (MM) 
approach with a more established model. The structure of the main modelling part in MCRA 
is also a mixed model, almost identical to the one we present in this report. However, the 
crucial difference is that MCRA does not allow for a multivariate analysis, i.e. fitting a model 
with both intake of iodine and bread (or salt in bread) as a function of age, sex etc. 
Additionally, MCRA does not allow for decomposing the variability between individuals and/or 
days to be different between the sexes. 
Comparing OIMs with the model based approaches 
Using two datapoints (i.e. the two days in Norkost) to estimate an individual mean will give 
an overestimation of the lower and upper percentiles across individuals, simply because the 
error with which we can estimate the ‘true’ mean intake for any given individual scales with 
the inverse square-root of the number of days. Figure IV-2 illustrates this by using the fitted 
model for Norkost 3. Using the MM-approach, we simulated iodine intake for 1, 2, 5, 10, 50 
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and 365 days, for 1787 individuals (corresponding to number of participants in Norkost 3). 
To chart the variability, for each number of days, one thousand replicates of these 1787 
individuals were simulated. The main purpose of this exercise is to show that the MM-model 
generates data commensurate with the underlying daily intake data. 
The shaded regions show the range of possible percentiles across these replicates and the 
cross indicates the percentile of the first day in Norkost or the OIMs of the two days. These 
simulations were not corrected for age, sex and education, so as to mimic the underlying 
data as much as possible. The upper most grey regions show the range of 95-percentiles 
using the model and the crosses indicate the 95-percentile of iodine intake for the first day 
(at Days sampled = 1) and the 95-percentile for the OIMs. The middle shaded regions 
denote the range of medians from the simulations, and the lower regions the 5-percentile. 
Simulating intakes for 1 and (mean of) 2 days generate exposure distributions that overlap 
with the observed data (crosses), except for a slight underestimation of the upper tail of the 
intakes for any single day. At 365 days the short horisontal black line indicate the percentile 
when sampling a very large (100 000) number of individuals.  
 
Figure IV-2 Simulated mean intakes over 1, 2, 4, 10, 50 and 365 days for 1787 individuals as in 
Norkost 3. The grey lines indicate the range of percentiles across 1000 replicated simulations, 
uppermost 95-percentile, mid – median and lower ones 5- percentiles. Black crosses indicate the 5, 50 
and 95% persentiles for 1 day or the mean of the 2 days of Norkost. The range of the simulations for 
1 and 2 days encompass the observed data, except for the 95-persentile for 1 day intake. The black 
lines at x=365 indicate the 5, 50 and 95-persentiles for the mean intake of 100 000 individuals over 
365 simulated days. 
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Increasing the number of simulated days shows that the range of iodine intakes becomes 
narrower, as the upper percentiles are decreasing, and lower percentile increasing towards 
the right in Figure IV-2. This indicates that the primary reason for the difference between 
OIMs and MM-method exposure estimates is due to an appropriate decomposition of and 
correction of variability to suitably estimate usual intakes, and simulating intakes for much 
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Appendix V – Exposure - additional 
estimates 
In this appendix we have presented some data that are not presented in chapter 6. I.e. 
exposures based on observed means of survey days (OIMs) for adults and adolescents from 
Norkost 3 and Ungkost 3, and exposure estimates and scenarios for food supplement users 
(users only). 
Exposures based on means of survey days (OIMs) 
The iodine exposures based on means of survey days (OIMs) from Norkost 3 and Ungkost 3 
are presented in Table V-1. Data for 1- and 2-year-olds are based on FFQ, and data are 
presented in Table 7.3.2-1. 
Table V-1 Iodine exposures calculated from reported food intake (without iodine supplements) 
from means of survey days in the national dietary surveys in different age groups, mean and 
percentiles (µg/day), and percentage of participants over AR/EAR and under UL. Iodine intake 
(µg/day) – observed individual means (OIMs). 
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103 43 95 193,49 47 78 100 
1 EAR depending on age group, see table 4.3-1. 
2 UL depending on age group, see table 4.3.1. 
Exposures and scenarios for food supplement users (users only) 
The iodine content in regular food supplements used in  Norkost 3 range from 25 to 150 µg 
per dose, but most iodine supplements contain 150 µg iodine per recommended daily dose. 
In Norkost 3, 16% (n=145) of the women reported use of iodine supplements with a mean 
iodine contribution of 95 µg/day. Among women between 18-45 years of age, a total of 17% 
(n=77) reported use of iodine supplements, with at mean iodine contribution of 96 µg/day. 
Similarly, 11% (n=92) of the men reported use of iodine supplements with a mean iodine 
contribution of 117 µg/day.  
In 13-year-olds in Ungkost 3, 4% of the girls (n=14) and 3% (n=9) of the boys reported to 
use iodine supplements. In 9-year-olds, 4% of the girls (n=13) and 2% (n=6) of the boys 
reported to use iodine supplements. In 4-year-olds, 4% of the girls (n=8) and 5% (n=12) of 
the boys reported to use iodine supplements. 
In Småbarnskost 3, 10% of the 2-year-olds reported to use iodine supplements. 
In Spedkost-07, there were no reported use of iodine supplements among the 1-year-old 
children.  
Iodine exposure estimates for adult food supplements users and the scenarios are presented 
in Table V-2 and Figure V-1. 
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Tabel V-2 Iodine exposure estimates (current intake level and scenarios MM-method) for adults 
supplement users (users only). 

















236 175 233 304 100 100 
Salt15 Men,  
18-70y 
324 207 315 472 100 99 
Women, 
18-70y 
260 194 257 337 100 100 
Women, 
18-45y 
247 188 244 315 100 100 
Bread 15 Men,  
18-70y 
347 224 338 502 100 98 
Women, 
18-70y 
274 203 270 355 100 100 
Women, 
18-45y 





363 240 354 518 100 98 
Women, 
18-70y 
285 215 281 366 100 100 
Women, 
18-45y 
273 209 270 347 100 100 
Salt20 Men,  
18-70y 
330 212 322 477 100 99 
Women, 
18-70y 
264 199 260 341 100 100 
Women, 
18-45y 
251 191 248 319 100 100 
Bread20 Men,  
18-70y 
362 234 352 519 100 98 
Women, 
18-70y 
282 211 278 366 100 100 
Women, 
18-45y 





383 255 373 540 100 98 
Women, 
18-70y 
297 226 293 382 100 100 
Women, 
18-45y 
285 218 282 363 100 100 
Salt25 Men,  
18-70y 
336 218 327 482 100 99 
 
 
VKM Report 2020: 05  301 






268 203 264 345 100 100 
Women, 
18-45y 
255 195 252 323 100 100 
Bread25 Men,  
18-70y 
375 244 365 537 100 98 
Women, 
18-70y 
290 216 286 377 100 100 
Women, 
18-45y 





401 270 391 563 100 97 
Women, 
18-70y 
309 236 305 396 100 100 
Women, 
18-45y 
298 228 294 379 100 100 
Salt50 Men,  
18-70y 
362 244 353 509 100 98 
Women, 
18-70y 
287 222 283 364 100 100 
Women, 
18-45y 
274 214 271 342 100 100 
Bread50 Men,  
18-70y 
440 288 427 633 100 93 
Women, 
18-70y 
332 245 326 438 100 100 
Women, 
18-45y 





492 341 480 686 100 87 
Women, 
18-70y 
370 283 364 476 100 100 
Women, 
18-45y 
360 276 354 463 100 100 
 
Iodine exposure estimates for 2-year-olds food supplements users (users only) and the 
scenarios are presented in Table V-3 and Figure V-2. 
Tabel V-3 Iodine exposure estimates (current intake level and scenarios) for 2-year-old supplement 
users (users only). 








237 125 224 420 100 37 
Girls,  
n=69 
221 99 219 365 100 38 
Salt15 Boys 
n=70 
246 134 233 429 100 34 
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230 108 228 374 100 30 
Bread15 Boys 
n=70 
259 145 254 450 100 24 
Girls,  
n=69 





268 154 263 459 100 21 
Girls,  
n=69 
248 129 244 401 100 25 
Salt20 Boys 
n=70 
249 137 236 432 100 30 
Girls,  
n=69 
233 111 231 377 100 29 
Bread20 Boys 
n=70 
266 150 263 460 100 23 
Girls,  
n=69 





278 162 275 472 100 21 
Girls,  
n=69 
258 140 252 411 100 20 
Salt25 Boys 
n=70 
252 140 239 435 100 29 
Girls,  
n=69 
236 114 234 380 100 28 
Bread25 Boys 
n=70 
273 156 270 469 100 21 
Girls,  
n=69 





288 171 285 484 100 16 
Girls,  
n=69 
267 152 260 422 100 16 
Salt50 Boys 
n=70 
267 155 254 450 100 20 
Girls,  
n=69 
251 129 249 395 100 22 
Bread50 Boys 
n=70 
310 183 300 498 100 10 
Girls,  
n=69 





340 213 330 528 100 3 
Girls,  
n=69 
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Figure V-1 Scenario estimates for iodization in adult males (blue lines), females (light red lines) and 
females 18-45 years old (dark red, almost indistinguishable from light red) when only using data for 
users of supplements. The three plots in the top row show total iodine intake (µg/day) if household 
salt, bread and both household salt and bread are iodized (0-50 mg iodine per kg salt). The curves 
represent the intakes in the 5th percentiles (lower dashed lines), median (full lines) and 95th 
percentile (upper dashed lines). The horisontal lines represent the age specific EAR (100 µg/day) and 
UL (600 µg/day) given in Table 4.3-1. The three plots in the middle row show percent of population 
group with iodine intakes above EAR (upper lines) and above UL (lower lines). The bottom plots show 
percentage of males and females with intakes both above EAR and below UL, and thus represent the 
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Figure V-2 Scenario estimates for iodization in 2-year-olds boys (blue lines) and girls (red lines) (with 
supplements – user only). The three plots in the top row show total iodine intake (µg/day) if 
household salt, bread and both household salt and bread are iodized (0-50 mg iodine per kg salt). The 
curves represent the intakes in the 5th percentiles (lower dashed lines), median (full lines) and 95th 
percentile (upper dashed lines). The horisontal lines represent the age specific EAR (65 µg/day) and 
UL (200 µg/day) given in Table 4.3-1. The three plots in the middle row show percent of population 
group with iodine intakes above EAR (upper lines) and above UL (lower lines). The bottom plots show 
percentage of boys and girls with intakes both above EAR and below UL, and thus represent the 
percentage of the target population deemed to be within the dietary reference values. Please note 
that these estimates are not modelled in the same manner as Norkost and Ungkost (Figures 7.4-1 
through 7.4-5), due to the nature of the underlying data (FFQ). 
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Appendix VI - Manuals for the QAT-tables for the various 
study designs 
Quality assessment tool for clinical studies 
Article reference 
Requires Yes for level  
A             B            C 
1. General questions and study design 
a) Research question/hypothesis clearly formulated? Yes         No         Can´t tell         NA x               x 
b) Was the study design suited to test the research hypothesis? Yes         No         Can´t tell         NA x               x 
c) Was the duration of the study suited to test the research hypothesis? Yes         No         Can´t tell         NA x 
d) Sample size and power calculations reported/ considered (relevant for the 
main outcome variable)? 
Yes         No         Can´t tell         NA x 
2. Participants and compliance 
a) Population (target group) well described and relevant (for VKM)? Yes         No         Can´t tell         NA x               x 
b) Sample (possible participants) reqruited in an acceptable way? Yes         No         Can´t tell         NA x               x 
c) Criteria for inclusion/exclusion clearly formulated and acceptable? Yes         No         Can´t tell         NA x 
d) Actual participants comparable with the relevant (target) population? Yes         No         Can´t tell         NA x 
e) Method of randomisation allocation stated and appropriate?   Yes         No         Can´t tell         NA x      
f) Was there an account of the comparability of groups with regard to relevant/ 
possible factors that might affect outcome? 
Yes         No         Can´t tell         NA x 
g) Compliance reported in an acceptable way? Compliance acceptable? Yes         No         Can´t tell         NA x           
h) Drop-out rate within an acceptable range? 6mo<30%, 12mo<40%, 
24mo<50% 
Yes         No         Can´t tell         NA x 
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Article reference 
Requires Yes for level  
A             B            C 
i) The drop-outs did not differ between the groups? Yes         No         Can´t tell         NA x 
3. Dietary intervention and assessment 
a) Intervention diets clearly defined and characterised (foods and nutrients)? Yes         No         Can´t tell         NA x               x 
b) Method used for dietary assessment valid/ adequately validated? Yes         No         Can´t tell         NA x 
c) Intervention diets consist of normal foods/ relevance to research question? Yes         No         Can´t tell         NA x 
d) Measurement errors in dietary reporting considered? Yes         No         Can´t tell         NA x 
e) Energy intake at credible level? Were the results adjusted for energy intake? Yes         No         Can´t tell         NA x               x 
c) Food composition database reported? Yes         No         Can´t tell         NA x                
4. Outcome, results and analysis 
a) Acceptable and clear definition of the outcome/ endpoint? Yes         No         Can´t tell         NA x               x             
b) Biological mechanism for endpoint plausible? Yes         No         Can´t tell         NA x               x        
c) Results analysed blind? Yes         No         Can´t tell         NA         
d) Attempts in the analysis phase made to adjust for imbalances between 
treatment arms with regard to important determinants for the outcome (e.g. 
through multivariate modelling)? 
Yes         No         Can´t tell         NA x  
e) Valid biomarkers used to study compliance with the dietary exposure Yes         No         Can´t tell         NA x if relevant 
f) Possible use of medication/ supplements taken into account? Yes         No         Can´t tell         NA x if relevant 
g) Between measurement variation minimised/ standardised? Yes         No         Can´t tell         NA  
h) Smallest effect clinically relevant/ reasonable? Yes         No         Can´t tell         NA  
i) No possible conflicts of interest affecting the study quality? Yes         No         Can´t tell         NA x 
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Quality assessment tool for prospective cohort studies 
Article reference Requires Yes for level  
A             B            C 
1. General questions and study design 
a) Research question clearly formulated? Yes         No         Can´t tell         NA x               x 
b) Outcome clearly defined? Yes         No         Can´t tell         NA x               x 
c) Was the study design suited to test the research hypothesis? Yes         No         Can´t tell         NA x               x 
2. Sampling (Ascertainment of cases and non-cases) 
a) Source population/study base well defined? Recruitment done in an 
acceptable way?   
Yes         No         Can´t tell         NA x               x               
b) Response rate reported and acceptable? Yes         No         Can´t tell         NA x 
c) Criteria for inclusion/exclusion clearly formulated and acceptable? Yes         No         Can´t tell         NA x               x                
d) Participants and non-participants comparable with Nordic population? Yes         No         Can´t tell         NA x 
e) Time period of baseline examinations clearly identified? Yes         No         Can´t tell         NA x 
f) Endpoint clearly ascertained and assessed in a valid way? Yes         No         Can´t tell         NA x               x 
g) Follow-up period clearly identified? Yes         No         Can´t tell         NA x 
h) Time-exposure-variable clearly defined (i.e., period non-cases being 
exposed)? 
Yes         No         Can´t tell         NA x 
i) Loss to follow up <20%? Yes         No         Can´t tell         NA x 
3. Dietary assessment 
a) Type of exposure (nutrients, food groups etc) reported in sufficient detail? Yes         No         Can´t tell         NA x               x 
b) Particulars of dietary assessment tool reported in sufficient detail? Yes         No         Can´t tell         NA x                
c) Food composition database reported? Yes         No         Can´t tell         NA x                
d) Concurrent validity (validation coefficients) of specific exposures reported? Yes         No         Can´t tell         NA x                
e) Associations between dietary exposures reported? Yes         No         Can´t tell         NA x                
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Article reference Requires Yes for level  
A             B            C 
f) Measurement errors in dietary reporting considered? Yes         No         Can´t tell         NA x               x             
g) Energy intake at credible level? Yes         No         Can´t tell         NA x               x        
h) Energy adjustment adequately done? Yes         No         Can´t tell         NA x  
i) Repeat assessment of diet during follow up? Yes         No         Can´t tell         NA x 
j) Use of dietary markers adequate? Details of assessment and handling 
reported? Valid biomarker assay? 
Yes         No         Can´t tell         NA x if relevant 
k) Time period between biomarker assessment and diagnosis acceptable? Yes         No         Can´t tell         NA x if relevant 
4. Anthropometry 
a) Assessment detailes clearly reported and assessment adequately performed? Yes         No         Can´t tell         NA x                
5. Physical activity 
a) Assessment detailes clearly reported and assessment adequately performed? Yes         No         Can´t tell         NA x                
6. Confounding 
a) Were important confounders identified/ascertained and considered by 
authors? 
Yes         No         Can´t tell         NA x               x 
b) The distribution of confounders similar in cases and non-cases? Yes         No         Can´t tell         NA x                
7. Statistical power 
a) Was the study power considered and sample size and power calculations 
reported? 
Yes         No         Can´t tell         NA X 
b) In view of multiple tests, were by chance findings considered? Yes         No         Can´t tell         NA x                
c) Sufficient size of study population and no. of outcomes/cases? Yes         No         Can´t tell         NA x                
8. Statistical analysis  
a) Appropriately handled? Yes         No         Can´t tell         NA x                
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Article reference Requires Yes for level  
A             B            C 
b) ) Relevant confounders adequately handled: Restriction, Stratified analysis, 
Multivariate modelling, Interaction tested? 
Yes         No         Can´t tell         NA x               x             
c) Ascertainment/detection bias considered (e.g. cases detected due to 
screening)? 
Yes         No         Can´t tell         NA x                
d) Cases detected early during the follow-up period removed?  Yes         No         Can´t tell         NA x               x 
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Quality assessment tool for cross-sectional studies 
Article reference Requires Yes for level  
A             B            C 
1. General questions and study design 
a) Research question clearly formulated? Yes         No         Can´t tell         NA x               x 
b) Outcome clearly defined? Yes         No         Can´t tell         NA x               x 
2. Recruitment/ Participation 
a) Source population well defined and recruitment done in an acceptable way?   Yes         No         Can´t tell         NA x                
b) Participation rate acceptable (>50%)? Yes         No         Can´t tell         NA x 
c) Criteria for inclusion/exclusion clearly formulated and acceptable? Yes         No         Can´t tell         NA x                
d) Were the participants with primary outcome adequately 
identified/diagnosed? 
Yes         No         Can´t tell         NA x 
e) Are the differences in outcome between groups relevant? Yes         No         Can´t tell         NA x 
f) Are the participants comparable with relevant (target) Nordic population? Yes         No         Can´t tell         NA x               x 
3. Dietary assessment 
a) Method used for dietary assessment adequate and valid? Yes         No         Can´t tell         NA x               x 
b) Diets/nutrients studied clearly defined and characterised? Yes         No         Can´t tell         NA x                
c) Energy intake at credible level? Yes         No         Can´t tell         NA x               x 
d) Energy adjustment adequately done? Yes         No         Can´t tell         NA x  
e) Use of biomarkers adequate? Yes         No         Can´t tell         NA x if relevant                
f) Results adjusted for mis/underreporting? Yes         No         Can´t tell         NA x               x 
g) Possible drug usage taken into account Yes         No         Can´t tell         NA x 
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Article reference Requires Yes for level  
A             B            C 
a) Were important confounders identified/ascertained and considered by 
authors? 
Yes         No         Can´t tell         NA x               x 
b) Relevant confounders adequately handled: restriction, stratified analyses, 
multivariate modelling, interaction tested? 
Yes         No         Can´t tell         NA x               x 
5. Anthropometry 
a) Assessment detailes clearly reported and assessment adequately performed? Yes         No         Can´t tell         NA x if relevant                
6. Physical activity 
a) Assessment detailes clearly reported and assessment adequately performed? Yes         No         Can´t tell         NA x if relevant                
7. Statistical power 
a) Was the study power considered and sample size and power calculations 
reported? 
Yes         No         Can´t tell         NA x 
8. Analysis  
a) Was the statistical method adequate  Yes         No         Can´t tell         NA x               x 
b) No possible conflicts of interest affecting the study quality? Yes         No         Can´t tell         NA x 
9. Summary of the study quality A                  B                 C   
A   The results from studies that have an acceptably low level of bias are considered valid. These studies adhere mostly to the commonly held concepts of high quality including 
the following: a comprehensive study design; clear description of the participants, setting, interventions, and control group(s); appropriate measurement of outcomes; 
appropriate statistical and analytical methods and reporting; no reporting errors; less than 30% percent dropout (depending on the length of the study see the QAT for clinical 
studies) or over 50% participation rate for prospective cohort studies; clear reporting of dropouts; and no obvious bias. Where appropriate, studies must provide a valid 
estimation of contaminant exposure, from assessments and/or biomarkers with a reasonable range of measurement error, and justification for approaches to control for 
confounding in the design and analyses.  
B   Studies may have some bias, but not sufficient to invalidate the results. They do not meet all the criteria in category “A”, they have some deficiencies but none likely to 
cause major bias. The study may be missing information, making it difficult to assess limitations and potential problems.  
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C   Studies have significant bias that may invalidate the results. These studies have serious errors in design, analysis, or reporting; there are large amounts of missing 
information, or discrepancies in reporting.  
